CN101821289A - 重组制造抗rsv抗体的方法 - Google Patents
重组制造抗rsv抗体的方法 Download PDFInfo
- Publication number
- CN101821289A CN101821289A CN200880106131A CN200880106131A CN101821289A CN 101821289 A CN101821289 A CN 101821289A CN 200880106131 A CN200880106131 A CN 200880106131A CN 200880106131 A CN200880106131 A CN 200880106131A CN 101821289 A CN101821289 A CN 101821289A
- Authority
- CN
- China
- Prior art keywords
- ser
- clone
- gly
- val
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 66
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 33
- 239000000203 mixture Substances 0.000 claims abstract description 70
- 230000010354 integration Effects 0.000 claims abstract description 43
- 238000001890 transfection Methods 0.000 claims abstract description 43
- 239000013604 expression vector Substances 0.000 claims abstract description 34
- 210000004027 cell Anatomy 0.000 claims description 282
- 108090000623 proteins and genes Proteins 0.000 claims description 92
- 102000004169 proteins and genes Human genes 0.000 claims description 45
- 239000003550 marker Substances 0.000 claims description 19
- 241000699802 Cricetulus griseus Species 0.000 claims description 11
- 210000001672 ovary Anatomy 0.000 claims description 11
- 238000010367 cloning Methods 0.000 claims description 10
- 210000005260 human cell Anatomy 0.000 claims description 6
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims description 5
- 108091006027 G proteins Proteins 0.000 claims description 5
- 102000030782 GTP binding Human genes 0.000 claims description 5
- 108091000058 GTP-Binding Proteins 0.000 claims description 5
- 241000233866 Fungi Species 0.000 claims description 4
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 4
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 4
- 201000000050 myeloid neoplasm Diseases 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 238000012790 confirmation Methods 0.000 claims description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 abstract description 19
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 4
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 241000282414 Homo sapiens Species 0.000 description 704
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 526
- 108020004414 DNA Proteins 0.000 description 147
- 102220023256 rs387907547 Human genes 0.000 description 101
- 102220023258 rs387907548 Human genes 0.000 description 99
- 102220369447 c.1352G>A Human genes 0.000 description 55
- 102220369446 c.1274G>A Human genes 0.000 description 52
- 239000000427 antigen Substances 0.000 description 47
- 108091007433 antigens Proteins 0.000 description 47
- 102000036639 antigens Human genes 0.000 description 47
- 102220369445 c.668T>C Human genes 0.000 description 45
- 235000018102 proteins Nutrition 0.000 description 38
- 239000000523 sample Substances 0.000 description 27
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 21
- 108090000765 processed proteins & peptides Proteins 0.000 description 21
- 238000002965 ELISA Methods 0.000 description 20
- 150000001413 amino acids Chemical class 0.000 description 19
- 239000002773 nucleotide Substances 0.000 description 19
- 125000003729 nucleotide group Chemical group 0.000 description 19
- 230000001580 bacterial effect Effects 0.000 description 17
- 239000012634 fragment Substances 0.000 description 17
- 230000003612 virological effect Effects 0.000 description 17
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 16
- 241000699666 Mus <mouse, genus> Species 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 210000002966 serum Anatomy 0.000 description 15
- 108060003951 Immunoglobulin Proteins 0.000 description 14
- 102000018358 immunoglobulin Human genes 0.000 description 14
- 238000006386 neutralization reaction Methods 0.000 description 14
- 229920001184 polypeptide Polymers 0.000 description 14
- 102000004196 processed proteins & peptides Human genes 0.000 description 14
- 229960000402 palivizumab Drugs 0.000 description 13
- 102220023257 rs387907546 Human genes 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 12
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 11
- 102000039446 nucleic acids Human genes 0.000 description 11
- 108020004707 nucleic acids Proteins 0.000 description 11
- 238000011160 research Methods 0.000 description 11
- 238000003757 reverse transcription PCR Methods 0.000 description 11
- 101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 description 10
- 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 238000004587 chromatography analysis Methods 0.000 description 10
- 238000010790 dilution Methods 0.000 description 10
- 239000012895 dilution Substances 0.000 description 10
- 230000012010 growth Effects 0.000 description 10
- 102220004457 rs11567847 Human genes 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 10
- 206010061603 Respiratory syncytial virus infection Diseases 0.000 description 9
- 108091023040 Transcription factor Proteins 0.000 description 9
- 102000040945 Transcription factor Human genes 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- 241000725643 Respiratory syncytial virus Species 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 230000008014 freezing Effects 0.000 description 8
- 238000007710 freezing Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 230000002103 transcriptional effect Effects 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 241000124008 Mammalia Species 0.000 description 7
- 241000700605 Viruses Species 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 238000013411 master cell bank Methods 0.000 description 7
- 230000008488 polyadenylation Effects 0.000 description 7
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 101000619564 Homo sapiens Putative testis-specific prion protein Proteins 0.000 description 6
- 102100022208 Putative testis-specific prion protein Human genes 0.000 description 6
- 229910021529 ammonia Inorganic materials 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000000295 complement effect Effects 0.000 description 6
- 210000004962 mammalian cell Anatomy 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 241000283707 Capra Species 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 101710120037 Toxin CcdB Proteins 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000012228 culture supernatant Substances 0.000 description 5
- 238000004949 mass spectrometry Methods 0.000 description 5
- 239000000902 placebo Substances 0.000 description 5
- 229940068196 placebo Drugs 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 230000014616 translation Effects 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 4
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 4
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- -1 acyl ammonia Chemical compound 0.000 description 4
- 230000006978 adaptation Effects 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 239000013613 expression plasmid Substances 0.000 description 4
- 239000005090 green fluorescent protein Substances 0.000 description 4
- 230000028993 immune response Effects 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 238000005342 ion exchange Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002777 nucleoside Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 108010077544 Chromatin Proteins 0.000 description 3
- 102100024746 Dihydrofolate reductase Human genes 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 241000701024 Human betaherpesvirus 5 Species 0.000 description 3
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 3
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 3
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 3
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 3
- 102000018120 Recombinases Human genes 0.000 description 3
- 108010091086 Recombinases Proteins 0.000 description 3
- 229910002091 carbon monoxide Inorganic materials 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 210000003483 chromatin Anatomy 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 108020001096 dihydrofolate reductase Proteins 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 102000005396 glutamine synthetase Human genes 0.000 description 3
- 108020002326 glutamine synthetase Proteins 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 210000000688 human artificial chromosome Anatomy 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000004255 ion exchange chromatography Methods 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 125000003835 nucleoside group Chemical group 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 210000004180 plasmocyte Anatomy 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 241000701161 unidentified adenovirus Species 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 2
- OXEUETBFKVCRNP-UHFFFAOYSA-N 9-ethyl-3-carbazolamine Chemical compound NC1=CC=C2N(CC)C3=CC=CC=C3C2=C1 OXEUETBFKVCRNP-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 2
- 238000011725 BALB/c mouse Methods 0.000 description 2
- 101150074155 DHFR gene Proteins 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 102100020997 Fractalkine Human genes 0.000 description 2
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 2
- 101000854520 Homo sapiens Fractalkine Proteins 0.000 description 2
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
- 102000003792 Metallothionein Human genes 0.000 description 2
- 108090000157 Metallothionein Proteins 0.000 description 2
- 102000010292 Peptide Elongation Factor 1 Human genes 0.000 description 2
- 108010077524 Peptide Elongation Factor 1 Proteins 0.000 description 2
- 101710197208 Regulatory protein cro Proteins 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 108010075344 Tryptophan synthase Proteins 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 210000001106 artificial yeast chromosome Anatomy 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000003399 chemotactic effect Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000001641 gel filtration chromatography Methods 0.000 description 2
- 238000001114 immunoprecipitation Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 2
- 210000000867 larynx Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 210000003720 plasmablast Anatomy 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000008521 reorganization Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 210000003705 ribosome Anatomy 0.000 description 2
- 238000003153 stable transfection Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- 229940036185 synagis Drugs 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000003146 transient transfection Methods 0.000 description 2
- 238000001419 two-dimensional polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- FXYZDFSNBBOHTA-UHFFFAOYSA-N 2-[amino(morpholin-4-ium-4-ylidene)methyl]guanidine;chloride Chemical group Cl.NC(N)=NC(=N)N1CCOCC1 FXYZDFSNBBOHTA-UHFFFAOYSA-N 0.000 description 1
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- 108010024878 Adenovirus E1A Proteins Proteins 0.000 description 1
- 101000689231 Aeromonas salmonicida S-layer protein Proteins 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 108010045123 Blasticidin-S deaminase Proteins 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108010078239 Chemokine CX3CL1 Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 101900009012 Epstein-Barr virus Replication and transcription activator Proteins 0.000 description 1
- 101001091269 Escherichia coli Hygromycin-B 4-O-kinase Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
- 102000013818 Fractalkine Human genes 0.000 description 1
- 101710160621 Fusion glycoprotein F0 Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000003676 Glucocorticoid Receptors Human genes 0.000 description 1
- 108090000079 Glucocorticoid Receptors Proteins 0.000 description 1
- 102000009127 Glutaminase Human genes 0.000 description 1
- 108010073324 Glutaminase Proteins 0.000 description 1
- 108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 101150003028 Hprt1 gene Proteins 0.000 description 1
- 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
- 102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 1
- 101710110377 Immediate early protein IE1 Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- 101710128836 Large T antigen Proteins 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 101100261636 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) trpB2 gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000007339 Nerve Growth Factor Receptors Human genes 0.000 description 1
- 108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 108010011356 Nucleoside phosphotransferase Proteins 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 241000700629 Orthopoxvirus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 101710122931 Replication and transcription activator Proteins 0.000 description 1
- 101150050559 SOAT1 gene Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- XZKQVQKUZMAADP-IMJSIDKUSA-N Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(O)=O XZKQVQKUZMAADP-IMJSIDKUSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 101001091268 Streptomyces hygroscopicus Hygromycin-B 7''-O-kinase Proteins 0.000 description 1
- 108091008874 T cell receptors Proteins 0.000 description 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
- 108700007696 Tetrahydrofolate Dehydrogenase Proteins 0.000 description 1
- 101000748795 Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) Cytochrome c oxidase polypeptide I+III Proteins 0.000 description 1
- IQHUITKNHOKGFC-MIMYLULJSA-N Thr-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IQHUITKNHOKGFC-MIMYLULJSA-N 0.000 description 1
- 108010022394 Threonine synthase Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 101150117115 V gene Proteins 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 230000010530 Virus Neutralization Effects 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 108010027570 Xanthine phosphoribosyltransferase Proteins 0.000 description 1
- 108010084455 Zeocin Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- AYLJOWKVELIZSY-UHFFFAOYSA-N acetic acid pyrrolidine-2,5-dione Chemical compound CC(O)=O.CC(O)=O.O=C1CCC(=O)N1 AYLJOWKVELIZSY-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001399 anti-metabolic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229930189065 blasticidin Natural products 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 238000011098 chromatofocusing Methods 0.000 description 1
- 238000011210 chromatographic step Methods 0.000 description 1
- 239000012501 chromatography medium Substances 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 210000001728 clone cell Anatomy 0.000 description 1
- 238000013377 clone selection method Methods 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 102000004419 dihydrofolate reductase Human genes 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 108700025184 hepatitis B virus X Proteins 0.000 description 1
- 101150113423 hisD gene Proteins 0.000 description 1
- YQYJSBFKSSDGFO-FWAVGLHBSA-N hygromycin A Chemical compound O[C@H]1[C@H](O)[C@H](C(=O)C)O[C@@H]1Oc1ccc(\C=C(/C)C(=O)N[C@@H]2[C@@H]([C@H]3OCO[C@H]3[C@@H](O)[C@@H]2O)O)cc1O YQYJSBFKSSDGFO-FWAVGLHBSA-N 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229960000951 mycophenolic acid Drugs 0.000 description 1
- HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000011330 nucleic acid test Methods 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 108090000721 thyroid hormone receptors Proteins 0.000 description 1
- 102000004217 thyroid hormone receptors Human genes 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000012096 transfection reagent Substances 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 101150081616 trpB gene Proteins 0.000 description 1
- 101150111232 trpB-1 gene Proteins 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
本发明涉及制造重组抗-RSV抗体及抗体组合物的方法。该方法包括获得以变体核酸序列之集合转染的细胞的集合,其中在该集合中的每个细胞均以单一独特的抗-RSV抗体转染,并能够表达它们。细胞是在适当的条件下培养以表达该抗-TSV抗体。通过以避免位点特异性整合的表达载体转染,将核酸序列导入细胞内。本方法适合制造可供治疗用途的重组的单-和多克隆抗-RSV抗体。
Description
技术领域
本发明涉及制造重组抗-RSV抗体,其使用不依赖位点特异性整合的生产系统。
现有技术
可通过从具有针对想要靶之免疫反应的供体中分离编码抗体之核酸,接着筛选与该想要靶特异地结合的抗体,来生重组多克隆抗体。可通过经适应之哺乳动物表达技术(其基于将一抗体表达质粒以位点特异性整合到每个细胞相同的基因组位置内,如同在WO 2004/061104中描述的),在容器中制造多克隆抗体。这类型多克隆抗体的一个实例为针对罗猴(Rhesus)D的重组多克隆抗体(WO 2006/007850)。其它实例为针对正痘病毒(orthopoxvirus)的重组多克隆抗体(WO 2007/065433)。使用位点特异性整合,导致在细胞群中,每个细胞中含有一单一拷贝,并预期其中的表达水平和生长速率是相对较一致的。
发明内容
本发明提供生产特定重组多克隆抗-RSV抗体的供选择方法,该方法不依赖位点特异性整合,并因此提供增加的关于细胞系选择的弹性,同时仍维持抗体的多克隆性(polyclonality)。此外,表达水平可比利用位点特异性整合的可能性有的更高。
本发明之方法是基于将编码抗-RSV抗体之基因随机整合到宿主细胞内,优选的是接着克隆具有想要特征之经稳定转染的单一细胞。然后混合分别产生该多克隆抗-RSV抗体之个别成员的个别细胞克隆,以产生制造多克隆之细胞系,用以产生多克隆抗-RSV抗体。
因此,第一方面本发明涉及多克隆细胞系,其包括2至n个细胞亚群,每个亚群表达重组多克隆抗-RSV抗体的一个独特(distinct)抗体成员,该细胞包括至少一个表达构建体,其编码一个独特的抗体成员,且随机并稳定地整合到基因组内,其中该重组多克隆抗-RSV抗体的独特成员选自由包括CDR1、CDR2和CDR3区(其选自由在本文表3中提供之VH和VL对所组成的组)的抗体分子所组成的组。本发明亦关于制造重组多克隆抗-RSV抗体的方法,包括培养这类多克隆细胞系,并从上清液中回收该多克隆抗体。
表3的抗体是分离自健康供体(其业已暴露在RSV感染下并已经升高针对RSV之免疫反应)的完全人类抗体。因此,包含来自表3的不同抗体之多克隆抗体,反映对RSV的人类多克隆免疫反应。
本发明允许重组多克隆抗-RSV抗体在一个容器中的商业生产,例如以用于医药组合物。本发明之一重要特征为在制造期间,使构成该多克隆抗-RSV抗体之个别分子的偏好表达保持在低水平,以将不想要的批-至-批变异减至最少,并避免在制造期间排除该多克隆抗-RSV抗体的成员。
在其它方面,本发明涉及使用依赖将表达构建体随机整合到宿主细胞之基因组内的表达系统,制造特定单克隆抗-RSV抗体的细胞系和方法。
特定而言,本发明涉及包括能够指导抗-RSV抗体表达之表达构建体的细胞,该抗体选自由至少包括在表3中列举的抗体之互补性-决定-区(CDR)的抗体所组成的组,其中该细胞包括至少一个表达构建体,其被稳定地整合在基因组中的随机位置。
这类细胞可通过以下产生:在允许随机整合至该细胞之基因组内的条件下,以编码该抗-RSV抗体之表达构建体转染细胞,并选择至少一个具有稳定整合在随机位置之表达构建体的细胞,该表达构建体编码抗-RSV抗体,其选自由至少包括在表3中列举的抗体之互补性-决定-区(CDR)的抗体所组成的组。
在优选的具体实施方案中,该多克隆细胞系是用作为制造多克隆的细胞系,并冷冻储存,且用作为多克隆主细胞库(polyclonal Master Cell Bank,pMCB),从其中可将试样融解,并用来作为多克隆工作细胞库(polyclonalWorking Cell Bank,pWCB)。为了制造单克隆抗体,使用单克隆细胞系以产生主细胞库(Master Cell Bank,MCB),可从其中产生工作细胞库(Working CellBank,WCB)。
定义
“蛋白质”或”多肽”意指任何链的氨基酸,不管长度或翻译-后修饰。蛋白质可以单体或多聚体形式存在,包括二或多个组装好的多肽链、蛋白质之片段、多肽、低聚肽或肽。
“重组多克隆抗体之独特成员”一词代表包括不同抗体分子之抗体组合物的一个抗体分子,其中每个抗体分子都是与该组合物之其它分子同源的,但亦含有一或多片可变多肽序列,其特征在于在该多克隆抗体的独特成员之间的氨基酸序列差异。
“抗体”一词描述血清的功能组份,且通常意指分子(抗体或免疫球蛋白)的集合,或为单一分子(抗体分子或免疫球蛋白分子)。抗体分子能够与特定的抗原决定位(抗原或抗原之抗原决定位)结合或反应,其可转而诱导免疫学之效应物机制。通常认为个别的抗体分子是单特异性的,而抗体分子之组合可能是单克隆(即由相同的抗体分子组成)或多克隆的(即由不同的抗体分子组成,其与在相同抗原上,或甚至是在个别、不同抗原上相同或不同的抗原决定位(表位)反应)。每个抗体分子均具有独特的结构,使其得以特异地结合其相对应之抗原,且所有天然的抗体分子均具有相同的整体基本结构,有两个相同的轻链和两个相同的重链。亦将抗体集体地称为免疫球蛋白。在本文中使用的抗体一词,亦企图包含嵌合型和单链抗体,还有抗体之结合片段,如Fab、Fv片段或scFv片段,以及多聚体形式,如二聚的IgA分子或五价IgM。
“多克隆抗体”一词描述不同抗体分子的组合物,其能够与在相同或在不同抗原上的数个不同的特定抗原性决定位结合或反应。通常,认为多克隆抗体的变异性是位在所谓的多克隆抗体之可变区。然而,在本发明之前后文中,亦可了解多克隆性是描述在个别抗体分子所属之所谓的恒定区之间的差异,例如在含有二或多个抗体同种型(如人类同种型IgG1、IgG2、IgG3、IgG4、IgA1、IgA2、IgM、IgD和IgE,或小鼠同种型IgG1、IgG2a、IgG2b、IgG3和IgA)之抗体混合物的情况下。
经常使用“免疫球蛋白”一词作为在血液或血清中找到之抗体混合物的集合名称,但亦可用来称呼衍生自其它来源之抗体的混合物。
“免疫球蛋白分子”一词代表个别的抗体分子,例如作为免疫球蛋白的一部分,或任何多克隆或单克隆抗体组合物的一部分。
使用“变体核酸分子库”一词,描述核酸分子的集合,其集体地编码”重组多克隆抗-RSV-抗体”。当用于转染时,将变体核酸分子库纳入表达载体库中。这类库典型地具有至少3、5、10、20、50、1000、104、105或106个个别的成员。
当在本文中使用时,应了解“独特的核酸序列”一词为可编码不同多肽链(其一起组成抗-RSV抗体)的核酸序列。在该独特的核酸序列由一个以上编码序列构成之处,这些序列可以呈双顺反子转录单元的形式,或若以可操作之方式与适当的启动子连接,它们便可以两个分开的转录单元来运作。同样的,若将选择标记连同编码抗体或其亚单元(亚基)之核酸一起纳入转录单元内,则可考虑使用三-或四顺反子转录单元。优选的是,本发明之独特的核酸序列为核酸分子(像是例如载体)的一部分。当将其导入细胞内时,一起编码完全组装好之抗体的基因,也在相同的载体中,因此在一个核酸序列中连接在一起。
当在本文中使用时,“载体”一词意指为了在不同遗传环境之间运送,和/或为了在宿主细胞中表达,可将核酸序列插入其中的核酸分子。若该载体带有经插入该载体之核酸序列的转录调节组件(至少一个适当的启动子),则在本文中将该载体称为“表达载体”。在本说明书中,可交替使用“噬菌体质粒载体”和”噬菌体载体”。可交替使用名词“质粒”和”载体”。本发明打算纳入这类提供相等功能的其它形式之载体,例如质粒、噬菌体质粒和病毒基因组,或任何能够在适当宿主中指导想要之蛋白质生产的核酸分子。
使用“载体库的每个成员”一词,描述具有衍生自载体库之独特的核酸序列的个别载体分子,其中该核酸序列编码该重组多克隆抗体的一个成员。
在本文中使用的“转染”一词,为将外来DNA导入细胞内的广义名词。该名词亦意味着涵盖其它将外来DNA导入细胞内之功能相当的方法,像是例如转染、感染、转导或供体细胞与接受者细胞的融合。
使用“选择”一词,描述其中能够将已经获得某些特征的细胞,与没有获得该特征之细胞分离的方法。这类特征可以是对胞毒剂的抵抗力,或产生必要营养、酶或颜色。
使用名词“可选择标记基因”、“选择标记基因”、“选择基因”和“标记基因”,描述编码可选择标记的基因(例如赋予针对某些胞毒药物-如某些抗生素之抗性的基因、能够产生可能从生长培养基中耗尽之必要营养的基因、编码产生可分析之代谢产物之酶的基因,或编码-例如可通过FACS挑选之有色蛋白质的基因),将其与编码抗-RSV抗体之基因一起导入细胞内。
使用“重组蛋白质”一词描述从以表达载体(其包括该蛋白质之编码序列)转染之细胞系中表达的蛋白质。
当在本文中使用时,“以可操作之方式连接”一词意指欲与另一段连接的一段,以有功能的关系与另一段放在一起。例如,若将编码信号序列的DNA以可操作之方式与编码多肽之DNA连接,则其以前导序列表达,并参与该多肽至内质网的运送。再者,若将启动子或增强子以可操作之方式与编码序列连接,则刺激该序列之转录。
“启动子”一词意指DNA中涉及与RNA聚合酶结合,以发动转录的区域。
“头-对-头启动子”一词意指位置紧密靠近的启动子对,以便通过以相反方向存在的启动子驱动两个基因片段的转录。亦可利用在两个启动子之间由无关核酸构成的填充序列(stuffer),构建头-对-头启动子。这类填充序列片段可轻易含有超过500个核苷酸。
“抗生素抗性基因”为编码可克服抗生素对细胞所具有之抑制或毒性影响之蛋白质的基因,以确保细胞在抗生素的存在下存活并持续增殖。
“内部核糖体进入位置”或”IRES”一词描述与在mRNA上正常5’加帽-结构不同的结构。两种结构均可由核糖体认出,以开始扫描AUG密码子,开始翻译。通过使用一启动子序列和两个开始AUG’s,可从单一mRNA中翻译第一和第二个多肽序列。因此,欲使得第一和第二个多核苷酸序列能够从单一双-顺反子mRNA中共同-翻译,可经由含有IRES序列之连接子序列(其能够翻译IRES序列下游的多核苷酸序列),以转录方式融合该第一和第二个多核苷酸序列。在该情况下,会从双-顺反子RNA分子的经加帽5’端还有从内部IRES序列两者中翻译该经转录之双-顺反子RNA分子,藉此产生第一和第二个多肽两者。
使用“诱导型表达”一词来描述需要诱导剂分子之交互作用,或辅-阻遏物分子之释放,以及用以发生表达之调节蛋白质的表达。
“组成型表达”一词意指通常不是可诱导型表达。
“混乱”(scrambling)一词描述其中从个别的细胞中表达由两个不同多肽链(例如来自免疫球蛋白超级家族)构成之多克隆蛋白质的二或多个独特成员的状况。可能在该个别细胞中已经有一对以上的基因片段被整合到基因组内,而其中每一对基因片段均编码该多克隆蛋白质的独特成员时发生该状况。在这类情况下,可能从该基因片段中表达多肽链的非想要组合。这些多肽链的非想要组合可能没有任何的治疗效果。
“VH-VL链混乱”一词是上文定义之混乱的实例。在本实例中,编码VH和VL之基因片段组成一对基因片段。当从细胞中产生VH和VL多肽之非故意组合(其中两个不同的编码VH和VL之基因片段对被整合到相同的细胞内)时发生混乱。这类混乱的抗体分子不可能保持原始的特异性,并因此可能没有任何的治疗效果。
“重组多克隆制造性细胞系”一词意指已经以变体核酸序列库转染之表达蛋白质之细胞的群体,使得个别的细胞(它们一起组成重组多克隆制造性细胞系)带有一或多个独特的核酸序列的拷贝,其编码该重组多克隆抗-RSV抗体的一个成员,并将一或多个拷贝整合到每个细胞的基因组内。就它们保持经整合之独特的核酸序列的能力,来选择构成重组多克隆制造性细胞系的细胞,例如通过抗生素选择。可组成这类制造性细胞系的细胞,可以是例如细菌、真菌、真核生物细胞,如酵母、昆虫细胞或哺乳动物细胞,尤其是永生化哺乳动物细胞系,如CHO细胞、COS细胞、BHK细胞、骨髓瘤细胞(例如Sp2/0细胞、NS0、YB2/0)、NIH 3T3和永生化人类细胞,如HeLa细胞、HEK 293细胞或PER.C6。
使用”偏好”一词表示在重组多克隆蛋白质生产期间的现象,其中多克隆载体、多克隆细胞系或多克隆蛋白质的组合物在一段时间内,因为随机的遗传突变、在个别细胞之间在增殖动力学上的差异、在不同表达构建体序列之间在表达水平上的差异,或在DNA之克隆效力上的差异而有所改变。
“RFLP”一词意指”限制片段长度的多态性”,一种方法藉此在以限制酶切开之后,分析核酸分子片段之移动凝胶图案。
“5’UTR”一词意指mRNA的5’未翻译区。
“避免位点特异性整合之条件”一词意指转染过程,其不包括任何可能获得位点特异性整合的方式。例如,可使用重组酶和在宿主细胞之染色体中之重组酶认知位置的组合,达到位点特异性整合。亦可使重组酶与认得在染色体中之特定位置的核苷酸片共价连接。亦可使用同种重组作用-虽然以较低之效率-达到位点特异性整合。避免位点特异性整合,若使用整合载体,结果通常会整合在整个宿主细胞之基因组中的随机位置处。
“随机整合”一词意指在随机的位置,将表达载体整合到宿主细胞之基因组内。随机的字典意义是每个项目,在这种情况下为整合位点,有相等的机会。当正在转染细胞时,所有的整合位置都不代表绝对相等的整合机会,因为某些部分的染色体有比其它更易发生整合事件的倾向。当没有东西引导表达载体至特定的整合位置时,其会整合在一群可能的整合位置内之随机位置处。因此,在本发明之前后文中,了解”随机整合”为其中没有东西去引导表达构建体至预定位置的转染程序。缺少引导表达载体至预定位置的工具,便足以确保”随机整合”。因此在经转染之群体中,整合位置会随着细胞而有所改变,故认为正确的整合位置是不可预测的。
“经稳定整合”一词意指将表达载体整合到宿主细胞之基因组内,其中该整合维持稳定超过至少20,优选的是30,更优选的是40,再更优选的是50,如75,例如100代或更多。
缩写:”CMV”=(人类)细胞巨大病毒。”AdMLP”=腺病毒主要晚期启动子。SV40聚A=猿病毒40聚A信号序列。GFP=绿荧光蛋白。TcR=T细胞受体。ELISA=酶-连接之免疫吸附测定。LTR=长端重复。
附图说明
图1.产生多克隆细胞库之过程的图解概要。
该图式图解说明获得多克隆细胞库,例如多克隆主细胞库所需之步骤。a)解释不同的表达载体Ab.1、Ab.2、Ab.3等等,其分别编码多克隆抗-RSV抗体的不同和独特成员。b)解释欲以表达载体转染的宿主细胞。c)解释表达载体整合在不同的位置上,并在个别细胞中有不同的拷贝数目。d)解释为多克隆抗-RSV抗体的每个成员,选择细胞克隆。在这个特定的场合中,为了易于解释,仅显示多克隆抗-RSV抗体的每个独特成员的一个克隆。步骤e)解释混合在步骤d)中选出的克隆,以产生多克隆细胞库。
图2a.编码重链和轻链的原型载体。组件如下:
●两个相同的头-对-头人类CMV启动子,之间有间隔子组件(填充序列)
●重链(VH+IgG1恒定区)和轻链(κ)的密码区
●bGH聚A=牛生长激素聚腺苷酸化序列
●SV40聚A=SV40聚腺苷酸化序列
●重链和轻链的基因组前导序列
●IRES+DHFR=ECMV内部核糖体进入位置和小鼠二氢叶酸还原酶cDNA
●pUC ori=pUC复制起点
●bla,amp=氨苄青霉素抗性基因
图2b.E1A表达载体pML29。该载体是基于pcDNA3.1+(Invitrogen)。组件如下:
CMV=人类CMV启动子
E1a=腺病毒第5型13S反式激活蛋白(transactivator)的cDNA
bGH聚A=牛生长激素聚腺苷酸化区
SV40EP=SV40早期起动基因
Neo=neo抗性基因
SV40聚A=SV40聚腺苷酸化区
AMP=编码氨苄青霉素抗性的β-内酰氨酶基因
图3.在还原(第2-5道)和非-还原条件(第8-11道)下,经纯化Sym003抗体818-4(第2和8道)、810-7(第3和9道)、824-7(第4和10道)与824-18(第5和11道)的SDS-PAGE。将1-8微克经纯化之蛋白质施用在凝胶上。字尾(-4、-7、-7、-18)代表表达抗体的细胞克隆。
发明详述
重组多克隆抗-RSV抗体表达系统
本发明提供一贯制造重组多克隆抗-RSV抗体的方法。这类方法包括完整抗体、Fab片段、Fv片段和单链Fv(scFv)片段。特定而言,考虑到可使用本发明来大规模制造和生产重组治疗性多克隆抗-RSV抗体。
本发明之制造方法的一项主要优点是可在一或数个生物反应器或其相等价物中制造构成该重组多克隆抗-RSV抗体的所有成员。此外,可从该反应器中纯化该重组多克隆抗-RSV抗体组合物,作为单一制剂,在该过程期间不必分离构成该重组多克隆抗-RSV抗体的独特成员。在本文中描述之技术通常可产生具有许多独特成员的多克隆抗-RSV抗体,原则上没有上限。
所使用之宿主细胞系优选的是哺乳动物细胞系,包括典型地用于生物药学蛋白质表达的那些,例如CHO细胞、COS细胞、BHK细胞、骨髓瘤细胞(例如Sp2/0细胞、NS0、YB2/0)、NIH 3T3和永生化人类细胞,如HeLa细胞、HEK 293细胞或PER.C6。在本发明中使用CHO细胞,更特定而言,是经修饰的DG44克隆。已经选择该特定细胞系,因为CHO细胞被广泛地用在抗体的重组制造上,并因为DG44克隆可与代谢选择标记DHFR并用,后者额外地允许经编码基因的扩增。已经通过转染和继代修饰DG44细胞系。进行该修饰以增加整体产量。继代-克隆之细胞系是非常稳定的细胞系,只要细胞克隆具有均一的生长速率,并对不同的抗-RSV抗体有均一且高的表达水平。
BHK-21细胞或CHO的dhfr-负突变种,如CHO-DUKX-B11或DG44或CHO-S或CHO-K1,是实行本发明的优选哺乳动物细胞。这些细胞为在技术领域中已熟知并可广泛获得的,例如从美国典型培养物收集中心(theAmerican Type Culture Collection,A.T.C.C.)Rockville,Md.(BHK-21),或从Lawrence Chasin博士,Columbia University,New York(CHO DUKX-B11或DG44)。这些细胞完全适应在悬浮培养中生长,和/或可在低血清浓度下生长,并可与DHFR选择标记并用。
因此,一般技艺人士能够如所述以其它克隆取代DG44克隆,并以其它哺乳动物细胞取代CHO细胞,或甚至使用其它类型的细胞,包括植物细胞、酵母细胞、昆虫细胞、真菌和细菌。因此,细胞类型的选择并无意限制本发明。
本发明之重组多克隆抗-RSV抗体打算涵盖抗-RSV抗体组合物,其包括不同但同种的抗-RSV抗体分子,其为天然可变的,意味着在优选的具体实施方案中,抗-RSV抗体包括天然存在的多样性。
在最广泛的观点中,多克隆细胞系包括2到n个亚群的细胞,每个亚群表达该重组多克隆抗-RSV抗体的一个独特抗体成员,该细胞包括至少一个表达构建体(其编码一个个别的抗体成员),随机并稳定地整合到基因组内,其中该重组多克隆抗-RSV抗体的独特成员,选自由包括CDR1、CDR2和CDR3区(其选自由在本文表3中提供之VH和VL对所组成的组)的抗体分子所组成的组。
从已经暴露在RSV感染下的健康成人中分离带有表3之CDR序列的抗体。因此,抗体反映对RSV感染的天然人类免疫反应,而可制造基于这些特异抗体的抗体组合,以反映天然的人类免疫反应。
来自表3之抗体的优选组合,由在本文表6中之抗体组合1至56构成。所有在本文表6的抗体组合都已经在体外进行针对一或多个RSV菌种(strain)的中和测试,且许多都是非常有效的。
特别优选的是其中组合独特成员,成为在本文表6中抗体组合2、9、13、17、18、28、33和56之任一者的抗体组合,再更优选的是抗体组合28、33和56的任一者。这些组合是非常有效的,并已经在RSV感染之动物模式中测试。当预防性投药时,它们能够明显地降低肺脏病毒负荷。
在其它的具体实施方案中,该多克隆抗体之独特成员选自由包括如本文定义之克隆735、736、744、793、795、796、799、800、801、804、810、811、812、814、816、817、818、819、824、825、827、829、830、831、835、838、841、853、855、856、857、858、859、861、863、868、870、871、880、881、884、886、888和894之VH和VL序列的抗体所组成的组。
在优选的具体实施方案中,所述独特成员选自由来自克隆793、800、810、816、818、819、824、825、827、831、853、855、856、858、868、880、888和894之抗体,和包括该抗体之CDR的抗体所组成的组。已经在病毒中和测定中测试这些抗体,为针对一或多个RSV分离株的单克隆抗体(表5)。
经修饰之CHO细胞,包括已经为了表达下列抗体而制备的经随机整合的表达构建体,该抗体包括克隆810、818、819、824、825、827、858、894、793、816、853、855和856的VH和VL序列。这些抗体已经以数个在表6中的组合进行测试,且为制造多克隆抗-RSV抗体的优选抗体。
包含在该多克隆抗-RSV抗体内的特别优选抗体,是由克隆824编码的抗体,或具有克隆824之CDR的抗体;以及由克隆810编码的抗体,或具有克隆810之CDR的抗体。
为了获得有效的抗-RSV抗体,优选的是该多克隆抗-RSV抗体包括至少一个能够与F蛋白质结合的个别抗体分子,以及至少一个能够与G-蛋白质结合的个别抗体分子。更优选的是,其包含至少两个靶定F-蛋白质的抗体,和两个靶定G-蛋白质的抗体。再更优选的是,该组合物包括至少3个分别针对两个靶蛋白质F和G的抗体。
该多克隆抗体可包括2或更多个抗体,如优选的是3或更多个,例如4或更多个,如5或更多个,例如6或更多个,如7或更多个,例如8或更多个,如9或更多个,例如10或更多个,如15或更多个,例如20或更多个,如25或更多个,例如30或更多个,如40或更多个,例如50或更多个。
假定每个抗体以等量出现,随着在该多克隆抗体中之个别抗体分子数目的增加,降低了每个抗体在终产物中的浓度。此外,随着由多克隆细胞系表达之抗体数目的增加,亦增加在制造期间丧失抗体之一的风险。因此,该多克隆抗体优选的是包括低于50个抗体,如低于40个抗体,例如低于30个抗体,如低于25个抗体,例如低于20个抗体,或甚至低于15个抗体。
在本发明之前后文中,亦可了解在该多肽序列中的变异性(多克隆性)是描述在居留在所谓的抗体多肽链之恒定区或C区中的个别抗体分子之间的差异,例如像是在含有二或多个不同抗体同种型(如人类同种型IgG1、IgG2、IgG3、IgG4、IgA1、IgA2、IgM、IgD和IgE)之抗体混合物的情况下。因此,重组多克隆抗-RSV抗体可包括抗体分子,其特征在于在可变区(V区)或在恒定区(C区)或两者中,在个别抗体分子之间的序列差异。优选的是该抗体属于相同的同种型,因为这使得后续的纯化相当容易。亦可想象例如同种型IgG1、IgG2和IgG4的混合抗体,因为这些都可使用蛋白质A亲和力层析法一起纯化。在优选的具体实施方案中,所有构成多克隆抗体的抗体均具有相同的恒定区,以利于进一步纯化。更优选的是,该抗体具有相同的重链恒定区。在个别抗体之间,轻链恒定区亦可以是相同的。
在所谓的恒定区,特别是抗体之重链中的多克隆性,与抗体之治疗应用有关。各种免疫球蛋白同种型具有不同的生物功能(在表1中概述),在使用抗体来治疗时可能想要混合它们,因为免疫球蛋白不同的同种型可能牵涉到不同方面的天然免疫反应(Canfield和Morrison 1991.J.Exp.Med.173,1483-91;Kumpel等人2002.Transfus.Clin.Biol.9,45-53;Stirnadel等人2000.Epidemiol.Infect.124,153-162)。
表1:人类免疫球蛋白同种型的生物功能
克隆的多样性
可通过RFLP对来自表达重组多克隆蛋白质之细胞库的分离克隆,分析细胞系的克隆多样性。(RT)-PCR产物的测序,代表分析克隆多样性的其它可能性。亦可通过功能测试(例如ELISA)对由该细胞系产生的重组多克隆抗-RSV抗体分析多样性。WO 2006/007853揭示了鉴定多克隆细胞系和多克隆蛋白质之特征的方法。可使用这些方法来分析细胞系,以及所得之多克隆抗-RSV抗体的克隆多样性。
若有的话,可通过将最初用于转染之库的克隆多样化,与在表达该重组多克隆抗-RSV抗体之细胞(细胞系)库中找到的多样性做比较,来评估克隆偏好(即在构成多克隆抗体之个别抗体的内容物方面逐渐改变)。
亦可根据该多克隆抗-RSV抗体之独特成员的分布,来评估克隆多样性。可根据在最终多克隆抗-RSV抗体组合物中不同独特成员的总数,与在转染期间内,一开始导入细胞系内之不同编码序列的数目做比较,来评估该分布。在这个场合中,当可鉴认在转染一开始使用之编码序列的至少50%为该最终多克隆抗-RSV抗体之不同独特成员时,便认为获得足够的多样性,优选的是至少75%,更优选的是至少80%,再更优选的是至少90%,如至少95%、97%、98%或99%。以其它方式表达,若在制造期间仅丧失该多克隆抗-RSV抗体的1个成员,或若丧失2、3、4或5个成员,便认为克隆多样性是足够的。
优选的是,针对在独特成员之中的互相分布,来评估该多克隆组合物之独特成员的分布。在该场合中,若没有该抗-RSV抗体组合物之单一成员构成超过75%的在最终多克隆抗-RSV抗体组合物中的蛋白质总量,便认为获得足够的克隆多样性。优选的是,没有独特成员超过50%,更优选的是25%,而最优选的是10%的在最终多克隆抗-RSV抗体组合物中的抗体总量。可通过RFLP分析、序列分析和蛋白质分析,如稍后对于鉴定多克隆抗-RSV抗体之特征所描述的方法,进行基于在该多克隆抗-RSV抗体组合物中之独特成员分布的克隆多样性评估。
亦可通过设定每个抗体在终产物中的预定相对量,来定义克隆多样性。对于有10个个别抗体的多克隆抗体,预定相对量可以是例如每个抗体10%。预定相对量也可以每个个别抗体是不同的。若在该产物中,个别抗体的量与预定相对量相差不超过75%,便可说克隆多样性是足够的。优选的是与该预定相对量相差不超过50%,更优选的是不超过25%,而最优选的是不超过10%。
可因为克隆偏好的结果而降低克隆多样性,而前者可起因于a)在表达水平上的差异、b)在细胞增殖上的变化。若出现这类偏好,可通过稍微修改如本文描述之方法,分别补救这些丧失克隆多样性的每个来源。
在细胞系中可能改变个别细胞的细胞增殖速率,可能是在延长的期间内、在该重组多克隆抗-RSV抗体表达内导入偏好、增加或减少由该细胞系表达之重组多克隆蛋白质的一些成员的存在。因为本方法是基于随机整合到宿主细胞的基因组内,故在该多克隆细胞系的成员之间,位置和拷贝数目两者皆有所不同。这可能在克隆中导致增殖速率和表达水平的差异。通过选择具有类似增殖速率的细胞克隆,将该问题减至最少。更有可能是对该多克隆蛋白质的每个成员,使用一个以上的克隆。例如,若使用3到5个之间的克隆来表达该多克隆蛋白质之单一成员,与该多克隆抗-RSV抗体之每个成员仅使用一个克隆相比较,可增加该组合物的稳定性。
表达该重组多克隆蛋白质之单一独特成员的细胞,优选的是衍生自1或多个克隆的细胞,如衍生自2或更多个,例如3或更多个,如4或更多个,例如5或更多个,如6或更多个,例如7或更多个,如8或更多个,例如9或更多个,如10或更多个,例如11或更多个,如12或更多个,例如13或更多个,如14或更多个,例如15或更多个,如16或更多个,例如17或更多个,如18或更多个,例如19或更多个,如20或更多个,例如21或更多个,如22或更多个,例如23或更多个,如24或更多个,例如25或更多个,如26或更多个,例如27或更多个,如28或更多个,例如29或更多个,如30或更多个,例如35或更多个,如40或更多个,例如45或更多个,如50或更多个,例如60或更多个,如70或更多个,例如80或更多个,如90或更多个,例如100或更多个。为了大多数的目的,经克隆细胞的数目少于50个,例如少于20个,如少于15个,例如少于10个。
其它解决该问题的方法是使用一或多个选择标准,以确保细胞在某些预定限制内是均一的,关于一或多个标准,选自由生长速率、倍增时间、表达水平、生产水平、在一段时间内生产的稳定性、存活能力、抗性、稳健性、形态学和拷贝数目所组成的组。
增殖速率改变的一个理由可能是构成初步转染所使用之起始细胞系的细胞群是异源的。已知在细胞系中的个别细胞,在延长的时间内以不同程度发育。欲确保较均一的起始材料,可在以表达载体转染之前,使用细胞系的限制稀释至单一细胞水平,并使每个单一细胞生长成新的细胞群(所谓的通过限制稀释之细胞继代克隆),进行细胞系的继代-克隆或重复继代-克隆。
单一细胞克隆以确保完全限定之细胞群的可供选择和优选方法,是在转染之后但在选择程序之前,使用荧光经活化细胞挑选(FACS)。可使用经荧光标示的抗体,增强衍生自以IgG构建体转染之细胞库的高生产力细胞(Brezinsky等人J.2003.Immunol Methods 277,141-155)。使用FACS挑选的优点是该方法混合单一细胞克隆(通过将单一细胞挑选到孔内),同时提供了关于每个单一细胞之表达水平的信息。欲进一步改良挑选程序,可纳入存活能力染色,以便抛弃已死或正在死亡的细胞。FACS程序使细胞经历颇严重的条件,包括剪切应力。这意味着间接选择对这类条件有抗性的细胞。此外,FACS程序是自动的,允许挑选大量的单一细胞。
亦可使用FACS方法,挑选表达类似水平之免疫球蛋白的细胞,藉此创造生产力均一的细胞群。同样地,通过使用以荧光染料5,6-羧基荧光素二醋酸盐琥珀酰亚氨基酯(CFSE)标示,可通过FACS方法选择显示出类似增殖速率的细胞。
本发明的重要具体实施方案是替该多克隆抗-RSV抗体的每个成员产生一或多个克隆的细胞系。可使用任一种标准技术来进行单一细胞克隆的产生。然而,结果是FACS细胞挑选,其中就存活能力和IgG水平来选择细胞,并分别挑选到孔内,结果一致地提供了适合制备多克隆工作细胞库的稳定克隆。优选的是在细胞挑选后,在选择压力下培养数天之后再选择个别的克隆。因为在挑选后同一天选择克隆,该克隆的生长速率会是相对均一的。除了这个之外,以肉眼检查菌落,抛弃与原始未经转染之细胞系相比较,在形态学上有显著改变和低生长速率的克隆。最后,可使用例如ELISA或其它分析技术测定抗体表达的水平,并可选择具有高和相对较均一之表达水平的克隆。
即使真的发展出增殖速率-诱导偏好,独特成员的丧失或过度-表示可能不一定是重要的,视终重组多克隆蛋白质产物的多样性需求和多样性在时间内的稳定性而定。
重组单克隆抗-RSV制造系统
本发明亦涉及表达某些单克隆抗-RSV抗体的细胞系。大部分针对多克隆抗体陈述的关于细胞系的建立、细胞的选择、载体的设计、克隆策略、细胞的培养和抗体的回收,亦与本发明的单克隆方面有关。
在最广泛的”单克隆”方面,本发明涉及包括能够指导抗-RSV抗体表达之表达构建体的细胞,该抗体选自由至少包括在表3中列举之抗体之互补性-决定-区(CDR)的抗体所组成之群体,其中该细胞包括至少一个被稳定整合在基因组中之随机位置处的表达构建体。
可通过在允许随机整合至该细胞之基因组内的条件下,以编码上文定义之该抗-RSV抗体的表达构建体转染细胞,并选择至少一个具有经稳定整合在随机位置之表达构建体的细胞,来产生这类细胞。在这类条件下的转染经常导致将二或多个表达构建体整合到该宿主细胞之基因组内的随机位置处。
为了充分使用随机整合,可在有利于扩增该表达载体的条件下进行转染和/或选择,而结果产生更高的表达水平。
在某些具体实施方案中,该单克隆抗-RSV抗体选自由包含来自克隆735、736、744、793、795、796、799、800、801、804、810、811、812、814、816、817、818、819、824、825、827、829、830、831、835、838、841、853、855、856、857、858、859、861、863、868、870、871、880、881、884、886、888和894之VH和VL序列对之CDR的抗体所组成的组。在本文中提供这些克隆的VH和轻链序列。
在优选的具体实施方案中,该单克隆抗-RSV抗体选自由来自克隆793、800、810、816、818、819、824、825、827、831、853、855、856、858、868、880、888和894的抗体,以及包含该抗体之CDR的抗体所组成的组。
甚至更优选的是,该单克隆抗-RSV抗体选自由来自克隆793、800、810、818、819、824、825、827、831、853、858、888和894之抗体所组成的组。
特别优选的是单克隆抗体,其中该CDR是来自克隆810,而甚至更优选的单克隆抗体,其中该CDR是来自克隆824。两种抗体皆显示出优异的病毒中和性能,并在RSV感染的动物模式中测试时也是一样地优异。
宿主细胞
可从任何可整合DNA至它们染色体内,或保持染色体外组件(如迷你染色体、YACs(酵母人造染色体)、MACs(小鼠人造染色体)或HACs(人类人造染色体))的细胞来产生宿主细胞。在WO 97/40183中详细描述了MACs和HACs,以引用方式纳入本文中。优选的是使用哺乳动物细胞,如CHO细胞、COS细胞、BHK细胞、骨髓瘤细胞(例如Sp2/0、YB2/0或NS0细胞)、成纤维细胞,如HIN 3T3,以及永生化人类细胞,如HeLa细胞、HEK 293细胞或PER.C6。然而,亦可使用非-哺乳动物真核生物或原核生物细胞,如植物细胞、昆虫细胞、酵母细胞、真菌、大肠杆菌等等。可使用相同的宿主细胞进行单-和多克隆抗体表达。
在本发明一具体实施方案中,通过在以载体库转染之前,进行所谓的限制稀释,将细胞系稀释至单一细胞水平,接着使每个单一细胞生长成新的细胞群,继代-克隆用来作为起始材料的细胞系。如果想要,亦可在选择正确细胞系的过程中稍后进行这类继代-克隆。单一细胞克隆的其它方法包括:FACS克隆(Brezinsky等人J.2003.Immunol Methods 277,141-155)、LEAPTM技术(来自Cyntellect,San Diego,California,USA)和ClonePix(来自Genetix,UK)。
整合用的载体
适当的载体包括适合的选择基因。适用于哺乳动物细胞表达的选择基因,包括但不限于能够进行营养选择的基因,如胸腺核苷激酶基因(TK)、谷氨酰氨合成酶基因(GS)、色氨酸合成酶基因(trpB)或组氨醇脱氢酶基因(hisD)。此外,选择标记为赋与药物抗性的抗代谢产物抗性基因,如二氢叶酸还原酶基因(dhfr)-其可利用次黄嘌呤和胸腺核苷缺陷培养基来进行选择,并进一步利用氨甲碟呤选择、黄嘌呤-鸟嘌呤磷酸核糖基转移酶基因(gpt)-其可利用霉酚酸进行选择、新霉素磷酸转移酶基因(neo)-其可在真核生物细胞中利用G418来选择,并可在原核生物细胞中利用新霉素或卡那霉素来选择、潮霉素B磷酸转移酶(hyg、hph、hpt)基因-其可利用潮霉素来选择、嘌呤霉素N-乙酰基-转移酶基因(pac)-其可利用嘌呤霉素来选择,或杀杀稻瘟菌素S脱氨酶基因(Bsd)-其可利用杀稻瘟菌素来选择、抗菌素(Zeocin)抗性基因(Shble)-其介导针对菌素和博来霉素的抗性。最后,亦可使用编码能够(例如通过流式细胞技术)进行挑选的蛋白质的基因作为选择标记,如绿荧光蛋白(GFP)、神经生长因子受体(NGFR)或其它膜蛋白,或β-半乳糖苷酶(LacZ)。
选择标记可位在分开的表达载体内,因此利用编码选择标记的表达载体和一或多个编码抗-RSV抗体或抗-RSV抗体之亚单元的表达载体,进行共同-转染。选择标记亦可位在编码抗体的表达载体中。在后者的情况下,该选择标记优选的是位在亦编码该抗体或其亚单元之一的转录物上。这可使用例如IRES构建体来进行。在抗体的场合中,选择标记优选的是位在编码最大亚单元的转录物上,像是例如抗体的重链。
用以整合抗体基因之载体,更包括编码该重组多克隆抗-RSV抗体之一成员的DNA,之前有它自己的哺乳动物启动子(其指导该蛋白质表达)。编码抗-RSV抗体链的DNA,可在它自己的哺乳动物启动子之后,该启动子指导每个链的高水平表达(双-向或单-向)。在双-向表达中,可使用为头-对-头启动子构型的表达载体,而对于单-向表达,为了表达可使用两个启动子或一个启动子与例如IRES序列之组合。同样可想象双-顺反子表达载体,其具有由相同转录物编码的两个不同亚单元,并通过IRES序列分开。
适当的头-对-头启动子构型为例如,但不限于在两个方位的AdMLP启动子与小鼠金属硫蛋白-1启动子一起、在两个方位的AdMLP启动子与延伸因子-1启动子一起,或在两个方位的CMV启动子与MPSV启动子一起,或在两个方位都使用CMV启动子。
在抗体的场合中,实验已经显示由细胞表达之重链的量,不应超过轻链的量。因此,指导轻链表达之激活基因优选的是至少像指导重链表达之启动子一样强。
可将编码有功能前导序列的核酸序列纳入表达载体内,以便指导基因产物至内质网或细胞内的特定位点置,如胞器。可使强聚腺苷酸化信号位在编码蛋白质之DNA序列的3’。该聚腺苷酸化信号确保新生RNA转录物的终止和聚腺苷酸化,并与信息稳定性有关。编码该重组多克隆抗-RSV抗体之成员的DNA,可例如编码抗体或抗体片段之重链和轻链两者,每个基因序列视需要在它自己的哺乳动物启动子组件之后,和/或接着是强聚A信号-其指导两链各自的高水平表达。
用以整合的表达载体可携带额外的转录调节组件,如增强子、抗-阻遏物或UCOE(遍存的染色质开放组件),以便在整合位置增加表达。增强子为特异地与涉及转录之核蛋白交互作用的核酸序列。UCOE打开染色质或维持染色质在开放状态,并有助于以可操作方式连接之基因可再现的表达(在WO00/05393和Benton等人,Cytotechnology 38:43-46,2002中更详细地描述)。更多的增强子包括基质附着区(MARs),如同在例如Girod&Mermod 2003(“第10章:Use of scaffold/matrix-attachment regions for protein production”,第359-379页,在Gene Transfer and Expression in Mammalian Cells中,SCMakrides(编辑),2003,Elsevier Science BV)中描述的。抗-阻遏物组件包括但不限于STAR组件(Kwaks等人Nat Biotechnol.2003年5月;21(5):553-8)。当将一或多个上述的调节组件整合到宿主细胞的染色体内时,便将其称为异源的调节组件。
为了抗-RSV抗体的高-水平表达,建立表达系统
将核酸序列导入细胞内的方法为在技术领域中已知的。这些方法典型地包括使用DNA载体,将感兴趣的序列导入细胞、基因组或染色体外的组件内。可通过本领域已知的方法,包括脂染作用、以化学方式介导之转染、磷酸钙沉淀、电穿孔、显微注射、脂质体融合、RBC空细胞(ghost)融合、原生质体融合、病毒转导以及类似者,完成细胞的转染。
关于宿主细胞系的转染,使用载体库-其中每个载体仅包括一个编码重组多克隆抗-RSV抗体之一成员之核酸序列的拷贝。该表达载体库整体地编码该重组多克隆抗-RSV抗体。在先前章节中描述了适合整合的载体。
可通过数个不同的转染和制造策略,产生重组多克隆制造性细胞系,并从这类细胞系中获得重组多克隆抗-RSV抗体的生产。
在图1中描述转染的优选方式,为高产量方法,其中使用组成该库之个别载体分别转染宿主细胞。将该方法称为个别转染。优选的是分别选择经个别转染的宿主细胞。然而,亦可在选择之前集合它们。可针对表达水平、增殖速率和整合模式,分析在选择后产生的个别细胞克隆,且优选的是,可使用具有类似生长速率、类似拷贝数目、类似表达和/或类似强健(robustness)水平的那些来产生多克隆抗-RSV抗体库原料。可在产生该原料之前、在已经从原料中取回它们后马上,或在短暂的增殖和适应时间之后,混合个别的细胞克隆,获得想要的多克隆细胞系。该方法可进一步改良组合物的稳定性。可使用步骤a-d来建立细胞系,以便表达单克隆抗-RSV抗体。
至于抗-RSV抗体,批量(bulk)转染容许多次整合至宿主细胞之基因组内,结果会导致亚单元的混乱。在许多情况下,如为了药学用途制造重组多克隆抗-RSV抗体,要避免混乱。关于多聚体的蛋白质,若混乱是可接受的,或若在确保只有一个拷贝整合到每个宿主细胞之基因组内的条件下进行转染,则可进行批量转染。这类方法的实例包括逆转录酶病毒转导和球芽(sphaeroblast)融合。
可在开始制造重组多克隆抗-RSV抗体之前,产生多克隆细胞系的冷冻原料。欲获得制造想要的多克隆细胞系,可在产生冷冻原料之前、在已经从该原料中取回它们之后马上,或在短暂的增殖和适应时间之后,混合克隆。
在上文概述之制造策略中共享的特征是构成该重组多克隆抗-RSV抗体的所有独特成员,均可在一个或有限数目的容器(如生物反应器)中生产。
若需要增加表达水平,可使用对DHFR基因或谷氨酰胺合成酶(GS)基因、hprt(次黄嘌呤磷酸核糖基转移酶)或色氨酸合成酶基因的选择,进行基因扩增。这需要使用包括这类选择标记的载体。本发明之一特定特征为保持相对较低的拷贝数目,以便保持高细胞稳定性。因此,优选的是使细胞在相对较适度的选择压力下(例如对于在实施例中所使用之构建体的类型,在具有低浓度之MTX(例如1-10nM)的无核苷培养基中),仅经历一轮选择。据信适度的选择压力导致经平衡之拷贝数目,结果产生高表达,同时避免了具有极高拷贝数目之细胞的不稳定性。
为了达到较高的表达水平,用来表达的细胞系可包含异源反式激活蛋白,其能够提高启动子控制的多克隆抗-RSV抗体的表达。以下列举反式激活蛋白和启动子之适当组合的实例:
反式激活蛋白 启动子实例
慢病毒Tat 长端重复(LTR)
腺病毒E1A HCMV主要IE增强子/启动子
单纯疱疹病毒VP16 单纯疱疹病毒基因启动子是
IE175(美国专利第6,635,478号)
B型肝炎病毒X蛋白质(HBx) SV40早期
合成的Zn-指蛋白质 合成的
SV40大T抗原 SV40晚期启动子
四环素-控制的反式激活蛋白(tTA)合成的
人类细胞巨大病毒IE2p86 HCMV主要IE增强子/启动子
人类细胞巨大病毒IE1p72 HCMV主要IE增强子/启动子
Epstein-barr病毒R反式激活蛋白(Rta) EBV启动子
甲状腺激素受体 生长激素启动子
糖皮质激素受体 乳腺瘤病毒(MMTV)启动子
优选的是,以编码反式激活蛋白之表达构建体转染细胞系,并使用限制稀释或其它适合单一细胞克隆的方法选择克隆。表达载体可包括诸如启动子、选择标记等等的组件,如同本文对于表达载体描述的。优选的是,控制反式激活蛋白之表达的启动子是组成的启动子,如延伸因子1启动子、CMV启动子、金属硫蛋白-1启动子或类似者。在优选的具体实施方案中,该启动子是CMV启动子。
至于制造多克隆抗-RSV抗体,每个抗-RSV抗体成员均由2个多肽链组成,链的组合对于其形成之抗-RSV抗体的亲和力、特异性和活性是很重要的。为了这个理由,优选的是将组成多克隆抗-RSV抗体之独特成员的多肽链放在用于整合的相同载体中,藉此确保在整个过程中将它们保持在一起。或者,可利用成对的表达载体(其编码关联的重链和轻链对)转染宿主细胞。
下列的说明是如何获得表达重组多克隆抗-RSV抗体之细胞系的实例。
可供组成表达的通用启动子盒具有两个启动子,以相反的转录方位安置,如可构建头-对-头结构,周围有可变重链和整个κ或λ轻链,允许将整个构建体运送至包括选择标记和重链恒定区的载体内。考虑到亦可使用适合可诱导表达的启动子盒。此外,可将启动子安排成尾-对-尾,其结果产生相反方向的转录,或尾-对-头,以供单一方向的转录。亦可为了控制表达而使用可诱导之启动子。在转染之后,优选的是在选择性条件下培养细胞,以选择稳定的转型物。
接着可使在这些条件下存活的细胞在不同的培养系统中生长,如传统的小型培养烧瓶、Nunc多层细胞工厂、小型高产量生物反应器(MiniPerm,INTEGRA-CELLine)和转瓶,以使纤维-和生物反应器WAVE袋凹陷(hollow)(Wave Biotech,Tagelswangen,Switzerland)。优选的是可使用ELISA测试细胞的抗体生产。在不含血清之培养基中,在选择压力下长时间,就悬浮生长之存活能力来选择多克隆细胞系。
在表达系统中评估多克隆性的维持
根据本发明,在表达系统中确保多克隆性经常是很重要的,其在生产期间并没有被严重地改变,以致于在真的改变多克隆性时,便可能停止生产。这可通过监视变体核酸序列的相对表达水平,根据本发明来进行。例如,可在mRNA层面,使用例如RFLP分析、阵列或实时PCR来监视表达水平,或在蛋白质层面,使用例如二维聚丙烯酰氨凝胶电泳、质谱分析或各种层析技术来监视表达水平。关于这些技术,可能会对所有个别表达水平中的一些,建立基准线值,然后在生产期间从培养物中取出试样,以便测量表达水平是否已经改变(总量和相对上两者)。在本发明的正常实施中,可建立在基准线值周围的数值范围,且若发现相对表达水平是在该范围之外,便终止生产。
细胞的培养和重组多克隆抗-RSV抗体的生产
在本文中描述之方法亦适用于制造本发明之单克隆抗-RSV抗体。
可使如上述生产的多克隆细胞系,在适合表达由插入细胞之基因组内的变体核酸序列编码之多克隆抗-RSV抗体的条件下,生长在适当的培养基中。可以数个步骤进行细胞培养。当使用哺乳动物细胞时,优选的是使所选出之细胞适应生长在悬浮液以及不含血清的条件下。亦可在为了多克隆细胞系而混合经克隆细胞系之前,有利地进行生长在不含血清之培养基中的适应。可在一或两个步骤中,有或无选择压力下,进行适应。优选的是使用选择系统,其允许在整个制造期间中选择,不会损害所制造之药物产品的纯度。通常,为了制造药学用途的重组抗-RSV抗体,其优选的是不使用例如抗生素或其它低分子量的药物来提供选择压力,因为其会需要确认终产物不含任何微量的抗生素。
当多克隆细胞系适应适当的条件时,可开始按比例放大。在此时可将多克隆工作细胞原料(多克隆工作细胞库,pWCB)和/或多克隆主细胞库(pMCB)冷冻。优选的是使用在30到100公升之间的生物反应器,但亦可使用较小(5-10公升)或较大(高达1,000、5,000、10,000、15,000公升或甚至更大)的生物反应器。适当的生产时间和生物反应器大小的选择,视来自该批之想要的蛋白质产量和来自该细胞系之表达水平而定。时间可从几天到最多三个月。可从细胞或上清液中回收所表达的重组多克隆抗-RSV抗体。可根据本领域技术人员已知的程序,纯化该重组抗-RSV抗体并鉴定特征。下文列举纯化程序的实例。可在例如WO 2006/007853中找到鉴定特征之程序的实例。
从培养物上清液中纯化重组多克隆抗-RSV抗体
可能使用各种层析技术(其利用在蛋白质之物理-化学特性上的差异,例如在分子量、净电荷、疏水性或对特定配体或蛋白质之亲和力上的差异),从培养物上清液中分离抗-RSV抗体。因此可根据分子量,使用凝胶过滤层析法,或根据净电荷,使用离子-交换(阳离子/阴离子)层析法,或另外使用层析聚焦法,分离蛋白质。同样地,可根据疏水性,使用疏水性交互作用,或电荷诱导层析法或亲和力层析法,利用在对特定经固定配体或蛋白质之亲和力上的差异,分离蛋白质。因此,可通过各种层析原理的连续组合,达成蛋白质之复合混合物,如抗-RSV抗体的纯化。
为了从例如细胞培养物上清液中纯化IgG(多克隆和单克隆的),经常使用与后续纯化步骤(如离子-交换层析法、疏水性交互作用和凝胶过滤)组合的亲和力层析法。亲和力纯化(其中该分离是基于在蛋白质和与层析基质偶联之特定配体之间的可逆交互作用)是一种容易且迅速的方法,其提供高选择性,通常在较小的体积中有高容量和浓度。蛋白质A和蛋白质G,两个细菌细胞表面蛋白质,对Fc区有高亲和力,并已经以经固定之形式用在许多例行的应用中,包括从各种物种中纯化单-和多克隆IgG及其亚类,以及免疫复合体的吸附和纯化。
在亲和力层析之后,可进行下游层析步骤,例如离子-交换和/或疏水性交互作用层析法,以移除宿主细胞蛋白质、漏出的蛋白质A和DNA。
可使用凝胶过滤(作为最后的纯化步骤),以移除污染分子,如二聚体和其它集合体,并将试样运送至储存缓冲溶液内。依据来源和表达条件,可能有必要纳入额外的纯化步骤,以达到所需的抗体纯度水平。因此,经常将疏水性交互作用层析法或离子-交换层析法与蛋白质A和凝胶过滤层析法组合,以纯化治疗用途的抗体。
为了易于纯化,优选的是该多克隆抗-RSV抗体的所有成员都共享相同的重和/或轻链恒定区。
为了纯化其它种类的抗体,必须使用供选择的亲和力层析介质,因为蛋白质A和G不与IgA和IgM结合。可使用免疫亲和力纯化(与固相偶联的抗-IgA或抗-IgM单克隆抗体),或者,可使用包括离子-交换和疏水性交互作用的多步骤纯化策略。
可使用应用已有之最高技术的方法,纯化在本文中揭示的单克隆抗体之一。
鉴定结构特征
鉴定多克隆抗-RSV抗体之结构特征需要高分辨率,因为混合物的复杂性(克隆多样性和糖基化)。诸如凝胶过滤、离子-交换层析法或电泳之类的传统方法,可能没有足够的分辨率,以辨别个别的抗体。已经使用二-维聚丙烯酰氨凝胶电泳(2D-PAGE)来描绘复杂的蛋白质混合物,接着是质谱分析(MS)或液体层析(LC)-MS(例如蛋白质组研究)。已经证明2D-PAGE(其组合基于蛋白质电荷和质量的分离)可用来辨别在血清试样中的多克隆、寡株和单克隆免疫球蛋白。然而,该方法有一些限制。层析技术,特别是与电喷雾离子化MS偶联的毛细管和LC,越来越适用于复杂肽混合物的分析。已经使用LC-MS鉴定单克隆抗体的特征。极为复杂之试样的分析,需要解析力更高的层析系统,可通过以二维(或更多)分离而获得。这类方法可在第一维中基于离子-交换,而在第二维中则基于逆-向层析法(或疏水性交互作用),视需要与MS偶联。
鉴定功能特征
例如可经由与对相同靶具有特异性或具有类似活性之抗-RSV抗体的比较研究,鉴定单-和多克隆抗-RSV抗体的功能特征。可在体外和在活体内进行这类研究。
在体外鉴定多克隆抗体之功能特征,可能是例如免疫沉淀,其为高度特异的技术,用以从粗制的细胞裂解物中分析分离靶抗原。通过将免疫沉淀与其它技术结合,如SDS-PAGE,接着是蛋白质染色(考马斯蓝、银染色或以生物素标示)和/或免疫印迹,例如有可能检测并定量抗原,并藉此评估抗体的某些功能特性。虽然该方法不能提供抗体分子数目的估计,也不能提供它们的结合亲和力,但提供了靶蛋白质的可视化,并因此提供特异性。同样地可使用该方法来监视在表达期间内,抗体针对抗原的可能差异(克隆多样性的完整性)。
在活体内鉴定单-或多克隆抗体之功能特征,可能是例如感染研究。例如,可利用RSV感染业已对其发展出多克隆抗-RSV抗体的实验动物-如小鼠。其可抑制该感染的程度,会代表该多克隆抗-RSV抗体的机能性。
治疗组合物
在本发明之具体实施方案中,打算将包括重组单-和多克隆抗-RSV抗体(作为其活性成分)的医药组合物,用来治疗或预防哺乳动物中之疾病,优选的是与在药学上可接受之赋形剂一起。
以原本已知的方式,制备本发明之医药组合物,例如通过传统的溶解、冷冻干燥、混合、粒化或confection制备。可根据传统的药学原则(参见例如,在雷明顿:制药的科学和实行(Remington:The Science and Practice ofPharmacy)(第20版),编辑A.R.Gennaro,2000,Lippincott Williams&Wilkins,Philadelphia,PA,以及药学技术的百科全书(Encyclopedia of PharmaceuticalTechnology),编辑J.Swarbrick和J.C.Boylan,1988-1999,Marcel Dekker,NewYork,NY),调配医药组合物。
优选的是使用活性成分之溶液,还有悬浮液,且特别是等张含水溶液或悬浮液,在例如经冷冻干燥组合物的情况下,其可能仅包括活性成分或与载剂一起,例如甘露糖醇,在使用之前才产生这类溶液或悬浮液。可将医药组合物灭菌,和/或其可包括赋形剂,例如防腐剂、稳定剂、湿润剂和/或乳化剂、促溶剂、调节渗透压的盐类和/或缓冲溶液,并以原本已知的方式制备,例如通过传统的溶解或冷冻干燥制备。该溶液或悬浮液可包括增粘物质,如羧甲基纤维素钠、羧甲基纤维素、葡聚糖、聚乙烯吡咯烷酮或明胶。
在无菌条件下以惯用方式制备注射组合物;同样亦适用于将该组合物导入安瓿或小瓶中,并密封该容器。
医药组合物可包括从大约1%到大约95%,优选的是从大约20%到大约90%的活性成分。根据本发明的医药组合物可以是例如单位剂型,如呈安瓿、小瓶、栓剂、糖衣锭、锭剂或胶囊之形式。
根据本发明之组合物的治疗用途
根据本发明,通过本发明之方法制造的医药组合物,可用来在哺乳动物中治疗、改善或预防RSV感染。
本发明一方面是在动物中治疗、改善或预防疾病的方法,其中投与有效量的该重组多克隆抗-RSV抗体或抗体片段。
实施例
下列的实施例解释本发明,但不应视为对本发明之范围的限制。
实施例1人类抗-RSV抗体的克隆和测序
在本实施例中,解释了含有关联VH和VL对(以具有抗-RSV特异性的全长抗体表达)之克隆的分离、筛选、选择和存于库。使用SymplexTM关联对克隆技术(Mejier等人,2006,J.Mol.Biol,358:764-772;WO 2005/042774)进行关联(cognate)对的克隆和连接。在同在申请中之PCT/DK2007/000113中描述了人类抗-RSV抗体的克隆、鉴定特征和功能测试。
供体
简言之,在RSV季节期间,在员工和在Hvidovreu医院小儿科部(Department of Paediatrics)(Denmark)住院儿童的父母中,招募总共89个供体。一开始抽取18毫升的血液试样,纯化CD19+B细胞,并使用ELISpot筛选抗-RSV抗体的存在,然后通过FACS分析决定浆细胞的频率。
在筛选最初的血液试样时发现有11个供体是阳性的,然后从这些的10个人中收集第二次450毫升的血液试样。对浆母细胞(plasma blast)进行单一细胞挑选,并在一部分CD19阳性B细胞上执行ELISpot。
在第二次捐血时,确认4位供体具有在0.2到0.6%之间,总浆细胞群之RSV特异性浆细胞(IgG+和IgA+)的ELISpot频率。认为这些频率高得足以进行关联VH和VL对的连接。
关联VH和VL密码对的分离
通过多重重迭-延伸RT-PCR,从来自五个供体之经单一细胞-挑选的浆细胞中分离编码抗体指令目录的核酸。该多重重迭-延伸RT-PCR,在重链可变区基因片段(VH)和全长轻链(LC)之间,创造物理连接。通过两组引子(一组用来扩增VH,一组则用来扩增κLC),设计扩增全部VH-基因家族之抗体基因和κ轻链的草案。在逆转录和多重重迭-延伸PCR之后,利用嵌套的引物组,使所连接之序列接受第二次PCR扩增。
分别处理每个供体,并通过多重重迭-延伸RT-PCR产生1480到2450个重迭产物。集合来自每个供体之关联经连接VH和VL密码对的经产生集合,并插入哺乳动物IgG表达载体内。将所产生之所有组成成分转化至大肠杆菌内,并合并成二十个384-孔的主培养盘,然后储存。每个供体的所有组成成分由1x106到3.6x106个克隆组成。
鉴定个别抗体之抗原特异性的特征
通过FLISA、ELISA和表面电浆子共振(SPR;Biacore)评估它们对单一RSV抗原(重组G蛋白质、重组或经纯化之F蛋白质)或其肽片段(G蛋白质的经保守区和半胱氨酸-核心基序、A和B亚型,以及SH蛋白质之细胞外功能部位、A和B亚型)之结合特异性,确认在筛选期间鉴认出的抗体。在ELISA中,通过与完全鉴定特征的商业抗体(在表2中显示其中一些)竞争,决定抗原决定位特异性。在鉴定本发明之每个个别抗体的特征时,不一定使用所有在表2中显示的抗体。简言之,以大量过量-即提供75%最大结合者100倍的浓度,凭经验决定(Ditzel等人,J.Mol.Biol.1997,267:684-695),将用于抗原决定位封闭的抗体或抗体片段与经固定抗原(RSV Long颗粒,HyTest)一起培养。在洗涤之后,将个别抗体克隆与各种浓度的经封闭抗原一起培养,并根据标准ELISA草案,使用山羊-抗-人类HRP共轭物(Serotec)检测任何经结合的人类IgG。在Biacore中,使用饱和浓度(凭经验决定)的封闭和探测抗体两者,通过在不同抗体克隆之间的逐对竞争,进一步鉴定抗原决定位特异性之特征。通过使用直接氨偶联(Biacore)作为抗原,固定经纯化之F或G蛋白质。在基于ELISA和Biacore的抗原决定位作图两者中,将在抗原决定位封闭之后的降低结合与未经竞争的结合作比较。
表2:用于抗-F和抗-G抗体之抗原决定位作图的单克隆抗体
MAb/Fab | 抗原 | 抗原性位置 | 抗原决定位(氨基酸) | 参考文献 |
131-2a | F | F1 | F1a | 1,2 |
MAb/Fab | 抗原 | 抗原性位置 | 抗原决定位(氨基酸) | 参考文献 |
9C5 | F | F1 | F1a | 5 |
92-11c | F | F1 | F1b | 1,2 |
102-10b | F | F1 | F1c | 1,2 |
133-1h | F | C | F2 | 1,2,3 |
130-8f | F | C | F2(241/421) | 1,2,3,4 |
143-6c | F | A/II | F3 | 1,2,3 |
帕利珠单抗(Palivizumab) | F | A/II | (272) | 8 |
1153 | F | A/II | (262) | 3,4 |
1142 | F | A/II | 3 | |
1200 | F | A/II | (272) | 2,4 |
1214 | F | A/II | (276) | 3,4 |
1237 | F | A/II | (276) | 3,4 |
1129 | F | A/II | (275) | 3,4 |
1121 | F | A/II | 3 | |
1112 | F | B/I | (389) | 3,6 |
1269 | F | B/I | (389) | 3,6 |
MAb/Fab | 抗原 | 抗原性位置 | 抗原决定位(氨基酸) | 参考文献 |
1243 | F | C | (241/421) | 3,6 |
Fab 19 | F | A/II | (266) | 7 |
MAb/Fab | 抗原 | 抗原性位置 | 抗原决定位(氨基酸) | 参考文献 |
RSVF2-5 | F | IV | (429) | 4 |
Mab19 | F | IV | (429) | 12 |
7.936 | F | V | (432-447) | 13 |
9.432 | F | VI | (436) | 13 |
63-10f | G(A) | G11 | GCRR(A171-187) | 1,2 |
130-6d | G(A) | G12 | (A174-214) | 1,2,9 |
131-2g | G(A+B) | G13 | (150-173) | 1,2,9 |
143-5a | G(A+B) | G5a | 2 | |
L9 | G(A+B) | A1/B1 | 保守的(164-176) | 14,15 |
8C5 | G | ND | 5 | |
1C2 | G(A) | ND | GCRR(A172-188) | 10,11 |
3F4 | G(A) | ND | 10,11 | |
4G4 | G(A) | ND | GCRR(A172-188) | 10,11 |
“抗原”栏代表被Mab/Fab结合的RSV关联抗原,且若已知亚型特异性,便以()表示。”抗原决定位(氨基酸)“栏代表被Mab/Fab识别出之抗原决定位的名称,此外在()中的氨基酸位置导致RSV逃逸(escape)突变种,或表示已经对其显示结合的肽/蛋白质片段。在表2中提供经编号的参考文献与下列相符:
1.Anderson等人,J.Clin.Microbiol.1986,23:475-480。
2.Anderson等人,J.Virol.1988,62:1232-4238。
3.Beeler&van Wyke Coelingh,J.Virol.1989,63:2941-2950。
4.Crowe等人,JID 1998,177:1073-1076。
5.Sominina等人,Vestn Ross Akad Med Nauk 1995,9:49-54。
6.Collins等人,Fields Virology,第1313-1351页。
7.Crowe等人,Virology 1998,252:373-375。
8.Zhao&Sullender,J.Virol.2004,79:3962-3968。
9.Sullender,Virology 1995,209:70-79。
10.Morgan等人,J.Gen.Virol.1987,68:2781-2788。
11.McGill等人,J.Immunol.Methods 2005,297:143-152。
12.Arbiza等人,J.Gen.Virol.1992,73:2225-2234。
13.Lopez等人J.Virol.1998,72:6922-6928。
14.Walsh等人,J.Gen.Virol.1989,70:2953-2961。
15.Walsh等人,J.Gen.Virol.1998,79:479-487。
此外,亦可通过FACS,从与以不同RSV菌种(Long和B1)感染之人类喉上皮HEp-2细胞(ATCC CLL-23)结合的观点,鉴定抗体克隆的特征。简言之,在不含血清之培养基中,以0.1pfu/细胞之比例,利用RSV Long(ATCC编号VR-26)菌种或RSV B1(ATCC编号VR-1400)菌种感染HEp-2细胞,持续24(Long菌种)或48小时(B1菌种)。在分离及洗涤之后,将细胞分配到96-孔培养盘中,并在37℃下与个别抗-RSV抗体之稀释物(4pM-200uM)一起培养1小时。以1%仲甲醛固定细胞,并通过在4℃下与山羊F(ab)2抗-人类IgG-PE共轭物(Beckman Coulter)一起培养30分钟,检测细胞表面-所结合之抗体。以类似方式分析对模仿-感染之HEp-2细胞的结合。亦通过ELISA,测试鉴认为蛋白质-G特异性之所选出克隆,与重组人类人神经趋化蛋白(fractalkine)(CX3CL1;R&D Systems)的交叉-反应性。使用抗-人类CX3CL1/人神经趋化蛋白单克隆抗体(R&D Systems)作为阳性对照组。
筛选
从以DNA(从来自主培养盘之细菌克隆来制备)暂时转染之CHO细胞中收获含有IgG抗体的上清液,并针对与RSV抗原之结合来筛选。将大约600个最初的命中测序和比对。大多数落在二或多个成员的群簇中,但亦有些克隆仅分离一次,所谓的单例(singleton)。使来自每个群簇的代表性克隆和单例接受确认研究。从更进一步鉴定特征中排除若干最初的命中,因为不想要的序列特征,如不成对的半胱氨酸、非-保守性突变,其为可能的PCR错误、多个密码子的插入和/或缺失,以及截短。
总共85个独特的克隆通过该确认。在表3中概述这些。每个克隆编号指定特定的VH和VL对。指出每个克隆的IGHV和IGKV基因家族,并列举所选出之克隆的架构区(FR)。显示从每个克隆中表达之抗体的互补性决定区(CDR)之氨基酸序列,其中CDRH1、CDRH2、CDRH3代表重链的CDR区1、2和3,且CDRL1、CDRL2和CDRL3代表轻链的CDR区1、2和3。
可从在表3中的信息,建立完整的可变重链和轻链序列。
下文提供表3之个别栏的更多细节。
根据官方HUGO/IMGT命名法(IMGT;lefranc&Lefranc,2001,免疫球蛋白纲要(The Immunoglobulin FactsBooks),Academic Press),指派IGHV和IGKV基因家族名称。根据Chothia(Al-Lazikani等人1997J.Mol.Biol.273:927-48)编号及排列。克隆809在CDRH1的5’具有2个密码子插入,其可能翻译成经延伸之CDR环。克隆831在CDRH1中位置31处有1个密码子缺失。
“Ag栏”代表被从已命名克隆中生产之抗体认出的RSV关联抗原,是通过ELISA、FLISA和/或Biacore确定。”+”代表与RSV颗粒和/或经RSV感染之细胞结合的克隆,但尚未鉴认出抗原。
“抗原决定位”栏代表被从已命名克隆中生产之抗体认出的抗原性位置或抗原决定位。”U”代表未知的抗原决定位。UC I和UC II意指未知的群簇I和II。属于这些群簇的抗体具有类似的反应性模式,但目前尚未指派特定的抗原决定位。某些抗体认出复杂的抗原决定位,如A&C。以()表示之抗原决定位仅曾在ELISA中鉴认。
以相同的顺序,在SEQ ID NO:201-285中显示在称为CDRH1之字段中从上到下的氨基酸序列。
以相同的顺序,在SEQ ID NO:286-370中显示在称为CDRH2之字段中从上到下的氨基酸序列。
以相同的顺序,在SEQ ID NO:371-455中显示在称为CDRH3之字段中从上到下的氨基酸序列。
以相同的顺序,在SEQ ID NO:456-540中显示在称为CDRL1之字段中从上到下的氨基酸序列。
以相同的顺序,在SEQ ID NO:541-625中显示在称为CDRL2之字段中从上到下的氨基酸序列。
以相同的顺序,在SEQ ID NO:626-710中显示在称为CDRL3之字段中从上到下的氨基酸序列。
结合动力学的特征
对许多抗体克隆,通过表面电浆子共振决定重组RSV抗原的结合亲和力。利用通过全长抗体之酶切开制备的Fab片段进行分析。在表4中提出一些具有范围在picomolar到nanomolar中之KD值的高亲和力抗体克隆的数据。以类似方式分析衍生自市售帕利珠单抗(赛纳吉(Synagis))之Fab片段,以供参考。
表4:所选出之克隆的动力学结合常数和亲和力
Fab克隆(抗原) | kon(105M-1秒-1) | koff(10-51/秒) | t1/2(分钟) | KD(pM) |
735(F) | 4.07 | 9.18 | 130 | 226 |
810(F) | 17.40 | 34.80 | 33 | 200 |
818(F) | 1.92 | 2.20 | 530 | 115 |
817(F) | 0.92 | 7.54 | 150 | 820 |
819(F) | 3.56 | 4.99 | 230 | 140 |
825(F) | 7.72 | 15.00 | 77 | 195 |
858(F) | 4.97 | 0.34 | 3400 | 7 |
831(F) | 3.72 | 42 | 28 | 1130 |
796(G) | 8.33 | 40.3 | 28.67 | 480 |
811(G) | 4.98 | 17.1 | 68 | 340 |
Fab克隆(抗原) | kon(105M-1秒-1) | koff(10-51/秒) | t1/2(分钟) | KD(pM) |
816(G) | 20.20 | 17.80 | 65 | 90 |
838(G) | 2.64 | 5.06 | 230 | 190 |
853(G) | 17.7 | 140 | 8.25 | 790 |
859(G) | 3.8 | 4.63 | 250 | 120 |
赛纳吉(F) | 2.00 | 75.70 | 15 | 3780 |
代表性人类抗-RSV抗体的序列
在SEQ ID NO:1-176中所示44个所选出之克隆的全序列(DNA和推论的氨基酸),该克隆分别表达来自单一关联VH和VL基因序列(克隆编号735、736、744、793、795、796、799、800、801、804、810、811、812、814、816、817、818、819、824、825、827、829、830、831、835、838、841、853、855、856、857、858、859、861、863、868、870、871、880、881、884、886、888、894)的独特抗体。
通过产生以下的VH序列(在SEQ ID NO:1-44中陈述之),鉴定44个克隆之特征:
克隆735号:
QVQLQESGPGLVKPSETLSLTCTVSNGAIGDYDWSWIRQSPGKGLEWIGN
INYRGNTNYNPSLKSRVTMSLRTSTMQFSLKLSSATAADTAVYYCARDVG
YGGGQYFAMDVWSPGTTVTVSS
克隆736号:
QVQLVESGGGVVQPGGSLRLSCTASGFTFSTYGMHWVRQAPGKGLEWV
AFIRYDGSTQDYVDSVKGRFTISRDNSKNMVYVQMNSLRVEDTAVYYCA
KDMDYYGSRSYSVTYYYGMDVWGQGTTVTVSS
克隆744号:
QVQLVQSGAEVKKPGASVKVSCKASGYTFSGYYMHWVRQAPGQGLEW
MGWINTSSGGTNYAQKFQGRVTMTRDTSISTAHMELRRLRSDDTAVYYC
AREDGTMGTNSWYGWFDPWGQGTLVTVSS
克隆793号:
QVQLVESGGGLVKPGGSLRLSCAASGFPFGDYYMSWIRQAPGKGLEWVA
YINRGGTTIYYADSVKGRFTISRDNAKNSLFLQMNSLRAGDTALYYCARG
LIIALPTATVELGAFDIWGQGTMVTVSS
克隆795号:
QVQLQESGPGLVKPSQTLSLTCTVSGASISSGDYYWSWIRQSPRKGLEWI
GYIFHSGTTYYNPSLKSRAVISLDTSKNQFSLRLTSVTAADTAVYYCARDV
DDFPVWGMNRYLALWGRGTLVTVSS
克隆796号:
QVQLVESGGGVVQPGRSLRLSCAASGFSFSHFGMHWVRQVPGKGLEWV
AIISYDGNNVHYADSVKGRFTISRDNSKNTLFLQMNSLRDDDTGVYYCA
KDDVATDLAAYYYFDVWGRGTLVTVSS
克隆799号:
QVQLVESGGGVVQPGRSLKLSCEASGFNFNNYGMHWVRQAPGKGLEWV
AVISYDGRNKYFADSVKGRFIISRDDSRNTVFLQMNSLRVEDTAVYYCAR
GSVQVWLHLGLFDNWGQGTLVTVSS
克隆800号:
QVQLVESGGAVVQPGRSLRLSCEVSGFSFSDYGMNWVRQGPGKGLEWV
AVIWHDGSNKNYLDSVKGRFTVSRDNSKNTLFLQMNSLRAEDTAVYYCA
RTPYEFWSGYYFDFWGQGTLVTVSS
克隆801号:
QVQLVESGGGVVQPGRSLRLSCAASGFPFNSYAMHWVRQAPGKGLEWV
AVIYYEGSNEYYADSVKGRFTISRDNSKNTLYLQMDSLRAEDTAVYYCAR
KWLGMDFWGQGTLVTVSS
克隆804号:
EVQLVESGGGLVRPGGSLRLSCSASGFTFSNYAMHWVRQAPGKRLEYVS
ATSTDGGSTYYADSLKGTFTISRDNSKNTLYLQMSSLSTEDTAIYYCARRF
WGFGNFFDYWGRGTLVTVSS
克隆810号:
QVQLVQSGAEVKKSGS SVKVSCRASGGTFGNYAINWVRQAPGQGLEWV
GRIIPVFDTTNYAQKFQGRVTITADRSTNTAIMQLSSLRPQDTAMYYCLRG
STRGWDTDGFDIWGQGTMVTVSS
克隆811号:
QVQLVQSGAVVETPGASVKVSCKASGYIFGNYYIHWVRQAPGQGEWM
AVINPNGGSTTSAQKFQDRITVTRDTSTTTVYLEVDNLRSEDTATYYCAR
QRSVTGGFDAWLLIPDASNTWGQGTMVTVSS
克隆812号:
QVQLVQSGAEMKKPGSSVKVSCKASGGSFSSYSISWVRQAPGRGLEWVG
MILPISGTTYAQTFQGRVIISADTSTSTAYMELTSLTSEDTAVYFCARVFRE
F STSTLDPYYFDYWGQGTLVTVSS
克隆814号:
QVQLVESGGGVVQPGKSVRLSCVGSGFRLMDYAMHWVRQAPGKGLDW
VAVISYDGANEYYAESVKGRFTVSRDNSDNTLYLQMKSLRAEDTAVYFC
ARAGRSSMNEEVIMYFDNWGLGTLVTVSS
克隆816号:
EVQLLESGGGLVQPGGSLRLSCVASGFTFSTYAMTWVRQAPGKGLEWVS
VIRASGDSEIYADSVRGRFTISRDNSKNTVFLQMDSLRVEDTAVYFCANIG
QRRYCSGDHCYGHFDYWGQGTLVTVSS
克隆817号:
QVQLVESGGGVVQPGRSLRLSCAASGFGFNTHGMHWVRQAPGKGLEWL
SIISLDGIKTHYADSVKGRFTISRDNSKNTVFLQLSGLRPEDTAVYYCAKD
HIGGTNAYFEWTVPFDGWGQGTLVTVSS
克隆818号:
QVTLRESGPAVVKPTETLTLTCAFSGFSLNAGRVGVSWIRQPPGQAPEWL
ARIDWDDDKAFRTSLKTRLSISKDSSKNQVVLTLSNMDPADTATYYCART
QVFASGGYYLYYLDHWGQGTLVTVSS
克隆819号:
QVQLQESGPGLVKPSQTLSLTCTVSSGAISGADYYWSWIRQPPGKGLEWV
GFIYDSGSTYYNPSLRSRVTISIDTSKKQFSLKLTSVTAADTAVYYCARDLG
YGGNSYSHSYYYGLDVWGRGTTVTVSS
克隆824号:
QVQLQESGPGLVKPSETLSLTCTVSGGSIGNYYWGWIRQPPGKGLEWIGH
IYFGGNTNYNPSLQSRVTISVDTSRNQFSLKLNSVTAADTAVYYCARDSSN
WPAGYEDWGQGTLVTVSS
克隆825号:
QVQLVQSGAEVKKPGASVKVSCKVSGYTFTSNGLSWVRQAPGQGFEWL
GWISASSGNKKYAPKFQGRVTLTTDISTSTAYMELRSLRSDDTAVYYCAK
DGGTYVPYSDAFDFWGQGTMVTVSS
克隆827号:
QVQLVQSGAEVKKPGASVKVSCRVSGHTFTALSKHWMRQGPGGGLEW
MGFFDPEDGDTGYAQKFQGRVTMTEDTARGTAYMELSSLTSDDTAVYYC
ATVAAAGNFDNWGQGTLVTVSS
克隆829号:
QVTLKESGPALVKATQTLTLTCTFSGFSLSRNRMSVSWIRQPPGKALEWL
ARIDWDDDKFYNTSLQTRLTISKDTSKNQVVLTMTNMDPVDTATYYCAR
TGIYDS SGYYLYYFDYWGQGTLVTVSS
克隆830号:
QVQLVQSGAEVKVPGASVKVSCKASGYTFTTYGVSWVRQAPGQGLEW
MGWISAYNGNTYYLQKLQGRVTMTTDTSTSTAYMELRGLRSDDTAMYY
CARDRVGGSSSEVLSRAKNYGLDVWGQGTTVTVSS
克隆831号:
QVQLVQSGAEVKKPGASVKVSCKASANIFTYAMHWVRQAPGQRLEWM
GWINVGNGQTKYSQRFQGRVTITRDTSATTAYMELSTLRSEDTAVYYCAR
RASQYGEVYGNYFDYWGQGTLVTVSS
克隆835号:
QVQLVQSGAEVKRPGASVKVSCKASGYTFISYGFSWVRQAPGQGLEWM
GWSSVYNGDTNYAQKFHGRVNMTTDTSTNTAYMELRGLRSDDTAVYFC
ARDRNVVLLPAAPFGGMDVWGQGTMVTVSS
克隆838号:
QVQLVESGGGVVQPGTSLRLSCAASGFTFSTFGMHWVRQAPGKGLEWV
AVISYDGNKKYYADSVKGRFTISRDNSKNTLYLQVNSLRVEDTAVYYCAA
QTPYFNESSGLVPDWGQGTLVTVSS
克隆841号:
QVQLVQSGAEVKKPGASVKVSCKASGYTFISFGISWVRQAPGQGLEWMG
WISAYNGNTDYAQRLQDRVTMTRDTATSTAYLELRSLKSDDTAVYYCTR
DESMLRGVTEGFGPIDYWGQGTLVTVSS
克隆853号:
EVQLVQSGAEVKKPGQSLKISCKTSGYIFTNYWIGWVRQRPGKGLEWMG
VIFPADSDARYSPSFQGQVTISADKSIGTAYLQWSSLKASDTAIYYCARPK
YYFDSSGQFSEMYYFDFWGQGTLVTVSS
克隆855号:
QVQLVQSGPEVKKPGASVKVSCKASGYVLTNYAFSWVRQAPGQGLEWL
GWISGSNGNTYYAEKFQGRVTMTTDTSTSTAYMELRSLRSDDTAVYFCAR
DLLRSTYFDYWGQGTLVTVSS
克隆856号:
QVQLVQSGAEVKKPGASVKVSCKASGYTFSNYGFSWVRQAPGRGLEWM
GWISAYNGNTYYAQNLQGRVTMTTDTSTTTAYMVLRSLRSDDTAMYYC
ARDGNTAGVDMWSRDGFDIWGQGTMVTVSS
克隆857号:
EVQLLESGGGLVQPGGPLRLSCVASGFSFSSYAMNWIRLAPGKGLEWVSG
ISGSGGSTYYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKEP
WIDIVVASVISPYYYDGMDVWGQGTTVTVSS
克隆858号:
QVQLVQSGAEVKKPGSSVKVSCKASGGSFDGYTISWLRQAPGQGLEWM
GRVVPTLGFPNYAQKFQGRVTVTADRSTNTAYLELSRLTSEDTAVYYCAR
MNLGSHSGRPGFDMWGQGTLVTVSS
克隆859号:
QVQLVESGGGVVQPGRSLRLSCAVSGSSFSKYGIHWVRQAPGKGLEWVA
VISYDGSKKYFTDSVKGRFTIARDNSQNTVFLQMNSLRAEDTAVYYCATG
GGVNVTSWSDVEHSSSLGYWGLGTLVTVSS
克隆861号:
QVQLVESGGGVVQPGGSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWV
AFIWNDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCV
KDEVYDSSGYYLYYFDSWGQGTLVTVSS
克隆863号:
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYTMSWVRQAPGKGLEWVS
SISASTVLTYYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAVYYCAKD
YDFWSGYPGGQYWFFDLWGRGTLVTVSS
克隆868号:
QVQLQESGPGLVTPSETLSVTCTVSNYSIDNAYYWGWIRQPPGKGLEWIG
SIHHSGSAYYNSSLKSRATISIDTSKNQFSLNLRSVTAADTAVYYCARDTIL
TFGEPHWFDPWGQGTLVTVSS
克隆870号:
QVQLQESGPGLVKPSETLSLTCTVSGDSISNYYWSWIRQPPGKGLEWIGEI
SNTWSTNYPSLKSRVTISLDMPKNQLSLKLSSVTAADTAVYYCARGLFY
DSGGYYLFYFQHWGQGTLVTVSS
克隆871号:
QVQLVESGGGVVQPGRSLRVSCAASGFTFSNYGMHWVRQAPGKGLEWV
AVIWYDDSNKQYGDSVKGRFTISRDNSKSTLYLQMDRLRVEDTAVYYCA
RASEYSISWRHRGVLDYWGQGTLVTVSS
克隆880号:
QITLKESGPTLVRPTQTLLTCTFSGFSLSTSKLGVGWIRQPPGKALEWLAL
VDWDDDRRYRPSLKSRLTVTKDTSKNQVVLTMTNMDPVDTATYYCAHS
AYYTSSGYYLQYFHHWGPGTLVTVSS
克隆881号:
EVQLVESGGGVVQPGGSLRLSCEVSGFTFNSYEMTWVRQAPGKGLEWV
SHIGNSGSMIYYADSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCAR
SDYYDSSGYYLLYLDSWGHGTLVTVSS
克隆884号:
QVQLVQSGAEVRKPGASVKVSCKASGHTFINFAMHWVRQAPGQGLEW
MGYINAVNGNTQYSQKFQGRVTFTRDTSANTAYMELSSLRSEDTAVYYC
ARNNGGSAIIFYYWGQGTLVTVSS
克隆886号:
QVQLVESGGGVVQPGRSLRLSCAASGFSFSSYGMHWVRQAPGKGLEWV
AVISNDGSNKYYADSVKGRFTISRDNSKKTMYLQMNSLRAEDTAVYFCA
KTTDQRLLVDWFDPWGQGTLVTVSS
克隆888号:
QLQLQESGPGLVKPSETLSLTCTASGGSINSSNFYWGWIRQPPGKGLEWIG
SIFYSGTTYYNPSLKSRVTISVDTSKNQFSLKLSPVTAADTAVYHCARHGF
RYCNNGVCSINLDAFDIWGQGTMVTVSS
克隆894号:
QVQLVESGGGVVQPGKSLRLSCAASGFRFSDYGMHWVRQAPSKGLEWV
AVIWHDGSNIRYADSVRGRFSISRDNSKNTLYLQMNSMRADDTAFYYCAR
VPFQIWSGLYFDHWGQGTLVTVSS
这些VH氨基酸序列是在由下列核酸序列编码之克隆中,亦以SEQ IDNO:45-88陈述之:
克隆735号:
caggtgcagctgcaggagtcgggcccaggactggtgaagccttcggagaccctgtccctcacgtgcactgtgtcta
atggcgccatcggcgactacgactggagctggattcgtcagtccccagggaagggactggagtggattgggaaca
taaattacagagggaacaccaactacaacccctccctcaagagtcgagtcaccatgtccctacgcacgtccacgatg
cagttctccctgaagctgagctctgcgaccgctgcggacacggccgtctattactgtgcgagagatgtaggctacgg
tggcgggcagtatttcgcgatggacgtctggagcccagggaccacggtcaccgtctcgagt
克隆736号:
caggtgcagctggtggagtctgggggaggcgtggtccagcctggggggtccctgagactctcctgtacagcgtct
ggattcaccttcagtacctatggcatgcactgggtccgccaggctcccggcaaggggctggaatgggtggcatttat
acggtatgatggaagtactcaagactatgtagactccgtgaagggccgattcaccatctccagagacaattccaaga
atatggtgtatgtgcagatgaacagcctgagagttgaggacacggctgtctattactgtgcgaaagacatggattact
atggttcgcggagttattctgtcacctactactacggaatggacgtctggggccaagggaccacggtcaccgtctcg
agt
克隆744号:
caggtgcagctggtgcagtctggggctgaggtgaagaagcctggggcctcagtgaaggtctcctgcaaggcttctg
gatacaccttcagcggctattatatgcactgggtgcgacaggcccctggacaagggcttgagtggatgggatggat
caacactagcagtggtggcacaaactatgcgcagaagtttcagggcagggtcaccatgaccagggacacgtccat
cagcacagcccacatggaactgaggaggctgagatctgacgacacggccgtgtattattgtgcgagagaggacgg
caccatgggtactaatagttggtatggctggttcgacccctggggccagggaaccctggtcaccgtctcgagt
克隆793号:
caggtgcagctggtggagtctgggggaggcttggtcaagcctggggggtccctgagactctcctgtgcggcctctg
gattccccttcggtgactactacatgagctggatccgccaggctccagggaagggactggagtgggttgcatacatt
aatagaggtggcactaccatatactacgcagactctgtgaagggccgattcaccatctccagggacaacgccaaga
actccctgtttctgcaaatgaacagcctgagagccggggacacggccctctattactgtgcgagagggctaattcta
gcactaccgactgctacggttgagttaggagcttttgatatctggggccaagggacaatggtcaccgtctcgagt
克隆795号:
caggtgcagctgcaggagtcgggcccaggactggtgaagccttcacagaccctgtccctcacctgcactgtctctg
gtgcctccatcagcagtggtgattattactggagttggatccgtcagtctccaaggaagggcctggagtggattgggt
acatcttccacagtgggaccacgtactacaacccgtccctcaagagtcgagctgtcatctcactggacacgtccaag
aaccaattctccctgaggctgacgtctgtgactgccgcagacacggccgtctattattgtgccagagatgtcgacgat
tttcccgtttggggtatgaatcgatatcttgccctctggggccggggaaccctggtcaccgtctcgagt
克隆796号:
caggtgcagctggtggagtctgggggaggcgtggtccagcctgggaggtccctgagactctcctgtgcagcctct
ggattcagcttcagtcactttggcatgcactgggtccgccaggttccaggcaaggggctggagtgggtggcaattat
atcatatgatgggaataatgtacactatgccgactccgtaaagggccgattcaccatctccagagacaattccaagaa
cacgctgtttctgcaaatgaacagcctgagagatgacgacacgggtgtgtattactgtgcgaaggacgacgtggcg
acagatttggctgcctactactacttcgatgtctggggccgtggcaccctggtcaccgtctcgagt
克隆799号:
caggtgcagctggtggagtctgggggcggcgtggtccagcctgggaggtccctgaaactctcttgtgaagcctctg
gattcaacttcaataattatggcatgcactgggtccgccaggcaccaggcaaggggctggagtgggtggcagttatt
tcatatgacggaagaaataagtattttgctgactccgtgaagggccgattcatcatctccagagacgattccaggaac
acagtgtttctgcaaatgaacagcctgcgagttgaagatacggccgtctattactgtgcgagaggcagcgtacaagt
ctggctacatttgggactttttgacaactggggccagggaaccctggtcaccgtctcgagt
克隆800号:
caggtgcagctggtggagtctgggggagccgtggtccagcctgggaggtccctgagactctcctgtgaagtgtctg
gattcagtttcagtgactatggcatgaactgggtccgccagggtccaggcaaggggctggagtgggtggcagttat
atggcatgacggaagtaataaaaattatctagactccgtgaagggccgattcaccgtctccagagacaattccaaga
acacattgtttctgcaaatgaacagcctgagagccgaagacacggctgtatattactgtgcgaggacgccttacgagt
tttggagtggctattactttgacttctggggccagggaaccctggtcaccgtctcgagt
克隆801号:
caggtgcagctggtggagtctgggggaggcgtggtccagcctgggaggtccctgagactctcctgtgcagcgtct
ggattccccttcaatagctatgccatgcactgggtccgccaggctccaggcaaggggctggagtgggtggcagtga
tatattatgaagggagtaatgaatattatgcagactccgtgaagggccgattcaccatctccagagacaattccaaga
acactctgtatttgcaaatggatagcctgagagccgaggacacggctgtctattactgtgcgaggaagtggctgggg
atggacttctggggccagggaaccctggtcaccgtctcgagt
克隆804号:
gaggtgcagctggtggagtctgggggaggcttggtccggcctggggggtccctgagactctcctgttcagcctctg
gattcaccttcagtaactatgctatgcactgggtccgccaggctccagggaagagactggaatatgtttcagctacta
gtactgatggggggagcacatactacgcagactccctaaagggcacattcaccatctccagagacaattccaagaa
cacactgtatcttcaaatgagcagtctcagtactgaggacacggctatttattactgcgcccgccgattctggggatttg
gaaacttttttgactactggggccggggaaccctggtcaccgtctcgagt
克隆810号:
caggtgcagctggtgcagtctggggctgaggtgaagaagtccgggtcctcggtgaaggtctcctgcagggcttctg
gaggcaccttcggcaattatgctatcaactgggtgcgacaggcccctggacaagggcttgagtgggtgggaagga
tcatccctgtctttgatacaacaaactacgcacagaagttccagggcagagtcacgattaccgcggacagatccaca
aacacagccatcatgcaactgagcagtctgcgacctcaggacacggccatgtattattgtttgagaggttccacccgt
ggctgggatactgatggttttgatatctggggccaagggacaatggtcaccgtctcgagt
克隆811号:
caggttcagctggtgcagtctggggctgtcgtggagacgcctggggcctcagtgaaggtctcctgcaaggcatctg
gatacatcttcggcaactactatatccactgggtgcggcaggcccctggacaagggcttgagtggatggcagttatc
aatcccaatggtggtagcacaacttccgcacagaagttccaagacagaatcaccgtgaccagggacacgtccacg
accactgtctatttggaggttgacaacctgagatctgaggacacggccacatattattgtgcgagacagagatctgta
acagggggctttgacgcgtggcttttaatcccagatgcttctaatacctggggccaggggacaatggtcaccgtctc
gagt
克隆812号:
caggtgcagctggtgcagtctggggctgagatgaagaagcctgggtcctcggtgaaggtctcctgcaaggcttctg
gaggctccttcagcagctattctatcagctgggtgcgacaggcccctggacgagggcttgagtgggtgggaatgat
cctgcctatctctggtacaacaaactacgcacagacatttcagggcagagtcatcattagcgcggacacatccacga
gcacagcctacatggagctgaccagcctcacatctgaagacacggccgtgtatttctgtgcgagagtctttagagaat
ttagcacctcgacccttgacccctactactttgactactggggccagggaaccctggtcaccgtctcgagt
克隆814号:
caggtgcagctggtggagtctgggggaggcgtggtccagcctgggaagtccgtgagactctcctgtgtaggctctg
gcttcaggctcatggactatgctatgcactgggtccgccaggctccaggcaagggactggattgggtggcagttattt
catatgatggagccaatgaatactacgcagagtccgtgaagggccgattcaccgtctccagagacaattcagacaa
cactctgtatctacaaatgaagagcctgagagctgaggacacggctgtgtatttctgtgcgagagcgggccgttcctc
tatgaatgaagaagttattatgtactttgacaactggggcctgggaaccctggtcaccgtctcgagt
克隆816号:
gaggtgcagctgttggagtctgggggaggcttggtccagcctggggggtccctgagactctcctgtgtagcctccg
gattcacctttagtacctacgccatgacctgggtccgccaggctccagggaaggggctggagtgggtctcagtcatt
cgtgctagtggtgatagtgaaatctacgcagactccgtgaggggccggttcaccatctccagagacaattccaagaa
cacggtgtttctgcaaatggacagcctgagagtcgaggacacggccgtatatttctgtgcgaatataggccagcgtc
ggtattgtagtggtgatcactgctacggacactttgactactggggccagggaaccctggtcaccgtctcgagt
克隆817号:
caggtgcagctggtggagtctgggggaggcgtggtccaacctgggaggtccctgagactctcctgtgcagcctctg
gattcggcttcaacacccatggcatgcactgggtccgccaggctccaggcaaggggctggagtggctgtcaattat
ctcacttgatgggattaagacccactatgcagactccgtgaagggccgattcaccatctccagagacaattccaaga
acacggtgtttctacaattgagtggcctgagacctgaagacacggctgtatattactgtgcgaaagatcatattgggg
ggacgaacgcatattttgaatggacagtcccgtttgacggctggggccagggaaccctggtcaccgtctcgagt
克隆818号:
caggtcaccttgagggagtctggtccagcggtggtgaagcccacagaaacgctcactctgacctgcgccttctctg
ggttctcactcaacgccggtagagtgggtgtgagttggatccgtcagcccccagggcaggccccggaatggcttgc
acgcattgattgggatgatgataaagcgttccgcacatctctgaagaccagactcagcatctccaaggactcctccaa
aaaccaggtggtccttacactgagcaacatggaccctgcggacacagccacatattactgtgcccggacacaggtc
ttcgcaagtggaggctactacttgtactaccttgaccactggggccagggaaccctggtcaccgtctcgagt
克隆819号:
caggtgcagctgcaggagtcgggcccaggactggtgaagccttcacagaccctgtccctcacctgcactgtctcta
gtggcgccatcagtggtgctgattactactggagttggatccgccagcccccagggaagggcctggagtgggttgg
gttcatctatgacagtgggagcacctactacaacccgtccctcaggagtcgagtgaccatatcaatagacacgtcca
agaagcagttctccctgaagctgacctctgtgactgccgcagacacggccgtgtattactgtgccagagatctaggc
tacggtggtaactcttactcccactcctactactacggtttggacgtctggggccgagggaccacggtcaccgtctcg
agt
克隆824号:
caggtgcagctgcaggagtcgggcccaggactggtgaagccttcggagaccctgtccctcacctgcactgtctctg
gtggctccatcggaaattactactggggctggatccggcagcccccagggaagggacttgagtggattgggcatat
ctacttcggtggcaacaccaactacaacccttccctccagagtcgagtcaccatttcagtcgacacgtccaggaacc
agttctccctgaagttgaactctgtgaccgccgcggacacggccgtgtattactgtgcgagggatagcagcaactgg
cccgcaggctatgaggactggggccagggaaccctggtcaccgtctcgagt
克隆825号:
caggttcagctggtgcagtctggagctgaggtgaagaagcctggggcctcagtgaaggtctcctgcaaggtttctg
gttacacctttaccagtaatggtctcagctgggtgcgacaggcccctggacaagggtttgagtggctgggatggatc
agcgctagtagtggaaacaaaaagtatgccccgaaattccagggaagagtcaccttgaccacagacatttccacga
gcacagcctacatggaactgaggagtctgagatctgacgatacggccgtatattactgtgcgaaagatgggggcac
ctacgtgccctattctgatgcctttgatttctggggccaggggacaatggtcaccgtctcgagt
克隆827号:
caggtccagctggtacagtctggggctgaggtgaagaagcctggggcctcagtgaaggtctcctgcagggtttccg
gacacactttcactgcattatccaaacactggatgcgacagggtcctggaggagggcttgagtggatgggattttttg
atcctgaagatggtgacacaggctacgcacagaagttccagggcagagtcaccatgaccgaggacacagccaca
ggcacagcctacatggagctgagcagcctgacatctgacgacacggccgtatattattgtgcaacagtagcggcag
ctggaaactttgacaactggggccagggaaccctggtcaccgtctcgagt
克隆829号:
caggtcaccttgaaggagtctggtcctgcgctggtgaaagccacacagaccctgacactgacctgcaccttctctgg
gttttcactcagtaggaatagaatgagtgtgagctggatccgtcagcccccagggaaggccctggagtggcttgcac
gcattgattgggatgatgataaattctacaacacatctctgcagaccaggctcaccatctccaaggacacctccaaaa
accaggtggtccttacaatgaccaacatggaccctgtggacacagccacctattactgcgcacggactgggatatat
gatagtagtggttattacctctactactttgactactggggccagggaaccctggtcaccgtctcgagt
克隆830号:
caggtgcagctggtgcagtctggagctgaggtgaaggtgcctggggcctcagtgaaggtctcctgcaaggcttctg
gttacacctttaccacttacggtgtcagctgggtgcggcaggcccctggacaagggcttgagtggatgggttggatc
agcgcttacaatggtaacacatactatctacagaagctccagggcagagtcaccatgaccacagacacatccacga
gcacagcctacatggagctgcggggcctgaggtctgacgacacggccatgtattactgtgcgagagatcgtgttgg
gggcagctcgtccgaggttctatcgcgggccaaaaactacggtttggacgtctggggccaagggaccacggtcac
cgtctcgagt
克隆831号:
caggttcagctggtgcagtctggggctgaggtgaagaagcctggggcctcagttaaggtttcctgcaaggcttctgc
aaacatcttcacttatgcaatgcattgggtgcgccaggcccccggacaaaggcttgagtggatgggatggatcaac
gttggcaatggtcagacaaaatattcacagaggttccagggcagagtcaccattaccagggacacgtccgcgacta
cagcctacatggagctgagcaccctgagatctgaggacacggctgtgtattactgtgcgaggcgtgcgagccaata
tggggaggtctatggcaactactttgactactggggccagggaaccctggtcaccgtctcgagt
克隆835号:
caggtgcagctggtgcagtctggagctgaggtgaagaggcctggggcctcagtgaaggtctcctgcaaggcttca
ggttacacctttatcagctatggtttcagctgggtgcgacaggcccctggacaagggcttgagtggatgggatggag
cagcgtttacaatggtgacacaaactatgcacagaagttccacggcagagtcaacatgacgactgacacatcgacg
aacacggcctacatggaactcaggggcctgagatctgacgacacggccgtgtatttctgtgcgagggatcgcaatg
ttgttctacttccagctgctccttttggaggtatggacgtctggggccaagggacaatggtcaccgtctcgagt
克隆838号:
caggtgcagctggtggagtctgggggaggcgtggtccagccggggacttccctgagactctcctgtgcagcctctg
gattcaccttcagtacgtttggcatgcactgggtccgccaggctccaggcaaggggctggagtgggtggcagttata
tcatatgatggaaataagaaatactatgcagactccgtgaagggccgattcaccatctccagagacaattccaagaa
cacgctgtatctgcaagtgaacagcctgagagtcgaggacacggctgtgtattactgtgcggcccaaactccatattt
caatgagagcagtgggttagtgccggactggggccagggcaccctggtcaccgtctcgagt
克隆841号:
caggtgcagctggtgcagtctggagctgaggtgaagaagcctggggcctcagtgaaggtctcctgcaaggcttctg
gttacacctttatcagttttggcatcagctgggtgcgacaggcccctggacaaggacttgagtggatgggatggatca
gcgcttacaatggtaacacagactatgcacagaggctccaggacagagtcaccatgactagagacacagccacga
gcacagcctacttggagctgaggagcctgaaatctgacgacacggccgtgtactattgcactagagacgagtcgat
gcttcggggagttactgaaggattcggacccattgactactggggccagggaaccctggtcaccgtctcgagt
克隆853号:
gaagtgcagctggtgcagtctggagcagaggtgaaaaagccggggcagtctctgaagatctcctgtaagacttctg
gatacatctttaccaactactggatcggctgggtgcgccagaggcccgggaaaggcctggagtggatgggggtca
tctttcctgctgactctgatgccagatacagcccgtcgttccaaggccaggtcaccatctcagccgacaagtccatcg
gtactgcctacctgcagtggagtagcctgaaggcctcggacaccgccatatattactgtgcgagaccgaaatattact
ttgatagtagtgggcaattctccgagatgtactactttgacttctggggccagggaaccctggtcaccgtctcgagt
克隆855号:
caggttcagctggtgcagtctggacctgaggtgaagaagcctggggcctcagtgaaggtctcctgcaaggcttctg
gttatgtgttgaccaactatgccttcagctgggtgcggcaggcccctggacaagggcttgagtggctgggatggatc
agcggctccaatggtaacacatactatgcagagaagttccagggccgagtcaccatgaccacagacacatccacg
agcacagcctacatggagctgaggagtctgagatctgacgacacggccgtttatttctgtgcgagagatcttctgcg
gtccacttactttgactactggggccagggaaccctggtcaccgtctcgagt
克隆856号:
caggtgcagctggtgcagtctggagctgaggtgaagaagcctggggcctcagtgaaggtctcctgcaaggcctctg
gttacaccttttccaactacggtttcagctgggtgcgacaggcccctggacgagggcttgagtggatgggatggatc
agcgcttacaatggtaacacatactatgcacagaacctccagggcagagtcaccatgaccacagacacatccacga
ccacagcctacatggtactgaggagcctgagatctgacgacacggccatgtattactgtgcgagagatggaaatac
agcaggggttgatatgtggtcgcgtgatggttttgatatctggggccaggggacaatggtcaccgtctcgagt
克隆857号:
gaggtgcagctgttggagtctgggggaggcttggtacagcctggggggcccctgaggctctcctgtgtagcctctg
gattcagctttagcagctatgccatgaactggatccgcctggctccagggaaggggctggagtgggtctcaggtatt
agtggtagcggtggtagcacttactacggagactccgtgaagggccggttcaccatctccagagacaattccaaga
acacgctgtatctgcaaatgaacagcctgagagccgaggacacggccgtatattactgtgcgaaagagccgtggat
cgatatagtagtggcatctgttatatccccctactactacgacggaatggacgtctggggccaagggaccacggtca
ccgtctcgagt
克隆858号:
caggttcagctggtgcagtctggggctgaggtgaagaagcctgggtcctcggtgaaggtctcctgcaaggcctctg
gaggatccttcgacggctacactatcagctggctgcgacaggcccctggacaggggcttgagtggatgggaaggg
tcgtccctacacttggttttccaaactacgcacagaagttccaaggcagagtcaccgttaccgcggacagatccacc
aacacagcctacttggaattgagcagactgacatctgaagacacggccgtatattactgtgcgaggatgaatctcgg
atcgcatagcgggcgccccgggttcgacatgtggggccaaggaaccctggtcaccgtctcgagt
克隆859号:
caggtgcagctggtggagtctgggggaggcgtggtccagcctgggaggtccttgagactctcctgtgcagtgtctg
gatccagcttcagtaaatatggcatacactgggtccgccaggctccaggcaaggggctggagtgggtggcagttat
atcgtatgatggaagtaaaaagtatttcacagactccgtgaagggccgattcaccatcgccagagacaattcccaga
acacggtttttctgcaaatgaacagcctgagagccgaggacacggctgtctattactgtgcgacaggagggggtgtt
aatgtcacctcgtggtccgacgtagagcactcgtcgtccttaggctactggggcctgggaaccctggtcaccgtctc
gagt
克隆861号:
caggtgcagctggtggagtctgggggaggcgtggtccagcctggggggtccctgagactctcctgtgcagcgtct
ggattcaccttcagtagctatggcatgcactgggtccgccaggctccaggcaaggggctggagtgggtggcatttat
atggaatgatggaagtaataaatactatgcagactccgtgaagggccgattcaccatctccagagacaattccaaga
acacgctgtatctgcaaatgaacagcctgagagctgaggacacggctgtgtattactgtgtgaaagatgaggtctatg
atagtagtggttattacctgtactactttgactcttggggccagggaaccctggtcaccgtctcgagt
克隆863号:
gaggtgcagctgttggagtctgggggaggcttggtacagcctggggggtccctgagactctcctgtgcagcctctg
gattcacgtttagctcctataccatgagctgggtccgccaggctccagggaaggggctggagtgggtctcaagtatt
agtgctagtactgttctcacatactacgcagactccgtgaagggccgcttcaccatctccagagacaattccaagaac
acgctgtatctgcaaatgagtagcctgagagccgaggacacggccgtatattactgtgcgaaagattacgatttttgg
agtggctatcccgggggacagtactggttcttcgatctctggggccgtggcaccctggtcaccgtctcgagt
克隆868号:
caggtgcagctgcaggagtcgggcccaggactggtgacgccttcggagaccctgtccgtcacttgcactgtctcta
attattccatcgacaatgcttactactggggctggatccggcagcccccagggaagggtctggagtggataggcagt
atccatcatagtgggagcgcctactacaattcgtccctcaagagtcgagccaccatatctatagacacgtccaagaac
caattctcgttgaacctgaggtctgtgaccgccgcagacacggccgtatattactgtgcgcgcgataccatcctcacg
ttcggggagccccactggttcgacccctggggccagggaaccctggtcaccgtctcgagt
克隆870号:
caggtgcagctgcaggagtcgggcccaggactggtgaagccttcggagaccttgtccctcacctgcactgtctcag
gtgactccatcagtaattactactggagttggatccggcagcccccagggaagggactggagtggattggagaaat
atctaacacttggagcaccaattacaacccctccctcaagagtcgagtcaccatatctctagacatgcccaagaacca
gttgtccctgaagctgagctctgtgaccgctgcggacacggccgtatattactgtgcgagagggcttttctatgacagt
ggtggttactacttgttttacttccaacactggggccagggcaccctggtcaccgtctcgagt
克隆871号:
caggtgcagctggtggagtctgggggaggcgtggtccagcctgggaggtccctgagagtctcctgtgcagcgtct
ggattcaccttcagtaactatggcatgcactgggtccgccaggctccaggcaaggggctggagtgggtggcagtta
tatggtatgatgacagtaataaacagtatggagactccgtgaagggccgattcaccatctccagagacaattccaag
agtacgctgtatctgcaaatggacagactgagagtcgaggacacggctgtgtattattgtgcgagagcctccgagta
tagtatcagctggcgacacaggggggtccttgactactggggccagggaaccctggtcaccgtctcgagt
克隆880号:
cagatcaccttgaaggagtctggtcctacgctggtgagacccacacagaccctcacactgacctgcaccttctctgg
gttctcactcagcactagtaaactgggtgtgggctggatccgtcagcccccaggaaaggccctggagtggcttgca
ctcgttgattgggatgatgataggcgctacaggccatctttgaagagcaggctcaccgtcaccaaggacacctccaa
aaaccaggtggtccttacaatgaccaacatggaccctgtggacacagccacatattactgtgcacacagtgcctact
atactagtagtggttattaccttcaatacttccatcactggggcccgggcaccctggtcaccgtctcgagt
克隆881号:
gaggtgcagctggtggagtctgggggaggcgtggtacagcctggaggctccctgagactctcctgtgaagtctcc
ggattcaccttcaatagttatgaaatgacctgggtccgccaggccccagggaaggggctggagtgggtttcacacat
tggtaatagtggttctatgatatactacgctgactctgtgaagggccgattcaccatctccagagacaacgccaagaa
ctcactatatctgcaaatgaacagcctgagagtcgaggacacggctgtttattactgtgcgaggtcagattactatgat
agtagtggttattatctcctctacttagactcctggggccatggaaccctggtcaccgtctcgagt
克隆884号:
caggtgcagctggtgcagtctggggctgaggtgaggaagcctggggcctcagtgaaggtttcctgcaaggcttctg
gacatactttcattaactttgctatgcattgggtgcgccaggcccccggacaggggcttgagtggatgggatacatca
acgctgtcaatggtaacacacagtattcacagaagttccagggcagagtcacctttacgagggacacatccgcgaa
cacagcctacatggagctgagcagcctgagatctgaagacacggctgtgtattactgtgcgagaaacaatgggggc
tctgctatcattttttactactggggccagggaaccctggtcaccgtctcgagt
克隆886号:
caggtgcagctggtggagtctgggggaggcgtggtccagcctgggaggtccctgagactctcctgtgcagcctct
ggattcagcttcagtagctatggcatgcactgggtccgccaggctccaggcaaggggctggagtgggtggcagtta
tatcaaatgatggaagtaataaatactatgcagactccgtgaagggccgattcaccatctccagagacaattccaaga
aaacgatgtatctgcaaatgaacagcctgagagctgaggacacggctgtgtatttctgtgcgaagacaacagacca
gcggctattagtggactggttcgacccctggggccagggaaccctggtcaccgtctcgagt
克隆888号:
cagctgcagctgcaggagtcgggcccaggactggtgaagccatcggagaccctgtccctcacctgcactgcctct
ggtggctccatcaacagtagtaatttctactggggctggatccgccagcccccagggaaggggctggagtggattg
ggagtatcttttatagtgggaccacctactacaacccgtccctcaagagtcgagtcaccatatccgtagacacgtcca
agaaccagttctccctgaagctgagccctgtgaccgccgcagacacggctgtctatcactgtgcgagacatggcttc
cggtattgtaataatggtgtatgctctataaatctcgatgcttttgatatctggggccaagggacaatggtcaccgtctc
gagt
克隆894号:
caggtgcagctggtggagtctgggggaggcgtcgtccagcctggaaagtccctgagactctcctgtgcagcgtctg
gattcagattcagtgactacggcatgcactgggtccggcaggctccaagcaaggggctggagtgggtggcagttat
ctggcatgacggaagtaatataaggtatgcagactccgtgaggggccgattttccatctccagagacaattccaaga
acacgctgtatttgcaaatgaacagcatgagagccgacgacacggctttttattattgtgcgagagtcccgttccagat
ttggagtggtctttattttgaccactggggccagggaaccctggtcaccgtctcgagt
在相同的克隆中,轻链的完整氨基酸序列(即包含恒定和可变区的轻链)具有下列的氨基酸序列,亦以SEQ ID NO:89-132陈述之:
克隆735号:
EIVLTQSPATLSLSPGERATLSCRASQSVNSHLAWYQQKPGQAPRLLIYNT
FNRVTGIPARFSGSGSGTDFTLTISSLATEDFGVYYCQQRSNWPPALTFGGG
TKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVD
NALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGL
SSPVTKSFNRGEC
克隆736号:
DIQMTQSPSSLSASVGDRVTFTCRASQRISNHLNWYQQKPGKAPKLLIFG
ASTLQSGAPSRFSGSGSGTDFTLTITNVQPDDFATYYCQQSYRTPPINFGQG
TRLDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVD
NALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGL
SSPVTKSFNRGEC
克隆744号:
EIVITQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYG
ASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYDSSLSTWTFGQ
GTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKV
DNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQ
GLSSPVTKSFNRGEC
克隆793号:
DIQMTQSPSSLSASVGDRVTITCRASQSITGYLNWYQQKPGKAPKLLIYAT
STLQSEVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYNTLTFGGGTKV
EIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNAL
QSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSP
VTKSFNRGEC
克隆795号:
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIHG
ASTGATGTPDRFSGSGSGTDFTLTISTLEPEDFAVYYCQQYGRTPYTFGQG
TKLENKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVD
NALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGL
SSPVTKSFNRGEC
克隆796号:
DIVMTQTPLSLSVTPGQPASISCRSSQSLLRSDGKTFLYWYLQKPGQSPQP
LMYEVSSRFSGVPDRFSGSGSGADFTLNISRVETEDVGIYYCMQGLKIRRT
FGPGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQW
KVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVT
HQGLSSPVTKSFNRGEC
克隆799号:
DIQMTQSPSTLSASVGDRVTFSCRASQSVSSWVAWYQQKPGKAPKLLISE
ASNLESGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQYHSYSGYTFGQ
GTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKV
DNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQ
GLSSPVTKSFNRGEC
克隆800号:
AIQLTQSPSSLSASVGDRVTLTCRASQGITDSLAWYQQKPGKAPKVLLYAA
SRLESGVPSRFSGRGSGTDFTLTISSLQPEDEATYYCQQYSKSPATFGPGTK
VEIRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNA
LQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSS
PVTKSFNRGEC
克隆801号:
DIVMTQSPLSLPVTPGEPASISCRSSQSLLNSNGFNYVDWYLQKPGQSPQL
LIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALETPL
TFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQ
WKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEV
THQGLSSPVTKSFNRGEC
克隆804号:
EIVLTQSPGTLSLSPGGRATLSCRASQSVSSGYLAWYQQKPGQAPRLLIYG
ASGRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYFGSPYTFGQGT
KLLELKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKWQWKVDN
ALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLS
SPVTKSFNRGEC
克隆810号:
NIQMTQSPSAMSASVGDRVTITCRASQGISNYLVWFQQKPGKVPKRLIYA
ASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNISPYTFGQGT
KLETKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNFYPREAKVQWKVDN
ALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLS
SPVTKSFNRGEC
克隆811号:
DIVMTQSPDSLAVSLGERATINCRSSETVLYTSKNQSYLAWYQQKARQPP
KLLLYWASTRESGVPARFSGSGSGTDFTLAISSLQAEDVAVYYCQQFFRSP
FTFGPGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQ
WKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEV
THQGLSSPVTKSFNRGEC
克隆812号:
EIVLTQSPGTLSLSPGERVTLSCRASQSVSSSYIAWYQQKPGQAPRLVIYAA
SRRATGVPDRFSGSGSATDFTLTISRLEPEDLAVYYCQHYGNSLFTFGPGT
KVDVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVD
NALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGL
SSPVTKSFNRGEC
克隆814号:
DIQMTQSPSTLSASVGDRVTITCRASQSIGSRLAWYQQQPGKAPKFLIYDA
SSLESGVPSRFSGSGSGTEFTLTISSLQPEDLATYYCQQYNRDSPWTFGQG
TKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVD
NALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGL
SSPVTKSFNRGEC
克隆816号:
DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSDGRYYVDWYLQKPGQSPHL
LIYLASNRASGVPDRFTGSGSGTDFTLKISRVEAEDVGVYYCMQGLHTP
WTFGQGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAK
VQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYAC
EVTHQGLSSPVTKSFNRGEC
克隆817号:
EIVMTQSPATLSASPGERATLSCWASQTIGGNLAWYQQKPGQAPRLLIYG
ASTRATGVPARFSGSGSGTEFTLAISSLQSEDFAVYYCQQYKNWYTFGQG
TKLELKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVD
NALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGL
SSPVTKSFNRGEC
克隆818号:
DIQMTQSPSSLSASVGDRVTITCRASQTIASYVNWYQQKPGRAPSLLIYAA
SNLQSGVPPRFSGSGSGTDFTLTISGLQPDDFATYYCQQSYSYRALTFGGG
TKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVD
NALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGL
SSPVTKSFNRGEC
克隆819号:
EIVLTQSPATLSLSPGERATLSCRASQSVSSSLAWYQQTPGQAPRLLIYDAS
YRVTGIPARFSGSGSGIDFTLTISSLEPEDFAVYYCQQRSNWPPGLTFGGGT
KVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDN
ALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLS
SPVTKSFNRGEC
克隆824号:
AIQLTQSPSSLSASVGDTVTVTCRPSQDISSALAWYQQKPGKPPKLLIYGA
STLDYGVPLRFSGTASGTHFTLTISSLQPEDFATYYCQQFNTYPFTFGPGTK
VDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNA
LQSGNSQESVTEQDSKDSTYSLSSTLSKADYEKHKVYACEVTHQGLSS
PVTKSFNRGEC
克隆825号:
DIVMTQSPDSLAVSLGERATINCKSSQSVLYNSNNKNYLAWYQQKPGQPP
KLLIHLASTREYGVPDRFSGSGSGTDFALIISSLQAEDVAVYYCQQYYQTP
LTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKV
QWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACE
VTHQGLSSPVTKSFNRGEC
克隆827号:
DIQMTQSPSSLAASVGDRVTITCRASQFISSYLHWYQQRPGKAPKLLMYA
ASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYTNPYTFGQGT
KLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDN
ALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLS
SPVTKSFNRGEC
克隆829号:
DIQMTQSPSSLSASVGDRVTITCRASQSIASYLNWYQQKPGKAPKKLIYAA
SSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHSYSTRFTFGPGTK
VDVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDN
ALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLS
SPVTKSFNRGEC
克隆830号:
DIQMTQSPSTLSASVGDRVTITCRASQSVTSELAWYQQKPGKAPNFLIYK
ASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSFPYTFGQGT
KLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDN
ALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLS
SPVTKSFNRGEC
克隆831号:
DIQMTQSPSTLSASVGDRLTITCRASQNIYNWLAWYQQKPGKAPKLLIYD
ASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSLSPTFGQGT
KVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDN
ALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLS
SPVTKSFNRGEC
克隆835号:
DIQLTQSPSFLSASLEDRVTITCRASQGISSYLAWYQQKPGKAPKLLLDAA
STLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPRTFGQGTK
VDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNA
LQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSS
PVTKSFNRGEC
克隆838号:
DIQMTQSPSSLSASVGDRVSITCRASQGISNYLAWYQQKPGKVPKLLIYAA
STLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQKYNSAPQTFGQGT
KVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDN
ALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLS
SPVTKSFNRGEC
克隆841号:
DIVMTQSPDSLAVSLGERATINCRSSQSVLYSSNNKNYLAWYQQKPGQPP
KLLVYWASTRASGVPDRFSGSGSGTDFTLTLSSLQAEDVVYYCQQFHST
PRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAK
VQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYAC
EVTHQGLSSPVTKSFNRGEC
克隆853号:
EIVLTQSPGTLSLSPGERATLSCRASQSVSSNYLAWYQQKPGQAPRLLIYG
ASSRAAGMPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGNSPLTFGGG
TEVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVD
NALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGL
SSPVTKSFNRGEC
克隆855号:
DIQMTQSPSSVSASVGDRVTITCRASQAISNWLAWYQQKPGKAPKLLIYA
ASSLQSGVPSRFSGSGSGTDFTLTISGLQPEDFATYYCQQADTFPFTFGPGT
KVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDN
ALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLS
SPVTKSFNRGEC
克隆856号:
DIVMTQTPLSLPVTPGEPASISCRSSQSLLDSNDGNTYLDWYLQKPGQSPQ
LLIYTFSYRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQRIEFPY
TFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQ
WKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEV
THQGLSSPVTKSFNRGEC
克隆857号:
DIVMTQSPLSLPVTPGEPASISCRSSQSLLHRNEEYNYLDWYLQKPGQSPQL
LIYWGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQTLQTPR
TFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQ
WKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEV
THQGLSSPVTKSFNRGEC
克隆858号:
DIQMTQSPSSVSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIFD
ATKLETGVPTRFIGSGSGTDFTVTITSLQPEDVATYYCQHFANLPYTFGQG
TKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVD
NALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGL
SSPVTKSFNRGEC
克隆859号:
DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKVPKLLVFA
ASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQRYNSAPLTFGGGT
KVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDN
ALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLS
SPVTKSFNRGEC
克隆861号:
DIQMTQSPSSLSASVGDRVTITCRASQIIASYLNWYQQKPGRAPKLLIYAA
SSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPIFTFGPGTK
VNIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNA
LQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSS
PVTKSFNRGEC
克隆863号:
EIVLTQSPATLSLSPGERATLSCRTSQSVSSYLAWYQQKPGQAPRLLIYDAS
NRTGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSDWLTFGGGTKV
EIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNAL
QSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSP
VTKSFNRGEC
克隆868号:
EIVMTQSPATLSVSPGERATLSCRASQSIKNNLAWYQVKPGQAPRLLTSGA
SARATGIPGRFSGSGSGTDFTLTISSLQSEDIAVYYCQEYNNWPLLTFGGGT
KVEIQRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDN
ALQSGNSQESVTEQDSKDSTYSLSSTLSKADYEKHKVYACEVTHQGLS
SPVTKSFNRGEC
克隆870号:
DIQMTQSPPSLSASVGDRVTITCRASQRIASYLNWYQQKPGRAPKLLIFAA
SSLQSGVPSRFSGSGSGTDFTLTISSLQPEDYATYYCQQSYSTPIYTFGQGT
KLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDN
ALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLS
SPVTKSFNRGEC
克隆871号:
DIQMTQSPSSLSASVGDRVTITCQASQGISNYLNWYQQKPGKAPKLLIFD
ASNLESEVPSRFSGRGSGTDFTFSISSLQPEDIATYFCQQYDNFPYTFGQGT
KLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDN
ALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLS
SPVTKSFNRGEC
克隆880号:
DIQMTQSPSSLAASVGDRVTITCRASQTIASYVNWYQQKPGKAPNLLIYA
ASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFASYFCQQSYSFPYTFGQGT
KLDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDN
ALQSGNSQESVTEQDSKDSTYSLSSTLSKADYEKHKVYACEVTHQGLS
SPVTKSFNRGEC
克隆881号:
DIQMTQSPS SLSASVGDRVTITCRASQTIASYVNWYQQKPGKAPKLLIYA
ASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSVPRLTFGGG
TKVDITRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVD
NALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGL
SSPVTKSFNRGEC
克隆884号:
DIQMTQSPSSLSASVGDRVTITCRSSQTISVFLNWYQQKPGKAPKLLIYAA
SSLHSAVPSRFSGSGSGTDFTLTISSLQPEDSATYYCQESFSSSTFGGGTKVE
IKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQ
SGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPV
TKSFNRGEC
克隆886号:
EIVMTQSPATLSVSPGETATLSCRASQSVS SNLAWYQHKPGQAPRLLIHSA
STRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNMWPPWTFGQG
TKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVD
NALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGL
SSPVTKSFNRGEC
克隆888号:
DIVMTQSPLSLPVTPGAPASISCRSSQSLLRTNGYNYLDWYLQKPGQSPQL
LIYLGSIRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQSLQTSITF
GQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQW
KVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVT
HQGLSSPVTKSFNRGEC
克隆894号:
EIVMTQSPATLSVSPGERATLSCRASQSVGNNLAWYQQRPGQAPRLLIYG
ASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYDKWPETFGQG
TKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVD
NALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGL
SSPVTKSFNRGEC
在这些克隆中,编码轻链的核酸片段具有下列的核酸序列,亦以SEQ IDNO:133176提供之:
克隆735号:
gaaattgtgttgacacagtctccagccaccctgtccttgtctccaggagaaagagccaccctctcctgcagggccag
tcagagtgttaacagccacttagcctggtaccaacagaaacctggccaggctcccaggctcctcatctataatacatt
caatagggtcactggcatcccagccaggttcagtggcagtgggtctgggacagacttcactctcaccatcagcagc
cttgcgactgaagattttggcgtttattactgtcagcagcgtagcaactggcctcccgccctcactttcggcggaggg
accaaagtggagatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctg
gaactgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgcc
ctccaatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcac
cctgacgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctc
gcccgtcacaaagagcttcaacaggggagagtgt
克隆736号:
gacatccagatgacccagtctccatcctccctgtctgcatctgtgggagacagagtcaccttcacttgccgggccagt
cagaggattagcaaccatttaaattggtatcaacaaaagccagggaaagcccctaaactcctgatctttggtgcatcc
actcttcaaagtggggccccatcaaggttcagtggcagtggatctgggacagatttcactctcaccatcactaatgtac
aacctgacgattttgcaacttactactgtcaacagagttacagaactcccccgatcaacttcggccaagggacacgcc
tggacattaagcgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgc
ctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatc
gggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacg
ctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtc
acaaagagcttcaacaggggagagtgt
克隆744号:
gaaattgtgttgacgcagtctccaggcaccctgtctttgtctccaggggaaagagccaccctctcctgcagggccag
tcagagtgttagcagcagctacttagcctggtatcagcagaaacctggccaggctcccaggctcctcatctatggtgc
atccagcagggccactggcatcccagacaggttcagtggcagtgggtctgggacagacttcactctcaccatcagc
agactggagcctgaagattttgcagtgtattactgtcagcagtatgatagctcactttctacgtggacgttcggccaag
ggaccaaggtggaaatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaat
ctggaactgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacg
ccctccaatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagc
accctgacgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgag
ctcgcccgtcacaaagagcttcaacaggggagagtgt
克隆793号:
gacatccagatgacccagtctccatcctccctgtctgcatctgtaggagacagagtcaccatcacttgccgggcaagt
cagagcattaccggctatttaaattggtatcagcagaaaccagggaaagcccctaaactcctgatctatgctacatcc
actttgcaaagtgaggtcccatcaaggttcagtggcagtggatctgggacagatttcactctcaccatcagcagtcttc
aacctgaagactttgcaacttactactgtcaacagagttataataccctcactttcggcggagggaccaaggtggagat
caaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcctctgttg
tgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcgggtaac
tcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgctgagca
aagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtcacaaaga
gcttcaacaggggagagtgt
克隆795号:
gaaattgtgttgacgcagtctccaggcaccctgtctttgtctccaggggaaagagccaccctctcctgcagggccag
tcagagtgttagcagcagctacttagcctggtatcagcagaaacctggccaggctcccaggctcctcatacatggcg
catccaccggggccactggcaccccagacaggttcagtggcagtgggtctgggacagacttcactctcaccatcag
tacactggagcctgaagattttgcagtgtattactgtcagcaatatggtaggacaccgtacacttttggccaggggacc
aagctggagaacaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctgga
actgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctc
caatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccct
gacgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgc
ccgtcacaaagagcttcaacaggggagagtgt
克隆796号:
gatattgtgatgacccagactccactctctctgtccgtcacccctggacagccggcctccatctcctgcaggtctagtc
agagcctcctgcgaagtgatggaaagacgtttttgtattggtatctgcagaagccaggccagtctccccaacccctaa
tgtatgaggtgtccagccggttctctggagtgccagataggttcagtggcagcgggtcaggggcagatttcacactg
aacatcagccgggtggagactgaggatgttgggatctattactgcatgcaaggtttgaaaattcgtcggacgtttggc
ccagggaccaaggtcgaaatcaagcgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttg
aaatctggaactgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggat
aacgccctccaatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcag
cagcaccctgacgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcct
gagctcgcccgtcacaaagagcttcaacaggggagagtgt
克隆799号:
gacatccagatgacccagtctccttccaccctgtctgcatctgtaggagacagagtcaccttctcttgccgggccagt
cagagtgttagtagttgggtggcctggtatcagcagaaaccaggaaaagcccctaagctcctgatctctgaggcctc
caatttggaaagtggggtcccatcccggttcagcggcagtggatccgggacagaattcactctcaccatcagcagc
ctgcagcctgaagattttgcaacttattactgccaacagtatcatagttactctgggtacacttttggccaggggaccaa
gttggaaatcaagcgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaact
gcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaa
tcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgac
gctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgt
cacaaagagcttcaacaggggagagtgt
克隆800号:
gccatccagttgacccagtctccatcgtccctgtctgcatctgtaggcgacagagtcaccctcacttgccgggcgagt
cagggcattaccgattctttagcctggtatcagcagaaaccagggaaagcccctaaggtcctgctctatgctgcttcc
agattggaaagtggggtcccatccaggttcagtggccgtggatctgggacggatttcactctcaccatcagcagcct
gcagcctgaagactttgcaacttattactgtcaacagtattctaagtcccctgcgacgttcggcccagggaccaaggt
ggaaatcagacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcc
tctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcg
ggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgct
gagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtca
caaagagcttcaacaggggagagtgt
克隆801号:
gatattgtgatgacccagtctccactctccctgcccgtcacccctggagagccggcctccatctcctgcaggtctagt
cagagcctcctaaatagtaatggattcaactatgtggattggtacctgcagaagccagggcagtctccacaactcctg
atctatttgggttctaatcgggcctccggggtccctgacaggttcagtggcagtggatcaggcacagattttacactga
aaatcagcagagtggaggctgaggatgttggggtttattactgcatgcaagctctagaaactccgctcactttcggcg
gagggaccaaggtggagatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttg
aaatctggaactgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggat
aacgccctccaatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcag
cagcaccctgacgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcct
gagctcgcccgtcacaaagagcttcaacaggggagagtgt
克隆804号:
gaaattgtgttgacgcagtctccaggcaccctgtctttgtctccagggggaagagccaccctctcctgcagggccag
tcagagtgttagcagcggctacttagcctggtaccagcagaaacctggccaggctcccaggctcctcatctatggtg
catccggcagggccactggcatcccagacaggttcagtggcagtgggtctgggacagacttcactctcaccatcag
cagactggagcctgaagattttgcagtgtattactgtcagcagtattttggctcaccgtacacttttggccaggggacc
aagctggagctcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaa
ctgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctcc
aatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctg
acgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcc
cgtcacaaagagcttcaacaggggagagtgt
克隆810号:
aacatccagatgacccagtctccatctgccatgtctgcatctgtaggagacagagtcaccatcacttgtcgggcgagt
cagggcattagtaattatttagtctggtttcagcagaaaccagggaaagtccctaagcgcctgatctatgctgcatcca
gtttgcaaagtggggtcccatcaaggttcagcggcagtggatctgggacagaattcactctcacaatcagcagcctg
cagcctgaagattttgcaacttattactgtctacagcataatatttccccttacacttttggccaggggaccaagctgga
gaccaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcctct
gttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcggg
taactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgctga
gcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtcacaa
agagcttcaacaggggagagtgt
克隆811号:
gacatcgtgatgacccagtctccagactccctggctgtgtctctgggcgagagggccaccatcaactgcaggtcca
gtgagactgttttatacacctctaaaaatcagagctacttagcttggtaccagcagaaagcacgacagcctcctaaact
actcctttactgggcatctacccgggaatccggggtccctgcccgattcagtggcagcggatctgggacagatttca
ctctcgccatcagcagcctgcaggctgaagatgtggcagtttattactgtcagcaattttttaggagtcctttcactttcg
gccccgggaccagactggagattaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagt
tgaaatctggaactgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtgg
ataacgccctccaatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctc
agcagcaccctgacgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcaggg
cctgagctcgcccgtcacaaagagcttcaacaggggagagtgt
克隆812号:
gaaattgtgttgacgcagtctccaggcaccctgtctttgtctccaggggaaagagttaccctctcttgcagggccagtc
agagtgttagcagcagttacatagcctggtaccagcagaagcctggccaggctcccaggctcgtcatctatgctgca
tcccgcagggccactggcgtcccagacaggttcagtggcagtgggtctgcgacagacttcactctcaccatcagta
gactggagcctgaagatcttgcagtgtattactgtcagcactatggtaactcactattcactttcggccctgggaccaa
ggtggatgtcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaact
gcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaa
tcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgac
gctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgt
cacaaagagcttcaacaggggagagtgt
克隆814号:
gacatccagatgacccagtctccctccaccctgtctgcatctgtcggagacagagtcaccatcacttgccgggccag
tcagagtattggtagccggttggcctggtatcagcagcaaccagggaaagcccctaaattcctgatctatgatgcctc
cagtttggaaagtggggtcccatcaaggttcagcggcagtggatcagggacagaattcactctcaccatcagcagc
ctgcagccggaggatcttgcaacttattactgccaacagtacaatagagattctccgtggacgttcggccaagggac
caaggtggaaatcaagcgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctgg
aactgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccct
ccaatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccc
tgacgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgc
ccgtcacaaagagcttcaacaggggagagtgt
克隆816号:
gatattgtgatgacccagtctccactctccctgcccgtcaccccaggagagccggcctccatctcctgcaggtctagt
cagagcctcctgcatagtgatggacgctactatgtggattggtacctgcagaagccagggcagtctccacacctcct
gatctatttggcttctaatcgggcctccggggtccctgacaggttcactggcagtggatcaggcacagattttacactg
aaaatcagcagagtggaggctgaggatgttggcgtttattactgcatgcaaggtctacacactccttggacgttcggc
caggggaccaaggtggacatcaagcgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagtt
gaaatctggaactgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtgga
taacgccctccaatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctca
gcagcaccctgacgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggc
ctgagctcgcccgtcacaaagagcttcaacaggggagagtgt
克隆817号:
gaaattgtaatgacacagtctccagccaccctgtctgcgtccccaggggaaagagccaccctctcctgttgggccag
tcagactattggaggcaacttagcctggtaccagcagaaacctggccaggctcccaggctcctcatctatggtgcat
ccaccagggccactggtgtcccagccaggttcagtggcagtgggtctgggacagagttcactctcgccatcagcag
cctgcagtctgaagattttgcagtttattactgtcagcagtataaaaactggtacacttttggccaggggaccaagctg
gagctcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcct
ctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcg
ggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgct
gagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtca
caaagagcttcaacaggggagagtgt
克隆818号:
gacatccagatgacccagtctccatcctccctgtctgcatctgtaggagacagagtcaccatcacttgccgggcaagt
cagaccattgccagttacgtaaattggtaccaacaaaaaccagggagagcccctagtctcctgatctatgctgcatct
aacttgcagagtggggtcccaccaaggttcagtggcagtggatctgggacagacttcactctcaccatcagcggtct
gcaacctgacgattttgcaacttattactgtcaacagagttacagttatcgagcgctcactttcggcggagggaccaa
ggtggagatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaact
gcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaa
tcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgac
gctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgt
cacaaagagcttcaacaggggagagtgt
克隆819号:
gaaattgtgttgacacagtctccagccaccctgtcgttgtccccaggggaaagagccaccctctcctgcagggcca
gtcagagtgttagcagctccttagcctggtaccaacagacacctggccaggctcccaggcttctcatctatgatgcgt
cctacagggtcactggcatcccagccaggttcagtggcagtgggtctgggatagacttcactctcaccatcagcagc
ctagagcctgaagattttgcagtttactattgtcagcagcgtagcaactggcctccggggctcactttcggcgggggg
accaaggtggagatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctg
gaactgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgcc
ctccaatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcac
cctgacgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctc
gcccgtcacaaagagcttcaacaggggagagtgt
克隆824号:
gccatccagttgacccagtctccatcctccctgtctgcatctgttggagacacagtcaccgtcacttgccggccaagt
caggacattagcagtgctttagcctggtatcagcagaaaccagggaaacctcctaagctcctgatctatggtgcctcc
actttggattatggggtcccattaaggttcagcggcactgcatctgggacacatttcactctcaccatcagcagcctgc
aacctgaagattttgcaacttattactgtcaacagtttaatacttacccattcactttcggccctgggaccaaagtggata
tcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcctctgtt
gtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcgggtaa
ctcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgctgagc
aaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtcacaaag
agcttcaacaggggagagtgt
克隆825号:
gacatcgtgatgacccagtctccagactccctggctgtgtctctgggcgagagggccaccatcaactgcaagtcca
gccagagtgttttatacaactccaacaataagaactacttagcctggtatcagcagaaaccaggacagcctcctaagc
tcctcattcacttggcatctacccgggaatacggggtccctgaccgattcagtggcagcgggtctgggacagatttcg
ctctcatcatcagcagcctgcaggctgaagatgtggcagtttattactgtcaacaatattatcaaactcctctaacttttg
gccaggggaccaaggtggagatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcag
ttgaaatctggaactgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtg
gataacgccctccaatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcct
cagcagcaccctgacgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagg
gcctgagctcgcccgtcacaaagagcttcaacaggggagagtgt
克隆827号:
gacatccagatgacccagtctccatcctccctggctgcatctgtaggagacagagtcaccatcacttgccgggcaag
tcagttcattagcagctatttacattggtatcagcaaagaccaggcaaggcccctaaactcctgatgtatgctgcctcc
actttgcaaagtggggtcccatcaaggttcagtggcagtggatctgggacagatttcactctcaccatcagcagtctg
caacctgaagattttgcaacttactactgtcaacagagttacactaacccatacacttttggccaggggaccaagctgg
agatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcctct
gttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcggg
taactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgctga
gcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtcacaa
agagcttcaacaggggagagtgt
克隆829号:
gacatccagatgacccagtctccatcctccctatctgcatctgtaggagacagagtcaccatcacttgccgggcaagt
cagagcattgccagctatttaaattggtatcagcagaaaccagggaaagcccccaaactcctgatctatgctgcatcc
agtttgcatagtggggtcccatcaagattcagtggcagtggatctgggacagatttcactctcaccatcagcagtctgc
aacctgaagattttgcaacttactactgtcaacacagttacagtactcgattcactttcggccctgggaccaaagtggat
gtcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcctctgt
tgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcgggta
actcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgctgag
caaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtcacaaa
gagcttcaacaggggagagtgt
克隆830号:
gacatccagatgacccagtctccttcgaccctgtctgcatctgtaggagacagagtcaccatcacttgccgggccag
tcagagtgttactagtgagttggcctggtatcagcagaaaccagggaaagcccctaacttcctgatctataaggcgtc
tagtttagaaagtggggtcccatcaaggttcagcggcagtggatctgggacagaattcactctcaccatcagcagcc
tgcagcctgatgattttgcaacttattactgccaacagtataatagttttccgtacacttttggccaggggaccaagctg
gagatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcct
ctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcg
ggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgct
gagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtca
caaagagcttcaacaggggagagtgt
克隆831号:
gacatccagatgacccagtctccttccaccctgtctgcatctgtaggcgacagactcaccatcacttgccgggccagt
cagaatatttataactggttggcctggtatcagcagaaaccagggaaagcccctaaactcctgatctatgacgcctcc
actttggaaagtggggtcccatcaaggttcagcggcagtggatctgggacagagttcactctcaccatcagcagcct
gcagcctgatgattttgcgacttattactgccaacaatataatagtttgtctccgacgttcggccaagggaccaaggtg
gaaatcaagcgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcct
ctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcg
ggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgct
gagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtca
caaagagcttcaacaggggagagtgt
克隆835号:
gacatccagttgacccagtctccatccttcctgtctgcatctttagaagacagagtcactatcacttgccgggccagtc
agggcattagcagttatttagcctggtatcagcaaaaaccagggaaagcccctaagctcctgctcgatgctgcatcc
actttgcaaagtggggtcccatcaaggttcagcggcagtggatctgggacagagttcactctcacaatcagcagcct
gcagcctgaagattttgcaacttattactgtcaacagcttaatagttaccctcggacgttcggccaagggaccaaggt
ggacatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcc
tctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcg
ggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgct
gagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtca
caaagagcttcaacaggggagagtgt
克隆838号:
gacatccagatgacccagtctccatcctccctgtctgcatctgtaggagacagagtcagcatcacttgccgggcgag
tcagggcattagcaattatttagcctggtatcagcagaaaccagggaaggttcctaagctcctgatctatgctgcatcc
actttgcaatcaggggtcccatctcggttcagtggcagtggatctgggacagatttcactctcaccatcagcagcctg
cagcctgaggatgttgcaacttattactgtcaaaagtataacagtgcccctcaaacgttcggccaagggaccaaggt
ggaaatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcc
tctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcg
ggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgct
gagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtca
caaagagcttcaacaggggagagtgt
克隆841号:
gacatcgtgatgacccagtctccagactccctggctgtgtctctgggcgagagggccaccatcaactgcaggtcca
gccagagtgttttatacagctccaacaataagaactacttagcttggtaccagcagaaaccaggacagcctcctaag
ctgctcgtttactgggcatcaacccgggcatccggggtccctgaccgattcagtggcagcgggtctgggacagattt
cactctcaccctcagcagcctgcaggctgaagatgtggcagtttattactgtcagcagtttcatagtactcctcggacg
ttcggccaagggaccaaggtggagatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgag
cagttgaaatctggaactgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaag
gtggataacgccctccaatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacag
cctcagcagcaccctgacgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatca
gggcctgagctcgcccgtcacaaagagcttcaacaggggagagtgt
克隆853号:
gaaattgtgttgacgcagtctccaggcaccctgtctttgtctccaggggaaagagccaccctctcctgcagggccag
tcagagtgttagcagcaactacttagcctggtaccagcagaaacctggccaggctcccaggctcctcatctatggtg
catccagcagggccgctggcatgccagacaggttcagtggcagtgggtctgggacagacttcactctcaccatcag
cagactggagcctgaagattttgcagtgt attactgtcagcagtatggtaactcaccgctcactttcggcggagggac
cgaggtggagatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctgg
aactgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccct
ccaatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccc
tgacgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgc
ccgtcacaaagagcttcaacaggggagagtgt
克隆855号:
gacatccagatgacccagtctccatcttctgtgtctgcatctgtaggagacagagtcaccatcacttgtcgggcgagt
caggctattagtaactggttagcctggtatcagcagaaaccaggaaaagcccctaagctcctgatctatgctgcatcc
agtttgcaaagtggggtcccatcaagattcagcggcagtggatctgggacagatttcactctcactatcagcggcctg
cagcctgaggattttgcaacttactattgtcaacaggctgacactttccctttcactttcggccctgggaccaaagtgga
tatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcctctg
ttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcgggt
aactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgctga
gcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtcacaa
agagcttcaacaggggagagtgt
克隆856号:
gatattgtgatgacccagactccactctccctgcccgtcacccctggagagccggcctccatctcctgcaggtctagt
cagagcctcttggatagtaatgatggaaacacctatttggactggtacctgcagaagccagggcagtctccacagct
cctgatttatacattttcctatcgggcctctggagtcccagacaggttcagtggcagtgggtctggcactgatttcacac
tgaaaatcagcagggtggaggccgaggatgttggagtttattactgcatgcaacgtatcgagtttccgtacacttttgg
ccaggggaccaagctggagatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagtt
gaaatctggaactgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtgga
taacgccctccaatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctca
gcagcaccctgacgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggc
ctgagctcgcccgtcacaaagagcttcaacaggggagagtgt
克隆857号:
gatattgtgatgacccagtctccactctccctgcccgtcacccctggagagccggcctccatctcctgcaggtctagt
cagagcctcctgcatagaaatgagtacaactatttggattggtacttgcagaagccagggcagtctccacagctcctg
atctattggggttctaatcgggcctccggggtccctgacaggttcagtggcagtggatcaggcacagattttacactg
aaaatcagcagagtggaggctgaggatgttggggtttattactgcatgcaaactctacaaactcctcggacgttcggc
caagggaccaaggtggaaatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttg
aaatctggaactgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggat
aacgccctccaatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcag
cagcaccctgacgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcct
gagctcgcccgtcacaaagagcttcaacaggggagagtgt
克隆858号:
gacatccagatgacccagtctccatcctccgtgtctgcatctgtgggagacagagtcaccatcacttgccaggcgag
tcaagacattagcaactatttaaattggtatcagcagaaaccagggaaagcccctaagctcctgatcttcgatgcaac
caaattggagacaggggtcccaacaaggttcattggaagtggatctgggacagattttactgtcaccatcaccagcct
gcagcctgaagatgttgcaacatattactgtcaacactttgctaatctcccatacacttttggccaggggaccaagctg
gagatcaagcgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcct
ctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcg
ggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgct
gagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtca
caaagagcttcaacaggggagagtgt
克隆859号:
gacatccagatgacccagtctccatcttccctgtctgcatctgtaggagacagagtcaccatcacttgccgggcgagt
cagggcattaggaattatttagcctggtatcagcagaaaccagggaaagttcctaagctcctggtctttgctgcatcca
ctttgcaatcaggggtcccatctcggttcagtggcagtggatctgggacagatttcactctcaccatcagcagcctgc
agcctgaggatgttgcaacttattactgtcaaaggtataacagtgccccgctcactttcggcggagggacgaaggtg
gagatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcct
ctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcg
ggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgct
gagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtca
caaagagcttcaacaggggagagtgt
克隆861号:
gacatccagatgacccagtctccatcctccctgtctgcatctgtaggagacagagtcaccatcacttgccgggcaagt
cagatcattgccagctatttaaattggtatcagcagaaaccaggcagagcccctaagctcctgatctatgctgcatcca
gtttgcaaagtggggtcccatcaaggttcagtggcagtggatctgggacagatttcactctcaccatcagcagtctgc
aacctgaagattttgcaacttactactgtcaacagagttacagtacccccatattcactttcggccctgggaccaaggt
gaatatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcct
ctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcg
ggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgct
gagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtca
caaagagcttcaacaggggagagtgt
克隆863号:
gaaattgtgttgacacagtctccagccaccctgtctttgtctccaggggaaagagccaccctctcctgcaggaccagt
cagagtgttagcagctacttagcctggtaccaacagaaacctggccaggctcccaggctcctcatctatgatgcttcc
aatagggccactggcatcccagccaggttcagtggcagtgggtctgggacagacttcactctcaccatcagcagcc
tagagcctgaagattttgcagtttattactgtcagcagcgtagtgactggctcactttcggcggagggaccaaggtgg
agatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcctct
gttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcggg
taactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgctga
gcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtcacaa
agagcttcaacaggggagagtgt
克隆868号:
gaaattgtaatgacacagtctccagccaccctgtctgtgtctccaggggaaagagccaccctctcctgcagggccag
tcagagtattaaaaacaacttggcctggtaccaggtgaaacctggccaggctcccaggctcctcacctctggtgcat
ccgccagggccactggaattccaggcaggttcagtggcagtgggtctgggactgacttcactctcaccatcagcag
cctccagtctgaagatattgcagttt attactgtcaggagtataataattggcccctgctcactttcggcggagggacca
aggtggagatccaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaa
ctgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctcc
aatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctg
acgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcc
cgtcacaaagagcttcaacaggggagagtgt
克隆870号:
gacatccagatgacccagtctcctccctccctgtctgcatctgtgggagacagagtcaccatcacttgccgggcaag
tcagaggattgccagctatttaaattggtatcagcagaaaccagggagagcccctaagctcctgatctttgctgcatcc
agtttacaaagtggggtcccatcaaggttcagtggcagtggatctgggacagacttcactctcaccatcagtagtctg
caacctgaag attatgcgacttactactgtcaacagagttacagtactcccatctacacttttggccaggggaccaagc
tggagatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgc
ctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatc
gggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacg
ctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtc
acaaagagcttcaacaggggagagtgt
克隆871号:
gacatccagatgacccagtctccatcctccctgtctgcatctgtaggagacagagtcaccatcacttgccaggcgagt
cagggcattagcaactatttaaattggtatcaacagaaaccagggaaagcccctaagctcctgatcttcgatgcatcc
aatttggaatcagaggtcccatcaaggttcagtggacgtggatctgggacagattttactttctccatcagcagcctgc
agcctgaagatattgcaacatatttctgtcaacagtatgataatttcccgtacacttttggccaggggaccaagctgga
gatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcctct
gttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcggg
taactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgctga
gcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtcacaa
agagcttcaacaggggagagtgt
克隆880号:
gacatccagatgacccagtctccatcctccctggctgcatctgtaggagacagagtcaccatcacctgccgggcaa
gtcagacgattgccagttatgtaaattggtatcaacagaaaccagggaaagcccctaatctcctgatctatgctgcatc
cagtttgcaaagtggggtcccatcaaggttcagtggcagtggatctgggacagatttcactctcaccatcagcagtct
gcaacctgaagattttgcatcttacttctgtcaacagagttacagtttcccgtacacttttggccaggggaccaagctgg
atatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcctct
gttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcggg
taactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgctga
gcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtcacaa
agagcttcaacaggggagagtgt
克隆881号:
gacatccagatgacccagtctccatcctccctgtctgcatctgtaggagacagagtcaccatcacttgccgggcaagt
cagaccattgccagctatgtaaattggtatcagcagaaaccagggaaagcccctaagctcctgatctatgctgcatcc
aatttgcaaagtggggtcccttcaaggttcagtggcagtggatctgggacagatttcactctcaccatcagcagtctgc
aacctgaagattttgcaacttactactgtcaacagagttacagtgtccctcggctcactttcggcggagggaccaagg
tggacatcacacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgc
ctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatc
gggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacg
ctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtc
acaaagagcttcaacaggggagagtgt
克隆884号:
gacatccagatgacccagtctccatcctccctgtctgcatctgtaggagacagagtcaccatcacttgccggtcaagt
cagaccattagcgtctttttaaattggtatcagcagaaaccagggaaagcccctaagctcctgatctatgccgcatcca
gtttgcacagtgcggtcccatcaaggttcagtggcagtggatctgggacagatttcactctcaccatcagcagtctgc
aacctgaagattctgcaacttactactgtcaagagagtttcagtagctcaactttcggcggagggaccaaggtggag
atcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaactgcctctgt
tgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaatcgggta
actcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgacgctgag
caaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgtcacaaa
gagcttcaacaggggagagtgt
克隆886号:
gaaattgtaatgacacagtctccagccaccctgtctgtgtctccaggggaaacagccaccctctcctgcagggccag
tcagagtgttagcagcaacttagcctggtaccaacataaacctggccaggctcccaggctcctcatccatagtgcatc
caccagggccactgggatcccagccaggttcagtggcagtgggtctgggacagagttcactctcaccataagcag
cctgcagtctgaagattttgcagtttattactgtcagcagtataatatgtggcctccctggacgttcggccaagggacc
aaggtggaaatcaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaa
ctgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctcc
aatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctg
acgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcc
cgtcacaaagagcttcaacaggggagagtgt
克隆888号:
gatattgtgatgacccagtctccactctccctgcccgtcacccctggagcgccggcctccatctcctgcaggtctagt
cagagcctcctgcgtactaatggatacaactatttggattggtacctgcagaagccagggcagtctccacagctcctg
atctatttgggttctattcgggcctccggggtccctgacaggttcagtggcagtggctcaggcacagattttacactga
aaatcagcagagtggaggctgaggatgttggggtttattactgcatgcaatctctacaaacttcgatcaccttcggcca
agggacacgactggagattaaacgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaa
atctggaactgcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataa
cgccctccaatcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagca
gcaccctgacgctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctg
agctcgcccgtcacaaagagcttcaacaggggagagtgt
克隆894号:
gaaattgtaatgacacagtctccagccaccctgtctgtgtctccgggggaaagagccaccctctcctgcagggctag
tcagagtgttggcaacaacttagcctggtaccagcagagacctggccaggctcccagactcctcatctatggtgcgt
ccaccagggccactggtatcccagccaggttcagtggcagtgggtctgggacagagttcactctcaccatcagcag
cctgcagtctgaggattttgcagtttattactgtcagcagtatgataagtggcctgagacgttcggccaggggaccaa
ggtggacatcaagcgaactgtggctgcaccatctgtcttcatcttcccgccatctgatgagcagttgaaatctggaact
gcctctgttgtgtgcctgctgaataacttctatcccagagaggccaaagtacagtggaaggtggataacgccctccaa
tcgggtaactcccaggagagtgtcacagagcaggacagcaaggacagcacctacagcctcagcagcaccctgac
gctgagcaaagcagactacgagaaacacaaagtctacgcctgcgaagtcacccatcagggcctgagctcgcccgt
cacaaagagcttcaacaggggagagtgt
在所有上文讨论的44个克隆中,经编码抗体包含相同的恒定IgG重链,
其具有下列的氨基酸序列(SEQ ID NO:178):
SASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGAL
TSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKR
VEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVD
VSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDW
LNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQV
SLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDK
SRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK
编码该重链之基因组序列具有下列的核酸序列(SEQ ID NO:177):
ggctatgcagtcccagtccagggcagcaaggcaggccccgtctgcctcttcacccggaggcctctgcccgcccca
ctcatgctcagggagagggtcttctggctttttccccaggctctgggcaggcacaggctaggtgcccctaacccagg
ccctgcacacaaaggggcaggtgctgggctcagacctgccaagagccatatccgggaggaccctgcccctgacc
taagcccaccccaaaggccaaactctccactccctcagctcggacaccttctctcctcccagattccagtaactccca
tcgccctccagctcaaggcgggacaggtgccctagagtagcctgcatccagggacaggccccagccgggtgctg
agggccacatggacagaggccggctcggcccaccctctgccctgagagtgaccgctgtaccaacctctgtcccta
在该序列中,以双重下标线表示外显子序列。此外,由于将经XhoI消化之PCR产物(其在IgG表达载体中编码可变重链位置)导入经XhoI消化的表达载体内,创造了编码最初之Ser的核苷酸agt(粗体下标线)。
根据在ELISA和/或FLISA中对各种抗原和肽的结合特异性、抗原决定位作图、抗原多样性和序列多样性,来选择上文讨论的VH和VL密码对。若鉴认出错误,便使所选出之关联V-基因对接受克隆修补。
实施例2单-和多克隆抗-RSV抗体的功能体外测试
已经利用单一抗体克隆和经纯化抗体之组合两者,进行在体外的中和实验。下述所有的抗体混合物均由若干本发明之个别抗-RSV抗体所组成,使用等量的不同抗体,将其混合成混合物。
制备活RSV以供在体外中使用
以1x107个细胞/烧瓶,将人类喉上皮HEp-2细胞(ATCC CLL-23)播种在175cm2的烧瓶中。在3毫升不含血清的培养基中,以0.1pfu/细胞之比例,利用RSV Long(ATCC编号VR-26)、RSV A2(Advanced Biotechnologies Inc.,ATCC编号VR-1540)、RSV B1(ATCC编号VR-1400)或RSV BWash/18537(Advanced Biotechnologies Inc.,ATCC编号VR-1580)菌种感染该细胞。在37℃;5%CO2下感染细胞2小时,接着加入37毫升完全MEM培养基。培养细胞,直到可看见细胞病变效应为止。通过刮擦分离细胞,并以音波振动处理培养基和细胞20秒并等分之,在液态氮中快速冷冻,并储存在-80℃下。
溶菌斑减少中和测试(PRNT)
以2x104个细胞/孔将HEp-2细胞播种在96-孔培养盘中,并在37℃;5%CO2下培养过夜。以不含血清之MEM稀释受试物质,并允许在37℃下,在有或无补体(来自兔子的补体血清,Sigma)之下,与RSV预先-培养30分钟。将该混合物施加在单层的HEp-2细胞上,并在37℃;5%CO2下培养24-72小时。以80%丙酮;20%PBS固定细胞20分钟。在洗涤之后,加入在带有1%BSA之PBS中(1∶200)之生物素基化的山羊抗-RSV抗体(AbD Serotec),并在室温下培养1小时。在洗涤之后,加入HRP-抗生物素蛋白,并允许培养30分钟。通过与3-氨基-9-乙基咔唑(AEC)受质一起培养,展开溶菌斑,直到可通过显微镜看见溶菌斑为止,例如25分钟(RSV Long)或45分钟(RSV B1)。在Bioreader(Bio-Sys GmbH)中计算溶菌斑的数目。在适用之处计算EC50值(引起溶菌斑数目降低50%所需之有效浓度),以允许进行效力的比较。
单一抗体的测试
在补体存在下,决定每个抗体针对RSV亚型A和B菌种的中和活性。在表5中显示若干经纯化抗体的EC50值。空白区域代表尚未进行该分析。ND代表在PRNT中无法决定EC50值,因为太低或缺少中和活性。
表5:经纯化之抗-RSV蛋白质F和蛋白质G抗体对RSV亚型A和B的EC50值
抗-F抗体之混合物
将抗-RSV蛋白质F之抗体的混合物中和RSV菌种(strain)之亚型A和B的能力与使用帕利珠单抗(Palivizumab)(亦为抗-F抗体)所获得之中和效果做比较。使用微中和(microneutralization)测试或PRNT评估中和能力。在初步实验中,使用微中和测试,对帕利珠单抗比较两个抗体混合物:抗-F(I)和抗-F(II),其分别含有5和11个个别的抗-F抗体。抗-F(I)由获自克隆810、818、819、825和827之抗体组成。抗-F(II)由获自克隆735、800、810、818、819、825、827、863、880、884和894之抗体组成。两种组合物抗-F(I)和F(II)在中和RSV菌种的两种亚型上都比帕利珠单抗有效。
已经改进在体外的测定和克隆的组合两者,因为已经确认该初步实验和一些F-特异性抗体克隆的组合,在补体存在下是极为有效的。在表6中列举以EC50值(引起溶菌斑数目降低50%所需之有效浓度)表示之额外抗-F抗体组合物的中和效力。不管在组合物中之克隆的精确数目,大多数受试的F-特异性抗体之组合在中和RSV菌种之亚型A上都比帕利珠单抗有效。
抗-G抗体的混合物
使用PRNT测试抗-G抗体之混合物中和RSV菌种之亚型A的能力。在表6中列举来自受试之抗-G抗体组合物的EC50值。与个别抗-G抗体相比较,大多数两个抗-G抗体之组合物都没有展现出明显增加之中和病毒的能力。二或三个抗-G抗体的一些组合(不管浓度),也未曾达到病毒的100%中和。然而,当将额外的抗-G抗体加至组合物中时,增加了效力,可能代表在抗-G抗体之间的协同中和效果。
抗-F和抗-G抗体的混合物
将抗-RSV蛋白质F和蛋白质G抗体5之混合物中和RSV亚型B菌种的能力,与使用帕利珠单抗所获得的中和效果做比较。
一开始,在微中和融合抑制测定中测量两个抗体混合物,抗-F(I)G和抗-F(II)G的中和活性。这些混合物分别含有上述之组合物抗-F(I)和抗-F(II)的抗-F抗体,以及获自克隆793、796、838、841、856和888之抗-G抗体。两种组合物抗-F(I)G和F(II)G在中和RSV B1菌种上都比帕利珠单抗有效。此外,两种混合物之中和活性是大约相等的。
已经在PRNT中,在有或无补体之下,测试了大量抗-F和抗-G抗体两者的不同组合。在表6中提出在活性补体的存在下,通过该测定获得之EC50值。所有包含抗-F和抗-G抗体两者的受试组合物都中和RSV亚型A,且其中大多数都比帕利珠单抗有效。
表6:抗-RSV抗体之组合针对RSV亚型A和B的EC50值。空白区域代表尚未进行该分析。ND代表在PRNT中无法决定EC50值,因为太低或缺少中和活性。
实施例3多-和单克隆抗-RSV抗体的活体内测试
在经RSV-感染之小鼠的肺脏中降低病毒负荷
已经在BALB/c小鼠模式中证实本发明之经纯化抗体的组合针对RAV感染的活体内保护能力(Taylor等人1984.Immunology 52,137-142;Mejias等人,2005.Antimicrob.Agents Chemother.49:4700-4707)。
小鼠攻击模式
在研究第-1天,以0.2毫升抗体制剂腹腔内接种7-8周龄雌性BALB/c小鼠。以0.1毫升PBS缓冲溶液,以类似方式腹腔内接种安慰剂处理的小鼠。在研究第0天,使用吸入的异氟烷(isofluorane)麻醉小鼠,并以50微升之10-6-10-7pfu的RSV菌种A2或以细胞裂解物(模仿接种物)鼻内接种。允许动物吸入接种物30秒,同时保持直立直到从麻醉中完全恢复为止。
在攻击之后5天,利用过量的戊巴比妥钠杀死小鼠。在验尸之后,通过从腋下血管放血获得血液,以供制备血清。移出肺脏,并在2.5毫升缓冲溶液中利用无菌的沙将其均质化。离心肺脏匀浆,使沙和细胞碎屑沉降,并等分上清液,然后储存在-70℃下。
一开始通过使用逆转录酶(RT-)PCR,定量在肺脏试样中之RSV RNA拷贝的数目,来决定病毒负荷。根据制造者的说明,使用MagNA Pure LC总核酸试剂盒(Roche Diagnostics)自动萃取系统,从肺脏匀浆试样中萃取RNA。通过单-管即-时RT-PCR,使用LightCycler仪器和试剂(Roche Diagnostics),利用对RSV亚型A之N基因特异的引子和经荧光-标示之探针,如同Whiley等人的描述(J.Clinical Microbiol.2002,40:4418-22),检测RSV RNA。以类似之方式分析具有已知RSV RNA拷贝数目的试样,以衍生标准曲线。
随后,使用定量逆转录酶(RT-)PCR,决定在肺脏试样中RSV RNA拷贝的数目。根据制造者的说明,使用RNeasy迷你试剂盒(Qiagen),从肺脏匀浆试样中萃取RAN。通过使用SuperScript III铂单一-步骤定量RT-PCR系统(Invitrogen),利用如下述对RSV亚型A之N基因特异的引子和经荧光-标示之探针,检测RSV RNA。以类似之方式分析具有已知RSV RNA拷贝数目的试样,以衍生标准曲线。
用于定量RT-PCR之RSV亚型A特异的引子和探针。
名称 | 序列5’-3’ |
RSV-A正向 | CAA CAA AGA TCA ACT TCT GTC ATC |
RSV-A逆向 | GCA CAT CAT AAT TAG GAG TAT CAA T |
RSA探针 | 6-FAM-CA CCA TCC AAC GGA GCA CAG GAG AT-TAMRA |
在表7a中,提出来自利用四个不同的抗-RSV rpAb(由等量的本发明之不同抗体克隆组成-在表6中描述)和单独克隆810之实验的数据,与来自相同实验之未感染对照组动物和经安慰剂(PBS)处理之动物的数据做比较。每个处理组分别含有5只小鼠,并在感染后第5天获得试样,在该模式中,大约是在病毒复制的高峰期。如在表7a中所示,当以25mg/kg体重的预防性给药时,rpAb组合有效地降低了病毒负荷至少一个数量级(an order ofmagnitude)。以平均值±标准偏差来表示拷贝数目。
表7a:在预防和RSV攻击之后,在小鼠肺脏中的病毒负荷。
处理组别(剂量) | 通过RT-PCR确定的病毒负荷(log10 RSV RNA拷贝/ng总RNA) |
未感染 | 阴性 |
PBS | 4.11±0.12 |
抗-RSV rpAb 18(25mg/kg) | 2.74±0.16 |
抗-RSV rpAb 18(5mg/kg) | 3.40±0.09 |
抗-RSV rpAb 9(25mg/kg) | 2.95±0.19 |
抗-RSV rpAb 9(5mg/kg) | 3.56±0.31 |
抗-RSV rpAb 17(25mg/kg) | 2.81±0.29 |
抗-RSV rpAb 17(5mg/kg) | 3.39±0.12 |
抗-RSV rpAb 13(25mg/kg) | 3.02±0.33 |
抗-RSV rpAb 13(5mg/kg) | 3.34±0.26 |
克隆810(25mg/kg) | 3.03±0.16 |
处理组别(剂量) | 通过RT-PCR确定的病毒负荷(log10 RSV RNA拷贝/ng总RNA) |
克隆810(5mg/kg) | 3.37±0.22 |
在表7b中,提出来自利用三个不同的抗RSV rpAb(由等量的本发明之不同抗体克隆组成-在表6中描述)和单独克隆824之第二个研究的数据,与来自相同实验之未感染对照组动物、经安慰剂(PBS)处理之动物和经帕利珠单抗(赛纳吉)处理之动物的数据做比较。每个处理组分别含有5只小鼠,并在感染后第5天获得试样。以平均值±标准偏差来表示拷贝数目。
在表7c中,提出来自利用抗-RSV rpAb 33(由等量的本发明之不同抗体克隆组成-在表6中描述)之第三个研究的数据,与来自相同实验之未感染对照组动物、经安慰剂(PBS)处理之动物和经帕利珠单抗(赛纳吉)处理之动物的数据做比较。除了最后三组之外,每个处理组分别含有5只小鼠,并在感染后第5天获得试样。从以15、5和1.5mg/kg体重之抗-RSV rpAb 33处理的各组中移出一只小鼠,因为发现它们从未注射抗体。以平均值±标准偏差来表示拷贝数目。
在所有的三个研究中,与经安慰剂处理之对照组相比较,在经抗体处理之组别中,RSV RNA拷贝数目有在统计学上明显的降低(p<0.05;等变异的(homoscedastic)t-检定)。在第二个研究中,在以本发明之抗体处理的组别中,病毒负荷明显比在以相当剂量之赛纳吉(synagis)处理的组别5中更低(表7b)。在第3个研究中,在以抗-RSV rpAb 33处理之组别中,病毒负荷明显比在以所有受试剂量之赛纳吉处理的组别中更低(表7c)。
表7b:在预防和RSV攻击之后,在小鼠肺脏中的病毒负荷。
处理组别(剂量) | 通过RT-PCR确定之病毒负荷(log10 RSV RNA拷贝/毫微克总RNA) |
未感染 | 阴性 |
PBS | 4.22±0.20 |
赛纳吉(15mg/kg) | 3.68±0.25 |
赛纳吉(3mg/kg) | 3.83±0.12 |
抗-RSV rpAb 28(15mg/kg) | 2.96±0.19 |
抗-RSV rpAb 28(3mg/kg) | 3.32±0.23 |
抗-RSV rpAb 33(15mg/kg) | 2.95±0.30 |
抗-RSV rpAb 33(3mg/kg) | 3.66±0.07 |
处理组别(剂量) | 通过RT-PCR确定之病毒负荷(log10 RSV RNA拷贝/毫微克总RNA) |
抗-RSV rpAb 56(15mg/kg) | 2.66±0.18 |
抗-RSV rpAb 56(3mg/kg) | 3.25±0.38 |
克隆824(15mg/kg) | 2.51±0.28 |
克隆824(3mg/kg) | 3.09±0.18 |
表7c:在预防和RSV攻击之后,在小鼠肺脏中的病毒负荷。星号代表仅含有四只动物的组别。
处理组别(剂量) | 通过RT-PCR确定之病毒负荷(log10 RSV RNA拷贝/毫微克总RNA) |
未感染 | 阴性 |
PBS | 4.13±0.17 |
赛纳吉(45mg/kg) | 3.56±0.22 |
赛纳吉(15mg/kg) | 3.60±0.27 |
赛纳吉(5mg/kg) | 3.77±0.14 |
赛纳吉(1.5mg/kg) | 3.86±0.12 |
抗-RSV rpAb 33(45mg/kg) | 2.38±0.18 |
抗-RSV rpAb 33(15mg/kg)* | 2.70±0.18 |
抗-RSV rpAb 33(5mg/kg)* | 3.15±0.24 |
抗-RSV rpAb 33(1.5mg/kg)* | 3.53±0.12 |
实施例4CHO细胞的衍生
表达抗体之CHO细胞克隆的衍生
表达载体
在图2a中显示所使用的IgG表达载体。
在图2b中显示E1A表达载体
细胞系
所使用之细胞系是获自Lawrence Chasin,Columbia University(亦可获自Gibco目录第12613-014号)的DHFR-阴性CHO细胞系DG44之衍生物。以在载体pcDNA3.1+(目录第V790-20号,Invitrogen)中之腺病毒第5型反式激活蛋白E1A的13S版本之cDNA(NCBI登录编号AY339865)转染DG44细胞,(该cDNA序列:
atgagacatattatctgccacggaggtgttattaccgaagaaatggccgccagtcttttggaccagctgatcgaagag
gtactggctgataatcttccacctcctagccattttgaaccacctacccttcacgaactgtatgatttagacgtgacggc
ccccgaagatcccaacgaggaggcggtttcgcagatttttcccgactctgtaatgttggcggtgcaggaagggattg
acttactcacttttccgccggcgcccggttctccggagccgcctcacctttcccggcagcccgagcagccggagca
gagagccttgggtccggtttctatgccaaaccttgtaccggaggtgatcgatcttacctgccacgaggctggctttcc
acccagtgacgacgaggatgaagagggtgaggagtttgtgttagattatgtggagcaccccgggcacggttgcag
gtcttgtcattatcaccggaggaatacgggggacccagatattatgtgttcgctttgctatatgaggacctgtggcatgt
ttgtctacagtcctgtgtctgaacctgagcctgagcccgagccagaaccggagcctgcaagacctacccgccgtcct
aaaatggcgcctgctatcctgagacgcccgacatcacctgtgtctagagaatgcaatagtagtacggatagctgtga
ctccggtccttctaacacacctcctgagatacacccggtggtcccgctgtgccccattaaaccagttgccgtgagagt
tggtgggcgtcgccaggctgtggaatgtatcgaggacttgcttaacgagcctgggcaacctttggacttgagctgta
aacgccccaggccataa)。利用浓度500微克/毫升的选择试剂(Invitrogen)选择转染物。在选择之后,通过限制稀释,对细胞进行单一-细胞克隆。针对通过以抗体质粒(上文显示)暂时转染的抗体表达,测试克隆。单一克隆在暂时测定中,与未经转染之DG44细胞系相比较,显示改善了表达水平达到因子3。在与稳定的转染进行比较时,与野外型DG44细胞系相比较,所选出之库显示增加了表达水平4-5倍。亚代克隆该克隆(称为ECHO)两次,且关于抗体的高表达似乎是稳定的。
实施例5:利用经随机整合的表达载体,建立表达抗-RSV抗体之细胞系抗体表达质粒
为了在ECHO细胞系中的表达,选出13个不同的抗-RSV抗体。如上述构建所使用之抗体表达质粒。该抗体为:
●Sym003-810(克隆810)
●Sym003-818(克隆818)
●Sym003-819(克隆819)
●Sym003-824(克隆824)
●Sym003-825(克隆825)
●Sym003-827(克隆827)
●Sym003-858(克隆858)
●Sym003-894(克隆894)
●Sym003-793(克隆793)
●Sym003-816(克隆816)
●Sym003-853(克隆853)
●Sym003-855(克隆855)
●Sym003-856(克隆856)
克隆编号意指在表3中的编号。在实施例1中找到该克隆之轻链和VH多肽,以及编码序列。在SEQ ID NO:177中找到CH序列,且其密码序列在SEQ ID NO:178中。在下文中解释以表达抗-RSV抗体之质粒转染ECHO细胞的一般程序。
IgG ELISA
通过三明治ELISA测量IgG。简言之,以山羊抗-人类Fc(Serotec,STAR106)涂覆96-孔培养盘(Maxisorp,NUNC),接着与试样及标准物(经纯化之人类单克隆IgG1κ抗体)一起培养。利用与辣根过氧化酶(SerotecSTAR100P)共轭的山羊抗-人类κ轻链进行检测。
ECHO细胞的转染
以0.15x106个细胞/每个烧瓶之密度,将ECHO细胞播种在T75烧瓶中之带有核苷(Invitrogen目录第32571号)和10%胎牛血清(FCS)(Invitrogen)的MEMα培养基中。第二天,以Fugene6(Roche)转染该细胞:
●将10微升的Fugene6与490微升杜贝可氏(Dulbecco’s)经过修改的Eagle’s培养基混合,并允许在室温下培养5分钟
●加入5微克表达质粒,并在室温下再培养该混合物15分钟
●将该混合物加至该细胞培养烧瓶中
在转染之后24小时,吸掉带有转染试剂的培养基,以5毫升带有10%经透析FCS(Invitrogen)的MEMα培养基(没有核苷;MEMα-)洗涤每个烧瓶一次。一起加入10毫升相同的培养基(MEMα-,带有10%经透析FCS)和用来选择之浓度3nM的氨甲碟呤。随后一周更换培养基三次。
在大约14到18天,以胰蛋白酶消化细胞,再悬浮于10毫升选择培养基中,并移至新的T75或T175烧瓶中。
第2天,更换培养基,并在24小时之后吸取medium试样,进行ELISA,并以胰蛋白酶消化细胞,计数并移至新的T-烧瓶中带有3nM氨甲碟呤之MEMα-中。通过对上清液进行IgG ELISA来测量生产力。在细胞到达汇合之前,将细胞库(pool)冷冻在含有20%DMSO和10%经透析FCS的培养基中。
为了产生单一-细胞克隆,将该库再度融化。亦可使细胞接受单一-细胞克隆,没有先前的冷冻步骤。在3天后,针对与表面结合之抗体将细胞染色,并将单一-细胞挑选到含有50%经ECHO-细胞调理之培养基(MEMα-)和50%未经调理之相同培养基的96-孔培养盘中。简言之,染色规程如下:
1.以胰蛋白酶消化细胞并计数
2.将1-5x106个细胞吸移至无菌的FACS管中
3.在4℃下以250g旋转细胞1分钟,并移除上清液
4.以2毫升无菌的FACS PBS(PBS+2%FCS)(5毫升)洗涤细胞
5.以100微升经稀释之Ab/106个细胞,以(山羊F(ab)2片段抗-人类IgGH+L-PE(Beckman-Coulter,IM1626)稀释1∶20)染色细胞,并培养20分钟(4℃下在暗处)
6.以2毫升FACS PBS(5毫升)洗涤细胞两次
7.将细胞再悬浮于FACS PBS(2毫升中)至1-5x106/毫升
8.加入碘化丙锭,10微克/毫升1∶100
记录30,000个事件,并鉴认高度表达的细胞为Sym003-824,使用下列的门限策略:首先在fsc/ssc点作图中设定门限(p1),让具有大约相同大小和粒性的细胞通过。然后,对活细胞设门限(p2),使用碘化丙锭染色作为死细胞的标记。第三,使用双重鉴别技术,利用ssc-高度和ssc-宽度(p3)排除多聚体的细胞团。最后,设定门限(P5),纳入0.2%最强染色的细胞。
使用该门限设定,使用FACS-Aris(Beckton-Dickinson)将为单一细胞之细胞挑选到96-孔培养盘中(每种抗体5个培养盘)。
在7天之后,通过显微镜检查各孔中单一克隆的存在。在检查之后,在各孔中加入100微升带有10%经透析FCS之MEMα培养基。
在挑选之后12天,分别通过IgG ELISA以单一稀释测定来自具有单一克隆之孔的上清液。基于孔的IgG ELISA值和目视检查(细胞数目和形态学),选出代表每个抗体的15-25个克隆继续培养。以胰蛋白酶消化所选出之克隆,并移至6-孔培养盘中,当6-孔接近汇合时再进一步移至T75烧瓶中。当培养物≥50%汇合时,更换培养基。24小时后,对上清液进行IgG ELISA,并计算细胞数目。选出若干具有适当生产力的克隆,冷冻并使其适应悬浮培养。
适应不含血清之悬浮培养
以胰蛋白酶消化细胞并计数。将6x106个细胞离心并再悬浮于12毫升ProCHO4不含血清之培养基(Lonza)中。将细胞移至50毫升细胞培养管(TRP,Switzerland)中,并在摇动器上在37℃下培养。一周两次计算细胞密度,持续至少2周,若需要每次将培养物稀释至每毫升0.5x106个细胞。当倍增时间稳定地低于60小时时,便为了每毫升0.5x106个细胞,一周三次稀释细胞。
通过对在稀释培养物之后取得的上清液试样和在之后48小时取得的上清液试样之IgG ELISA决定比生产力(象形图/细胞/24小时)。让高-表达克隆继续适应。
在6至8周之后,大多数克隆的倍增时间都接近35小时,在此时认为它们已适应不含血清之培养基。然后通过一周三次将培养物稀释至每毫升0.5x106个细胞,在摇瓶中培养细胞。逐步使培养物体积增加至150毫升。
在冷冻培养基(50%经调理培养基:50%新鲜培养基+7.5%DMSO)中冷冻悬浮细胞。欲确保细胞在冷冻之前是以指数生长,在冷冻前的最后24小时期间内,倍增时间必须为35小时或更低。如上述,通过IgG ELISA决定在冷冻当天的比生产力(specific productivity)。
针对13个抗-RSV抗体分别制备经适应的细胞克隆。
实施例6:纯化在ECHO细胞系中表达之个别SYM003抗体,并鉴定初步特征
通过亲和力层析法,使用MAb选择SuRe(GE Healthcare,UK)纯化重组抗体试样。通过离心和使用0.22微米滤纸的过滤,使来自摇瓶的培养物上清液预-澄清,并使用包装在小型单次使用之管柱中的0.1毫升MAb选择SuRe纯化。简言之,以PBS缓冲溶液,pH7.4平衡该MAb选择SuRe管柱。在室温下,使用重力流速,将培养物上清液施用在管柱上。随后使用PBS,pH7.4,使用重力流速洗涤该管柱,并使用0.1M甘氨酸-HCl,pH2.7洗脱,亦使用重力流速。通过加入1M Tris,pH7.0中和经纯化之抗体试样,并使用SDS-PAGE进一步分析。经纯化的量典型地是在10到250微克之间。
图3显示抗体818、810,以及824的两个克隆(824-8和824-17)的SDS-PAGE实例。
实施例7:建立多克隆细胞库
欲建立能够在相同容器中表达数个抗体的多克隆细胞库,制备克隆的混合物。基于在适应期间进行的细胞计数,考虑倍增时间的可能程度。小心照料使克隆配合类似的倍增时间。
混合克隆,使得代表每个抗体之细胞的数目,构成在混合物中细胞总数的相同百分比。
序列表
<110>西福根有限公司(Symphogen A/S)
<120>重组制造抗RSV抗体的方法
<130>P116PCT00
<160>714
<170>PatentIn version 3.5
<210>1
<211>122
<212>PRT
<213>人(homo sapiens)
<400>1
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu
1 5 10 15
Thr Leu Ser Leu Thr Cys Thr Val Ser Asn Gly Ala Ile Gly Asp Tyr
20 25 30
Asp Trp Ser Trp Ile Arg Gln Ser Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Asn Ile Asn Tyr Arg Gly Asn Thr Asn Tyr Asn Pro Ser Leu Lys
50 55 60
Ser Arg Val Thr Met Ser Leu Arg Thr Ser Thr Met Gln Phe Ser Leu
65 70 75 80
Lys Leu Ser Ser Ala Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala
85 90 95
Arg Asp Val Gly Tyr Gly Gly Gly Gln Tyr Phe Ala Met Asp Val Trp
100 105 110
Ser Pro Gly Thr Thr Val Thr Val Ser Ser
115 120
<210>2
<211>129
<212>PRT
<213>人(homo sapiens)
<400>2
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Phe Thr Phe Ser Thr Tyr
20 25 30
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Phe Ile Arg Tyr Asp Gly Ser Thr Gln Asp Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Met Val Tyr
65 70 75 80
Val Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Lys Asp Met Asp Tyr Tyr Gly Ser Arg Ser Tyr Ser Val Thr Tyr
100 105 110
Tyr Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser
115 120 125
Ser
<210>3
<211>125
<212>PRT
<213>人(homo sapiens)
<400>3
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ser Gly Tyr
20 25 30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Asn Thr Ser Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala His
65 70 75 80
Met Glu Leu Arg Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Glu Asp Gly Thr Met Gly Thr Asn Ser Trp Tyr Gly Trp Phe
100 105 110
Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210>4
<211>127
<212>PRT
<213>人(homo sapiens)
<400>4
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Pro Phe Gly Asp Tyr
20 25 30
Tyr Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Tyr Ile Asn Arg Gly Gly Thr Thr Ile Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Phe
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Leu Tyr Tyr Cys
85 90 95
Ala Arg Gly Leu Ile Leu Ala Leu Pro Thr Ala Thr Val Glu Leu Gly
100 105 110
Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
115 120 125
<210>5
<211>126
<212>PRT
<213>人(homo sapiens)
<400>5
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln
1 5 10 15
Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Ala Ser Ile Ser Ser Gly
20 25 30
Asp Tyr Tyr Trp Ser Trp Ile Arg Gln Ser Pro Arg Lys Gly Leu Glu
35 40 45
Trp Ile Gly Tyr Ile Phe His Ser Gly Thr Thr Tyr Tyr Asn Pro Ser
50 55 60
Leu Lys Ser Arg Ala Val Ile Ser Leu Asp Thr Ser Lys Asn Gln Phe
65 70 75 80
Ser Leu Arg Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Asp Val Asp Asp Phe Pro Val Trp Gly Met Asn Arg Tyr
100 105 110
Leu Ala Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210>6
<211>124
<212>PRT
<213>人(homo sapiens)
<400>6
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 l5
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Phe Ser His Phe
20 25 30
Gly Met His Trp Val Arg Gln Val Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Ile Ile Ser Tyr Asp Gly Asn Asn Val His Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Phe
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Asp Asp Asp Thr Gly Val Tyr Tyr Cys
85 90 95
Ala Lys Asp Asp Val Ala Thr Asp Leu Ala Ala Tyr Tyr Tyr Phe Asp
100 105 110
Val Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser
115 120
<210>7
<211>123
<212>PRT
<213>人(homo sapiens)
<400>7
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Lys Leu Ser Cys Glu Ala Ser Gly Phe Asn Phe Asn Asn Tyr
20 25 30
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Val Ile Ser Tyr Asp Gly Arg Asn Lys Tyr Phe Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Ile Ile Ser Arg Asp Asp Ser Arg Asn Thr Val Phe
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Ser Val Gln Val Trp Leu His Leu Gly Leu Phe Asp Asn
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210>8
<211>122
<212>PRT
<213>人(homo sapiens)
<400>8
Gln Val Gln Leu Val Glu Ser Gly Gly Ala Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Glu Val Ser Gly Phe Ser Phe Ser Asp Tyr
20 25 30
Gly Met Asn Trp Val Arg Gln Gly Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Val Ile Trp His Asp Gly Ser Asn Lys Asn Tyr Leu Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Val Ser Arg Asp Asn Ser Lys Asn Thr Leu Phe
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Thr Pro Tyr Glu Phe Trp Ser Gly Tyr Tyr Phe Asp Phe Trp
100 105 110
Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210>9
<211>116
<212>PRT
<213>人(homo sapiens)
<400>9
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Pro Phe Asn Ser Tyr
20 25 30
Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Val Ile Tyr Tyr Glu Gly Ser Asn Glu Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Lys Trp Leu Gly Met Asp Phe Trp Gly Gln Gly Thr Leu Val
100 105 110
Thr Val Ser Ser
115
<210>10
<211>120
<212>PRT
<213>人(homo sapiens)
<400>10
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Arg Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ser Ala Ser Gly Phe Thr Phe Ser Asn Tyr
20 25 30
Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Arg Leu Glu Tyr Val
35 40 45
Ser Ala Thr Ser Thr Asp Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Leu
50 55 60
Lys Gly Thr Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Ser Ser Leu Ser Thr Glu Asp Thr Ala Ile Tyr Tyr Cys
85 90 95
Ala Arg Arg Phe Trp Gly Phe Gly Asn Phe Phe Asp Tyr Trp Gly Arg
100 105 110
Gly Thr Leu Val Thr Val Ser Ser
115 120
<210>11
<211>122
<212>PRT
<213>人(homo sapiens)
<400>11
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Ser Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Arg Ala Ser Gly Gly Thr Phe Gly Asn Tyr
20 25 30
Ala Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Val
35 40 45
Gly Arg Ile Ile Pro Val Phe Asp Thr Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Arg Ser Thr Asn Thr Ala Ile
65 70 75 80
Met Gln Leu Ser Ser Leu Arg Pro Gln Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Leu Arg Gly Ser Thr Arg Gly Trp Asp Thr Asp Gly Phe Asp Ile Trp
100 105 110
Gly Gln Gly Thr Met Val Thr Val Ser Ser
115 120
<210>12
<211>129
<212>PRT
<213>人(homo sapiens)
<400>12
Gln Val Gln Leu Val Gln Ser Gly Ala Val Val Glu Thr Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Ile Phe Gly Asn Tyr
20 25 30
Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Ala Val Ile Asn Pro Asn Gly Gly Ser Thr Thr Ser Ala Gln Lys Phe
50 55 60
Gln Asp Arg Ile Thr Val Thr Arg Asp Thr Ser Thr Thr Thr Val Tyr
65 70 75 80
Leu Glu Val Asp Asn Leu Arg Ser Glu Asp Thr Ala Thr Tyr Tyr Cys
85 90 95
Ala Arg Gln Arg Ser Val Thr Gly Gly Phe Asp Ala Trp Leu Leu Ile
100 105 110
Pro Asp Ala Ser Asn Thr Trp Gly Gln Gly Thr Met Val Thr Val Ser
115 120 125
Ser
<210>13
<211>126
<212>PRT
<213>人(homo sapiens)
<400>13
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Met Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Ser Phe Ser Ser Tyr
20 25 30
Ser Ile Ser Trp Val Arg Gln Ala Pro Gly Arg Gly Leu Glu Trp Val
35 40 45
Gly Met Ile Leu Pro Ile Ser Gly Thr Thr Asn Tyr Ala Gln Thr Phe
50 55 60
Gln Gly Arg Val Ile Ile Ser Ala Asp Thr Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Thr Ser Leu Thr Ser Glu Asp Thr Ala Val Tyr Phe Cys
85 90 95
Ala Arg Val Phe Arg Glu Phe Ser Thr Ser Thr Leu Asp Pro Tyr Tyr
100 105 110
Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210>14
<211>125
<212>PRT
<213>人(homo sapiens)
<400>14
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Lys
1 5 10 15
Ser Val Arg Leu Ser Cys Val Gly Ser Gly Phe Arg Leu Met Asp Tyr
20 25 30
Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Asp Trp Val
35 40 45
Ala Val Ile Ser Tyr Asp Gly Ala Asn Glu Tyr Tyr Ala Glu Ser Val
50 55 60
Lys Gly Arg Phe Thr Val Ser Arg Asp Asn Ser Asp Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Lys Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Phe Cys
85 90 95
Ala Arg Ala Gly Arg Ser Ser Met Asn Glu Glu Val Ile Met Tyr Phe
100 105 110
Asp Asn Trp Gly Leu Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210>15
<211>127
<212>PRT
<213>人(homo sapiens)
<400>15
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Phe Thr Phe Ser Thr Tyr
20 25 30
Ala Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ser Val Ile Arg Ala Ser Gly Asp Ser Glu Ile Tyr Ala Asp Ser Val
50 55 60
Arg Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Val Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Phe Cys
85 90 95
Ala Asn Ile Gly Gln Arg Arg Tyr Cys Ser Gly Asp His Cys Tyr Gly
100 105 110
His Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210>16
<211>127
<212>PRT
<213>人(homo sapiens)
<400>16
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Gly Phe Asn Thr His
20 25 30
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Leu
35 40 45
Ser Ile Ile Ser Leu Asp Gly Ile Lys Thr His Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Val Phe
65 70 75 80
Leu Gln Leu Ser Gly Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Lys Asp His Ile Gly Gly Thr Asn Ala Tyr Phe Glu Trp Thr Val
100 105 110
Pro Phe Asp Gly Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210>17
<211>126
<212>PRT
<213>人(homo sapiens)
<400>17
Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Val Val Lys Pro Thr Glu
1 5 10 15
Thr Leu Thr Leu Thr Cys Ala Phe Ser Gly Phe Ser Leu Asn Ala Gly
20 25 30
Arg Val Gly Val Ser Trp Ile Arg Gln Pro Pro Gly Gln Ala Pro Glu
35 40 45
Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Ala Phe Arg Thr Ser
50 55 60
Leu Lys Thr Arg Leu Ser Ile Ser Lys Asp Ser Ser Lys Asn Gln Val
65 70 75 80
Val Leu Thr Leu Ser Asn Met Asp Pro Ala Asp Thr Ala Thr Tyr Tyr
85 90 95
Cys Ala Arg Thr Gln Val Phe Ala Ser Gly Gly Tyr Tyr Leu Tyr Tyr
100 105 110
Leu Asp His Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210>18
<211>129
<212>PRT
<213>人(homo sapiens)
<400>18
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln
1 5 10 15
Thr Leu Ser Leu Thr Cys Thr Val Ser Ser Gly Ala Ile Ser Gly Ala
20 25 30
Asp Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Gly Phe Ile Tyr Asp Ser Gly Ser Thr Tyr Tyr Asn Pro Ser
50 55 60
Leu Arg Ser Arg Val Thr Ile Ser Ile Asp Thr Ser Lys Lys Gln Phe
65 70 75 80
Ser Leu Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Asp Leu Gly Tyr Gly Gly Asn Ser Tyr Ser His Ser Tyr
100 105 110
Tyr Tyr Gly Leu Asp Val Trp Gly Arg Gly Thr Thr Val Thr Val Ser
115 120 125
Ser
<210>19
<211>119
<212>PRT
<213>人(homo sapiens)
<400>19
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu
1 5 10 15
Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Gly Asn Tyr
20 25 30
Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly His Ile Tyr Phe Gly Gly Asn Thr Asn Tyr Asn Pro Ser Leu Gln
50 55 60
Ser Arg Val Thr Ile Ser Val Asp Thr Ser Arg Asn Gln Phe Ser Leu
65 70 75 80
Lys Leu Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala
85 90 95
Arg Asp Ser Ser Asn Trp Pro Ala Gly Tyr Glu Asp Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser
115
<210>20
<211>123
<212>PRT
<213>人(homo sapiens)
<400>20
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Ser Asn
20 25 30
Gly Leu Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Phe Glu Trp Leu
35 40 45
Gly Trp Ile Ser Ala Ser Ser Gly Asn Lys Lys Tyr Ala Pro Lys Phe
50 55 60
Gln Gly Arg Val Thr Leu Thr Thr Asp Ile Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Lys Asp Gly Gly Thr Tyr Val Pro Tyr Ser Asp Ala Phe Asp Phe
100 105 110
Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
115 120
<210>21
<211>118
<212>PRT
<213>人(homo sapiens)
<400>21
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Arg Val Ser Gly His Thr Phe Thr Ala Leu
20 25 30
Ser Lys His Trp Met Arg Gln Gly Pro Gly Gly Gly Leu Glu Trp Met
35 40 45
Gly Phe Phe Asp Pro Glu Asp Gly Asp Thr Gly Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Met Thr Glu Asp Thr Ala Thr Gly Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Thr Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Thr Val Ala Ala Ala Gly Asn Phe Asp Asn Trp Gly Gln Gly Thr
100 105 110
Leu Val Thr Val Ser Ser
115
<210>22
<211>126
<212>PRT
<213>人(homo sapiens)
<400>22
Gln Val Thr Leu Lys Glu Ser Gly Pro Ala Leu Val Lys Ala Thr Gln
1 5 10 15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Arg Asn
20 25 30
Arg Met Ser Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
35 40 45
Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Phe Tyr Asn Thr Ser
50 55 60
Leu Gln Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val
65 70 75 80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
85 90 95
Cys Ala Arg Thr Gly Ile Tyr Asp Ser Ser Gly Tyr Tyr Leu Tyr Tyr
100 105 110
Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210>23
<211>130
<212>PRT
<213>人(homo sapiens)
<400>23
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Val Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Thr Tyr
20 25 30
Gly Val Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Ser Ala Tyr Asn Gly Asn Thr Tyr Tyr Leu Gln Lys Leu
50 55 60
Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Arg Gly Leu Arg Ser Asp Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Asp Arg Val Gly Gly Ser Ser Ser Glu Val Leu Ser Arg Ala
100 105 110
Lys Asn Tyr Gly Leu Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val
115 120 125
Ser Ser
130
<210>24
<211>123
<212>PRT
<213>人(homo sapiens)
<400>24
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Ala Asn Ile Phe Thr Tyr Ala
20 25 30
Met His Trp Val Arg Gln Ala Pro Gly Gln Arg Leu Glu Trp Met Gly
35 40 45
Trp Ile Asn Val Gly Asn Gly Gln Thr Lys Tyr Ser Gln Arg Phe Gln
50 55 60
Gly Arg Val Thr Ile Thr Arg Asp Thr Ser Ala Thr Thr Ala Tyr Met
65 70 75 80
Glu Leu Ser Thr Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys Ala
85 90 95
Arg Arg Ala Ser Gln Tyr Gly Glu Val Tyr Gly Asn Tyr Phe Asp Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210>25
<211>126
<212>PRT
<213>人(homo sapiens)
<400>25
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Arg Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ile Ser Tyr
20 25 30
Gly Phe Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ser Ser Val Tyr Asn Gly Asp Thr Asn Tyr Ala Gln Lys Phe
50 55 60
His Gly Arg Val Asn Met Thr Thr Asp Thr Ser Thr Asn Thr Ala Tyr
65 70 75 80
Met Glu Leu Arg Gly Leu Arg Ser Asp Asp Thr Ala Val Tyr Phe Cys
85 90 95
Ala Arg Asp Arg Asn Val Val Leu Leu Pro Ala Ala Pro Phe Gly Gly
100 105 110
Met Asp Val Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
115 120 125
<210>26
<211>123
<212>PRT
<213>人(homo sapiens)
<400>26
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Thr
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Phe
20 25 30
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Val Ile Ser Tyr Asp Gly Asn Lys Lys Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Val Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Ala Gln Thr Pro Tyr Phe Asn Glu Ser Ser Gly Leu Val Pro Asp
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210>27
<211>126
<212>PRT
<213>人(homo sapiens)
<400>27
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ile Ser Phe
20 25 30
Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Ser Ala Tyr Asn Gly Asn Thr Asp Tyr Ala Gln Arg Leu
50 55 60
Gln Asp Arg Val Thr Met Thr Arg Asp Thr Ala Thr Ser Thr Ala Tyr
65 70 75 80
Leu Glu Leu Arg Ser Leu Lys Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Thr Arg Asp Glu Ser Met Leu Arg Gly Val Thr Glu Gly Phe Gly Pro
100 105 110
Ile Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210>28
<211>128
<212>PRT
<213>人(homo sapiens)
<400>28
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Gln
1 5 10 15
Ser Leu Lys Ile Ser Cys Lys Thr Ser Gly Tyr Ile Phe Thr Asn Tyr
20 25 30
Trp Ile Gly Trp Val Arg Gln Arg Pro Gly Lys Gly Leu Glu Trp Met
35 40 45
Gly Val Ile Phe Pro Ala Asp Ser Asp Ala Arg Tyr Ser Pro Ser Phe
50 55 60
Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Gly Thr Ala Tyr
65 70 75 80
Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Ile Tyr Tyr Cys
85 90 95
Ala Arg Pro Lys Tyr Tyr Phe Asp Ser Ser Gly Gln Phe Ser Glu Met
100 105 110
Tyr Tyr Phe Asp Phe Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210>29
<211>119
<212>PRT
<213>人(homo sapiens)
<400>29
Gln Val Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Val Leu Thr Asn Tyr
20 25 30
Ala Phe Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Leu
35 40 45
Gly Trp Ile Ser Gly Ser Asn Gly Asn Thr Tyr Tyr Ala Glu Lys Phe
50 55 60
Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Phe Cys
85 90 95
Ala Arg Asp Leu Leu Arg Ser Thr Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser
115
<210>30
<211>126
<212>PRT
<213>人(homo sapiens)
<400>30
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ser Asn Tyr
20 25 30
Gly Phe Ser Trp Val Arg Gln Ala Pro Gly Arg Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Ser Ala Tyr Asn Gly Asn Thr Tyr Tyr Ala Gln Asn Leu
50 55 60
Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Thr Thr Ala Tyr
65 70 75 80
Met Val Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Asp Gly Asn Thr Ala Gly Val Asp Met Trp Ser Arg Asp Gly
100 105 110
Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
115 120 125
<210>31
<211>131
<212>PRT
<213>人(homo sapiens)
<400>31
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Pro Leu Arg Leu Ser Cys Val Ala Ser Gly Phe Ser Phe Ser Ser Tyr
20 25 30
Ala Met Asn Trp Ile Arg Leu Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ser Gly Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Gly Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Lys Glu Pro Trp Ile Asp Ile Val Val Ala Ser Val Ile Ser Pro
100 105 110
Tyr Tyr Tyr Asp Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr
115 120 125
Val Ser Ser
130
<210>32
<211>123
<212>PRT
<213>人(homo sapiens)
<400>32
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Ser Phe Asp Gly Tyr
20 25 30
Thr Ile Ser Trp Leu Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Arg Val Val Pro Thr Leu Gly Phe Pro Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Val Thr Ala Asp Arg Ser Thr Asn Thr Ala Tyr
65 70 75 80
Leu Glu Leu Ser Arg Leu Thr Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Met Asn Leu Gly Ser His Ser Gly Arg Pro Gly Phe Asp Met
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210>33
<211>129
<212>PRT
<213>人(homo sapiens)
<400>33
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Val Ser Gly Ser Ser Phe Ser Lys Tyr
20 25 30
Gly Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Val Ile Ser Tyr Asp Gly Ser Lys Lys Tyr Phe Thr Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ala Arg Asp Asn Ser Gln Asn Thr Val Phe
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Thr Gly Gly Gly Val Asn Val Thr Ser Trp Ser Asp Val Glu His
100 105 110
Ser Ser Ser Leu Gly Tyr Trp Gly Leu Gly Thr Leu Val Thr Val Ser
115 120 125
Ser
<210>34
<211>125
<212>PRT
<213>人(homo sapiens)
<400>34
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Phe Ile Trp Asn Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Val Lys Asp Glu Val Tyr Asp Ser Ser Gly Tyr Tyr Leu Tyr Tyr Phe
100 105 110
Asp Ser Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210>35
<211>127
<212>PRT
<213>人(homo sapiens)
<400>35
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Thr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ser Ser Ile Ser Ala Ser Thr Val Leu Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Ser Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Lys Asp Tyr Asp Phe Trp Ser Gly Tyr Pro Gly Gly Gln Tyr Trp
100 105 110
Phe Phe Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210>36
<211>123
<212>PRT
<213>人(homo sapiens)
<400>36
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Thr Pro Ser Glu
1 5 10 15
Thr Leu Ser Val Thr Cys Thr Val Ser Asn Tyr Ser Ile Asp Asn Ala
20 25 30
Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp
35 40 45
Ile Gly Ser Ile His His Ser Gly Ser Ala Tyr Tyr Asn Ser Ser Leu
50 55 60
Lys Ser Arg Ala Thr Ile Ser Ile Asp Thr Ser Lys Asn Gln Phe Ser
65 70 75 80
Leu Asn Leu Arg Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Asp Thr Ile Leu Thr Phe Gly Glu Pro His Trp Phe Asp Pro
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210>37
<211>124
<212>PRT
<213>人(homo sapiens)
<400>37
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu
1 5 10 15
Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Asp Ser Ile Ser Asn Tyr
20 25 30
Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Glu Ile Ser Asn Thr Trp Ser Thr Asn Tyr Asn Pro Ser Leu Lys
50 55 60
Ser Arg Val Thr Ile Ser Leu Asp Met Pro Lys Asn Gln Leu Ser Leu
65 70 75 80
Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala
85 90 95
Arg Gly Leu Phe Tyr Asp Ser Gly Gly Tyr Tyr Leu Phe Tyr Phe Gln
100 105 110
His Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210>38
<211>125
<212>PRT
<213>人(homo sapiens)
<400>38
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Val Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr
20 25 30
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Val Ile Trp Tyr Asp Asp Ser Asn Lys Gln Tyr Gly Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Ser Thr Leu Tyr
65 70 75 80
Leu Gln Met Asp Arg Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ala Ser Glu Tyr Ser Ile Ser Trp Arg His Arg Gly Val Leu
100 105 110
Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210>39
<211>126
<212>PRT
<213>人(homo sapiens)
<400>39
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Arg Pro Thr Gln
1 5 10 15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Lys Leu Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
35 40 45
Trp Leu Ala Leu Val Asp Trp Asp Asp Asp Arg Arg Tyr Arg Pro Ser
50 55 60
Leu Lys Ser Arg Leu Thr Val Thr Lys Asp Thr Ser Lys Asn Gln Val
65 70 75 80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
85 90 95
Cys Ala His Ser Ala Tyr Tyr Thr Ser Ser Gly Tyr Tyr Leu Gln Tyr
100 105 110
Phe His His Trp Gly Pro Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210>40
<211>125
<212>PRT
<213>人(homo sapiens)
<400>40
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Glu Val Ser Gly Phe Thr Phe Asn Ser Tyr
20 25 30
Glu Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ser His Ile Gly Asn Ser Gly Ser Met Ile Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Asp Tyr Tyr Asp Ser Ser Gly Tyr Tyr Leu Leu Tyr Leu
100 105 110
Asp Ser Trp Gly His Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210>41
<211>120
<212>PRT
<213>人(homo sapiens)
<400>41
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Arg Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly His Thr Phe Ile Asn Phe
20 25 30
Ala Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Tyr Ile Asn Ala Val Asn Gly Asn Thr Gln Tyr Ser Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Phe Thr Arg Asp Thr Ser Ala Asn Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Asn Asn Gly Gly Ser Ala Ile Ile Phe Tyr Tyr Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser
115 120
<210>42
<211>122
<212>PRT
<213>人(homo sapiens)
<400>42
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Phe Ser Ser Tyr
20 25 30
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Val Ile Ser Asn Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Lys Thr Met Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Phe Cys
85 90 95
Ala Lys Thr Thr Asp Gln Arg Leu Leu Val Asp Trp Phe Asp Pro Trp
100 105 110
Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210>43
<211>130
<212>PRT
<213>人(homo sapiens)
<400>43
Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu
1 5 10 15
Thr Leu Ser Leu Thr Cys Thr Ala Ser Gly Gly Ser Ile Asn Ser Ser
20 25 30
Asn Phe Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu
35 40 45
Trp Ile Gly Ser Ile Phe Tyr Ser Gly Thr Thr Tyr Tyr Asn Pro Ser
50 55 60
Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe
65 70 75 80
Ser Leu Lys Leu Ser Pro Val Thr Ala Ala Asp Thr Ala Val Tyr His
85 90 95
Cys Ala Arg His Gly Phe Arg Tyr Cys Asn Asn Gly Val Cys Ser Ile
100 105 110
Asn Leu Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val
115 120 125
Ser Ser
130
<210>44
<211>122
<212>PRT
<213>人(homo sapiens)
<400>44
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Lys
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Arg Phe Ser Asp Tyr
20 25 30
Gly Met His Trp Val Arg Gln Ala Pro Ser Lys Gly Leu Glu Trp Val
35 40 45
Ala Val Ile Trp His Asp Gly Ser Asn Ile Arg Tyr Ala Asp Ser Val
50 55 60
Arg Gly Arg Phe Ser Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Met Arg Ala Asp Asp Thr Ala Phe Tyr Tyr Cys
85 90 95
Ala Arg Val Pro Phe Gln Ile Trp Ser Gly Leu Tyr Phe Asp His Trp
100 105 110
Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210>45
<211>366
<212>DNA
<213>人(homo sapiens)
<400>45
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc 60
acgtgcactg tgtctaatgg cgccatcggc gactacgact ggagctggat tcgtcagtcc 120
ccagggaagg gactggagtg gattgggaac ataaattaca gagggaacac caactacaac 180
ccctccctca agagtcgagt caccatgtcc ctacgcacgt ccacgatgca gttctccctg 240
aagctgagct ctgcgaccgc tgcggacacg gccgtctatt actgtgcgag agatgtaggc 300
tacggtggcg ggcagtattt cgcgatggac gtctggagcc cagggaccac ggtcaccgtc 360
tcgagt 366
<210>46
<211>387
<212>DNA
<213>人(homo sapiens)
<400>46
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctggggggtc cctgagactc 60
tcctgtacag cgtctggatt caccttcagt acctatggca tgcactgggt ccgccaggct 120
cccggcaagg ggctggaatg ggtggcattt atacggtatg atggaagtac tcaagactat 180
gtagactccg tgaagggccg attcaccatc tccagagaca attccaagaa tatggtgtat 240
gtgcagatga acagcctgag agttgaggac acggctgtct attactgtgc gaaagacatg 300
gattactatg gttcgcggag ttattctgtc acctactact acggaatgga cgtctggggc 360
caagggacca cggtcaccgt ctcgagt 387
<210>47
<211>375
<212>DNA
<213>人(homo sapiens)
<400>47
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc 60
tcctgcaagg cttctggata caccttcagc ggctattata tgcactgggt gcgacaggcc 120
cctggacaag ggcttgagtg gatgggatgg atcaacacta gcagtggtgg cacaaactat 180
gcgcagaagt ttcagggcag ggtcaccatg accagggaca cgtccatcag cacagcccac 240
atggaactga ggaggctgag atctgacgac acggccgtgt attattgtgc gagagaggac 300
ggcaccatgg gtactaatag ttggtatggc tggttcgacc cctggggcca gggaaccctg 360
gtcaccgtct cgagt 375
<210>48
<211>381
<212>DNA
<213>人(homo sapiens)
<400>48
caggtgcagc tggtggagtc tgggggaggc ttggtcaagc ctggggggtc cctgagactc 60
tcctgtgcgg cctctggatt ccccttcggt gactactaca tgagctggat ccgccaggct 120
ccagggaagg gactggagtg ggttgcatac attaatagag gtggcactac catatactac 180
gcagactctg tgaagggccg attcaccatc tccagggaca acgccaagaa ctccctgttt 240
ctgcaaatga acagcctgag agccggggac acggccctct attactgtgc gagagggcta 300
attctagcac taccgactgc tacggttgag ttaggagctt ttgatatctg gggccaaggg 360
acaatggtca ccgtctcgag t 381
<210>49
<211>378
<212>DNA
<213>人(homo sapiens)
<400>49
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc 60
acctgcactg tctctggtgc ctccatcagc agtggtgatt attactggag ttggatccgt 120
cagtctccaa ggaagggcct ggagtggatt gggtacatct tccacagtgg gaccacgtac 180
tacaacccgt ccctcaagag tcgagctgtc atctcactgg acacgtccaa gaaccaattc 240
tccctgaggc tgacgtctgt gactgccgca gacacggccg tctattattg tgccagagat 300
gtcgacgatt ttcccgtttg gggtatgaat cgatatcttg ccctctgggg ccggggaacc 360
ctggtcaccg tctcgagt 378
<210>50
<211>372
<212>DNA
<213>人(homo sapiens)
<400>50
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc 60
tcctgtgcag cctctggatt cagcttcagt cactttggca tgcactgggt ccgccaggtt 120
ccaggcaagg ggctggagtg ggtggcaatt atatcatatg atgggaataa tgtacactat 180
gccgactccg taaagggccg attcaccatc tccagagaca attccaagaa cacgctgttt 240
ctgcaaatga acagcctgag agatgacgac acgggtgtgt attactgtgc gaaggacgac 300
gtggcgacag atttggctgc ctactactac ttcgatgtct ggggccgtgg caccctggtc 360
accgtctcga gt 372
<210>51
<211>369
<212>DNA
<213>人(homo sapiens)
<400>51
caggtgcagc tggtggagtc tgggggcggc gtggtccagc ctgggaggtc cctgaaactc 60
tcttgtgaag cctctggatt caacttcaat aattatggca tgcactgggt ccgccaggca 120
ccaggcaagg ggctggagtg ggtggcagtt atttcatatg acggaagaaa taagtatttt 180
gctgactccg tgaagggccg attcatcatc tccagagacg attccaggaa cacagtgttt 240
ctgcaaatga acagcctgcg agttgaagat acggccgtct attactgtgc gagaggcagc 300
gtacaagtct ggctacattt gggacttttt gacaactggg gccagggaac cctggtcacc 360
gtctcgagt 369
<210>52
<211>366
<212>DNA
<213>人(homo sapiens)
<400>52
caggtgcagc tggtggagtc tgggggagcc gtggtccagc ctgggaggtc cctgagactc 60
tcctgtgaag tgtctggatt cagtttcagt gactatggca tgaactgggt ccgccagggt 120
ccaggcaagg ggctggagtg ggtggcagtt atatggcatg acggaagtaa taaaaattat 180
ctagactccg tgaagggccg attcaccgtc tccagagaca attccaagaa cacattgttt 240
ctgcaaatga acagcctgag agccgaagac acggctgtat attactgtgc gaggacgcct 300
tacgagtttt ggagtggcta ttactttgac ttctggggcc agggaaccct ggtcaccgtc 360
tcgagt 366
<210>53
<211>348
<212>DNA
<213>人(homo sapiens)
<400>53
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc 60
tcctgtgcag cgtctggatt ccccttcaat agctatgcca tgcactgggt ccgccaggct 120
ccaggcaagg ggctggagtg ggtggcagtg atatattatg aagggagtaa tgaatattat 180
gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cactctgtat 240
ttgcaaatgg atagcctgag agccgaggac acggctgtct attactgtgc gaggaagtgg 300
ctggggatgg acttctgggg ccagggaacc ctggtcaccg tctcgagt 348
<210>54
<211>360
<212>DNA
<213>人(homo sapiens)
<400>54
gaggtgcagc tggtggagtc tgggggaggc ttggtccggc ctggggggtc cctgagactc 60
tcctgttcag cctctggatt caccttcagt aactatgcta tgcactgggt ccgccaggct 120
ccagggaaga gactggaata tgtttcagct actagtactg atggggggag cacatactac 180
gcagactccc taaagggcac attcaccatc tccagagaca attccaagaa cacactgtat 240
cttcaaatga gcagtctcag tactgaggac acggctattt attactgcgc ccgccgattc 300
tggggatttg gaaacttttt tgactactgg ggccggggaa ccctggtcac cgtctcgagt 360
<210>55
<211>366
<212>DNA
<213>人(homo sapiens)
<400>55
caggtgcagc tggtgcagtc tggggctgag gtgaagaagt ccgggtcctc ggtgaaggtc 60
tcctgcaggg cttctggagg caccttcggc aattatgcta tcaactgggt gcgacaggcc 120
cctggacaag ggcttgagtg ggtgggaagg atcatccctg tctttgatac aacaaactac 180
gcacagaagt tccagggcag agtcacgatt accgcggaca gatccacaaa cacagccatc 240
atgcaactga gcagtctgcg acctcaggac acggccatgt attattgttt gagaggttcc 300
acccgtggct gggatactga tggttttgat atctggggcc aagggacaat ggtcaccgtc 360
tcgagt 366
<210>56
<211>387
<212>DNA
<213>人(homo sapiens)
<400>56
caggttcagc tggtgcagtc tggggctgtc gtggagacgc ctggggcctc agtgaaggtc 60
tcctgcaagg catctggata catcttcggc aactactata tccactgggt gcggcaggcc 120
cctggacaag ggcttgagtg gatggcagtt atcaatccca atggtggtag cacaacttcc 180
gcacagaagt tccaagacag aatcaccgtg accagggaca cgtccacgac cactgtctat 240
ttggaggttg acaacctgag atctgaggac acggccacat attattgtgc gagacagaga 300
tctgtaacag ggggctttga cgcgtggctt ttaatcccag atgcttctaa tacctggggc 360
caggggacaa tggtcaccgt ctcgagt 387
<210>57
<211>378
<212>DNA
<213>人(homo sapiens)
<400>57
caggtgcagc tggtgcagtc tggggctgag atgaagaagc ctgggtcctc ggtgaaggtc 60
tcctgcaagg cttctggagg ctccttcagc agctattcta tcagctgggt gcgacaggcc 120
cctggacgag ggcttgagtg ggtgggaatg atcctgccta tctctggtac aacaaactac 180
gcacagacat ttcagggcag agtcatcatt agcgcggaca catccacgag cacagcctac 240
atggagctga ccagcctcac atctgaagac acggccgtgt atttctgtgc gagagtcttt 300
agagaattta gcacctcgac ccttgacccc tactactttg actactgggg ccagggaacc 360
ctggtcaccg tctcgagt 378
<210>58
<211>375
<212>DNA
<213>人(homo sapiens)
<400>58
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaagtc cgtgagactc 60
tcctgtgtag gctctggctt caggctcatg gactatgcta tgcactgggt ccgccaggct 120
ccaggcaagg gactggattg ggtggcagtt atttcatatg atggagccaa tgaatactac 180
gcagagtccg tgaagggccg attcaccgtc tccagagaca attcagacaa cactctgtat 240
ctacaaatga agagcctgag agctgaggac acggctgtgt atttctgtgc gagagcgggc 300
cgttcctcta tgaatgaaga agttattatg tactttgaca actggggcct gggaaccctg 360
gtcaccgtct cgagt 375
<210>59
<211>381
<212>DNA
<213>人(homo sapiens)
<400>59
gaggtgcagc tgttggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc 60
tcctgtgtag cctccggatt cacctttagt acctacgcca tgacctgggt ccgccaggct 120
ccagggaagg ggctggagtg ggtctcagtc attcgtgcta gtggtgatag tgaaatctac 180
gcagactccg tgaggggccg gttcaccatc tccagagaca attccaagaa cacggtgttt 240
ctgcaaatgg acagcctgag agtcgaggac acggccgtat atttctgtgc gaatataggc 300
cagcgtcggt attgtagtgg tgatcactgc tacggacact ttgactactg gggccaggga 360
accctggtca ccgtctcgag t 381
<210>60
<211>381
<212>DNA
<213>人(homo sapiens)
<400>60
caggtgcagc tggtggagtc tgggggaggc gtggtccaac ctgggaggtc cctgagactc 60
tcctgtgcag cctctggatt cggcttcaac acccatggca tgcactgggt ccgccaggct 120
ccaggcaagg ggctggagtg gctgtcaatt atctcacttg atgggattaa gacccactat 180
gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacggtgttt 240
ctacaattga gtggcctgag acctgaagac acggctgtat attactgtgc gaaagatcat 300
attgggggga cgaacgcata ttttgaatgg acagtcccgt ttgacggctg gggccaggga 360
accctggtca ccgtctcgag t 381
<210>61
<211>378
<212>DNA
<213>人(homo sapiens)
<400>61
caggtcacct tgagggagtc tggtccagcg gtggtgaagc ccacagaaac gctcactctg 60
acctgcgcct tctctgggtt ctcactcaac gccggtagag tgggtgtgag ttggatccgt 120
cagcccccag ggcaggcccc ggaatggctt gcacgcattg attgggatga tgataaagcg 180
ttccgcacat ctctgaagac cagactcagc atctccaagg actcctccaa aaaccaggtg 240
gtccttacac tgagcaacat ggaccctgcg gacacagcca catattactg tgcccggaca 300
caggtcttcg caagtggagg ctactacttg tactaccttg accactgggg ccagggaacc 360
ctggtcaccg tctcgagt 378
<210>62
<211>387
<212>DNA
<213>人(homo sapiens)
<400>62
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc 60
acctgcactg tctctagtgg cgccatcagt ggtgctgatt actactggag ttggatccgc 120
cagcccccag ggaagggcct ggagtgggtt gggttcatct atgacagtgg gagcacctac 180
tacaacccgt ccctcaggag tcgagtgacc atatcaatag acacgtccaa gaagcagttc 240
tccctgaagc tgacctctgt gactgccgca gacacggccg tgtattactg tgccagagat 300
ctaggctacg gtggtaactc ttactcccac tcctactact acggtttgga cgtctggggc 360
cgagggacca cggtcaccgt ctcgagt 387
<210>63
<211>357
<212>DNA
<213>人(homo sapiens)
<400>63
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc 60
acctgcactg tctctggtgg ctccatcgga aattactact ggggctggat ccggcagccc 120
ccagggaagg gacttgagtg gattgggcat atctacttcg gtggcaacac caactacaac 180
ccttccctcc agagtcgagt caccatttca gtcgacacgt ccaggaacca gttctccctg 240
aagttgaact ctgtgaccgc cgcggacacg gccgtgtatt actgtgcgag ggatagcagc 300
aactggcccg caggctatga ggactggggc cagggaaccc tggtcaccgt ctcgagt 357
<210>64
<211>369
<212>DNA
<213>人(homo sapiens)
<400>64
caggttcagc tggtgcagtc tggagctgag gtgaagaagc ctggggcctc agtgaaggtc 60
tcctgcaagg tttctggtta cacctttacc agtaatggtc tcagctgggt gcgacaggcc 120
cctggacaag ggtttgagtg gctgggatgg atcagcgcta gtagtggaaa caaaaagtat 180
gccccgaaat tccagggaag agtcaccttg accacagaca tttccacgag cacagcctac 240
atggaactga ggagtctgag atctgacgat acggccgtat attactgtgc gaaagatggg 300
ggcacctacg tgccctattc tgatgccttt gatttctggg gccaggggac aatggtcacc 360
gtctcgagt 369
<210>65
<211>354
<212>DNA
<213>人(homo sapiens)
<400>65
caggtccagc tggtacagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc 60
tcctgcaggg tttccggaca cactttcact gcattatcca aacactggat gcgacagggt 120
cctggaggag ggcttgagtg gatgggattt tttgatcctg aagatggtga cacaggctac 180
gcacagaagt tccagggcag agtcaccatg accgaggaca cagccacagg cacagcctac 240
atggagctga gcagcctgac atctgacgac acggccgtat attattgtgc aacagtagcg 300
gcagctggaa actttgacaa ctggggccag ggaaccctgg tcaccgtctc gagt 354
<210>66
<211>378
<212>DNA
<213>人(homo sapiens)
<400>66
caggtcacct tgaaggagtc tggtcctgcg ctggtgaaag ccacacagac cctgacactg 60
acctgcacct tctctgggtt ttcactcagt aggaatagaa tgagtgtgag ctggatccgt 120
cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaattc 180
tacaacacat ctctgcagac caggctcacc atctccaagg acacctccaa aaaccaggtg 240
gtccttacaa tgaccaacat ggaccctgtg gacacagcca cctattactg cgcacggact 300
gggatatatg atagtagtgg ttattacctc tactactttg actactgggg ccagggaacc 360
ctggtcaccg tctcgagt 378
<210>67
<211>390
<212>DNA
<213>人(homo sapiens)
<400>67
caggtgcagc tggtgcagtc tggagctgag gtgaaggtgc ctggggcctc agtgaaggtc 60
tcctgcaagg cttctggtta cacctttacc acttacggtg tcagctgggt gcggcaggcc 120
cctggacaag ggcttgagtg gatgggttgg atcagcgctt acaatggtaa cacatactat 180
ctacagaagc tccagggcag agtcaccatg accacagaca catccacgag cacagcctac 240
atggagctgc ggggcctgag gtctgacgac acggccatgt attactgtgc gagagatcgt 300
gttgggggca gctcgtccga ggttctatcg cgggccaaaa actacggttt ggacgtctgg 360
ggccaaggga ccacggtcac cgtctcgagt 390
<210>68
<211>369
<212>DNA
<213>人(homo sapiens)
<400>68
caggttcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agttaaggtt 60
tcctgcaagg cttctgcaaa catcttcact tatgcaatgc attgggtgcg ccaggccccc 120
ggacaaaggc ttgagtggat gggatggatc aacgttggca atggtcagac aaaatattca 180
cagaggttcc agggcagagt caccattacc agggacacgt ccgcgactac agcctacatg 240
gagctgagca ccctgagatc tgaggacacg gctgtgtatt actgtgcgag gcgtgcgagc 300
caatatgggg aggtctatgg caactacttt gactactggg gccagggaac cctggtcacc 360
gtctcgagt 369
<210>69
<211>378
<212>DNA
<213>人(homo sapiens)
<400>69
caggtgcagc tggtgcagtc tggagctgag gtgaagaggc ctggggcctc agtgaaggtc 60
tcctgcaagg cttcaggtta cacctttatc agctatggtt tcagctgggt gcgacaggcc 120
cctggacaag ggcttgagtg gatgggatgg agcagcgttt acaatggtga cacaaactat 180
gcacagaagt tccacggcag agtcaacatg acgactgaca catcgacgaa cacggcctac 240
atggaactca ggggcctgag atctgacgac acggccgtgt atttctgtgc gagggatcgc 300
aatgttgttc tacttccagc tgctcctttt ggaggtatgg acgtctgggg ccaagggaca 360
atggtcaccg tctcgagt 378
<210>70
<211>369
<212>DNA
<213>人(homo sapiens)
<400>70
caggtgcagc tggtggagtc tgggggaggc gtggtccagc cggggacttc cctgagactc 60
tcctgtgcag cctctggatt caccttcagt acgtttggca tgcactgggt ccgccaggct 120
ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaaataa gaaatactat 180
gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat 240
ctgcaagtga acagcctgag agtcgaggac acggctgtgt attactgtgc ggcccaaact 300
ccatatttca atgagagcag tgggttagtg ccggactggg gccagggcac cctggtcacc 360
gtctcgagt 369
<210>71
<211>378
<212>DNA
<213>人(homo sapiens)
<400>71
caggtgcagc tggtgcagtc tggagctgag gtgaagaagc ctggggcctc agtgaaggtc 60
tcctgcaagg cttctggtta cacctttatc agttttggca tcagctgggt gcgacaggcc 120
cctggacaag gacttgagtg gatgggatgg atcagcgctt acaatggtaa cacagactat 180
gcacagaggc tccaggacag agtcaccatg actagagaca cagccacgag cacagcctac 240
ttggagctga ggagcctgaa atctgacgac acggccgtgt actattgcac tagagacgag 300
tcgatgcttc ggggagttac tgaaggattc ggacccattg actactgggg ccagggaacc 360
ctggtcaccg tctcgagt 378
<210>72
<211>384
<212>DNA
<213>人(homo sapiens)
<400>72
gaagtgcagc tggtgcagtc tggagcagag gtgaaaaagc cggggcagtc tctgaagatc 60
tcctgtaaga cttctggata catctttacc aactactgga tcggctgggt gcgccagagg 120
cccgggaaag gcctggagtg gatgggggtc atctttcctg ctgactctga tgccagatac 180
agcccgtcgt tccaaggcca ggtcaccatc tcagccgaca agtccatcgg tactgcctac 240
ctgcagtgga gtagcctgaa ggcctcggac accgccatat attactgtgc gagaccgaaa 300
tattactttg atagtagtgg gcaattctcc gagatgtact actttgactt ctggggccag 360
ggaaccctgg tcaccgtctc gagt 384
<210>73
<211>357
<212>DNA
<213>人(homo sapiens)
<400>73
caggttcagc tggtgcagtc tggacctgag gtgaagaagc ctggggcctc agtgaaggtc 60
tcctgcaagg cttctggtta tgtgttgacc aactatgcct tcagctgggt gcggcaggcc 120
cctggacaag ggcttgagtg gctgggatgg atcagcggct ccaatggtaa cacatactat 180
gcagagaagt tccagggccg agtcaccatg accacagaca catccacgag cacagcctac 240
atggagctga ggagtctgag atctgacgac acggccgttt atttctgtgc gagagatctt 300
ctgcggtcca cttactttga ctactggggc cagggaaccc tggtcaccgt ctcgagt 357
<210>74
<211>378
<212>DNA
<213>人(homo sapiens)
<400>74
caggtgcagc tggtgcagtc tggagctgag gtgaagaagc ctggggcctc agtgaaggtc 60
tcctgcaagg cttctggtta caccttttcc aactacggtt tcagctgggt gcgacaggcc 120
cctggacgag ggcttgagtg gatgggatgg atcagcgctt acaatggtaa cacatactat 180
gcacagaacc tccagggcag agtcaccatg accacagaca catccacgac cacagcctac 240
atggtactga ggagcctgag atctgacgac acggccatgt attactgtgc gagagatgga 300
aatacagcag gggttgatat gtggtcgcgt gatggttttg atatctgggg ccaggggaca 360
atggtcaccg tctcgagt 378
<210>75
<211>393
<212>DNA
<213>人(homo sapiens)
<400>75
gaggtgcagc tgttggagtc tgggggaggc ttggtacagc ctggggggcc cctgaggctc 60
tcctgtgtag cctctggatt cagctttagc agctatgcca tgaactggat ccgcctggct 120
ccagggaagg ggctggagtg ggtctcaggt attagtggta gcggtggtag cacttactac 180
ggagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgctgtat 240
ctgcaaatga acagcctgag agccgaggac acggccgtat attactgtgc gaaagagccg 300
tggatcgata tagtagtggc atctgttata tccccctact actacgacgg aatggacgtc 360
tggggccaag ggaccacggt caccgtctcg agt 393
<210>76
<211>369
<212>DNA
<213>人(homo sapiens)
<400>76
caggttcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc 60
tcctgcaagg cctctggagg atccttcgac ggctacacta tcagctggct gcgacaggcc 120
cctggacagg ggcttgagtg gatgggaagg gtcgtcccta cacttggttt tccaaactac 180
gcacagaagt tccaaggcag agtcaccgtt accgcggaca gatccaccaa cacagcctac 240
ttggaattga gcagactgac atctgaagac acggccgtat attactgtgc gaggatgaat 300
ctcggatcgc atagcgggcg ccccgggttc gacatgtggg gccaaggaac cctggtcacc 360
gtctcgagt 369
<210>77
<211>387
<212>DNA
<213>人(homo sapiens)
<400>77
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cttgagactc 60
tcctgtgcag tgtctggatc cagcttcagt aaatatggca tacactgggt ccgccaggct 120
ccaggcaagg ggctggagtg ggtggcagtt atatcgtatg atggaagtaa aaagtatttc 180
acagactccg tgaagggccg attcaccatc gccagagaca attcccagaa cacggttttt 240
ctgcaaatga acagcctgag agccgaggac acggctgtct attactgtgc gacaggaggg 300
ggtgttaatg tcacctcgtg gtccgacgta gagcactcgt cgtccttagg ctactggggc 360
ctgggaaccc tggtcaccgt ctcgagt 387
<210>78
<211>375
<212>DNA
<213>人(homo sapiens)
<400>78
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctggggggtc cctgagactc 60
tcctgtgcag cgtctggatt caccttcagt agctatggca tgcactgggt ccgccaggct 120
ccaggcaagg ggctggagtg ggtggcattt atatggaatg atggaagtaa taaatactat 180
gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat 240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgt gaaagatgag 300
gtctatgata gtagtggtta ttacctgtac tactttgact cttggggcca gggaaccctg 360
gtcaccgtct cgagt 375
<210>79
<211>381
<212>DNA
<213>人(homo sapiens)
<400>79
gaggtgcagc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc 60
tcctgtgcag cctctggatt cacgtttagc tcctatacca tgagctgggt ccgccaggct 120
ccagggaagg ggctggagtg ggtctcaagt attagtgcta gtactgttct cacatactac 180
gcagactccg tgaagggccg cttcaccatc tccagagaca attccaagaa cacgctgtat 240
ctgcaaatga gtagcctgag agccgaggac acggccgtat attactgtgc gaaagattac 300
gatttttgga gtggctatcc cgggggacag tactggttct tcgatctctg gggccgtggc 360
accctggtca ccgtctcgag t 381
<210>80
<211>369
<212>DNA
<213>人(homo sapiens)
<400>80
caggtgcagc tgcaggagtc gggcccagga ctggtgacgc cttcggagac cctgtccgtc 60
acttgcactg tctctaatta ttccatcgac aatgcttact actggggctg gatccggcag 120
cccccaggga agggtctgga gtggataggc agtatccatc atagtgggag cgcctactac 180
aattcgtccc tcaagagtcg agccaccata tctatagaca cgtccaagaa ccaattctcg 240
ttgaacctga ggtctgtgac cgccgcagac acggccgtat attactgtgc gcgcgatacc 300
atcctcacgt tcggggagcc ccactggttc gacccctggg gccagggaac cctggtcacc 360
gtctcgagt 369
<210>81
<211>372
<212>DNA
<213>人(homo sapiens)
<400>81
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cttgtccctc 60
acctgcactg tctcaggtga ctccatcagt aattactact ggagttggat ccggcagccc 120
ccagggaagg gactggagtg gattggagaa atatctaaca cttggagcac caattacaac 180
ccctccctca agagtcgagt caccatatct ctagacatgc ccaagaacca gttgtccctg 240
aagctgagct ctgtgaccgc tgcggacacg gccgtatatt actgtgcgag agggcttttc 300
tatgacagtg gtggttacta cttgttttac ttccaacact ggggccaggg caccctggtc 360
accgtctcga gt 372
<210>82
<211>375
<212>DNA
<213>人(homo sapiens)
<400>82
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagagtc 60
tcctgtgcag cgtctggatt caccttcagt aactatggca tgcactgggt ccgccaggct 120
ccaggcaagg ggctggagtg ggtggcagtt atatggtatg atgacagtaa taaacagtat 180
ggagactccg tgaagggccg attcaccatc tccagagaca attccaagag tacgctgtat 240
ctgcaaatgg acagactgag agtcgaggac acggctgtgt attattgtgc gagagcctcc 300
gagtatagta tcagctggcg acacaggggg gtccttgact actggggcca gggaaccctg 360
gtcaccgtct cgagt 375
<210>83
<211>378
<212>DNA
<213>人(homo sapiens)
<400>83
cagatcacct tgaaggagtc tggtcctacg ctggtgagac ccacacagac cctcacactg 60
acctgcacct tctctgggtt ctcactcagc actagtaaac tgggtgtggg ctggatccgt 120
cagcccccag gaaaggccct ggagtggctt gcactcgttg attgggatga tgataggcgc 180
tacaggccat ctttgaagag caggctcacc gtcaccaagg acacctccaa aaaccaggtg 240
gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacagt 300
gcctactata ctagtagtgg ttattacctt caatacttcc atcactgggg cccgggcacc 360
ctggtcaccg tctcgagt 378
<210>84
<211>375
<212>DNA
<213>人(homo sapiens)
<400>84
gaggtgcagc tggtggagtc tgggggaggc gtggtacagc ctggaggctc cctgagactc 60
tcctgtgaag tctccggatt caccttcaat agttatgaaa tgacctgggt ccgccaggcc 120
ccagggaagg ggctggagtg ggtttcacac attggtaata gtggttctat gatatactac 180
gctgactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactatat 240
ctgcaaatga acagcctgag agtcgaggac acggctgttt attactgtgc gaggtcagat 300
tactatgata gtagtggtta ttatctcctc tacttagact cctggggcca tggaaccctg 360
gtcaccgtct cgagt 375
<210>85
<211>360
<212>DNA
<213>人(homo sapiens)
<400>85
caggtgcagc tggtgcagtc tggggctgag gtgaggaagc ctggggcctc agtgaaggtt 60
tcctgcaagg cttctggaca tactttcatt aactttgcta tgcattgggt gcgccaggcc 120
cccggacagg ggcttgagtg gatgggatac atcaacgctg tcaatggtaa cacacagtat 180
tcacagaagt tccagggcag agtcaccttt acgagggaca catccgcgaa cacagcctac 240
atggagctga gcagcctgag atctgaagac acggctgtgt attactgtgc gagaaacaat 300
gggggctctg ctatcatttt ttactactgg ggccagggaa ccctggtcac cgtctcgagt 360
<210>86
<211>366
<212>DNA
<213>人(homo sapiens)
<400>86
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc 60
tcctgtgcag cctctggatt cagcttcagt agctatggca tgcactgggt ccgccaggct 120
ccaggcaagg ggctggagtg ggtggcagtt atatcaaatg atggaagtaa taaatactat 180
gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa aacgatgtat 240
ctgcaaatga acagcctgag agctgaggac acggctgtgt atttctgtgc gaagacaaca 300
gaccagcggc tattagtgga ctggttcgac ccctggggcc agggaaccct ggtcaccgtc 360
tcgagt 366
<210>87
<211>390
<212>DNA
<213>人(homo sapiens)
<400>87
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc catcggagac cctgtccctc 60
acctgcactg cctctggtgg ctccatcaac agtagtaatt tctactgggg ctggatccgc 120
cagcccccag ggaaggggct ggagtggatt gggagtatct tttatagtgg gaccacctac 180
tacaacccgt ccctcaagag tcgagtcacc atatccgtag acacgtccaa gaaccagttc 240
tccctgaagc tgagccctgt gaccgccgca gacacggctg tctatcactg tgcgagacat 300
ggcttccggt attgtaataa tggtgtatgc tctataaatc tcgatgcttt tgatatctgg 360
ggccaaggga caatggtcac cgtctcgagt 390
<210>88
<211>366
<212>DNA
<213>人(homo sapiens)
<400>88
caggtgcagc tggtggagtc tgggggaggc gtcgtccagc ctggaaagtc cctgagactc 60
tcctgtgcag cgtctggatt cagattcagt gactacggca tgcactgggt ccggcaggct 120
ccaagcaagg ggctggagtg ggtggcagtt atctggcatg acggaagtaa tataaggtat 180
gcagactccg tgaggggccg attttccatc tccagagaca attccaagaa cacgctgtat 240
ttgcaaatga acagcatgag agccgacgac acggcttttt attattgtgc gagagtcccg 300
ttccagattt ggagtggtct ttattttgac cactggggcc agggaaccct ggtcaccgtc 360
tcgagt 366
<210>89
<211>216
<212>PRT
<213>人(homo sapiens)
<400>89
Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Asn Ser His
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile
35 40 45
Tyr Asn Thr Phe Asn Arg Val Thr Gly Ile Pro Ala Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Ala Thr
65 70 75 80
Glu Asp Phe Gly Val Tyr Tyr Cys Gln Gln Arg Ser Asn Trp Pro Pro
85 90 95
Ala Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val
100 105 110
Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys
115 120 125
Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg
130 135 140
Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn
145 150 155 160
Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser
165 170 175
Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys
180 185 190
Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr
195 200 205
Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210>90
<211>215
<212>PRT
<213>人(homo sapiens)
<400>90
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Phe Thr Cys Arg Ala Ser Gln Arg Ile Ser Asn His
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Gly Ala Ser Thr Leu Gln Ser Gly Ala Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Thr Asn Val Gln Pro
65 70 75 80
Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Arg Thr Pro Pro
85 90 95
Ile Asn Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys Arg Thr Val Ala
100 105 110
Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser
115 120 125
Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu
130 135 140
Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser
145 150 155 160
Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu
165 170 175
Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val
180 185 190
Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys
195 200 205
Ser Phe Asn Arg Gly Glu Cys
210 215
<210>91
<211>217
<212>PRT
<213>人(homo sapiens)
<400>91
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
20 25 30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
35 40 45
Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
50 55 60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65 70 75 80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asp Ser Ser Leu
85 90 95
Ser Thr Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr
100 105 110
Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu
115 120 125
Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro
130 135 140
Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly
145 150 155 160
Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr
165 170 175
Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His
180 185 190
Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val
195 200 205
Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210>92
<211>213
<212>PRT
<213>人(homo sapiens)
<400>92
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Thr Gly Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Thr Ser Thr Leu Gln Ser Glu Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Asn Thr Leu Thr
85 90 95
Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210>93
<211>215
<212>PRT
<213>人(homo sapiens)
<400>93
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
20 25 30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
35 40 45
Ile His Gly Ala Ser Thr Gly Ala Thr Gly Thr Pro Asp Arg Phe Ser
50 55 60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Thr Leu Glu
65 70 75 80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Arg Thr Pro
85 90 95
Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Asn Lys Arg Thr Val Ala
100 105 110
Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser
115 120 125
Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu
130 135 140
Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser
145 150 155 160
Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu
165 170 175
Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val
180 185 190
Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys
195 200 205
Ser Phe Asn Arg Gly Glu Cys
210 215
<210>94
<211>219
<212>PRT
<213>人(homo sapiens)
<400>94
Asp Ile Val Met Thr Gln Thr Pro Leu Ser Leu Ser Val Thr Pro Gly
1 5 10 15
Gln Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu Arg Ser
20 25 30
Asp Gly Lys Thr Phe Leu Tyr Trp Tyr Leu Gln Lys Pro Gly Gln Ser
35 40 45
Pro Gln Pro Leu Met Tyr Glu Val Ser Ser Arg Phe Ser Gly Val Pro
50 55 60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Ala Asp Phe Thr Leu Asn Ile
65 70 75 80
Ser Arg Val Glu Thr Glu Asp Val Gly Ile Tyr Tyr Cys Met Gln Gly
85 90 95
Leu Lys Ile Arg Arg Thr Phe Gly Pro Gly Thr Lys Val Glu Ile Lys
100 105 110
Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu
115 120 125
Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
130 135 140
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln
145 150 155 160
Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser
165 170 175
Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu
180 185 190
Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser
195 200 205
Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210>95
<211>215
<212>PRT
<213>人(homo sapiens)
<400>95
Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Phe Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Trp
20 25 30
Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Ser Glu Ala Ser Asn Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr His Ser Tyr Ser Gly
85 90 95
Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val Ala
100 105 110
Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser
115 120 125
Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu
130 135 140
Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser
145 150 155 160
Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu
165 170 175
Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val
180 185 190
Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys
195 200 205
Ser Phe Asn Arg Gly Glu Cys
210 215
<210>96
<211>214
<212>PRT
<213>人(homo sapiens)
<400>96
Ala Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Leu Thr Cys Arg Ala Ser Gln Gly Ile Thr Asp Ser
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Val Leu Leu
35 40 45
Tyr Ala Ala Ser Arg Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Arg Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Ser Lys Ser Pro Ala
85 90 95
Thr Phe Gly Pro Gly Thr Lys Val Glu Ile Arg Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>97
<211>219
<212>PRT
<213>人(homo sapiens)
<400>97
Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly
1 5 10 15
Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu Asn Ser
20 25 30
Asn Gly Phe Asn Tyr Val Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser
35 40 45
Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro
50 55 60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65 70 75 80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala
85 90 95
Leu Glu Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
100 105 110
Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu
115 120 125
Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
130 135 140
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln
145 150 155 160
Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser
165 170 175
Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu
180 185 190
Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser
195 200 205
Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210>98
<211>215
<212>PRT
<213>人(homo sapiens)
<400>98
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
Gly Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Gly
20 25 30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
35 40 45
Ile Tyr Gly Ala Ser Gly Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
50 55 60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65 70 75 80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Phe Gly Ser Pro
85 90 95
Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Leu Lys Arg Thr Val Ala
100 105 110
Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser
115 120 125
Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu
130 135 140
Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser
145 150 155 160
Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu
165 170 175
Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val
180 185 190
Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys
195 200 205
Ser Phe Asn Arg Gly Glu Cys
210 215
<210>99
<211>214
<212>PRT
<213>人(homo sapiens)
<400>99
Asn Ile Gln Met Thr Gln Ser Pro Ser Ala Met Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Asn Tyr
20 25 30
Leu Val Trp Phe Gln Gln Lys Pro Gly Lys Val Pro Lys Arg Leu Ile
35 40 45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Leu Gln His Asn Ile Ser Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Thr Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>100
<211>220
<212>PRT
<213>人(homo sapiens)
<400>100
Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly
1 5 10 15
Glu Arg Ala Thr Ile Asn Cys Arg Ser Ser Glu Thr Val Leu Tyr Thr
20 25 30
Ser Lys Asn Gln Ser Tyr Leu Ala Trp Tyr Gln Gln Lys Ala Arg Gln
35 40 45
Pro Pro Lys Leu Leu Leu Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val
50 55 60
Pro Ala Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Ala
65 70 75 80
Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln
85 90 95
Phe Phe Arg Ser Pro Phe Thr Phe Gly Pro Gly Thr Arg Leu Glu Ile
100 105 110
Lys Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp
115 120 125
Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn
130 135 140
Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu
145 150 155 160
Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp
165 170 175
Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr
180 185 190
Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser
195 200 205
Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215 220
<210>101
<211>215
<212>PRT
<213>人(homo sapiens)
<400>101
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
Glu Arg Val Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
20 25 30
Tyr Ile Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Val
35 40 45
Ile Tyr Ala Ala Ser Arg Arg Ala Thr Gly Val Pro Asp Arg Phe Ser
50 55 60
Gly Ser Gly Ser Ala Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65 70 75 80
Pro Glu Asp Leu Ala Val Tyr Tyr Cys Gln His Tyr Gly Asn Ser Leu
85 90 95
Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Val Lys Arg Thr Val Ala
100 105 110
Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser
115 120 125
Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu
130 135 140
Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser
145 150 155 160
Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu
165 170 175
Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val
180 185 190
Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys
195 200 205
Ser Phe Asn Arg Gly Glu Cys
210 215
<210>102
<211>215
<212>PRT
<213>人(homo sapiens)
<400>102
Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Gly Ser Arg
20 25 30
Leu Ala Trp Tyr Gln Gln Gln Pro Gly Lys Ala Pro Lys Phe Leu Ile
35 40 45
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Leu Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Arg Asp Ser Pro
85 90 95
Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala
100 105 110
Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser
115 120 125
Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu
130 135 140
Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser
145 150 155 160
Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu
165 170 175
Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val
180 185 190
Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys
195 200 205
Ser Phe Asn Arg Gly Glu Cys
210 215
<210>103
<211>219
<212>PRT
<213>人(homo sapiens)
<400>103
Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly
1 5 10 15
Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser
20 25 30
Asp Gly Arg Tyr Tyr Val Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser
35 40 45
Pro His Leu Leu Ile Tyr Leu Ala Ser Asn Arg Ala Ser Gly Val Pro
50 55 60
Asp Arg Phe Thr Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65 70 75 80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Gly
85 90 95
Leu His Thr Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Asp Ile Lys
100 105 110
Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu
115 120 125
Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
130 135 140
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln
145 150 155 160
Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser
165 170 175
Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu
180 185 190
Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser
195 200 205
Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210>104
<211>213
<212>PRT
<213>人(homo sapiens)
<400>104
Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Ala Ser Pro Gly
1 5 10 15
Glu Arg Ala Thr Leu Ser Cys Trp Ala Ser Gln Thr Ile Gly Gly Asn
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile
35 40 45
Tyr Gly Ala Ser Thr Arg Ala Thr Gly Val Pro Ala Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Ala Ile Ser Ser Leu Gln Ser
65 70 75 80
Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Lys Asn Trp Tyr Thr
85 90 95
Phe Gly Gln Gly Thr Lys Leu Glu Leu Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210>105
<211>215
<212>PRT
<213>人(homo sapiens)
<400>105
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Thr Ile Ala Ser Tyr
20 25 30
Val Asn Trp Tyr Gln Gln Lys Pro Gly Arg Ala Pro Ser Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Asn Leu Gln Ser Gly Val Pro Pro Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Gly Leu Gln Pro
65 70 75 80
Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Tyr Arg Ala
85 90 95
Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala
100 105 110
Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser
115 120 125
Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu
130 135 140
Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser
145 150 155 160
Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu
165 170 175
Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val
180 185 190
Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys
195 200 205
Ser Phe Asn Arg Gly Glu Cys
210 215
<210>106
<211>216
<212>PRT
<213>人(homo sapiens)
<400>106
Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
20 25 30
Leu Ala Trp Tyr Gln Gln Thr Pro Gly Gln Ala Pro Arg Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Tyr Arg Val Thr Gly Ile Pro Ala Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Ile Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro
65 70 75 80
Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Ser Asn Trp Pro Pro
85 90 95
Gly Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val
100 105 110
Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys
115 120 125
Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg
130 135 140
Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn
145 150 155 160
Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser
165 170 175
Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys
180 185 190
Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr
195 200 205
Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210>107
<211>214
<212>PRT
<213>人(homo sapiens)
<400>107
Ala Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Thr Val Thr Val Thr Cys Arg Pro Ser Gln Asp Ile Ser Ser Ala
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Pro Pro Lys Leu Leu Ile
35 40 45
Tyr Gly Ala Ser Thr Leu Asp Tyr Gly Val Pro Leu Arg Phe Ser Gly
50 55 60
Thr Ala Ser Gly Thr His Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Phe Asn Thr Tyr Pro Phe
85 90 95
Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
l45 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>108
<211>220
<212>PRT
<213>人(homo sapiens)
<400>108
Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly
1 5 10 15
Glu Arg Ala Thr Ile Asn Cys Lys SerSer Gln Ser Val Leu Tyr Asn
20 25 30
Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln
35 40 45
Pro Pro Lys Leu Leu Ile His Leu Ala Ser Thr Arg Glu Tyr Gly Val
50 55 60
Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Ala Leu Ile
65 70 75 80
Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln
85 90 95
Tyr Tyr Gln Thr Pro Leu Thr Phe Gly Gln Gly Thr Lys Val Glu Ile
100 105 110
Lys Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp
115 120 125
Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn
130 135 140
Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu
145 150 155 160
Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp
165 170 175
Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr
180 185 190
Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser
195 200 205
Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215 220
<210>109
<211>214
<212>PRT
<213>人(homo sapiens)
<400>109
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ala Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Phe Ile Ser Ser Tyr
20 25 30
Leu His Trp Tyr Gln Gln Arg Pro Gly Lys Ala Pro Lys Leu Leu Met
35 40 45
Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Thr Asn Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Ash Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>110
<211>214
<212>PRT
<213>人(homo sapiens)
<400>110
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ala Ser Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Ser Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln His Ser Tyr Ser Thr Arg Phe
85 90 95
Thr Phe Gly Pro Gly Thr Lys Val Asp Val Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>111
<211>214
<212>PRT
<213>人(homo sapiens)
<400>11l
Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Thr Ser Glu
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Asn Phe Leu Ile
35 40 45
Tyr Lys Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ser Phe Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>112
<211>214
<212>PRT
<213>人(homo sapiens)
<400>112
Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Leu Thr Ile Thr Cys Arg Ala Ser Gln Asn Ile Tyr Asn Trp
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Thr Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ser Leu Ser Pro
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>113
<211>2l4
<212>PRT
<213>人(homo sapiens)
<400>113
Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Leu Glu
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Leu
35 40 45
Asp Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Leu Asn Ser Tyr Pro Arg
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Asp Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>114
<211>214
<212>PRT
<213>人(homo sapiens)
<400>114
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Ser Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Asn Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Val Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Val Ala Thr Tyr Tyr Cys Gln Lys Tyr Asn Ser Ala Pro Gln
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>115
<211>220
<212>PRT
<213>人(homo sapiens)
<400>115
Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly
1 5 10 15
Glu Arg Ala Thr Ile Asn Cys Arg Ser Ser Gln Ser Val Leu Tyr Ser
20 25 30
Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln
35 40 45
Pro Pro Lys Leu Leu Val Tyr Trp Ala Ser Thr Arg Ala Ser Gly Val
50 55 60
Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr
65 70 75 80
Leu Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln
85 90 95
Phe His Ser Thr Pro Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile
100 105 110
Lys Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp
115 120 125
Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn
130 135 140
Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu
145 150 155 160
Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp
165 170 175
Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr
180 185 190
Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser
195 200 205
Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215 220
<210>116
<211>215
<212>PRT
<213>人(homo sapiens)
<400>116
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn
20 25 30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
35 40 45
Ile Tyr Gly Ala Ser Ser Arg Ala Ala Gly Met Pro Asp Arg Phe Ser
50 55 60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65 70 75 80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Asn Ser Pro
85 90 95
Leu Thr Phe Gly Gly Gly Thr Glu Val Glu Ile Lys Arg Thr Val Ala
100 105 110
Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser
115 120 125
Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu
130 135 140
Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser
145 150 155 160
Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu
165 170 175
Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val
180 185 190
Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys
195 200 205
Ser Phe Asn Arg Gly Glu Cys
210 215
<210>117
<211>214
<212>PRT
<213>人(homo sapiens)
<400>117
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ala Ile Ser Asn Trp
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Gly Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ala Asp Thr Phe Pro Phe
85 90 95
Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>118
<211>220
<212>PRT
<213>人(homo sapiens)
<400>118
Asp Ile Val Met Thr Gln Thr Pro Leu Ser Leu Pro Val Thr Pro Gly
1 5 10 15
Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu Asp Ser
20 25 30
Asn Asp Gly Asn Thr Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln
35 40 45
Ser Pro Gln Leu Leu Ile Tyr Thr Phe Ser Tyr Arg Ala Ser Gly Val
50 55 60
Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys
65 70 75 80
Ile Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln
85 90 95
Arg Ile Glu Phe Pro Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile
100 105 110
Lys Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp
115 120 125
Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn
130 135 140
Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu
145 150 155 160
Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp
165 170 175
Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr
180 185 190
Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser
195 200 205
Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215 220
<210>119
<211>219
<212>PRT
<213>人(homo sapiens)
<400>119
Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly
1 5 10 15
Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Arg
20 25 30
Asn Glu Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser
35 40 45
Pro Gln Leu Leu Ile Tyr Trp Gly Ser Asn Arg Ala Ser Gly Val Pro
50 55 60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65 70 75 80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Thr
85 90 95
Leu Gln Thr Pro Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
100 105 110
Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu
115 120 125
Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
130 135 140
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln
145 150 155 160
Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser
165 170 175
Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu
180 185 190
Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser
195 200 205
Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210>120
<211>214
<212>PRT
<213>人(homo sapiens)
<400>120
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Asp Ala Thr Lys Leu Glu Thr Gly Val Pro Thr Arg Phe Ile Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Val Thr Ile Thr Ser Leu Gln Pro
65 70 75 80
Glu Asp Val Ala Thr Tyr Tyr Cys Gln His Phe Ala Asn Leu Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>121
<211>214
<212>PRT
<213>人(homo sapiens)
<400>121
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Arg Asn Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Val Pro Lys Leu Leu Val
35 40 45
Phe Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Val Ala Thr Tyr Tyr Cys Gln Arg Tyr Asn Ser Ala Pro Leu
85 90 95
Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>122
<211>215
<212>PRT
<213>人(homo sapiens)
<400>122
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ile Ile Ala Ser Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Arg Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Ile
85 90 95
Phe Thr Phe Gly Pro Gly Thr Lys Val Asn Ile Lys Arg Thr Val Ala
100 105 110
Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser
115 120 125
Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu
130 135 140
Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser
145 150 155 160
Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu
165 170 175
Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val
180 185 190
Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys
195 200 205
Ser Phe Asn Arg Gly Glu Cys
210 215
<210>123
<211>213
<212>PRT
<213>人(homo sapiens)
<400>123
Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
Glu Arg Ala Thr Leu Ser Cys Arg Thr Ser Gln Ser Val Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro
65 70 75 80
Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Ser Asp Trp Leu Thr
85 90 95
Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210>124
<211>215
<212>PRT
<213>人(homo sapiens)
<400>124
Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly
1 5 10 15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Ile Lys Asn Asn
20 25 30
Leu Ala Trp Tyr Gln Val Lys Pro Gly Gln Ala Pro Arg Leu Leu Thr
35 40 45
Ser Gly Ala Ser Ala Arg Ala Thr Gly Ile Pro Gly Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser
65 70 75 80
Glu Asp Ile Ala Val Tyr Tyr Cys Gln Glu Tyr Asn Asn Trp Pro Leu
85 90 95
Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Gln Arg Thr Val Ala
100 105 110
Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser
115 120 125
Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu
130 135 140
Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser
145 150 155 160
Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu
165 170 175
Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val
180 185 190
Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys
195 200 205
Ser Phe Asn Arg Gly Glu Cys
210 215
<210>125
<211>215
<212>PRT
<213>人(homo sapiens)
<400>125
Asp Ile Gln Met Thr Gln Ser Pro Pro Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Arg Ile Ala Ser Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Arg Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Tyr Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Ile
85 90 95
Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val Ala
100 105 110
Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser
115 120 125
Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu
130 135 140
Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser
145 150 155 160
Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu
165 170 175
Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val
180 185 190
Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys
195 200 205
Ser Phe Asn Arg Gly Glu Cys
210 215
<210>126
<211>214
<212>PRT
<213>人(homo sapiens)
<400>126
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Gly Ile Ser Asn Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Asp Ala Ser Asn Leu Glu Ser Glu Val Pro Ser Arg Phe Ser Gly
50 55 60
Arg Gly Ser Gly Thr Asp Phe Thr Phe Ser Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Ile Ala Thr Tyr Phe Cys Gln Gln Tyr Asp Asn Phe Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>127
<211>214
<212>PRT
<213>人(homo sapiens)
<400>127
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ala Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Thr Ile Ala Ser Tyr
20 25 30
Val Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Asn Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Ser Tyr Phe Cys Gln Gln Ser Tyr Ser Phe Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Asp Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>128
<211>215
<212>PRT
<213>人(homo sapiens)
<400>128
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Thr Ile Ala Ser Tyr
20 25 30
Val Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Asn Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Val Pro Arg
85 90 95
Leu Thr Phe Gly Gly Gly Thr Lys Val Asp Ile Thr Arg Thr Val Ala
100 105 110
Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser
115 120 125
Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu
130 135 140
Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser
145 150 155 160
Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu
165 170 175
Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val
180 185 190
Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys
195 200 205
Ser Phe Asn Arg Gly Glu Cys
210 215
<210>129
<211>213
<212>PRT
<213>人(homo sapiens)
<400>129
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ser Ser Gln Thr Ile Ser Val Phe
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Ser Leu His Ser Ala Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Ser Ala Thr Tyr Tyr Cys Gln Glu Ser Phe Ser Ser Ser Thr
85 90 95
Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210>130
<211>215
<212>PRT
<213>人(homo sapiens)
<400>130
Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly
1 5 10 15
Glu Thr Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn
20 25 30
Leu Ala Trp Tyr Gln His Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile
35 40 45
His Ser Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser
65 70 75 80
Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Met Trp Pro Pro
85 90 95
Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala
100 105 110
Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser
115 120 125
Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu
130 135 140
Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser
145 150 155 160
Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu
165 170 175
Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val
180 185 190
Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys
195 200 205
Ser Phe Asn Arg Gly Glu Cys
210 215
<210>131
<211>219
<212>PRT
<213>人(homo sapiens)
<400>131
Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly
1 5 10 15
Ala Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu Arg Thr
20 25 30
Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser
35 40 45
Pro Gln Leu Leu Ile Tyr Leu Gly Ser Ile Arg Ala Ser Gly Val Pro
50 55 60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65 70 75 80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ser
85 90 95
Leu Gln Thr Ser Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys
100 105 110
Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu
115 120 125
Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
130 135 140
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln
145 150 155 160
Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser
165 170 175
Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu
180 185 190
Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser
195 200 205
Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210>132
<211>214
<212>PRT
<213>人(homo sapiens)
<400>132
Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly
1 5 10 15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Gly Asn Asn
20 25 30
Leu Ala Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Arg Leu Leu Ile
35 40 45
Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser
65 70 75 80
Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asp Lys Trp Pro Glu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Asp Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>133
<211>648
<212>DNA
<213>人(homo sapiens)
<400>133
gaaattgtgt tgacacagtc tccagccacc ctgtccttgt ctccaggaga aagagccacc 60
ctctcctgca gggccagtca gagtgttaac agccacttag cctggtacca acagaaacct 120
ggccaggctc ccaggctcct catctataat acattcaata gggtcactgg catcccagcc 180
aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag ccttgcgact 240
gaagattttg gcgtttatta ctgtcagcag cgtagcaact ggcctcccgc cctcactttc 300
ggcggaggga ccaaagtgga gatcaaacga actgtggctg caccatctgt cttcatcttc 360
ccgccatctg atgagcagtt gaaatctgga actgcctctg ttgtgtgcct gctgaataac 420
ttctatccca gagaggccaa agtacagtgg aaggtggata acgccctcca atcgggtaac 480
tcccaggaga gtgtcacaga gcaggacagc aaggacagca cctacagcct cagcagcacc 540
ctgacgctga gcaaagcaga ctacgagaaa cacaaagtct acgcctgcga agtcacccat 600
cagggcctga gctcgcccgt cacaaagagc ttcaacaggg gagagtgt 648
<210>134
<211>645
<212>DNA
<213>人(homo sapiens)
<400>134
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtgggaga cagagtcacc 60
ttcacttgcc gggccagtca gaggattagc aaccatttaa attggtatca acaaaagcca 120
gggaaagccc ctaaactcct gatctttggt gcatccactc ttcaaagtgg ggccccatca 180
aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcactaa tgtacaacct 240
gacgattttg caacttacta ctgtcaacag agttacagaa ctcccccgat caacttcggc 300
caagggacac gcctggacat taagcgaact gtggctgcac catctgtctt catcttcccg 360
ccatctgatg agcagttgaa atctggaact gcctctgttg tgtgcctgct gaataacttc 420
tatcccagag aggccaaagt acagtggaag gtggataacg ccctccaatc gggtaactcc 480
caggagagtg tcacagagca ggacagcaag gacagcacct acagcctcag cagcaccctg 540
acgctgagca aagcagacta cgagaaacac aaagtctacg cctgcgaagt cacccatcag 600
ggcctgagct cgcccgtcac aaagagcttc aacaggggag agtgt 645
<210>135
<211>651
<212>DNA
<213>人(homo sapiens)
<400>135
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc 60
ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta tcagcagaaa 120
cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca 180
gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag 240
cctgaagatt ttgcagtgta ttactgtcag cagtatgata gctcactttc tacgtggacg 300
ttcggccaag ggaccaaggt ggaaatcaaa cgaactgtgg ctgcaccatc tgtcttcatc 360
ttcccgccat ctgatgagca gttgaaatct ggaactgcct ctgttgtgtg cctgctgaat 420
aacttctatc ccagagaggc caaagtacag tggaaggtgg ataacgccct ccaatcgggt 480
aactcccagg agagtgtcac agagcaggac agcaaggaca gcacctacag cctcagcagc 540
accctgacgc tgagcaaagc agactacgag aaacacaaag tctacgcctg cgaagtcacc 600
catcagggcc tgagctcgcc cgtcacaaag agcttcaaca ggggagagtg t 651
<210>136
<211>639
<212>DNA
<213>人(homo sapiens)
<400>136
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc 60
atcacttgcc gggcaagtca gagcattacc ggctatttaa attggtatca gcagaaacca 120
gggaaagccc ctaaactcct gatctatgct acatccactt tgcaaagtga ggtcccatca 180
aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tcttcaacct 240
gaagattttg caacttacta ctgtcaacag agttataata ccctcacttt cggcggaggg 300
accaaggtgg agatcaaacg aactgtggct gcaccatctg tcttcatctt cccgccatct 360
gatgagcagt tgaaatctgg aactgcctct gttgtgtgcc tgctgaataa cttctatccc 420
agagaggcca aagtacagtg gaaggtggat aacgccctcc aatcgggtaa ctcccaggag 480
agtgtcacag agcaggacag caaggacagc acctacagcc tcagcagcac cctgacgctg 540
agcaaagcag actacgagaa acacaaagtc tacgcctgcg aagtcaccca tcagggcctg 600
agctcgcccg tcacaaagag cttcaacagg ggagagtgt 639
<210>137
<211>645
<212>DNA
<213>人(homo sapiens)
<400>137
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc 60
ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta tcagcagaaa 120
cctggccagg ctcccaggct cctcatacat ggcgcatcca ccggggccac tggcacccca 180
gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag tacactggag 240
cctgaagatt ttgcagtgta ttactgtcag caatatggta ggacaccgta cacttttggc 300
caggggacca agctggagaa caaacgaact gtggctgcac catctgtctt catcttcccg 360
ccatctgatg agcagttgaa atctggaact gcctctgttg tgtgcctgct gaataacttc 420
tatcccagag aggccaaagt acagtggaag gtggataacg ccctccaatc gggtaactcc 480
caggagagtg tcacagagca ggacagcaag gacagcacct acagcctcag cagcaccctg 540
acgctgagca aagcagacta cgagaaacac aaagtctacg cctgcgaagt cacccatcag 600
ggcctgagct cgcccgtcac aaagagcttc aacaggggag agtgt 645
<210>138
<211>657
<212>DNA
<213>人(homo sapiens)
<400>138
gatattgtga tgacccagac tccactctct ctgtccgtca cccctggaca gccggcctcc 60
atctcctgca ggtctagtca gagcctcctg cgaagtgatg gaaagacgtt tttgtattgg 120
tatctgcaga agccaggcca gtctccccaa cccctaatgt atgaggtgtc cagccggttc 180
tctggagtgc cagataggtt cagtggcagc gggtcagggg cagatttcac actgaacatc 240
agccgggtgg agactgagga tgttgggatc tattactgca tgcaaggttt gaaaattcgt 300
cggacgtttg gcccagggac caaggtcgaa atcaagcgaa ctgtggctgc accatctgtc 360
ttcatcttcc cgccatctga tgagcagttg aaatctggaa ctgcctctgt tgtgtgcctg 420
ctgaataact tctatcccag agaggccaaa gtacagtgga aggtggataa cgccctccaa 480
tcgggtaact cccaggagag tgtcacagag caggacagca aggacagcac ctacagcctc 540
agcagcaccc tgacgctgag caaagcagac tacgagaaac acaaagtcta cgcctgcgaa 600
gtcacccatc agggcctgag ctcgcccgtc acaaagagct tcaacagggg agagtgt 657
<210>139
<211>645
<212>DNA
<213>人(homo sapiens)
<400>139
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc 60
ttctcttgcc gggccagtca gagtgttagt agttgggtgg cctggtatca gcagaaacca 120
ggaaaagccc ctaagctcct gatctctgag gcctccaatt tggaaagtgg ggtcccatcc 180
cggttcagcg gcagtggatc cgggacagaa ttcactctca ccatcagcag cctgcagcct 240
gaagattttg caacttatta ctgccaacag tatcatagtt actctgggta cacttttggc 300
caggggacca agttggaaat caagcgaact gtggctgcac catctgtctt catcttcccg 360
ccatctgatg agcagttgaa atctggaact gcctctgttg tgtgcctgct gaataacttc 420
tatcccagag aggccaaagt acagtggaag gtggataacg ccctccaatc gggtaactcc 480
caggagagtg tcacagagca ggacagcaag gacagcacct acagcctcag cagcaccctg 540
acgctgagca aagcagacta cgagaaacac aaagtctacg cctgcgaagt cacccatcag 600
ggcctgagct cgcccgtcac aaagagcttc aacaggggag agtgt 645
<210>140
<211>642
<212>DNA
<213>人(homo sapiens)
<400>140
gccatccagt tgacccagtc tccatcgtcc ctgtctgcat ctgtaggcga cagagtcacc 60
ctcacttgcc gggcgagtca gggcattacc gattctttag cctggtatca gcagaaacca 120
gggaaagccc ctaaggtcct gctctatgct gcttccagat tggaaagtgg ggtcccatcc 180
aggttcagtg gccgtggatc tgggacggat ttcactctca ccatcagcag cctgcagcct 240
gaagactttg caacttatta ctgtcaacag tattctaagt cccctgcgac gttcggccca 300
gggaccaagg tggaaatcag acgaactgtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210>141
<211>657
<212>DNA
<213>人(homo sapiens)
<400>141
gatattgtga tgacccagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc 60
atctcctgca ggtctagtca gagcctccta aatagtaatg gattcaacta tgtggattgg 120
tacctgcaga agccagggca gtctccacaa ctcctgatct atttgggttc taatcgggcc 180
tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc 240
agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct agaaactccg 300
ctcactttcg gcggagggac caaggtggag atcaaacgaa ctgtggctgc accatctgtc 360
ttcatcttcc cgccatctga tgagcagttg aaatctggaa ctgcctctgt tgtgtgcctg 420
ctgaataact tctatcccag agaggccaaa gtacagtgga aggtggataa cgccctccaa 480
tcgggtaact cccaggagag tgtcacagag caggacagca aggacagcac ctacagcctc 540
agcagcaccc tgacgctgag caaagcagac tacgagaaac acaaagtcta cgcctgcgaa 600
gtcacccatc agggcctgag ctcgcccgtc acaaagagct tcaacagggg agagtgt 657
<210>142
<211>645
<212>DNA
<213>人(homo sapiens)
<400>142
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccaggggg aagagccacc 60
ctctcctgca gggccagtca gagtgttagc agcggctact tagcctggta ccagcagaaa 120
cctggccagg ctcccaggct cctcatctat ggtgcatccg gcagggccac tggcatccca 180
gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag 240
cctgaagatt ttgcagtgta ttactgtcag cagtattttg gctcaccgta cacttttggc 300
caggggacca agctggagct caaacgaact gtggctgcac catctgtctt catcttcccg 360
ccatctgatg agcagttgaa atctggaact gcctctgttg tgtgcctgct gaataacttc 420
tatcccagag aggccaaagt acagtggaag gtggataacg ccctccaatc gggtaactcc 480
caggagagtg tcacagagca ggacagcaag gacagcacct acagcctcag cagcaccctg 540
acgctgagca aagcagacta cgagaaacac aaagtctacg cctgcgaagt cacccatcag 600
ggcctgagct cgcccgtcac aaagagcttc aacaggggag agtgt 645
<210>143
<211>642
<212>DNA
<213>人(homo sapiens)
<400>143
aacatccaga tgacccagtc tccatctgcc atgtctgcat ctgtaggaga cagagtcacc 60
atcacttgtc gggcgagtca gggcattagt aattatttag tctggtttca gcagaaacca 120
gggaaagtcc ctaagcgcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca 180
aggttcagcg gcagtggatc tgggacagaa ttcactctca caatcagcag cctgcagcct 240
gaagattttg caacttatta ctgtctacag cataatattt ccccttacac ttttggccag 300
gggaccaagc tggagaccaa acgaactgtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210>144
<211>660
<212>DNA
<213>人(homo sapiens)
<400>144
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc 60
atcaactgca ggtccagtga gactgtttta tacacctcta aaaatcagag ctacttagct 120
tggtaccagc agaaagcacg acagcctcct aaactactcc tttactgggc atctacccgg 180
gaatccgggg tccctgcccg attcagtggc agcggatctg ggacagattt cactctcgcc 240
atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaatt ttttaggagt 300
cctttcactt tcggccccgg gaccagactg gagattaaac gaactgtggc tgcaccatct 360
gtcttcatct tcccgccatc tgatgagcag ttgaaatctg gaactgcctc tgttgtgtgc 420
ctgctgaata acttctatcc cagagaggcc aaagtacagt ggaaggtgga taacgccctc 480
caatcgggta actcccagga gagtgtcaca gagcaggaca gcaaggacag cacctacagc 540
ctcagcagca ccctgacgct gagcaaagca gactacgaga aacacaaagt ctacgcctgc 600
gaagtcaccc atcagggcct gagctcgccc gtcacaaaga gcttcaacag gggagagtgt 660
<210>145
<211>645
<212>DNA
<213>人(homo sapiens)
<400>145
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagttacc 60
ctctcttgca gggccagtca gagtgttagc agcagttaca tagcctggta ccagcagaag 120
cctggccagg ctcccaggct cgtcatctat gctgcatccc gcagggccac tggcgtccca 180
gacaggttca gtggcagtgg gtctgcgaca gacttcactc tcaccatcag tagactggag 240
cctgaagatc ttgcagtgta ttactgtcag cactatggta actcactatt cactttcggc 300
cctgggacca aggtggatgt caaacgaact gtggctgcac catctgtctt catcttcccg 360
ccatctgatg agcagttgaa atctggaact gcctctgttg tgtgcctgct gaataacttc 420
tatcccagag aggccaaagt acagtggaag gtggataacg ccctccaatc gggtaactcc 480
caggagagtg tcacagagca ggacagcaag gacagcacct acagcctcag cagcaccctg 540
acgctgagca aagcagacta cgagaaacac aaagtctacg cctgcgaagt cacccatcag 600
ggcctgagct cgcccgtcac aaagagcttc aacaggggag agtgt 645
<210>146
<211>645
<212>DNA
<213>人(homo sapiens)
<400>146
gacatccaga tgacccagtc tccctccacc ctgtctgcat ctgtcggaga cagagtcacc 60
atcacttgcc gggccagtca gagtattggt agccggttgg cctggtatca gcagcaacca 120
gggaaagccc ctaaattcct gatctatgat gcctccagtt tggaaagtgg ggtcccatca 180
aggttcagcg gcagtggatc agggacagaa ttcactctca ccatcagcag cctgcagccg 240
gaggatcttg caacttatta ctgccaacag tacaatagag attctccgtg gacgttcggc 300
caagggacca aggtggaaat caagcgaact gtggctgcac catctgtctt catcttcccg 360
ccatctgatg agcagttgaa atctggaact gcctctgttg tgtgcctgct gaataacttc 420
tatcccagag aggccaaagt acagtggaag gtggataacg ccctccaatc gggtaactcc 480
caggagagtg tcacagagca ggacagcaag gacagcacct acagcctcag cagcaccctg 540
acgctgagca aagcagacta cgagaaacac aaagtctacg cctgcgaagt cacccatcag 600
ggcctgagct cgcccgtcac aaagagcttc aacaggggag agtgt 645
<210>147
<211>657
<212>DNA
<213>人(homo sapiens)
<400>147
gatattgtga tgacccagtc tccactctcc ctgcccgtca ccccaggaga gccggcctcc 60
atctcctgca ggtctagtca gagcctcctg catagtgatg gacgctacta tgtggattgg 120
tacctgcaga agccagggca gtctccacac ctcctgatct atttggcttc taatcgggcc 180
tccggggtcc ctgacaggtt cactggcagt ggatcaggca cagattttac actgaaaatc 240
agcagagtgg aggctgagga tgttggcgtt tattactgca tgcaaggtct acacactcct 300
tggacgttcg gccaggggac caaggtggac atcaagcgaa ctgtggctgc accatctgtc 360
ttcatcttcc cgccatctga tgagcagttg aaatctggaa ctgcctctgt tgtgtgcctg 420
ctgaataact tctatcccag agaggccaaa gtacagtgga aggtggataa cgccctccaa 480
tcgggtaact cccaggagag tgtcacagag caggacagca aggacagcac ctacagcctc 540
agcagcaccc tgacgctgag caaagcagac tacgagaaac acaaagtcta cgcctgcgaa 600
gtcacccatc agggcctgag ctcgcccgtc acaaagagct tcaacagggg agagtgt 657
<210>148
<211>639
<212>DNA
<213>人(homo sapiens)
<400>148
gaaattgtaa tgacacagtc tccagccacc ctgtctgcgt ccccagggga aagagccacc 60
ctctcctgtt gggccagtca gactattgga ggcaacttag cctggtacca gcagaaacct 120
ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tgtcccagcc 180
aggttcagtg gcagtgggtc tgggacagag ttcactctcg ccatcagcag cctgcagtct 240
gaagattttg cagtttatta ctgtcagcag tataaaaact ggtacacttt tggccagggg 300
accaagctgg agctcaaacg aactgtggct gcaccatctg tcttcatctt cccgccatct 360
gatgagcagt tgaaatctgg aactgcctct gttgtgtgcc tgctgaataa cttctatccc 420
agagaggcca aagtacagtg gaaggtggat aacgccctcc aatcgggtaa ctcccaggag 480
agtgtcacag agcaggacag caaggacagc acctacagcc tcagcagcac cctgacgctg 540
agcaaagcag actacgagaa acacaaagtc tacgcctgcg aagtcaccca tcagggcctg 600
agctcgcccg tcacaaagag cttcaacagg ggagagtgt 639
<210>149
<211>645
<212>DNA
<213>人(homo sapiens)
<400>149
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc 60
atcacttgcc gggcaagtca gaccattgcc agttacgtaa attggtacca acaaaaacca 120
gggagagccc ctagtctcct gatctatgct gcatctaact tgcagagtgg ggtcccacca 180
aggttcagtg gcagtggatc tgggacagac ttcactctca ccatcagcgg tctgcaacct 240
gacgattttg caacttatta ctgtcaacag agttacagtt atcgagcgct cactttcggc 300
ggagggacca aggtggagat caaacgaact gtggctgcac catctgtctt catcttcccg 360
ccatctgatg agcagttgaa atctggaact gcctctgttg tgtgcctgct gaataacttc 420
tatcccagag aggccaaagt acagtggaag gtggataacg ccctccaatc gggtaactcc 480
caggagagtg tcacagagca ggacagcaag gacagcacct acagcctcag cagcaccctg 540
acgctgagca aagcagacta cgagaaacac aaagtctacg cctgcgaagt cacccatcag 600
ggcctgagct cgcccgtcac aaagagcttc aacaggggag agtgt 645
<210>150
<211>648
<212>DNA
<213>人(homo sapiens)
<400>150
gaaattgtgt tgacacagtc tccagccacc ctgtcgttgt ccccagggga aagagccacc 60
ctctcctgca gggccagtca gagtgttagc agctccttag cctggtacca acagacacct 120
ggccaggctc ccaggcttct catctatgat gcgtcctaca gggtcactgg catcccagcc 180
aggttcagtg gcagtgggtc tgggatagac ttcactctca ccatcagcag cctagagcct 240
gaagattttg cagtttacta ttgtcagcag cgtagcaact ggcctccggg gctcactttc 300
ggcgggggga ccaaggtgga gatcaaacga actgtggctg caccatctgt cttcatcttc 360
ccgccatctg atgagcagtt gaaatctgga actgcctctg ttgtgtgcct gctgaataac 420
ttctatccca gagaggccaa agtacagtgg aaggtggata acgccctcca atcgggtaac 480
tcccaggaga gtgtcacaga gcaggacagc aaggacagca cctacagcct cagcagcacc 540
ctgacgctga gcaaagcaga ctacgagaaa cacaaagtct acgcctgcga agtcacccat 600
cagggcctga gctcgcccgt cacaaagagc ttcaacaggg gagagtgt 648
<210>151
<211>642
<212>DNA
<213>人(homo sapiens)
<400>151
gccatccagt tgacccagtc tccatcctcc ctgtctgcat ctgttggaga cacagtcacc 60
gtcacttgcc ggccaagtca ggacattagc agtgctttag cctggtatca gcagaaacca 120
gggaaacctc ctaagctcct gatctatggt gcctccactt tggattatgg ggtcccatta 180
aggttcagcg gcactgcatc tgggacacat ttcactctca ccatcagcag cctgcaacct 240
gaagattttg caacttatta ctgtcaacag tttaatactt acccattcac tttcggccct 300
gggaccaaag tggatatcaa acgaactgtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210>152
<211>660
<212>DNA
<213>人(homo sapiens)
<400>152
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc 60
atcaactgca agtccagcca gagtgtttta tacaactcca acaataagaa ctacttagcc 120
tggtatcagc agaaaccagg acagcctcct aagctcctca ttcacttggc atctacccgg 180
gaatacgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cgctctcatc 240
atcagcagcc tgcaggctga agatgtggca gtttattact gtcaacaata ttatcaaact 300
cctctaactt ttggccaggg gaccaaggtg gagatcaaac gaactgtggc tgcaccatct 360
gtcttcatct tcccgccatc tgatgagcag ttgaaatctg gaactgcctc tgttgtgtgc 420
ctgctgaata acttctatcc cagagaggcc aaagtacagt ggaaggtgga taacgccctc 480
caatcgggta actcccagga gagtgtcaca gagcaggaca gcaaggacag cacctacagc 540
ctcagcagca ccctgacgct gagcaaagca gactacgaga aacacaaagt ctacgcctgc 600
gaagtcaccc atcagggcct gagctcgccc gtcacaaaga gcttcaacag gggagagtgt 660
<210>153
<211>642
<212>DNA
<213>人(homo sapiens)
<400>153
gacatccaga tgacccagtc tccatcctcc ctggctgcat ctgtaggaga cagagtcacc 60
atcacttgcc gggcaagtca gttcattagc agctatttac attggtatca gcaaagacca 120
ggcaaggccc ctaaactcct gatgtatgct gcctccactt tgcaaagtgg ggtcccatca 180
aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct 240
gaagattttg caacttacta ctgtcaacag agttacacta acccatacac ttttggccag 300
gggaccaagc tggagatcaa acgaactgtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210>154
<211>642
<212>DNA
<213>人(homo sapiens)
<400>154
gacatccaga tgacccagtc tccatcctcc ctatctgcat ctgtaggaga cagagtcacc 60
atcacttgcc gggcaagtca gagcattgcc agctatttaa attggtatca gcagaaacca 120
gggaaagccc ccaaactcct gatctatgct gcatccagtt tgcatagtgg ggtcccatca 180
agattcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct 240
gaagattttg caacttacta ctgtcaacac agttacagta ctcgattcac tttcggccct 300
gggaccaaag tggatgtcaa acgaactgtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210>155
<211>642
<212>DNA
<213>人(homo sapiens)
<400>155
gacatccaga tgacccagtc tccttcgacc ctgtctgcat ctgtaggaga cagagtcacc 60
atcacttgcc gggccagtca gagtgttact agtgagttgg cctggtatca gcagaaacca 120
gggaaagccc ctaacttcct gatctataag gcgtctagtt tagaaagtgg ggtcccatca 180
aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct 240
gatgattttg caacttatta ctgccaacag tataatagtt ttccgtacac ttttggccag 300
gggaccaagc tggagatcaa acgaactgtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210>156
<211>642
<212>DNA
<213>人(homo sapiens)
<400>156
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggcga cagactcacc 60
atcacttgcc gggccagtca gaatatttat aactggttgg cctggtatca gcagaaacca 120
gggaaagccc ctaaactcct gatctatgac gcctccactt tggaaagtgg ggtcccatca 180
aggttcagcg gcagtggatc tgggacagag ttcactctca ccatcagcag cctgcagcct 240
gatgattttg cgacttatta ctgccaacaa tataatagtt tgtctccgac gttcggccaa 300
gggaccaagg tggaaatcaa gcgaactgtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210>157
<211>642
<212>DNA
<213>人(homo sapiens)
<400>157
gacatccagt tgacccagtc tccatccttc ctgtctgcat ctttagaaga cagagtcact 60
atcacttgcc gggccagtca gggcattagc agttatttag cctggtatca gcaaaaacca 120
gggaaagccc ctaagctcct gctcgatgct gcatccactt tgcaaagtgg ggtcccatca 180
aggttcagcg gcagtggatc tgggacagag ttcactctca caatcagcag cctgcagcct 240
gaagattttg caacttatta ctgtcaacag cttaatagtt accctcggac gttcggccaa 300
gggaccaagg tggacatcaa acgaactgtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210>158
<211>642
<212>DNA
<213>人(homo sapiens)
<400>158
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcagc 60
atcacttgcc gggcgagtca gggcattagc aattatttag cctggtatca gcagaaacca 120
gggaaggttc ctaagctcct gatctatgct gcatccactt tgcaatcagg ggtcccatct 180
cggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag cctgcagcct 240
gaggatgttg caacttatta ctgtcaaaag tataacagtg cccctcaaac gttcggccaa 300
gggaccaagg tggaaatcaa acgaactgtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210>159
<211>660
<212>DNA
<213>人(homo sapiens)
<400>159
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc 60
atcaactgca ggtccagcca gagtgtttta tacagctcca acaataagaa ctacttagct 120
tggtaccagc agaaaccagg acagcctcct aagctgctcg tttactgggc atcaacccgg 180
gcatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc 240
ctcagcagcc tgcaggctga agatgtggca gtttattact gtcagcagtt tcatagtact 300
cctcggacgt tcggccaagg gaccaaggtg gagatcaaac gaactgtggc tgcaccatct 360
gtcttcatct tcccgccatc tgatgagcag ttgaaatctg gaactgcctc tgttgtgtgc 420
ctgctgaata acttctatcc cagagaggcc aaagtacagt ggaaggtgga taacgccctc 480
caatcgggta actcccagga gagtgtcaca gagcaggaca gcaaggacag cacctacagc 540
ctcagcagca ccctgacgct gagcaaagca gactacgaga aacacaaagt ctacgcctgc 600
gaagtcaccc atcagggcct gagctcgccc gtcacaaaga gcttcaacag gggagagtgt 660
<210>160
<211>645
<212>DNA
<213>人(homo sapiens)
<400>160
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc 60
ctctcctgca gggccagtca gagtgttagc agcaactact tagcctggta ccagcagaaa 120
cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccgc tggcatgcca 180
gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag 240
cctgaagatt ttgcagtgta ttactgtcag cagtatggta actcaccgct cactttcggc 300
ggagggaccg aggtggagat caaacgaact gtggctgcac catctgtctt catcttcccg 360
ccatctgatg agcagttgaa atctggaact gcctctgttg tgtgcctgct gaataacttc 420
tatcccagag aggccaaagt acagtggaag gtggataacg ccctccaatc gggtaactcc 480
caggagagtg tcacagagca ggacagcaag gacagcacct acagcctcag cagcaccctg 540
acgctgagca aagcagacta cgagaaacac aaagtctacg cctgcgaagt cacccatcag 600
ggcctgagct cgcccgtcac aaagagcttc aacaggggag agtgt 645
<210>161
<211>642
<212>DNA
<213>人(homo sapiens)
<400>161
gacatccaga tgacccagtc tccatcttct gtgtctgcat ctgtaggaga cagagtcacc 60
atcacttgtc gggcgagtca ggctattagt aactggttag cctggtatca gcagaaacca 120
ggaaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca 180
agattcagcg gcagtggatc tgggacagat ttcactctca ctatcagcgg cctgcagcct 240
gaggattttg caacttacta ttgtcaacag gctgacactt tccctttcac tttcggccct 300
gggaccaaag tggatatcaa acgaactgtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210>162
<211>660
<212>DNA
<213>人(homo sapiens)
<400>162
gatattgtga tgacccagac tccactctcc ctgcccgtca cccctggaga gccggcctcc 60
atctcctgca ggtctagtca gagcctcttg gatagtaatg atggaaacac ctatttggac 120
tggtacctgc agaagccagg gcagtctcca cagctcctga tttatacatt ttcctatcgg 180
gcctctggag tcccagacag gttcagtggc agtgggtctg gcactgattt cacactgaaa 240
atcagcaggg tggaggccga ggatgttgga gtttattact gcatgcaacg tatcgagttt 300
ccgtacactt ttggccaggg gaccaagctg gagatcaaac gaactgtggc tgcaccatct 360
gtcttcatct tcccgccatc tgatgagcag ttgaaatctg gaactgcctc tgttgtgtgc 420
ctgctgaata acttctatcc cagagaggcc aaagtacagt ggaaggtgga taacgccctc 480
caatcgggta actcccagga gagtgtcaca gagcaggaca gcaaggacag cacctacagc 540
ctcagcagca ccctgacgct gagcaaagca gactacgaga aacacaaagt ctacgcctgc 600
gaagtcaccc atcagggcct gagctcgccc gtcacaaaga gcttcaacag gggagagtgt 660
<210>163
<211>657
<212>DNA
<213>人(homo sapiens)
<400>163
gatattgtga tgacccagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc 60
atctcctgca ggtctagtca gagcctcctg catagaaatg agtacaacta tttggattgg 120
tacttgcaga agccagggca gtctccacag ctcctgatct attggggttc taatcgggcc 180
tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc 240
agcagagtgg aggctgagga tgttggggtt tattactgca tgcaaactct acaaactcct 300
cggacgttcg gccaagggac caaggtggaa atcaaacgaa ctgtggctgc accatctgtc 360
ttcatcttcc cgccatctga tgagcagttg aaatctggaa ctgcctctgt tgtgtgcctg 420
ctgaataact tctatcccag agaggccaaa gtacagtgga aggtggataa cgccctccaa 480
tcgggtaact cccaggagag tgtcacagag caggacagca aggacagcac ctacagcctc 540
agcagcaccc tgacgctgag caaagcagac tacgagaaac acaaagtcta cgcctgcgaa 600
gtcacccatc agggcctgag ctcgcccgtc acaaagagct tcaacagggg agagtgt 657
<210>164
<211>642
<212>DNA
<213>人(homo sapiens)
<400>164
gacatccaga tgacccagtc tccatcctcc gtgtctgcat ctgtgggaga cagagtcacc 60
atcacttgcc aggcgagtca agacattagc aactatttaa attggtatca gcagaaacca 120
gggaaagccc ctaagctcct gatcttcgat gcaaccaaat tggagacagg ggtcccaaca 180
aggttcattg gaagtggatc tgggacagat tttactgtca ccatcaccag cctgcagcct 240
gaagatgttg caacatatta ctgtcaacac tttgctaatc tcccatacac ttttggccag 300
gggaccaagc tggagatcaa gcgaactgtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210>165
<211>642
<212>DNA
<213>人(homo sapiens)
<400>165
gacatccaga tgacccagtc tccatcttcc ctgtctgcat ctgtaggaga cagagtcacc 60
atcacttgcc gggcgagtca gggcattagg aattatttag cctggtatca gcagaaacca 120
gggaaagttc ctaagctcct ggtctttgct gcatccactt tgcaatcagg ggtcccatct 180
cggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag cctgcagcct 240
gaggatgttg caacttatta ctgtcaaagg tataacagtg ccccgctcac tttcggcgga 300
gggacgaagg tggagatcaa acgaactgtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210>166
<211>645
<212>DNA
<213>人(homo sapiens)
<400>166
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc 60
atcacttgcc gggcaagtca gatcattgcc agctatttaa attggtatca gcagaaacca 120
ggcagagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca 180
aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct 240
gaagattttg caacttacta ctgtcaacag agttacagta cccccatatt cactttcggc 300
cctgggacca aggtgaatat caaacgaact gtggctgcac catctgtctt catcttcccg 360
ccatctgatg agcagttgaa atctggaact gcctctgttg tgtgcctgct gaataacttc 420
tatcccagag aggccaaagt acagtggaag gtggataacg ccctccaatc gggtaactcc 480
caggagagtg tcacagagca ggacagcaag gacagcacct acagcctcag cagcaccctg 540
acgctgagca aagcagacta cgagaaacac aaagtctacg cctgcgaagt cacccatcag 600
ggcctgagct cgcccgtcac aaagagcttc aacaggggag agtgt 645
<210>167
<211>639
<212>DNA
<213>人(homo sapiens)
<400>167
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc 60
ctctcctgca ggaccagtca gagtgttagc agctacttag cctggtacca acagaaacct 120
ggccaggctc ccaggctcct catctatgat gcttccaata gggccactgg catcccagcc 180
aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct 240
gaagattttg cagtttatta ctgtcagcag cgtagtgact ggctcacttt cggcggaggg 300
accaaggtgg agatcaaacg aactgtggct gcaccatctg tcttcatctt cccgccatct 360
gatgagcagt tgaaatctgg aactgcctct gttgtgtgcc tgctgaataa cttctatccc 420
agagaggcca aagtacagtg gaaggtggat aacgccctcc aatcgggtaa ctcccaggag 480
agtgtcacag agcaggacag caaggacagc acctacagcc tcagcagcac cctgacgctg 540
agcaaagcag actacgagaa acacaaagtc tacgcctgcg aagtcaccca tcagggcctg 600
agctcgcccg tcacaaagag cttcaacagg ggagagtgt 639
<210>168
<211>645
<212>DNA
<213>人(homo sapiens)
<400>168
gaaattgtaa tgacacagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc 60
ctctcctgca gggccagtca gagtattaaa aacaacttgg cctggtacca ggtgaaacct 120
ggccaggctc ccaggctcct cacctctggt gcatccgcca gggccactgg aattccaggc 180
aggttcagtg gcagtgggtc tgggactgac ttcactctca ccatcagcag cctccagtct 240
gaagatattg cagtttatta ctgtcaggag tataataatt ggcccctgct cactttcggc 300
ggagggacca aggtggagat ccaacgaact gtggctgcac catctgtctt catcttcccg 360
ccatctgatg agcagttgaa atctggaact gcctctgttg tgtgcctgct gaataacttc 420
tatcccagag aggccaaagt acagtggaag gtggataacg ccctccaatc gggtaactcc 480
caggagagtg tcacagagca ggacagcaag gacagcacct acagcctcag cagcaccctg 540
acgctgagca aagcagacta cgagaaacac aaagtctacg cctgcgaagt cacccatcag 600
ggcctgagct cgcccgtcac aaagagcttc aacaggggag agtgt 645
<210>169
<211>645
<212>DNA
<213>人(homo sapiens)
<400>169
gacatccaga tgacccagtc tcctccctcc ctgtctgcat ctgtgggaga cagagtcacc 60
atcacttgcc gggcaagtca gaggattgcc agctatttaa attggtatca gcagaaacca 120
gggagagccc ctaagctcct gatctttgct gcatccagtt tacaaagtgg ggtcccatca 180
aggttcagtg gcagtggatc tgggacagac ttcactctca ccatcagtag tctgcaacct 240
gaagattatg cgacttacta ctgtcaacag agttacagta ctcccatcta cacttttggc 300
caggggacca agctggagat caaacgaact gtggctgcac catctgtctt catcttcccg 360
ccatctgatg agcagttgaa atctggaact gcctctgttg tgtgcctgct gaataacttc 420
tatcccagag aggccaaagt acagtggaag gtggataacg ccctccaatc gggtaactcc 480
caggagagtg tcacagagca ggacagcaag gacagcacct acagcctcag cagcaccctg 540
acgctgagca aagcagacta cgagaaacac aaagtctacg cctgcgaagt cacccatcag 600
ggcctgagct cgcccgtcac aaagagcttc aacaggggag agtgt 645
<210>170
<211>642
<212>DNA
<213>人(homo sapiens)
<400>170
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc 60
atcacttgcc aggcgagtca gggcattagc aactatttaa attggtatca acagaaacca 120
gggaaagccc ctaagctcct gatcttcgat gcatccaatt tggaatcaga ggtcccatca 180
aggttcagtg gacgtggatc tgggacagat tttactttct ccatcagcag cctgcagcct 240
gaagatattg caacatattt ctgtcaacag tatgataatt tcccgtacac ttttggccag 300
gggaccaagc tggagatcaa acgaactgtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210>171
<211>642
<212>DNA
<213>人(homo sapiens)
<400>171
gacatccaga tgacccagtc tccatcctcc ctggctgcat ctgtaggaga cagagtcacc 60
atcacctgcc gggcaagtca gacgattgcc agttatgtaa attggtatca acagaaacca 120
gggaaagccc ctaatctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca 180
aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct 240
gaagattttg catcttactt ctgtcaacag agttacagtt tcccgtacac ttttggccag 300
gggaccaagc tggatatcaa acgaactgtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210>172
<211>645
<212>DNA
<213>人(homo sapiens)
<400>172
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc 60
atcacttgcc gggcaagtca gaccattgcc agctatgtaa attggtatca gcagaaacca 120
gggaaagccc ctaagctcct gatctatgct gcatccaatt tgcaaagtgg ggtcccttca 180
aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct 240
gaagattttg caacttacta ctgtcaacag agttacagtg tccctcggct cactttcggc 300
ggagggacca aggtggacat cacacgaact gtggctgcac catctgtctt catcttcccg 360
ccatctgatg agcagttgaa atctggaact gcctctgttg tgtgcctgct gaataacttc 420
tatcccagag aggccaaagt acagtggaag gtggataacg ccctccaatc gggtaactcc 480
caggagagtg tcacagagca ggacagcaag gacagcacct acagcctcag cagcaccctg 540
acgctgagca aagcagacta cgagaaacac aaagtctacg cctgcgaagt cacccatcag 600
ggcctgagct cgcccgtcac aaagagcttc aacaggggag agtgt 645
<210>173
<211>639
<212>DNA
<213>人(homo sapiens)
<400>173
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc 60
atcacttgcc ggtcaagtca gaccattagc gtctttttaa attggtatca gcagaaacca 120
gggaaagccc ctaagctcct gatctatgcc gcatccagtt tgcacagtgc ggtcccatca 180
aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct 240
gaagattctg caacttacta ctgtcaagag agtttcagta gctcaacttt cggcggaggg 300
accaaggtgg agatcaaacg aactgtggct gcaccatctg tcttcatctt cccgccatct 360
gatgagcagt tgaaatctgg aactgcctct gttgtgtgcc tgctgaataa cttctatccc 420
agagaggcca aagtacagtg gaaggtggat aacgccctcc aatcgggtaa ctcccaggag 480
agtgtcacag agcaggacag caaggacagc acctacagcc tcagcagcac cctgacgctg 540
agcaaagcag actacgagaa acacaaagtc tacgcctgcg aagtcaccca tcagggcctg 600
agctcgcccg tcacaaagag cttcaacagg ggagagtgt 639
<210>174
<211>645
<212>DNA
<213>人(homo sapiens)
<400>174
gaaattgtaa tgacacagtc tccagccacc ctgtctgtgt ctccagggga aacagccacc 60
ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca acataaacct 120
ggccaggctc ccaggctcct catccatagt gcatccacca gggccactgg gatcccagcc 180
aggttcagtg gcagtgggtc tgggacagag ttcactctca ccataagcag cctgcagtct 240
gaagattttg cagtttatta ctgtcagcag tataatatgt ggcctccctg gacgttcggc 300
caagggacca aggtggaaat caaacgaact gtggctgcac catctgtctt catcttcccg 360
ccatctgatg agcagttgaa atctggaact gcctctgttg tgtgcctgct gaataacttc 420
tatcccagag aggccaaagt acagtggaag gtggataacg ccctccaatc gggtaactcc 480
caggagagtg tcacagagca ggacagcaag gacagcacct acagcctcag cagcaccctg 540
acgctgagca aagcagacta cgagaaacac aaagtctacg cctgcgaagt cacccatcag 600
ggcctgagct cgcccgtcac aaagagcttc aacaggggag agtgt 645
<210>175
<211>657
<212>DNA
<213>人(homo sapiens)
<400>175
gatattgtga tgacccagtc tccactctcc ctgcccgtca cccctggagc gccggcctcc 60
atctcctgca ggtctagtca gagcctcctg cgtactaatg gatacaacta tttggattgg 120
tacctgcaga agccagggca gtctccacag ctcctgatct atttgggttc tattcgggcc 180
tccggggtcc ctgacaggtt cagtggcagt ggctcaggca cagattttac actgaaaatc 240
agcagagtgg aggctgagga tgttggggtt tattactgca tgcaatctct acaaacttcg 300
atcaccttcg gccaagggac acgactggag attaaacgaa ctgtggctgc accatctgtc 360
ttcatcttcc cgccatctga tgagcagttg aaatctggaa ctgcctctgt tgtgtgcctg 420
ctgaataact tctatcccag agaggccaaa gtacagtgga aggtggataa cgccctccaa 480
tcgggtaact cccaggagag tgtcacagag caggacagca aggacagcac ctacagcctc 540
agcagcaccc tgacgctgag caaagcagac tacgagaaac acaaagtcta cgcctgcgaa 600
gtcacccatc agggcctgag ctcgcccgtc acaaagagct tcaacagggg agagtgt 657
<210>176
<211>642
<212>DNA
<213>人(homo sapiens)
<400>176
gaaattgtaa tgacacagtc tccagccacc ctgtctgtgt ctccggggga aagagccacc 60
ctctcctgca gggctagtca gagtgttggc aacaacttag cctggtacca gcagagacct 120
ggccaggctc ccagactcct catctatggt gcgtccacca gggccactgg tatcccagcc 180
aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct 240
gaggattttg cagtttatta ctgtcagcag tatgataagt ggcctgagac gttcggccag 300
gggaccaagg tggacatcaa gcgaactgtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210>177
<211>1602
<212>DNA
<213>人(homo sapiens)
<220>
<221>CDS
<222>(1)..(298)
<220>
<221>CDS
<222>(690)..(734)
<220>
<221>CDS
<222>(853)..(1182)
<220>
<221>CDS
<222>(1280)..(1599)
<400>177
agt gcc tcc acc aag ggc cca tcg gtc ttc ccc ctg gca ccc tcc tcc 48
Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser
1 5 10 15
aag agc acc tct ggg ggc aca gcg gcc ctg ggc tgc ctg gtc aag gac 96
Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp
20 25 30
tac ttc ccc gaa ccg gtg acg gtg tcg tgg aac tca ggc gcc ctg acc 144
Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr
35 40 45
agc ggc gtg cac acc ttc ccg gct gtc cta cag tcc tca gga ctc tac 192
Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr
50 55 60
tcc ctc agc agc gtg gtg acc gtg ccc tcc agc agc ttg ggc acc cag 240
Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln
65 70 75 80
acc tac atc tgc aac gtg aat cac aag ccc agc aac acc aag gtg gac 288
Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp
85 90 95
aag aga gtt g gtgagaggcc agcacaggga gggagggtgt ctgctggaag 338
Lys Arg Val
ccaggctcag cgctcctgcc tggacgcatc ccggctatgc agtcccagtc cagggcagca 398
aggcaggccc cgtctgcctc ttcacccgga ggcctctgcc cgccccactc atgctcaggg 458
agagggtctt ctggcttttt ccccaggctc tgggcaggca caggctaggt gcccctaacc 518
caggccctgc acacaaaggg gcaggtgctg ggctcagacc tgccaagagc catatccggg 578
aggaccctgc ccctgaccta agcccacccc aaaggccaaa ctctccactc cctcagctcg 638
gacaccttct ctcctcccag attccagtaa ctcccaatct tctctctgca g ag ccc 694
Glu Pro
aaa tct tgt gac aaa act cac aca tgc cca ccg tgc cca g gtaagccagc 744
Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro
105 110
ccaggcctcg ccctccagct caaggcggga caggtgccct agagtagcct gcatccaggg 804
acaggcccca gccgggtgct gacacgtcca cctccatctc ttcctcag ca cct gaa 860
Ala Pro Glu
ctc ctg ggg gga ccg tca gtc ttc ctc ttc ccc cca aaa ccc aag gac 908
Leu Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp
120 125 130
acc ctc atg atc tcc cgg acc cct gag gtc aca tgc gtg gtg gtg gac 956
Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp
135 140 145
gtg agc cac gaa gac cct gag gtc aag ttc aac tgg tac gtg gac ggc 1004
Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly
150 155 160 165
gtg gag gtg cat aat gcc aag aca aag ccg cgg gag gag cag tac aac 1052
Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn
170 175 180
agc acg tac cgt gtg gtc agc gtc ctc acc gtc ctg cac cag gac tgg 1100
Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp
185 190 195
ctg aat ggc aag gag tac aag tgc aag gtc tcc aac aaa gcc ctc cca 1148
Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro
200 205 210
gcc ccc atc gag aaa acc atc tcc aaa gcc aaa g gtgggacccg 1192
Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys
215 220
tggggtgcga gggccacatg gacagaggcc ggctcggccc accctctgcc ctgagagtga 1252
ccgctgtacc aacctctgtc cctacag gg cag ccc cga gaa cca cag gtg tac 1305
Gly Gln Pro Arg Glu Pro Gln Val Tyr
230
acc ctg ccc cca tcc cgg gag gag atg acc aag aac cag gtc agc ctg 1353
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
235 240 245
acc tgc ctg gtc aaa ggc ttc tat ccc agc gac atc gcc gtg gag tgg 1401
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
250 255 260 265
gag agc aat ggg cag ccg gag aac aac tac aag acc acg cct ccc gtg 1449
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
270 275 280
ctg gac tcc gac ggc tcc ttc ttc ctc tat agc aag ctc acc gtg gac 1497
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
285 290 295
aag agc agg tgg cag cag ggg aac gtc ttc tca tgc tcc gtg atg cat 1545
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
300 305 310
gag gct ctg cac aac cac tac acg cag aag agc ctc tcc ctg tcc ccg 1593
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
315 320 325
ggt aaa tga 1602
Gly Lys
330
<210>178
<211>331
<212>PRT
<213>人(homo sapiens)
<400>178
Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser
1 5 10 15
Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp
20 25 30
Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr
35 40 45
Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr
50 55 60
Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln
65 70 75 80
Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp
85 90 95
Lys Arg Val Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro
100 105 110
Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Leu Phe Pro
115 120 125
Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr
130 135 140
Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn
145 150 155 160
Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg
165 170 175
Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val
180 185 190
Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser
195 200 205
Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys
210 215 220
Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu
225 230 235 240
Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe
245 250 255
Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu
260 265 270
Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe
275 280 285
Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly
290 295 300
Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr
305 310 315 320
Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
325 330
<210>179
<211>20
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<220>
<221>misc_feature
<222>(4)..(4)
<223>n是G或C
<4000>179
gacngatggg cccttggtgg 20
<210>180
<211>20
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<400>180
gagtggctcc tgggggaaga 20
<210>181
<211>36
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<220>
<221>misc_feature
<222>(21)..(21)
<223>n是a或g
<220>
<221>misc_feature
<222>(35)..(35)
<223>n是a或g
<400>181
tattcccatg gcgcgcccag ntgcagctgg tgcant 36
<210>182
<211>36
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<220>
<221>misc_feature
<222>(18)..(18)
<223>n是g或c
<220>
<221>misc_feature
<222>(32)..(32)
<223>n是a或g
<400>182
tattcccatg gcgcgccnag gtccagctgg tncagt 36
<210>183
<211>36
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<220>
<221>misc_feature
<222>(21)..(21)
<223>n是a或g
<400>183
tattcccatg gcgcgcccag ntcaccttga aggagt 36
<210>184
<211>35
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<220>
<221>misc_feature
<222>(18)..(18)
<223>n是g或c
<400>184
tattcccatg gcgcgccnag gtgcagctgg tggag 35
<210>185
<211>36
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<400>185
tattcccatg gcgcgcccag gtgcagctac agcagt 36
<210>186
<211>36
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<220>
<221>misc_feature
<222>(21)..(21)
<223>n是g或c
<400>186
tattcccatg gcgcgcccag ntgcagctgc aggagt 36
<210>187
<211>36
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<220>
<221>misc_feature
<222>(20)..(20)
<223>n是a或g
<400>187
tattcccatg gcgcgccgan gtgcagctgg tgcagt 36
<210>188
<211>37
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<400>188
tattcccatg gcgcgcccag gtacagctgc agcagtc 37
<210>189
<211>38
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<400>189
atatatatgc ggccgcttat taacactctc ccctgttg 38
<210>190
<211>45
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<220>
<221>misc_feature
<222>(34)..(34)
<223>n是a或t
<400>190
ggcgcgccat gggaatagct agccgacatc cagntgaccc agtct 45
<210>191
<211>45
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<400>191
ggcgcgccat gggaatagct agccgatgtt gtgatgactc agtct 45
<210>192
<211>45
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<220>
<221>misc_feature
<222>(34)..(34)
<223>n是a或t
<220>
<221>misc_feature
<222>(39)..(39)
<223>n是a或g
<400>192
ggcgcgccat gggaatagct agccgaaatt gtgntgacnc agtct 45
<210>193
<211>45
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<400>193
ggcgcgccat gggaatagct agccgatatt gtgatgaccc acact 45
<210>194
<211>43
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<400>194
ggcgcgccat gggaatagct agccgaaacg acactcacgc agt 43
<210>195
<211>45
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<400>195
ggcgcgccat gggaatagct agccgaaatt gtgctgactc agtct 45
<210>196
<211>51
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<400>196
accgcctcca ccggcggccg cttattaaca ctctcccctg ttgaagctct t 51
<210>197
<211>30
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<400>197
ggaggcgctc gagacggtga ccagggtgcc 30
<210>198
<211>30
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<400>198
ggaggcgctc gagacggtga ccattgtccc 30
<210>199
<211>30
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<400>199
ggaggcgctc gagacggtga ccagggt tcc 30
<210>200
<211>30
<212>DNA
<213>人工序列
<220>
<223>合成的DNA引物
<400>200
ggaggcgctc gagacggtga ccgtggtccc 30
<210>201
<211>5
<212>PRT
<213>人(homo sapiens)
<400>201
Asp Tyr Asp Trp Ser
1 5
<210>202
<211>5
<212>PRT
<213>人(homo sapiens)
<400>202
Thr Tyr Gly Met His
1 5
<210>203
<211>5
<212>PRT
<213>人(homo sapiens)
<400>203
Thr Tyr Ala Leu Thr
1 5
<210>204
<211>5
<212>PRT
<213>人(homo sapiens)
<400>204
Gly Tyr Tyr Met His
1 5
<210>205
<211>5
<212>PRT
<213>人(homo sapiens)
<400>205
Asp Tyr Tyr Met Ser
1 5
<210>206
<211>5
<212>PRT
<213>人(homo sapiens)
<400>206
Asn Tyr Gly Leu Asn
1 5
<210>207
<211>7
<212>PRT
<213>人(homo sapiens)
<400>207
Ser Gly Asp Tyr Tyr Trp Ser
1 5
<210>208
<211>5
<212>PRT
<213>人(homo sapiens)
<400>208
His Phe Gly Met His
1 5
<210>209
<211>5
<212>PRT
<213>人(homo sapiens)
<400>209
Arg Phe Gly Ile Ser
1 5
<210>210
<211>5
<212>PRT
<213>人(homo sapiens)
<400>210
Ser Tyr Val Met Asn
1 5
<210>211
<211>5
<212>PRT
<213>人(homo sapiens)
<400>211
Asn Tyr Gly Met His
1 5
<210>212
<211>5
<212>PRT
<213>人(homo sapiens)
<400>212
Asp Tyr Gly Met Asn
1 5
<210>213
<211>5
<212>PRT
<213>人(homo sapiens)
<400>213
Ser Tyr Ala Met His
1 5
<210>214
<211>5
<212>PRT
<213>人(homo sapiens)
<400>214
Ser Tyr Glu Met Asn
1 5
<210>215
<211>7
<212>PRT
<213>人(homo sapiens)
<400>215
Ser Gly Asp Tyr Phe Trp Ser
1 5
<210>216
<211>5
<212>PRT
<213>人(homo sapiens)
<400>216
Asn Tyr Ala Met His
1 5
<210>217
<211>5
<212>PRT
<213>人(homo sapiens)
<400>217
Gly Asp Phe Trp Ser
1 5
<210>218
<211>5
<212>PRT
<213>人(homo sapiens)
<400>218
Ser Tyr Trp Ile Gly
1 5
<210>219
<211>7
<212>PRT
<213>人(homo sapiens)
<400>219
Thr Thr Arg Met Ser Val Ser
1 5
<210>220
<211>7
<212>PRT
<213>人(homo sapiens)
<400>220
Phe Val Ser Thr Trp Ile Gly
1 5
<210>221
<211>5
<212>PRT
<213>人(homo sapiens)
<400>221
Asn Tyr Ala Ile Asn
1 5
<210>222
<211>5
<212>PRT
<213>人(homo sapiens)
<400>222
Asn Tyr Tyr Ile His
1 5
<210>223
<211>5
<212>PRT
<213>人(homo sapiens)
<400>223
Ser Tyr Ser Ile Ser
1 5
<210>224
<211>5
<212>PRT
<213>人(homo sapiens)
<400>224
Ser Tyr Trp Ile Gly
1 5
<210>225
<211>5
<212>PRT
<213>人(homo sapiens)
<400>225
Asp Tyr Ala Met His
1 5
<210>226
<211>5
<212>PRT
<213>人(homo sapiens)
<400>226
Thr Tyr Ala Met Thr
1 5
<210>227
<211>5
<212>PRT
<213>人(homo sapiens)
<400>227
Thr His Gly Met His
1 5
<210>228
<211>7
<212>PRT
<213>人(homo sapiens)
<400>228
Ala Gly Arg Val Gly Val Ser
1 5
<210>229
<211>7
<212>PRT
<213>人(homo sapiens)
<400>229
Gly Ala Asp Tyr Tyr Trp Ser
1 5
<210>230
<211>5
<212>PRT
<213>人(homo sapiens)
<400>230
Asn Ser Trp Ile Gly
1 5
<210>231
<211>6
<212>PRT
<213>人(homo sapiens)
<400>231
Ser Gly His Phe Trp Gly
1 5
<210>232
<211>5
<212>PRT
<213>人(homo sapiens)
<400>232
Asn Tyr Tyr Trp Gly
1 5
<210>233
<211>5
<212>PRT
<213>人(homo sapiens)
<400>233
Ser Asn Gly Leu Ser
1 5
<210>234
<211>5
<212>PRT
<213>人(homo sapiens)
<400>234
Ala Leu Ser Lys His
1 5
<210>235
<211>5
<212>PRT
<213>人(homo sapiens)
<400>235
Thr Asn Gly Leu His
1 5
<210>236
<211>7
<212>PRT
<213>人(homo sapiens)
<400>236
Arg Asn Arg Met Ser Val Ser
1 5
<210>237
<211>5
<212>PRT
<213>人(homo sapiens)
<400>237
Thr Tyr Gly Val Ser
1 5
<210>238
<211>4
<212>PRT
<213>人(homo sapiens)
<400>238
Tyr Ala Met His
1
<210>239
<211>5
<212>PRT
<213>人(homo sapiens)
<400>239
Tyr Ile Gly Met His
1 5
<210>240
<211>5
<212>PRT
<213>人(homo sapiens)
<400>240
Thr Tyr Gly Leu Asn
1 5
<210>241
<211>5
<212>PRT
<213>人(homo sapiens)
<400>241
Ser Tyr Gly Phe Ser
1 5
<210>242
<211>6
<212>PRT
<213>人(homo sapiens)
<400>242
Ser Gly His Tyr Trp Gly
1 5
<210>243
<211>5
<212>PRT
<213>人(homo sapiens)
<400>243
Thr Phe Gly Met His
1 5
<210>244
<211>5
<212>PRT
<213>人(homo sapiens)
<400>244
Ser Tyr Gly Leu His
1 5
<210>245
<211>5
<212>PRT
<213>人(homo sapiens)
<400>245
Ser Phe Gly Ile Ser
1 5
<210>246
<211>5
<212>PRT
<213>人(homo sapiens)
<400>246
Arg Tyr Gly Ile Ser
1 5
<210>247
<211>5
<212>PRT
<213>人(homo sapiens)
<400>247
Asn Ser Gly Val Ser
1 5
<210>248
<211>5
<212>PRT
<213>人(homo sapiens)
<400>248
Ser Tyr Gly Ile Ser
1 5
<210>249
<211>7
<212>PRT
<213>人(homo sapiens)
<400>249
Ser Gly Gly Tyr Ser Trp Ser
1 5
<210>250
<211>7
<212>PRT
<213>人(homo sapiens)
<400>250
Ser Asp Lys Asn Tyr Trp Ser
1 5
<210>251
<211>5
<212>PRT
<213>人(homo sapiens)
<400>251
Gly Ser Thr Met His
1 5
<210>252
<211>5
<212>PRT
<213>人(homo sapiens)
<400>252
Thr Tyr Thr Leu His
1 5
<210>253
<211>5
<212>PRT
<213>人(homo sapiens)
<400>253
Ser Leu Gly Phe Ser
1 5
<210>254
<211>5
<212>PRT
<213>人(homo sapiens)
<400>254
Gly Tyr Thr Ile His
1 5
<210>255
<211>5
<212>PRT
<213>人(homo sapiens)
<400>255
Asn Tyr Trp Ile Gly
1 5
<210>256
<211>5
<212>PRT
<213>人(homo sapiens)
<400>256
Asn Tyr Ala Phe Ser
1 5
<210>257
<211>5
<212>PRT
<213>人(homo sapiens)
<400>257
Asn Tyr Gly Phe Ser
1 5
<210>258
<211>5
<212>PRT
<213>人(homo sapiens)
<400>258
Ser Tyr Ala Met Asn
1 5
<210>259
<211>5
<212>PRT
<213>人(homo sapiens)
<400>259
Gly Tyr Thr Ile Ser
1 5
<210>260
<211>5
<212>PRT
<213>人(homo sapiens)
<400>260
Lys Tyr Gly Ile His
1 5
<210>261
<211>5
<212>PRT
<213>人(homo sapiens)
<400>261
Ser Tyr Gly Met His
1 5
<210>262
<211>5
<212>PRT
<213>人(homo sapiens)
<400>262
Ser Tyr Thr Met Ser
1 5
<210>263
<211>5
<212>PRT
<213>人(homo sapiens)
<400>263
Thr Tyr Gly Ile Ser
1 5
<210>264
<211>5
<212>PRT
<213>人(homo sapiens)
<400>264
Arg Tyr Thr Ile His
1 5
<210>265
<211>6
<212>PRT
<213>人(homo sapiens)
<400>265
Asn Ala Tyr Tyr Trp Gly
1 5
<210>266
<211>5
<212>PRT
<213>人(homo sapiens)
<400>266
Tyr Tyr Ala Met His
1 5
<210>267
<211>5
<212>PRT
<213>人(homo sapiens)
<400>267
Asn Tyr Tyr Trp Ser
1 5
<210>268
<211>5
<212>PRT
<213>人(homo sapiens)
<400>268
Asn Tyr Gly Met His
1 5
<210>269
<211>5
<212>PRT
<213>人(homo sapiens)
<400>269
His Tyr Gly Met His
1 5
<210>270
<211>5
<212>PRT
<213>人(homo sapiens)
<400>270
Ala Tyr Ala Met Ser
1 5
<210>271
<211>7
<212>PRT
<213>人(homo sapiens)
<400>271
Thr Ser Lys Leu Gly Val Gly
1 5
<210>272
<211>5
<212>PRT
<213>人(homo sapiens)
<400>272
Ser Tyr Glu Met Thr
1 5
<210>273
<211>5
<212>PRT
<213>人(homo sapiens)
<400>273
Asn Phe Ala Met His
1 5
<210>274
<211>6
<212>PRT
<213>人(homo sapiens)
<400>274
Ser Asn Tyr Tyr Trp Gly
1 5
<210>275
<211>5
<212>PRT
<213>人(homo sapiens)
<400>275
Ser Tyr Gly Met His
1 5
<210>276
<211>7
<212>PRT
<213>人(homo sapiens)
<400>276
Thr Ser Arg Met Ser Val Ser
1 5
<210>277
<211>7
<212>PRT
<213>人(homo sapiens)
<400>277
Ser Ser Asn Phe Tyr Trp Gly
1 5
<210>278
<211>5
<212>PRT
<213>人(homo sapiens)
<400>278
Thr Tyr Gly Ile Ser
1 5
<210>279
<211>5
<212>PRT
<213>人(homo sapiens)
<400>279
Lys Phe Tyr Ile His
1 5
<210>280
<211>5
<212>PRT
<213>人(homo sapiens)
<400>280
Ser Tyr Thr Met His
1 5
<210>281
<211>5
<212>PRT
<213>人(homo sapiens)
<400>281
Asn Ala Trp Met Ser
1 5
<210>282
<211>5
<212>PRT
<213>人(homo sapiens)
<400>282
Ile Tyr Gly Met His
1 5
<210>283
<211>5
<212>PRT
<213>人(homo sapiens)
<400>283
Asp Tyr Gly Met His
1 5
<210>284
<211>6
<212>PRT
<213>人(homo sapiens)
<400>284
Ser Glu Tyr Tyr Trp Gly
1 5
<210>285
<211>5
<212>PRT
<213>人(homo sapiens)
<400>285
Asp Tyr Cys Met His
1 5
<210>286
<211>16
<212>PRT
<213>人(homo sapiens)
<400>286
Asn Ile Asn Tyr Arg Gly Asn Thr Asn Tyr Asn Pro Ser Leu Lys Ser
1 5 10 15
<210>287
<211>17
<212>PRT
<213>人(homo sapiens)
<400>287
Phe Ile Arg Tyr Asp Gly Ser Thr Gln Asp Tyr Val Asp Ser Val Lys
1 5 10 15
Gly
<210>288
<211>17
<212>PRT
<213>人(homo sapiens)
<400>288
Arg Ile Thr Pro Met Phe Asp Ile Thr Asn Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>289
<211>17
<212>PRT
<213>人(homo sapiens)
<400>289
Trp Ile Asn Thr Ser Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>290
<211>17
<212>PRT
<213>人(homo sapiens)
<400>290
Tyr Ile Asn Arg Gly Gly Thr Thr Ile Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>291
<211>17
<212>PRT
<213>人(homo sapiens)
<400>291
Trp Ile Asn Ala Tyr Asn Asp Asn Thr Tyr Tyr Ser Pro Ser Leu Gln
1 5 10 15
Gly
<210>292
<211>16
<212>PRT
<213>人(homo sapiens)
<400>292
Tyr Ile Phe His Ser Gly Thr Thr Tyr Tyr Asn Pro Ser Leu Lys Ser
1 5 10 15
<210>293
<211>17
<212>PRT
<213>人(homo sapiens)
<400>293
Ile Ile Ser Tyr Asp Gly Asn Asn Val His Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>294
<211>17
<212>PRT
<213>人(homo sapiens)
<400>294
Trp Ile Ser Ala Asp Asn Gly Asn Thr Tyr Tyr Ala Gln Asn Phe Gln
1 5 10 15
Asp
<210>295
<211>17
<212>PRT
<213>人(homo sapiens)
<400>295
Trp Ile Asn Thr Asn Thr Gly Asp Pro Ala Tyr Ala Gln Asp Phe Thr
1 5 10 15
Gly
<210>296
<211>17
<212>PRT
<213>人(homo sapiens)
<400>296
Val Ile Ser Tyr Asp Gly Arg Asn Lys Tyr Phe Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>297
<211>17
<212>PRT
<213>人(homo sapiens)
<400>297
Val Ile Trp His Asp Gly Ser Asn Lys Asn Tyr Leu Asp Ser Val Lys
1 5 10 15
Gly
<210>298
<211>17
<212>PRT
<213>人(homo sapiens)
<400>298
Val Ile Tyr Tyr Glu Gly Ser Asn Glu Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>299
<211>17
<212>PRT
<213>人(homo sapiens)
<400>299
Tyr Ile Gly Thr Gly Gly Ser Asp Ile Tyr Tyr Gly Asp Ser Val Lys
1 5 10 15
Gly
<210>300
<211>16
<212>PRT
<213>人(homo sapiens)
<400>300
Tyr Ile Tyr Ser Ser Gly Ser Thr Phe Tyr Asn Ala Ser Leu Lys Ser
1 5 10 15
<210>301
<211>17
<212>PRT
<213>人(homo sapiens)
<400>301
Ala Thr Ser Thr Asp Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Leu Lys
1 5 10 15
Gly
<210>302
<211>16
<212>PRT
<213>人(homo sapiens)
<400>302
Tyr Ile Tyr Tyr Arg Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser
1 5 10 15
<210>303
<211>17
<212>PRT
<213>人(homo sapiens)
<400>303
Ile Val Tyr Pro Gly Asp Ser Asp Thr Thr Tyr Ser Pro Ser Phe Gln
1 5 10 15
Gly
<210>304
<211>16
<212>PRT
<213>人(homo sapiens)
<400>304
Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser Leu Lys Thr
1 5 10 15
<210>305
<211>17
<212>PRT
<213>人(homo sapiens)
<400>305
Ile Ile Asn Pro Ala Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe Gln
1 5 10 15
Gly
<210>306
<211>17
<212>PRT
<213>人(homo sapiens)
<400>306
Arg Ile Ile Pro Val Phe Asp Thr Thr Asn Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>307
<211>17
<212>PRT
<213>人(homo sapiens)
<400>307
Val Ile Asn Pro Asn Gly Gly Ser Thr Thr Ser Ala Gln Lys Phe Gln
1 5 10 15
Asp
<210>308
<211>17
<212>PRT
<213>人(homo sapiens)
<400>308
Met Ile Leu Pro Ile Ser Gly Thr Thr Asn Tyr Ala Gln Thr Phe Gln
1 5 10 15
Gly
<210>309
<211>17
<212>PRT
<213>人(homo sapiens)
<400>309
Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Asn Ser Pro Ser Phe Gln
1 5 10 15
Gly
<210>310
<211>17
<212>PRT
<213>人(homo sapiens)
<400>310
Val Ile Ser Tyr Asp Gly Ala Asn Glu Tyr Tyr Ala Glu Ser Val Lys
1 5 10 15
Gly
<210>311
<211>17
<212>PRT
<213>人(homo sapiens)
<400>311
Val Ile Arg Ala Ser Gly Asp Ser Glu Ile Tyr Ala Asp Ser Val Arg
1 5 10 15
Gly
<210>312
<211>17
<212>PRT
<213>人(homo sapiens)
<400>312
Ile Ile Ser Leu Asp Gly Ile Lys Thr His Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>313
<211>16
<212>PRT
<213>人(homo sapiens)
<400>313
Arg Ile Asp Trp Asp Asp Asp Lys Ala Phe Arg Thr Ser Leu Lys Thr
1 5 10 15
<210>314
<211>16
<212>PRT
<213>人(homo sapiens)
<400>314
Phe Ile Tyr Asp Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Arg Ser
1 5 10 15
<210>315
<211>17
<212>PRT
<213>人(homo sapiens)
<400>315
Ile Ile Tyr Pro Gly Asp Ser Thr Thr Thr Tyr Thr Pro Ser Phe Gln
1 5 10 15
Gly
<210>316
<211>16
<212>PRT
<213>人(homo sapiens)
<400>316
Ser Ile Phe His Ser Gly Thr Thr Phe His Asn Pro Ser Leu Lys Ser
1 5 10 15
<210>317
<211>16
<212>PRT
<213>人(homo sapiens)
<400>317
His Ile Tyr Phe Gly Gly Asn Thr Asn Tyr Asn Pro Ser Leu Gln Ser
1 5 10 15
<210>318
<211>17
<212>PRT
<213>人(homo sapiens)
<400>318
Trp Ile Ser Ala Ser Ser Gly Asn Lys Lys Tyr Ala Pro Lys Phe Gln
1 5 10 15
Gly
<210>319
<211>17
<212>PRT
<213>人(homo sapiens)
<400>319
Phe Phe Asp Pro Glu Asp Gly Asp Thr Gly Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>320
<211>17
<212>PRT
<213>人(homo sapiens)
<400>320
Leu Ile Asn Ala Gly Asn Gly Asp Thr Arg Phe Ser Gln Lys Phe Gln
1 5 10 15
Gly
<210>321
<211>16
<212>PRT
<213>人(homo sapiens)
<400>321
Arg Ile Asp Trp Asp Asp Asp Lys Phe Tyr Asn Thr Ser Leu Gln Thr
1 5 10 15
<210>322
<211>17
<212>PRT
<213>人(homo sapiens)
<400>322
Trp Ile Ser Ala Tyr Asn Gly Asn Thr Tyr Tyr Leu Gln Lys Leu Gln
1 5 10 15
Gly
<210>323
<211>17
<212>PRT
<213>人(homo sapiens)
<400>323
Trp Ile Asn Val Gly Asn Gly Gln Thr Lys Tyr Ser Gln Arg Phe Gln
1 5 10 15
Gly
<210>324
<211>17
<212>PRT
<213>人(homo sapiens)
<400>324
Ala Ile Ser Tyr Asp Gly Ser Asn Lys Gln Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>325
<211>17
<212>PRT
<213>人(homo sapiens)
<400>325
Trp Val Ser Ala His Asn Gly Asn Thr Tyr Tyr Ala Glu Lys Phe His
1 5 10 15
Asp
<210>326
<211>17
<212>PRT
<213>人(homo sapiens)
<400>326
Trp Ser Ser Val Tyr Asn Gly Asp Thr Asn Tyr Ala Gln Lys Phe His
1 5 10 15
Gly
<210>327
<211>16
<212>PRT
<213>人(homo sapiens)
<400>327
Ser Ile Tyr Asp Ser Gly Asn Thr Tyr Tyr Thr Pro Ser Leu Lys Ser
1 5 10 15
<210>328
<211>17
<212>PRT
<213>人(homo sapiens)
<400>328
Val Ile Ser Tyr Asp Gly Asn Lys Lys Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>329
<211>17
<212>PRT
<213>人(homo sapiens)
<400>329
Glu Ile Ser Tyr Asp Gly Gly Ser Lys Phe Tyr Thr Asp Ser Val Lys
1 5 10 15
Gly
<210>330
<211>17
<212>PRT
<213>人(homo sapiens)
<400>330
Trp Ile Ser Ala Tyr Asn Gly Asn Thr Asp Tyr Ala Gln Arg Leu Gln
1 5 10 15
Asp
<210>331
<211>17
<212>PRT
<213>人(homo sapiens)
<400>331
Trp Ile Ser Ala Tyr Asn Gly Asn Thr Tyr Tyr Ala Gln Asn Leu Gln
1 5 10 15
Gly
<210>332
<211>17
<212>PRT
<213>人(homo sapiens)
<400>332
Trp Ile Ser Ala Tyr Asn Gly Asn Thr Tyr Tyr Arg Gln Ser Leu Gln
1 5 10 15
Asp
<210>333
<211>17
<212>PRT
<213>人(homo sapiens)
<400>333
Trp Ile Gly Thr Asp Asn Gly Asn Thr Tyr Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>334
<211>16
<212>PRT
<213>人(homo sapiens)
<400>334
Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser
1 5 10 15
<210>335
<211>16
<212>PRT
<213>人(homo sapiens)
<400>335
Arg Leu Tyr Pro Ser Gly Asn Thr Asp Tyr His Pro Ser Leu Lys Ser
1 5 10 15
<210>336
<211>19
<212>PRT
<213>人(homo sapiens)
<400>336
Arg Ile Arg Ser Lys Ala Asn Ser Tyr Ala Thr Glu Tyr Ala Ala Ser
1 5 10 15
Val Lys Gly
<210>337
<211>17
<212>PRT
<213>人(homo sapiens)
<400>337
Leu Ile Asn Ala Ala Asn Gly His Thr Lys Tyr Ser Gln Arg Phe Gln
1 5 10 15
Gly
<210>338
<211>17
<212>PRT
<213>人(homo sapiens)
<400>338
Trp Thr Ser Ala His Asn Gly Asn Thr Tyr Tyr Ala Glu Glu Phe Gln
1 5 10 15
Asp
<210>339
<211>17
<212>PRT
<213>人(homo sapiens)
<400>339
Arg Leu Val Pro Ser Leu Asn Ile Pro Asn Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>340
<211>17
<212>PRT
<213>人(homo sapiens)
<400>340
Val Ile Phe Pro Ala Asp Ser Asp Ala Arg Tyr Ser Pro Ser Phe Gln
1 5 10 15
Gly
<210>341
<211>17
<212>PRT
<213>人(homo sapiens)
<400>341
Trp Ile Ser Gly Ser Asn Gly Asn Thr Tyr Tyr Ala Glu Lys Phe Gln
1 5 10 15
Gly
<210>342
<211>17
<212>PRT
<213>人(homo sapiens)
<400>342
Trp Ile Ser Ala Tyr Asn Gly Asn Thr Tyr Tyr Ala Gln Asn Leu Gln
1 5 10 15
Gly
<210>343
<211>17
<212>PRT
<213>人(homo sapiens)
<400>343
Gly Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Gly Asp Ser Val Lys
1 5 10 15
Gly
<210>344
<211>17
<212>PRT
<213>人(homo sapiens)
<400>344
Arg Val Val Pro Thr Leu Gly Phe Pro Asn Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>345
<211>17
<212>PRT
<213>人(homo sapiens)
<400>345
Val Ile Ser Tyr Asp Gly Ser Lys Lys Tyr Phe Thr Asp Ser Val Lys
1 5 10 15
Gly
<210>346
<211>17
<212>PRT
<213>人(homo sapiens)
<400>346
Phe Ile Trp Asn Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>347
<211>17
<212>PRT
<213>人(homo sapiens)
<400>347
Ser Ile Ser Ala Ser Thr Val Leu Thr Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>348
<211>17
<212>PRT
<213>人(homo sapiens)
<400>348
Trp Ile Ser Ala Asp Asn Gly Asn Thr Tyr Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>349
<211>17
<212>PRT
<213>人(homo sapiens)
<400>349
Arg Val Val Pro Ser Leu Gly Ile Pro Asn Tyr Ala Pro Lys Phe Gln
1 5 10 15
Gly
<210>350
<211>16
<212>PRT
<213>人(homo sapiens)
<400>350
Ser Ile His His Ser Gly Ser Ala Tyr Tyr Asn Ser Ser Leu Lys Ser
1 5 10 15
<210>351
<211>17
<212>PRT
<213>人(homo sapiens)
<400>351
Val Ile Ser Tyr Gly Glu Thr Asn Lys Leu Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>352
<211>16
<212>PRT
<213>人(homo sapiens)
<400>352
Glu Ile Ser Asn Thr Trp Ser Thr Asn Tyr Asn Pro Ser Leu Lys Ser
1 5 10 15
<210>353
<211>17
<212>PRT
<213>人(homo sapiens)
<400>353
Val Ile Trp Tyr Asp Asp Ser Asn Lys Gln Tyr Gly Asp Ser Val Lys
1 5 10 15
Gly
<210>354
<211>17
<212>PRT
<213>人(homo sapiens)
<400>354
Val Ile Ser His Asp Gly Asn Ile Lys Tyr Ser Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>355
<211>17
<212>PRT
<213>人(homo sapiens)
<400>355
Ala Ile Ser Gly Gly Gly Gly Thr Thr Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>356
<211>16
<212>PRT
<213>人(homo sapiens)
<400>356
Leu Val Asp Trp Asp Asp Asp Arg Arg Tyr Arg Pro Ser Leu Lys Ser
1 5 10 15
<210>357
<211>17
<212>PRT
<213>人(homo sapiens)
<400>357
His Ile Gly Asn Ser Gly Ser Met Ile Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>358
<211>17
<212>PRT
<213>人(homo sapiens)
<400>358
Tyr Ile Asn Ala Val Asn Gly Asn Thr Gln Tyr Ser Gln Lys Phe Gln
1 5 10 15
Gly
<210>359
<211>16
<212>PRT
<213>人(homo sapiens)
<400>359
Ser Met His His Ser Gly Ser Ser Tyr Tyr Lys Pro Ser Leu Lys Ser
1 5 10 15
<210>360
<211>17
<212>PRT
<213>人(homo sapiens)
<400>360
Val Ile Ser Asn Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>361
<211>16
<212>PRT
<213>人(homo sapiens)
<400>361
Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser Leu Lys Thr
1 5 10 15
<210>362
<211>16
<212>PRT
<213>人(homo sapiens)
<400>362
Ser Ile Phe Tyr Ser Gly Thr Thr Tyr Tyr Asn Pro Ser Leu Lys Ser
1 5 10 15
<210>363
<211>17
<212>PRT
<213>人(homo sapiens)
<400>363
Trp Ile Ser Ala Tyr Asn Gly Asn Thr Phe Tyr Ala Gln Arg Leu Gln
1 5 10 15
Gly
<210>364
<211>17
<212>PRT
<213>人(homo sapiens)
<400>364
Ile Ile Asn Pro Ser Gly Gly Ser Thr Thr Tyr Ala Gln Thr Phe Gln
1 5 10 15
Asp
<210>365
<211>17
<212>PRT
<213>人(homo sapiens)
<400>365
Val Val Ser Tyr Asp Gly Asn His Asn Asp Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>366
<211>19
<212>PRT
<213>人(homo sapiens)
<400>366
Leu Ile Lys Ser His Phe Glu Gly Gly Ala Thr Asp Tyr Ala Ala Pro
1 5 10 15
Val Lys Gly
<210>367
<211>17
<212>PRT
<213>人(homo sapiens)
<400>367
Val Ile Ser Tyr Asp Gly Ala Lys Lys Phe Tyr Ala Asn Ser Val Lys
1 5 10 15
Gly
<210>368
<211>17
<212>PRT
<213>人(homo sapiens)
<400>368
Val Ile Trp His Asp Gly Ser Asn Ile Arg Tyr Ala Asp Ser Val Arg
1 5 10 15
Gly
<210>369
<211>16
<212>PRT
<213>人(homo sapiens)
<400>369
Ser Val His His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys Ser
1 5 10 15
<210>370
<211>17
<212>PRT
<213>人(homo sapiens)
<400>370
Ile Leu Asn Pro Asp Gly Gly Thr Thr Phe Tyr Ala Glu Lys Phe Gln
1 5 10 15
Asp
<210>371
<211>18
<212>PRT
<213>人(homo sapiens)
<400>371
Cys Ala Arg Asp Val Gly Tyr Gly Gly Gly Gln Tyr Phe Ala Met Asp
1 5 10 15
Val Trp
<210>372
<211>24
<212>PRT
<213>人(homo sapiens)
<400>372
Cys Ala Lys Asp Met Asp Tyr Tyr Gly Ser Arg Ser Tyr Ser Val Thr
1 5 10 15
Tyr Tyr Tyr Gly Met Asp Val Trp
20
<210>373
<211>24
<212>PRT
<213>人(homo sapiens)
<400>373
Cys Ala Arg Arg Gly Ala Val Ala Leu Val Pro Ala Ala Glu Asp Pro
1 5 10 15
Tyr Tyr Tyr Gly Met Asp Val Trp
20
<210>374
<211>20
<212>PRT
<213>人(homo sapiens)
<400>374
Cys Ala Arg Glu Asp Gly Thr Met Gly Thr Asn Ser Trp Tyr Gly Trp
1 5 10 15
Phe Asp Pro Trp
20
<210>375
<211>22
<212>PRT
<213>人(homo sapiens)
<400>375
Cys Ala Arg Gly Leu Ile Leu Ala Leu Pro Thr Ala Thr Val Glu Leu
1 5 10 15
Gly Ala Phe Asp Ile Trp
20
<210>376
<211>26
<212>PRT
<213>人(homo sapiens)
<400>376
Cys Ala Arg Ser Tyr Arg Ser Gln Thr Asp Ile Leu Thr Gly Arg Tyr
1 5 10 15
Lys Gly Pro Gly Asp Val Phe Asp Asn Trp
20 25
<210>377
<211>20
<212>PRT
<213>人(homo sapiens)
<400>377
Cys Ala Arg Asp Val Asp Asp Phe Pro Val Trp Gly Met Asn Arg Tyr
1 5 10 15
Leu Ala Leu Trp
20
<210>378
<211>19
<212>PRT
<213>人(homo sapiens)
<400>378
Cys Ala Lys Asp Asp Val Ala Thr Asp Leu Ala Ala Tyr Tyr Tyr Phe
1 5 10 15
Asp Val Trp
<210>379
<211>20
<212>PRT
<213>人(homo sapiens)
<400>379
Cys Val Arg Gly Gly Val Val Thr Asn Arg Val Tyr Tyr Tyr Tyr Gly
1 5 10 15
Met Asp Val Trp
20
<210>380
<211>13
<212>PRT
<213>人(homo sapiens)
<400>380
Cys Ala Trp Phe Gly Glu Phe Gly Leu Phe Asp Tyr Trp
1 5 10
<210>381
<211>18
<212>PRT
<213>人(homo sapiens)
<400>381
Cys Ala Arg Gly Ser Val Gln Val Trp Leu His Leu Gly Leu Phe Asp
1 5 10 15
Asn Trp
<210>382
<211>17
<212>PRT
<213>人(homo sapiens)
<400>382
Cys Ala Arg Thr Pro Tyr Glu Phe Trp Ser Gly Tyr Tyr Phe Asp Phe
1 5 10 15
Trp
<210>383
<211>11
<212>PRT
<213>人(homo sapiens)
<400>383
Cys Ala Arg Lys Trp Leu Gly Met Asp Phe Trp
1 5 10
<210>384
<211>13
<212>PRT
<213>人(homo sapiens)
<400>384
Cys Ala Arg Ala Arg Pro Gly Tyr Lys Val Asp Phe Trp
1 5 10
<210>385
<211>17
<212>PRT
<213>人(homo sapiens)
<400>385
Cys Ala Arg Gly Gly Thr Leu Tyr Thr Thr Gly Gly Glu Met His Ile
1 5 10 15
Trp
<210>386
<211>15
<212>PRT
<213>人(homo sapiens)
<400>386
Cys Ala Arg Arg Phe Trp Gly Phe Gly Asn Phe Phe Asp Tyr Trp
1 5 10 15
<210>387
<211>20
<212>PRT
<213>人(homo sapiens)
<400>387
Cys Ala Arg Glu Gly His His Ser Gly Ser Gly Asp Tyr Tyr Ser Phe
1 5 10 15
Phe Asp Tyr Trp
20
<210>388
<211>22
<212>PRT
<213>人(homo sapiens)
<400>388
Cys Val Arg Arg Gly Gly Phe Cys Thr Ala Thr Gly Cys Tyr Ala Gly
1 5 10 15
His Trp Phe Asp Pro Trp
20
<210>389
<211>20
<212>PRT
<213>人(homo sapiens)
<400>389
Cys Ala Arg Ile Val Phe His Thr Ser Gly Gly Tyr Tyr Asn Pro Tyr
1 5 10 15
Met Asp Val Trp
20
<210>390
<211>15
<212>PRT
<213>人(homo sapiens)
<400>390
Cys Ala Arg Arg Ala Tyr Asp Ser Gly Trp His Phe Glu His Trp
1 5 10 15
<210>391
<211>17
<212>PRT
<213>人(homo sapiens)
<400>391
Cys Leu Arg Gly Ser Thr Arg Gly Trp Asp Thr Asp Gly Phe Asp Ile
1 5 10 15
Trp
<210>392
<211>24
<212>PRT
<213>人(homo sapiens)
<400>392
Cys Ala Arg Gln Arg Ser Val Thr G ly Gly Phe Asp Ala Trp Leu Leu
1 5 10 15
Ile Pro Asp Ala Ser Asn Thr Trp
20
<210>393
<211>21
<212>PRT
<213>人(homo sapiens)
<400>393
Cys Ala Arg Val Phe Arg Glu Phe Ser Thr Ser Thr Leu Asp Pro Tyr
1 5 10 15
Tyr Phe Asp Tyr Trp
20
<210>394
<211>22
<212>PRT
<213>人(homo sapiens)
<400>394
Cys Val Arg Gln Gly Gly Tyr Tyr Asp Arg Asn Gly Tyr His Glu Lys
1 5 10 15
Tyr Ala Phe Asp Ile Trp
20
<210>395
<211>20
<212>PRT
<213>人(homo sapiens)
<400>395
Cys Ala Arg Ala Gly Arg Ser Ser Met Asn Glu Glu Val Ile Met Tyr
1 5 10 15
Phe Asp Asn Trp
20
<210>396
<211>22
<212>PRT
<213>人(homo sapiens)
<400>396
Cys Ala Asn Ile Gly Gln Arg Arg Tyr Cys Ser Gly Asp His Cys Tyr
1 5 10 15
Gly His Phe Asp Tyr Trp
20
<210>397
<211>22
<212>PRT
<213>人(homo sapiens)
<400>397
Cys Ala Lys Asp His Ile Gly Gly Thr Asn Ala Tyr Phe Glu Trp Thr
1 5 10 15
Val Pro Phe Asp Gly Trp
20
<210>398
<211>20
<212>PRT
<213>人(homo sapiens)
<400>398
Cys Ala Arg Thr Gln Val Phe Ala Ser Gly Gly Tyr Tyr Leu Tyr Tyr
1 5 10 15
Leu Asp His Trp
20
<210>399
<211>23
<212>PRT
<213>人(homo sapiens)
<400>399
Cys Ala Arg Asp Leu Gly Tyr Gly Gly Asn Ser Tyr Ser His Ser Tyr
1 5 10 15
Tyr Tyr Gly Leu Asp Val Trp
20
<210>400
<211>11
<212>PRT
<213>人(homo sapiens)
<400>400
Cys Ala Arg Gln Gly Arg Gly Phe Gly Leu Trp
1 5 10
<210>401
<211>12
<212>PRT
<213>人(homo sapiens)
<400>401
Cys Ala Arg Val His Gly Gly Gly Phe Asp His Trp
1 5 10
<210>402
<211>15
<212>PRT
<213>人(homo sapiens)
<400>402
Cys Ala Arg Asp Ser Ser Asn Trp Pro Ala Gly Tyr Glu Asp Trp
1 5 10 15
<210>403
<211>18
<212>PRT
<213>人(homo sapiens)
<400>403
Cys Ala Lys Asp Gly Gly Thr Tyr Val Pro Tyr Ser Asp Ala Phe Asp
1 5 10 15
Phe Trp
<210>404
<211>13
<212>PRT
<213>人(homo sapiens)
<400>404
Cys Ala Thr Val Ala Ala Ala Gly Asn Phe Asp Asn Trp
1 5 10
<210>405
<211>16
<212>PRT
<213>人(homo sapiens)
<400>405
Cys Ala Arg Ile Ala Ile Thr Met Val Arg Asn Pro Phe Asp Ile Trp
1 5 10 15
<210>406
<211>20
<212>PRT
<213>人(homo sapiens)
<400>406
Cys Ala Arg Thr Gly Ile Tyr Asp Ser Ser Gly Tyr Tyr Leu Tyr Tyr
1 5 10 15
Phe Asp Tyr Trp
20
<210>407
<211>25
<212>PRT
<213>人(homo sapiens)
<400>407
Cys Ala Arg Asp Arg Val Gly Gly Ser Ser Ser Glu Val Leu Ser Arg
1 5 10 15
Ala Lys Asn Tyr Gly Leu Asp Val Trp
20 25
<210>408
<211>19
<212>PRT
<213>人(homo sapiens)
<400>408
Cys Ala Arg Arg Ala Ser Gln Tyr Gly Glu Val Tyr Gly Asn Tyr Phe
1 5 10 15
Asp Tyr Trp
<210>409
<211>21
<212>PRT
<213>人(homo sapiens)
<400>409
Cys Ala Lys Asp Asp Phe Gly Asn Ser Asn Gly Val Phe Phe Met Ser
1 5 10 15
Arg Val Ala Phe Trp
20
<210>410
<211>21
<212>PRT
<213>人(homo sapiens)
<400>410
Cys Val Arg Gly Phe Asn Glu Gln Gln Leu Val Pro Gly Leu Ser Phe
1 5 10 15
Trp Phe Asp Tyr Trp
20
<210>411
<211>21
<212>PRT
<213>人(homo sapiens)
<400>411
Cys Ala Arg Asp Arg Asn Val Val Leu Leu Pro Ala Ala Pro Phe Gly
1 5 10 15
Gly Met Asp Val Trp
20
<210>412
<211>13
<212>PRT
<213>人(homo sapiens)
<400>412
Cys Ala Arg Gly Ser Pro Gly Asp Ala Phe Asp Ile Trp
1 5 10
<210>413
<211>18
<212>PRT
<213>人(homo sapiens)
<400>413
Cys Ala Ala Gln Thr Pro Tyr Phe Asn Glu Ser Ser Gly Leu Val Pro
1 5 10 15
Asp Trp
<210>414
<211>18
<212>PRT
<213>人(homo sapiens)
<400>414
Cys Ala Arg Asp Leu Gly Asp Gly Tyr Thr Ala Trp Gly Trp Phe Asp
1 5 10 15
Pro Trp
<210>415
<211>21
<212>PRT
<213>人(homo sapiens)
<400>415
Cys Thr Arg Asp Glu Ser Met Leu Arg Gly Val Thr Glu Gly Phe Gly
1 5 10 15
Pro Ile Asp Tyr Trp
20
<210>416
<211>18
<212>PRT
<213>人(homo sapiens)
<400>416
Cys Val Ile Ser Phe Asp Ser Thr Ile Ala Ala Ala Glu Tyr Phe Asp
1 5 10 15
Tyr Trp
<210>417
<211>22
<212>PRT
<213>人(homo sapiens)
<400>417
Cys Ala Arg Glu Gly His Tyr Ser Gly Ser Ser Ser Tyr Gln Arg Asp
1 5 10 15
Asp Ala Phe Asp Ile Trp
20
<210>418
<211>23
<212>PRT
<213>人(homo sapiens)
<400>418
Cys Ala Arg Gly Gly Thr Ile Glu Ala Thr Pro Glu Arg Glu Tyr Tyr
1 5 10 15
Tyr Tyr Gly Met Asp Val Trp
20
<210>419
<211>13
<212>PRT
<213>人(homo sapiens)
<400>419
Cys Ala Ser Arg Ser Phe Tyr Gly Asp Tyr Val Tyr Trp
1 5 10
<210>420
<211>13
<212>PRT
<213>人(homo sapiens)
<400>420
Cys Ala Lys Glu Gly Ser Gly Trp Tyr Phe Glu Ser Trp
1 5 10
<210>421
<211>18
<212>PRT
<213>人(homo sapiens)
<400>421
Cys Thr Arg His Val Gly Glu Met Ser Thr Ile Trp Trp Tyr Phe Asp
1 5 10 15
Leu Trp
<210>422
<211>19
<212>PRT
<213>人(homo sapiens)
<400>422
Cys Ala Lys Ser Gly Ser His Tyr Gly Glu Val Tyr Gly Ala Tyr Phe
1 5 10 15
Asp Tyr Trp
<210>423
<211>20
<212>PRT
<213>人(homo sapiens)
<400>423
Cys Ala Arg Asp Arg Gly Pro Gly Tyr Ser Asp Ser Ser Phe Tyr Val
1 5 10 15
Phe Asp Tyr Trp
20
<210>424
<211>18
<212>PRT
<213>人(homo sapiens)
<400>424
Cys Thr Arg Ala Pro Arg Gly Ser Thr Ala Ser His Leu Leu Phe Asp
1 5 10 15
Tyr Trp
<210>425
<211>23
<212>PRT
<213>人(homo sapiens)
<400>425
Cys Ala Arg Pro Lys Tyr Tyr Phe Asp Ser Ser Gly Gln Phe Ser Glu
1 5 10 15
Met Tyr Tyr Phe Asp Phe Trp
20
<210>426
<211>14
<212>PRT
<213>人(homo sapiens)
<400>426
Cys Ala Arg Asp Leu Leu Arg Ser Thr Tyr Phe Asp Tyr Trp
1 5 10
<210>427
<211>21
<212>PRT
<213>人(homo sapiens)
<400>427
Cys Ala Arg Asp Gly Asn Thr Ala Gly Val Asp Met Trp Ser Arg Asp
1 5 10 15
Gly Phe Asp Ile Trp
20
<210>428
<211>26
<212>PRT
<213>人(homo sapiens)
<400>428
Cys Ala Lys Glu Pro Trp Ile Asp Ile Val Val Ala Ser Val Ile Ser
1 5 10 15
Pro Tyr Tyr Tyr Asp Gly Met Asp Val Trp
20 25
<210>429
<211>18
<212>PRT
<213>人(homo sapiens)
<400>429
Cys Ala Arg Met Asn Leu Gly Ser His Ser Gly Arg Pro Gly Phe Asp
1 5 10 15
Met Trp
<210>430
<211>24
<212>PRT
<213>人(homo sapiens)
<400>430
Cys Ala Thr Gly Gly Gly Val Asn Val Thr Ser Trp Ser Asp Val Glu
1 5 10 15
His Ser Ser Ser Leu Gly Tyr Trp
20
<210>431
<211>20
<212>PRT
<213>人(homo sapiens)
<400>431
Cys Val Lys Asp Glu Val Tyr Asp Ser Ser Gly Tyr Tyr Leu Tyr Tyr
1 5 10 15
Phe Asp Ser Trp
20
<210>432
<211>22
<212>PRT
<213>人(homo sapiens)
<400>432
Cys Ala Lys Asp Tyr Asp Phe Trp Ser Gly Tyr Pro Gly Gly Gln Tyr
1 5 10 15
Trp Phe Phe Asp Leu Trp
20
<210>433
<211>21
<212>PRT
<213>人(homo sapiens)
<400>433
Cys Val Arg Gly Gly Thr Tyr Ser Ser Asp Val Glu Tyr Tyr Tyr Tyr
1 5 10 15
Gly Met Asp Val Trp
20
<210>434
<211>18
<212>PRT
<213>人(homo sapiens)
<400>434
Cys Ala Arg Leu Thr Leu Gly Ser Tyr Thr Gly Arg Pro Gly Phe Asp
1 5 10 15
Ser Trp
<210>435
<211>18
<212>PRT
<213>人(homo sapiens)
<400>435
Cys Ala Arg Asp Thr Ile Leu Thr Phe Gly Glu Pro His Trp Phe Asp
1 5 10 15
Pro Trp
<210>436
<211>19
<212>PRT
<213>人(homo sapiens)
<400>436
Cys Ala Arg Asp Leu Arg Tyr Leu Thr Tyr Tyr Ser Gly Ser Gly Asp
1 5 10 15
Asp Ser Trp
<210>437
<211>20
<212>PRT
<213>人(homo sapiens)
<400>437
Cys Ala Arg Gly Leu Phe Tyr Asp Ser Gly Gly Tyr Tyr Leu Phe Tyr
1 5 10 15
Phe Gln His Trp
20
<210>438
<211>20
<212>PRT
<213>人(homo sapiens)
<400>438
Cys Ala Arg Ala Ser Glu Tyr Ser Ile Ser Trp Arg His Arg Gly Val
1 5 10 15
Leu Asp Tyr Trp
20
<210>439
<211>19
<212>PRT
<213>人(homo sapiens)
<400>439
Cys His Gly Glu Gly Tyr Ser Thr Ser Trp Leu Gly Thr Ala Ala Leu
1 5 10 15
Asp Tyr Trp
<210>440
<211>18
<212>PRT
<213>人(homo sapiens)
<400>440
Cys Ala Lys Thr Arg Gly Tyr Ser Tyr Thr Trp Gly Asp Ala Phe Asp
1 5 10 15
Leu Trp
<210>441
<211>20
<212>PRT
<213>人(homo sapiens)
<400>441
Cys Ala His Ser Ala Tyr Tyr Thr Ser Ser Gly Tyr Tyr Leu Gln Tyr
1 5 10 15
Phe His His Trp
20
<210>442
<211>20
<212>PRT
<213>人(homo sapiens)
<400>442
Cys Ala Arg Ser Asp Tyr Tyr Asp Ser Ser Gly Tyr Tyr Leu Leu Tyr
1 5 10 15
Leu Asp Ser Trp
20
<210>443
<211>15
<212>PRT
<213>人(homo sapiens)
<400>443
Cys Ala Arg Asn Asn Gly Gly Ser Ala Ile Ile Phe Tyr Tyr Trp
1 5 10 15
<210>444
<211>20
<212>PRT
<213>人(homo sapiens)
<400>444
Cys Ala Arg Asp Leu Val Val Val Thr Asp Ile Ser Ile Lys Asn Tyr
1 5 10 15
Phe Asp Pro Trp
20
<210>445
<211>17
<212>PRT
<213>人(homo sapiens)
<400>445
Cys Ala Lys Thr Thr Asp Gln Arg Leu Leu Val Asp Trp Phe Asp Pro
1 5 10 15
Trp
<210>446
<211>20
<212>PRT
<213>人(homo sapiens)
<400>446
Cys Ala Arg Thr Leu Val Tyr Ala Pro Asp Ser Tyr Tyr Leu Tyr Tyr
1 5 10 15
Phe Asp Tyr Trp
20
<210>447
<211>24
<212>PRT
<213>人(homo sapiens)
<400>447
Cys Ala Arg His Gly Phe Arg Tyr Cys Asn Asn Gly Val Cys Ser Ile
1 5 10 15
Asn Leu Asp Ala Phe Asp Ile Trp
20
<210>448
<211>21
<212>PRT
<213>人(homo sapiens)
<400>448
Cys Ala Arg Asp Leu Arg Met Leu Pro Gly Gly Leu Pro Thr Arg Arg
1 5 10 15
Gly Met Asp Val Trp
20
<210>449
<211>25
<212>PRT
<213>人(homo sapiens)
<400>449
Cys Ala Arg Gly Ile Arg Glu Gly Gly Val Ser Val Glu Asp Trp Met
1 5 10 15
Leu Val Tyr Ser Trp Phe Asp Pro Trp
20 25
<210>450
<211>13
<212>PRT
<213>人(homo sapiens)
<400>450
Cys Val Arg Ala Pro Gly Ser Met Gly Leu Asp Val Trp
1 5 10
<210>451
<211>13
<212>PRT
<213>人(homo sapiens)
<400>451
Cys Ala Pro Leu Gly Gly Pro Thr Pro Phe Asp Tyr Trp
1 5 10
<210>452
<211>15
<212>PRT
<213>人(homo sapiens)
<400>452
Cys Ala Thr Ala Ser Thr Tyr Phe Tyr Asp Ser Arg Asp Tyr Trp
1 5 10 15
<210>453
<211>17
<212>PRT
<213>人(homo sapiens)
<400>453
Cys Ala Arg Val Pro Phe Gln Ile Trp Ser Gly Leu Tyr Phe Asp His
1 5 10 15
Trp
<210>454
<211>18
<212>PRT
<213>人(homo sapiens)
<400>454
Cys Ala Arg Asp Arg Val Ala Leu Gly Val His Tyr Trp Tyr Phe Asp
1 5 10 15
Ile Trp
<210>455
<211>23
<212>PRT
<213>人(homo sapiens)
<400>455
Cys Ala Ile Leu Ile Ala Arg Ala Tyr Cys Gly Leu Ala Asp Gly Gln
1 5 10 15
Glu Gly Asp Phe Asp Thr Trp
20
<210>456
<211>11
<212>PRT
<213>人(homo sapiens)
<400>456
Arg Ala Ser Gln Ser Val Asn Ser His Leu Ala
1 5 10
<210>457
<211>11
<212>PRT
<213>人(homo sapiens)
<400>457
Arg Ala Ser Gln Arg Ile Ser Asn His Leu Asn
1 5 10
<210>458
<211>16
<212>PRT
<213>人(homo sapiens)
<400>458
Arg Ser Ser Gln Ser Leu Leu His Ser Asn Gly Asn Asn Tyr Leu Asp
1 5 10 15
<210>459
<211>12
<212>PRT
<213>人(homo sapiens)
<400>459
Arg Ala Ser Gln Ser Val Ser Ser Ser Tyr Leu Ala
1 5 10
<210>460
<211>11
<212>PRT
<213>人(homo sapiens)
<400>460
Arg Ala Ser Gln Ser Ile Thr Gly Tyr Leu Asn
1 5 10
<210>461
<211>11
<212>PRT
<213>人(homo sapiens)
<400>461
Arg Ala Ser Glu Gly Ile Ser Ser Trp Leu Ala
1 5 10
<210>462
<211>12
<212>PRT
<213>人(homo sapiens)
<400>462
Arg Ala Ser Gln Ser Val Ser Ser Ser Tyr Leu Ala
1 5 10
<210>463
<211>16
<212>PRT
<213>人(homo sapiens)
<400>463
Arg Ser Ser Gln Ser Leu Leu Arg Ser Asp Gly Lys Thr Phe Leu Tyr
1 5 10 15
<210>464
<211>11
<212>PRT
<213>人(homo sapiens)
<400>464
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210>465
<211>11
<212>PRT
<213>人(homo sapiens)
<400>465
Arg Ala Ser Gln Asp Ile Asn Asn Tyr Leu Ala
1 5 10
<210>466
<211>11
<212>PRT
<213>人(homo sapiens)
<400>466
Arg Ala Ser Gln Ser Val Ser Ser Trp Val Ala
1 5 10
<210>467
<211>11
<212>PRT
<213>人(homo sapiens)
<400>467
Arg Ala Ser Gln Gly Ile Thr Asp Ser Leu Ala
1 5 10
<210>468
<211>16
<212>PRT
<213>人(homo sapiens)
<400>468
Arg Ser Ser Gln Ser Leu Leu Asn Ser Asn Gly Phe Asn Tyr Val Asp
1 5 10 15
<210>469
<211>11
<212>PRT
<213>人(homo sapiens)
<400>469
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210>470
<211>12
<212>PRT
<213>人(homo sapiens)
<400>470
Arg Ala Ser Gln Thr Val Ser Ser Ser Tyr Leu Val
1 5 10
<210>471
<211>12
<212>PRT
<213>人(homo sapiens)
<400>471
Arg Ala Ser Gln Ser Val Ser Ser Gly Tyr Leu Ala
1 5 10
<210>472
<211>11
<212>PRT
<213>人(homo sapiens)
<400>472
Arg Ala Ser Gln Gly Ile Asn Thr Tyr Leu Asn
1 5 10
<210>473
<211>12
<212>PRT
<213>人(homo sapiens)
<400>473
Arg Ala Ser Gln Ser Ile Ser Ser Gly Tyr Leu Ala
1 5 10
<210>474
<211>11
<212>PRT
<213>人(homo sapiens)
<400>474
Arg Ala Ser Gln Thr Ile Ala Ser Tyr Leu Ser
1 5 10
<210>475
<211>11
<212>PRT
<213>人(homo sapiens)
<400>475
Arg Ala Ser Gln Ser Val Gly Ser Lys Leu Ala
1 5 10
<210>476
<211>11
<212>PRT
<213>人(homo sapiens)
<400>476
Arg Ala Ser Gln Gly Ile Ser Asn Tyr Leu Val
1 5 10
<210>477
<211>17
<212>PRT
<213>人(homo sapiens)
<400>477
Arg Ser Ser Glu Thr Val Leu Tyr Thr Ser Lys Asn Gln Ser Tyr Leu
1 5 10 15
Ala
<210>478
<211>12
<212>PRT
<213>人(homo sapiens)
<400>478
Arg Ala Ser Gln Ser Val Ser Ser Ser Tyr Ile Ala
1 5 10
<210>479
<211>11
<212>PRT
<213>人(homo sapiens)
<400>479
Arg Ala Ser Gln Ser Ile Ser Ser Trp Leu Ala
1 5 10
<210>480
<211>11
<212>PRT
<213>人(homo sapiens)
<400>480
Arg Ala Ser Gln Ser Ile Gly Ser Arg Leu Ala
1 5 10
<210>481
<211>16
<212>PRT
<213>人(homo sapiens)
<400>481
Arg Ser Ser Gln Ser Leu Leu His Ser Asp Gly Arg Tyr Tyr Val Asp
1 5 10 15
<210>482
<211>11
<212>PRT
<213>人(homo sapiens)
<400>482
Trp Ala Ser Gln Thr Ile Gly Gly Asn Leu Ala
1 5 10
<210>483
<211>11
<212>PRT
<213>人(homo sapiens)
<400>483
Arg Ala Ser Gln Thr Ile Ala Ser Tyr Val Asn
1 5 10
<210>484
<211>11
<212>PRT
<213>人(homo sapiens)
<400>484
Arg Ala Ser Gln Ser Val Ser Ser Ser Leu Ala
1 5 10
<210>485
<211>11
<212>PRT
<213>人(homo sapiens)
<400>485
Gln Ala Ser Gln Asp Ile Thr Tyr Tyr Leu Ser
1 5 10
<210>486
<211>11
<212>PRT
<213>人(homo sapiens)
<400>486
Gln Ala Ser Gln Asp Ile Gly Asp Ser Leu Asn
1 5 10
<210>487
<211>11
<212>PRT
<213>人(homo sapiens)
<400>487
Arg Pro Ser Gln Asp Ile Ser Ser Ala Leu Ala
1 5 10
<210>488
<211>17
<212>PRT
<213>人(homo sapiens)
<400>488
Lys Ser Ser Gln Ser Val Leu Tyr Asn Ser Asn Asn Lys Asn Tyr Leu
1 5 10 15
Ala
<210>489
<211>11
<212>PRT
<213>人(homo sapiens)
<400>489
Arg Ala Ser Gln Phe Ile Ser Ser Tyr Leu His
1 5 10
<210>490
<211>11
<212>PRT
<213>人(homo sapiens)
<400>490
Arg Ala Ser Gln Ser Ile Gly Ser Trp Leu Ala
1 5 10
<210>491
<211>11
<212>PRT
<213>人(homo sapiens)
<400>491
Arg Ala Ser Gln Ser Ile Ala Ser Tyr Leu Asn
1 5 10
<210>492
<211>11
<212>PRT
<213>人(homo sapiens)
<400>492
Arg Ala Ser Gln Ser Val Thr Ser Glu Leu Ala
1 5 10
<210>493
<211>11
<212>PRT
<213>人(homo sapiens)
<400>493
Arg Ala Ser Gln Asn Ile Tyr Asn Trp Leu Ala
1 5 10
<210>494
<211>11
<212>PRT
<213>人(homo sapiens)
<400>494
Arg Ala Asn Gln Asp Ile Asp Asn Tyr Leu Ala
1 5 10
<210>495
<211>11
<212>PRT
<213>人(homo sapiens)
<400>495
Arg Ala Ser Gln Gly Ile Ser Lys Arg Leu Ala
1 5 10
<210>496
<211>11
<212>PRT
<213>人(homo sapiens)
<400>496
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210>497
<211>11
<212>PRT
<213>人(homo sapiens)
<400>497
Arg Ala Ser Gln Gly Ile Gly Thr Trp Leu Ala
1 5 10
<210>498
<211>11
<212>PRT
<213>人(homo sapiens)
<400>498
Arg Ala Ser Gln Gly Ile Ser Asn Tyr Leu Ala
1 5 10
<210>499
<211>12
<212>PRT
<213>人(homo sapiens)
<400>499
Arg Ala Ser Gln Ser Val Gly Gly Arg Ser Leu Ala
1 5 10
<210>500
<211>17
<212>PRT
<213>人(homo sapiens)
<400>500
Arg Ser Ser Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr Leu
1 5 10 15
Ala
<210>501
<211>11
<212>PRT
<213>人(homo sapiens)
<400>501
Arg Ala Ser Gln Thr Ile Ser Asn Ser Leu Ala
1 5 10
<210>502
<211>11
<212>PRT
<213>人(homo sapiens)
<400>502
Arg Ala Ser Gln Gly Ile Ser Asn Tyr Leu Ala
1 5 10
<210>503
<211>11
<212>PRT
<213>人(homo sapiens)
<400>503
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210>504
<211>12
<212>PRT
<213>人(homo sapiens)
<400>504
Arg Ala Ser Gln Ser Val Ser Ser Ser Tyr Leu Ala
1 5 10
<210>505
<211>11
<212>PRT
<213>人(homo sapiens)
<400>505
Arg Ala Ser Gln Gly Ile Ser Ala Trp Leu Ala
1 5 10
<210>506
<211>11
<212>PRT
<213>人(homo sapiens)
<400>506
Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn
1 5 10
<210>507
<211>11
<212>PRT
<213>人(homo sapiens)
<400>507
Arg Ala Ser Gln Asn Ile Tyr Asn Trp Leu Ala
1 5 10
<210>508
<211>16
<212>PRT
<213>人(homo sapiens)
<400>508
Arg Ser Ser Gln Ser Leu Val Asn Ser Asp Gly Asn Thr Tyr Leu Ser
1 5 10 15
<210>509
<211>11
<212>PRT
<213>人(homo sapiens)
<400>509
Gln Ala Ser Gln Asp Val Ser Tyr Tyr Leu Asn
1 5 10
<210>510
<211>12
<212>PRT
<213>人(homo sapiens)
<400>510
Arg Ala Ser Gln Ser Val Ser Ser Asn Tyr Leu Ala
1 5 10
<210>511
<211>11
<212>PRT
<213>人(homo sapiens)
<400>511
Arg Ala Ser Gln Ala Ile Ser Asn Trp Leu Ala
1 5 10
<210>512
<211>17
<212>PRT
<213>人(homo sapiens)
<400>512
Arg Ser Ser Gln Ser Leu Leu Asp Ser Asn Asp Gly Asn Thr Tyr Leu
1 5 10 15
Asp
<210>513
<211>16
<212>PRT
<213>人(homo sapiens)
<400>513
Arg Ser Ser Gln Ser Leu Leu His Arg Asn Glu Tyr Asn Tyr Leu Asp
1 5 10 15
<210>514
<211>11
<212>PRT
<213>人(homo sapiens)
<400>514
Gln Ala Ser Gln Asp Ile Ser Asn Tyr Leu Asn
1 5 10
<210>515
<211>11
<212>PRT
<213>人(homo sapiens)
<400>515
Arg Ala Ser Gln Gly Ile Arg Asn Tyr Leu Ala
1 5 10
<210>516
<211>11
<212>PRT
<213>人(homo sapiens)
<400>516
Arg Ala Ser Gln Ile Ile Ala Ser Tyr Leu Asn
1 5 10
<210>517
<211>11
<212>PRT
<213>人(homo sapiens)
<400>517
Arg Thr Ser Gln Ser Val Ser Ser Tyr Leu Ala
1 5 10
<210>518
<211>11
<212>PRT
<213>人(homo sapiens)
<400>518
Arg Ala Ser Gln Gly Ile Ser Ile Tyr Leu Ala
1 5 10
<210>519
<211>11
<212>PRT
<213>人(homo sapiens)
<400>519
Gln Ala Ser Gln Asp Ile Asn Asn Tyr Leu Asn
1 5 10
<210>520
<211>11
<212>PRT
<213>人(homo sapiens)
<400>520
Arg Ala Ser Gln Ser Ile Lys Asn Asn Leu Ala
1 5 10
<210>521
<211>12
<212>PRT
<213>人(homo sapiens)
<400>521
Arg Ala Ser Gln Ser Leu Ser Asp Asn Tyr Leu Ala
1 5 10
<210>522
<211>11
<212>PRT
<213>人(homo sapiens)
<400>522
Arg Ala Ser Gln Arg Ile Ala Ser Tyr Leu Asn
1 5 10
<210>523
<211>11
<212>PRT
<213>人(homo sapiens)
<400>523
Gln Ala Ser Gln Gly Ile Ser Asn Tyr Leu Asn
1 5 10
<210>524
<211>11
<212>PRT
<213>人(homo sapiens)
<400>524
Arg Ala Ser Gln Gly Ile Arg Asn Phe Leu Ala
1 5 10
<210>525
<211>11
<212>PRT
<213>人(homo sapiens)
<400>525
Arg Ala Ser Gln Ser Val Thr Ser Asn Leu Ala
1 5 10
<210>526
<211>11
<212>PRT
<213>人(homo sapiens)
<400>526
Arg Ala Ser Gln Thr Ile Ala Ser Tyr Val Asn
1 5 10
<210>527
<211>11
<212>PRT
<213>人(homo sapiens)
<400>527
Arg Ala Ser Gln Thr Ile Ala Ser Tyr Val Asn
1 5 10
<210>528
<211>11
<212>PRT
<213>人(homo sapiens)
<400>528
Arg Ser Ser Gln Thr Ile Ser Val Phe Leu Asn
1 5 10
<210>529
<211>11
<212>PRT
<213>人(homo sapiens)
<400>529
Arg Ala Ser Gln Ser Val Thr Lys Tyr Leu Ala
1 5 10
<210>530
<211>11
<212>PRT
<213>人(homo sapiens)
<400>530
Arg Ala Ser Gln Ser Val Ser Ser Asn Leu Ala
1 5 10
<210>531
<211>11
<212>PRT
<213>人(homo sapiens)
<400>531
Arg Ala Ser Gln Thr Ile Ala Ser Tyr Val ASn
1 5 10
<210>532
<211>16
<212>PRT
<213>人(homo sapiens)
<400>532
Arg Ser Ser Gln Ser Leu Leu Arg Thr Asn Gly Tyr Asn Tyr Leu Asp
1 5 10 15
<210>533
<211>11
<212>PRT
<213>人(homo sapiens)
<400>533
Arg Ala Ser Gln Ser Ile Ser Ser Trp Leu Ala
1 5 10
<210>534
<211>11
<212>PRT
<213>人(homo sapiens)
<400>534
Arg Ala Ser Gln Asn Ile Arg Thr Phe Ile Asn
1 5 10
<210>535
<211>16
<212>PRT
<213>人(homo sapiens)
<400>535
Arg Ser Ser Gln Ser Leu Leu His Arg Asn Gly Tyr Asn His Leu Asp
1 5 10 15
<210>536
<211>11
<212>PRT
<213>人(homo sapiens)
<400>536
Arg Ala Gly Gln Gly Ile Arg Asn Asp Leu Gly
1 5 10
<210>537
<211>16
<212>PRT
<213>人(homo sapiens)
<400>537
Arg Ser Ser Arg Ser Leu Val His Ser Asp Gly Asn Thr Tyr Leu Ser
1 5 10 15
<210>538
<211>11
<212>PRT
<213>人(homo sapiens)
<400>538
Arg Ala Ser Gln Ser Val Gly Asn Asn Leu Ala
1 5 10
<210>539
<211>11
<212>PRT
<213>人(homo sapiens)
<400>539
Arg Ala Ser Gln Ser Val Ser Ser His Leu Ala
1 5 10
<210>540
<211>11
<212>PRT
<213>人(homo sapiens)
<400>540
Arg Ala Ser Arg Ser Ile Thr Ser Trp Leu Ala
1 5 10
<210>541
<211>7
<212>PRT
<213>人(homo sapiens)
<400>541
Asn Thr Phe Asn Arg Val Thr
1 5
<210>542
<211>7
<212>PRT
<213>人(homo sapiens)
<400>542
Gly Ala Ser Thr Leu Gln Ser
1 5
<210>543
<211>7
<212>PRT
<213>人(homo sapiens)
<400>543
Leu Ala Ser Asn Arg Ala Ser
1 5
<210>544
<211>7
<212>PRT
<213>人(homo sapiens)
<400>544
Gly Ala Ser Ser Arg Ala Thr
1 5
<210>545
<211>7
<212>PRT
<213>人(homo sapiens)
<400>545
Ala Thr Ser Thr Leu Gln Ser
1 5
<210>546
<211>7
<212>PRT
<213>人(homo sapiens)
<400>546
Ala Ala Ser Thr Leu Gln Ser
1 5
<210>547
<211>7
<212>PRT
<213>人(homo sapiens)
<400>547
Gly Ala Ser Thr Gly Ala Thr
1 5
<210>548
<211>7
<212>PRT
<213>人(homo sapiens)
<400>548
Glu Val Ser Ser Arg Phe Ser
1 5
<210>549
<211>7
<212>PRT
<213>人(homo sapiens)
<400>549
Ala Ala Ser Thr Leu Gln Ser
1 5
<210>550
<211>7
<212>PRT
<213>人(homo sapiens)
<400>550
Ala Ala Ser Ser Leu Gln Ser
1 5
<210>551
<211>7
<212>PRT
<213>人(homo sapiens)
<400>551
Glu Ala Ser Asn Leu Glu Ser
1 5
<210>552
<211>7
<212>PRT
<213>人(homo sapiens)
<400>552
Ala Ala Ser Arg Leu Glu Ser
1 5
<210>553
<211>7
<212>PRT
<213>人(homo sapiens)
<400>553
Leu Gly Ser Asn Arg Ala Ser
1 5
<210>554
<211>7
<212>PRT
<213>人(homo sapiens)
<400>554
Val Ala Ser Ile Leu Glu Ser
1 5
<210>555
<211>7
<212>PRT
<213>人(homo sapiens)
<400>555
Gly Ala Ser Thr Arg Ala Thr
1 5
<210>556
<211>7
<212>PRT
<213>人(homo sapiens)
<400>556
Gly Ala Ser Gly Arg Ala Thr
1 5
<210>557
<211>7
<212>PRT
<213>人(homo sapiens)
<400>557
Ala Ala Ser Ser Leu Gln Ser
1 5
<210>558
<211>7
<212>PRT
<213>人(homo sapiens)
<400>558
Gly Ala Ser His Arg Ala Thr
1 5
<210>559
<211>7
<212>PRT
<213>人(homo sapiens)
<400>559
Thr Ala Ser Ser Leu Gln Ser
1 5
<210>560
<211>7
<212>PRT
<213>人(homo sapiens)
<400>560
Gly Ala Ser Thr Arg Ala Thr
1 5
<210>561
<211>7
<212>PRT
<213>人(homo sapiens)
<400>561
Ala Ala Ser Ser Leu Gln Ser
1 5
<210>562
<211>7
<212>PRT
<213>人(homo sapiens)
<400>562
Trp Ala Ser Thr Arg Glu Ser
1 5
<210>563
<211>7
<212>PRT
<213>人(homo sapiens)
<400>563
Ala Ala Ser Arg Arg Ala Thr
1 5
<210>564
<211>7
<212>PRT
<213>人(homo sapiens)
<400>564
Lys Ser Ser Ile Leu Glu Ser
1 5
<210>565
<211>7
<212>PRT
<213>人(homo sapiens)
<400>565
Asp Ala Ser Ser Leu Glu Ser
1 5
<210>566
<211>7
<212>PRT
<213>人(homo sapiens)
<400>566
Leu Ala Ser Asn Arg Ala Ser
1 5
<210>567
<211>7
<212>PRT
<213>人(homo sapiens)
<400>567
Gly Ala Ser Thr Arg Ala Thr
1 5
<210>568
<211>7
<212>PRT
<213>人(homo sapiens)
<400>568
Ala Ala Ser Asn Leu Gln Ser
1 5
<210>569
<211>7
<212>PRT
<213>人(homo sapiens)
<400>569
Asp Ala Ser Tyr Arg Val Thr
1 5
<210>570
<211>7
<212>PRT
<213>人(homo sapiens)
<400>570
Asp Val Ser Asn Leu Glu Arg
1 5
<210>571
<211>7
<212>PRT
<213>人(homo sapiens)
<400>571
Asp Ala Ser Asn Leu Glu Thr
1 5
<210>572
<211>7
<212>PRT
<213>人(homo sapiens)
<400>572
Gly Ala Ser Thr Leu Asp Tyr
1 5
<210>573
<211>7
<212>PRT
<213>人(homo sapiens)
<400>573
Leu Ala Ser Thr Arg Glu Tyr
1 5
<210>574
<211>7
<212>PRT
<213>人(homo sapiens)
<400>574
Ala Ala Ser Thr Leu Gln Ser
1 5
<210>575
<211>7
<212>PRT
<213>人(homo sapiens)
<400>575
Lys Glu Ser Asn Leu Glu Ser
1 5
<210>576
<211>7
<212>PRT
<213>人(homo sapiens)
<400>576
Ala Ala Ser Ser Leu His Ser
1 5
<210>577
<211>7
<212>PRT
<213>人(homo sapiens)
<400>577
Lys Ala Ser Ser Leu Glu Ser
1 5
<210>578
<211>7
<212>PRT
<213>人(homo sapiens)
<400>578
Asp Ala Ser Thr Leu Glu Ser
1 5
<210>579
<211>7
<212>PRT
<213>人(homo sapiens)
<400>579
Gly Ala Ser Lys Leu Gln Thr
1 5
<210>580
<211>7
<212>PRT
<213>人(homo sapiens)
<400>580
Gly Ala Ser Ser Leu Gln His
1 5
<210>581
<211>7
<212>PRT
<213>人(homo sapiens)
<400>581
Ala Ala Ser Thr Leu Gln Ser
1 5
<210>582
<211>7
<212>PRT
<213>人(homo sapiens)
<400>582
Ala Ala Ser Arg Leu Gln Ser
1 5
<210>583
<211>7
<212>PRT
<213>人(homo sapiens)
<400>583
Ala Ala Ser Thr Leu Gln Ser
1 5
<210>584
<211>7
<212>PRT
<213>人(homo sapiens)
<400>584
Asp Ala Ser Asn Arg Ala Thr
1 5
<210>585
<211>7
<212>PRT
<213>人(homo sapiens)
<400>585
Trp Ala Ser Thr Arg Ala Ser
1 5
<210>586
<211>7
<212>PRT
<213>人(homo sapiens)
<400>586
Lys Ala Ser Thr Leu Glu Ser
1 5
<210>587
<211>7
<212>PRT
<213>人(homo sapiens)
<400>587
Thr Thr Ser Thr Leu Arg Ser
1 5
<210>588
<211>7
<212>PRT
<213>人(homo sapiens)
<400>588
Ala Ala Ser Thr Leu Gln Ser
1 5
<210>589
<211>7
<212>PRT
<213>人(homo sapiens)
<400>589
Gly Ala Ser Ser Arg Ala Thr
1 5
<210>590
<211>7
<212>PRT
<213>人(homo sapiens)
<400>590
Asp Ala Ser Thr Leu Ala Ser
1 5
<210>591
<211>7
<212>PRT
<213>人(homo sapiens)
<400>591
Ala Ala Ser Ser Leu Gln Ser
1 5
<210>592
<211>7
<212>PRT
<213>人(homo sapiens)
<400>592
Asp Ala Ser Ser Leu Glu Ser
1 5
<210>593
<211>7
<212>PRT
<213>人(homo sapiens)
<400>593
Gln Ile Ser Lys Arg Phe Ser
1 5
<210>594
<211>7
<212>PRT
<213>人(homo sapiens)
<400>594
Asp Thr Ser Asn Leu Val Thr
1 5
<210>595
<211>7
<212>PRT
<213>人(homo sapiens)
<400>595
Gly Ala Ser Ser Arg Ala Ala
1 5
<210>596
<211>7
<212>PRT
<213>人(homo sapiens)
<400>596
Ala Ala Ser Ser Leu Gln Ser
1 5
<210>597
<211>7
<212>PRT
<213>人(homo sapiens)
<400>597
Thr Phe Ser Tyr Arg Ala Ser
1 5
<210>598
<211>7
<212>PRT
<213>人(homo sapiens)
<400>598
Trp Gly Ser Asn Arg Ala Ser
1 5
<210>599
<211>7
<212>PRT
<213>人(homo sapiens)
<400>599
Asp Ala Thr Lys Leu Glu Thr
1 5
<210>600
<211>7
<212>PRT
<213>人(homo sapiens)
<400>600
Ala Ala Ser Thr Leu Gln Ser
1 5
<210>601
<211>7
<212>PRT
<213>人(homo sapiens)
<400>601
Ala Ala Ser Ser Leu Gln Ser
1 5
<210>602
<211>7
<212>PRT
<213>人(homo sapiens)
<400>602
Asp Ala Ser Asn Arg Ala Thr
1 5
<210>603
<211>7
<212>PRT
<213>人(homo sapiens)
<400>603
Ala Ala Ser Thr Leu Gln Thr
1 5
<210>604
<211>7
<212>PRT
<213>人(homo sapiens)
<400>604
Asp Ala Thr Asp Leu Glu Thr
1 5
<210>605
<211>7
<212>PRT
<213>人(homo sapiens)
<400>605
Gly Ala Ser Ala Arg Ala Thr
1 5
<210>606
<211>7
<212>PRT
<213>人(homo sapiens)
<400>606
Gly Ala Ser Ser Arg Pro Thr
1 5
<210>607
<211>7
<212>PRT
<213>人(homo sapiens)
<400>607
Ala Ala Ser Ser Leu Gln Ser
1 5
<210>608
<211>7
<212>PRT
<213>人(homo sapiens)
<400>608
Asp Ala Ser Asn Leu Glu Ser
1 5
<210>609
<211>7
<212>PRT
<213>人(homo sapiens)
<400>609
Ala Ala Ser Thr Leu Gln Ser
1 5
<210>610
<211>7
<212>PRT
<213>人(homo sapiens)
<400>610
Gly Ala Ser Thr Arg Ala Thr
1 5
<210>611
<211>7
<212>PRT
<213>人(homo sapiens)
<400>611
Ala Ala Ser Ser Leu Gln Ser
1 5
<210>612
<211>7
<212>PRT
<213>人(homo sapiens)
<400>612
Ala Ala Ser Asn Leu Gln Ser
1 5
<210>613
<211>7
<212>PRT
<213>人(homo sapiens)
<400>613
Ala Ala Ser Ser Leu His Ser
1 5
<210>614
<211>7
<212>PRT
<213>人(homo sapiens)
<400>614
Asp Ala Ser Asn Arg Ala Thr
1 5
<210>615
<211>7
<212>PRT
<213>人(homo sapiens)
<400>615
Ser Ala Ser Thr Arg Ala Thr
1 5
<210>616
<211>7
<212>PRT
<213>人(homo sapiens)
<400>616
Ala Ala Ser Arg Leu Gln Ser
1 5
<210>617
<211>7
<212>PRT
<213>人(homo sapiens)
<400>617
Leu Gly Ser Ile Arg Ala Ser
1 5
<210>618
<211>7
<212>PRT
<213>人(homo sapiens)
<400>618
Lys Ala Ser Ser Leu Glu Ser
1 5
<210>619
<211>7
<212>PRT
<213>人(homo sapiens)
<400>619
Ala Ala Ser Lys Leu Glu Ser
1 5
<210>620
<211>7
<212>PRT
<213>人(homo sapiens)
<400>620
Leu Gly Ser Asn Arg Ala Ser
1 5
<210>621
<211>7
<212>PRT
<213>人(homo sapiens)
<400>621
Gly Ala Ser Thr Leu Gln Ser
1 5
<210>622
<211>7
<212>PRT
<213>人(homo sapiens)
<400>622
Lys Ile Ser Asn Arg Phe Ser
1 5
<210>623
<211>7
<212>PRT
<213>人(homo sapiens)
<400>623
Gly Ala Ser Thr Arg Ala Thr
1 5
<210>624
<211>7
<212>PRT
<213>人(homo sapiens)
<400>624
Gly Ala Ser Thr Arg Ala Thr
1 5
<210>625
<211>7
<212>PRT
<213>人(homo sapiens)
<400>625
Lys Ala Ser Ser Leu Gin Ser
1 5
<210>626
<211>13
<212>PRT
<213>人(homo sapiens)
<400>626
Cys Gln Gln Arg Ser Asn Trp Pro Pro Ala Leu Thr Phe
1 5 10
<210>627
<211>12
<212>PRT
<213>人(homo sapiens)
<400>627
Cys Gln Gln Ser Tyr Arg Thr Pro Pro Ile Asn Phe
1 5 10
<210>628
<211>10
<212>PRT
<213>人(homo sapiens)
<400>628
Cys Met Gln Ser Leu Gln Thr Pro Thr Phe
1 5 10
<210>629
<211>13
<212>PRT
<213>人(homo sapiens)
<400>629
Cys Gln Gln Tyr Asp Ser Ser Leu Ser Thr Trp Thr Phe
1 5 10
<210>630
<211>10
<212>PRT
<213>人(homo sapiens)
<400>630
Cys Gln Gln Ser Tyr Asn Thr Leu Thr Phe
1 5 10
<210>631
<211>11
<212>PRT
<213>人(homo sapiens)
<400>631
Cys Gln Gln Thr Asn Ser Phe Pro Tyr Thr Phe
1 5 10
<210>632
<211>11
<212>PRT
<213>人(homo sapiens)
<400>632
Cys Gln Gln Tyr Gly Arg Thr Pro Tyr Thr Phe
1 5 10
<210>633
<211>11
<212>PRT
<213>人(homo sapiens)
<400>633
Cys Met Gln Gly Leu Lys Ile Arg Arg Thr Phe
1 5 10
<210>634
<211>11
<212>PRT
<213>人(homo sapiens)
<400>634
Cys Gln Gln Val Asp Thr Tyr Pro Leu Thr Phe
1 5 10
<210>635
<211>11
<212>PRT
<213>人(homo sapiens)
<400>635
Cys Gln Gln Tyr Lys Ser Leu Pro Phe Thr Phe
1 5 10
<210>636
<211>12
<212>PRT
<213>人(homo sapiens)
<400>636
Cys Gln Gln Tyr His Ser Tyr Ser Gly Tyr Thr Phe
1 5 10
<210>637
<211>11
<212>PRT
<213>人(homo sapiens)
<400>637
Cys Gln Gln Tyr Ser Lys Ser Pro Ala Thr Phe
1 5 10
<210>638
<211>11
<212>PRT
<213>人(homo sapiens)
<400>638
Cys Met Gln Ala Leu Glu Thr Pro Leu Thr Phe
1 5 10
<210>639
<211>11
<212>PRT
<213>人(homo sapiens)
<400>639
Cys Gln Gln Ser Lys Ser Phe Pro Pro Thr Phe
1 5 10
<210>640
<211>11
<212>PRT
<213>人(homo sapiens)
<400>640
Cys Gln Gln Tyr Gly Gly Ser Gly Leu Thr Phe
1 5 10
<210>641
<211>11
<212>PRT
<213>人(homo sapiens)
<400>641
Cys Gln Gln Tyr Phe Gly Ser Pro Tyr Thr Phe
1 5 10
<210>642
<211>11
<212>PRT
<213>人(homo sapiens)
<400>642
Cys Gln Gln Ser Ala Asn Ser Pro His Thr Phe
1 5 10
<210>643
<211>11
<212>PRT
<213>人(homo sapiens)
<400>643
Cys Gln Gln Tyr Gly Ser Ser Leu Trp Thr Phe
1 5 10
<210>644
<211>11
<212>PRT
<213>人(homo sapiens)
<400>644
Cys Gln His Ser Tyr Asn Thr Pro Tyr Thr Phe
1 5 10
<210>645
<211>12
<212>PRT
<213>人(homo sapiens)
<400>645
Cys Gln Gln Tyr Asn Asn Trp Pro Pro Tyr Thr Phe
1 5 10
<210>646
<211>11
<212>PRT
<213>人(homo sapiens)
<400>646
Cys Leu Gln His Asn Ile Ser Pro Tyr Thr Phe
1 5 10
<210>647
<211>11
<212>PRT
<213>人(homo sapiens)
<400>647
Cys Gln Gln Phe Phe Arg Ser Pro Phe Thr Phe
1 5 10
<210>648
<211>11
<212>PRT
<213>人(homo sapiens)
<400>648
Cys Gln His Tyr Gly Asn Ser Leu Phe Thr Phe
1 5 10
<210>649
<211>11
<212>PRT
<213>人(homo sapiens)
<400>649
Cys Gln His Tyr Asn Ser Tyr Ser Gly Thr Phe
1 5 10
<210>650
<211>12
<212>PRT
<213>人(homo sapiens)
<400>650
Cys Gln Gln Tyr Asn Arg Asp Ser Pro Trp Thr Phe
1 5 10
<210>651
<211>11
<212>PRT
<213>人(homo sapiens)
<400>651
Cys Met Gln Gly Leu His Thr Pro Trp Thr Phe
1 5 10
<210>652
<211>10
<212>PRT
<213>人(homo sapiens)
<400>652
Cys Gln Gln Tyr Lys Asn Trp Tyr Thr Phe
1 5 10
<210>653
<211>12
<212>PRT
<213>人(homo sapiens)
<400>653
Cys Gln Gln Ser Tyr Ser Tyr Arg Ala Leu Thr Phe
1 5 10
<210>654
<211>13
<212>PRT
<213>人(homo sapiens)
<400>654
Cys Gln Gln Arg Ser Asn Trp Pro Pro Gly Leu Thr Phe
1 5 10
<210>655
<211>11
<212>PRT
<213>人(homo sapiens)
<400>655
Cys Gln Gln Tyr Asp Phe Leu Pro Tyr Thr Phe
1 5 10
<210>656
<211>13
<212>PRT
<213>人(homo sapiens)
<400>656
Cys Gln His Tyr Val Asn Leu Pro Pro Ser Phe Thr Phe
1 5 10
<210>657
<211>11
<212>PRT
<213>人(homo sapiens)
<400>657
Cys Gln Gln Phe Asn Thr Tyr Pro Phe Thr Phe
1 5 10
<210>658
<211>11
<212>PRT
<213>人(homo sapiens)
<400>658
Cys Gln Gln Tyr Tyr Gln Thr Pro Leu Thr Phe
1 5 10
<210>659
<211>11
<212>PRT
<213>人(homo sapiens)
<400>659
Cys Gln Gln Ser Tyr Thr Asn Pro Tyr Thr Phe
1 5 10
<210>660
<211>10
<212>PRT
<213>人(homo sapiens)
<400>660
Cys Gln Gln Tyr Lys Asn Asp Trp Thr Phe
1 5 10
<210>661
<211>11
<212>PRT
<213>人(homo sapiens)
<400>661
Cys Gln His Ser Tyr Ser Thr Arg Phe Thr Phe
1 5 10
<210>662
<211>11
<212>PRT
<213>人(homo sapiens)
<400>662
Cys Gln Gln Tyr Asn Ser Phe Pro Tyr Thr Phe
1 5 10
<210>663
<211>11
<212>PRT
<213>人(homo sapiens)
<400>663
Cys Gln Gln Tyr Asn Ser Leu Ser Pro Thr Phe
1 5 10
<210>664
<211>11
<212>PRT
<213>人(homo sapiens)
<400>664
Cys Gln Gln Ala Lys Ser Phe Pro Phe Thr Phe
1 5 10
<210>665
<211>11
<212>PRT
<213>人(homo sapiens)
<400>665
Cys Gln Gln Ala Asp Ser Phe Pro Phe Thr Phe
1 5 10
<210>666
<211>11
<212>PRT
<213>人(homo sapiens)
<400>666
Cys Gln Gln Leu Asn Ser Tyr Pro Arg Thr Phe
1 5 10
<210>667
<211>11
<212>PRT
<213>人(homo sapiens)
<400>667
Cys Gln Gln Ala Tyr Ser Phe Pro Arg Thr Phe
1 5 10
<210>668
<211>11
<212>PRT
<213>人(homo sapiens)
<400>668
Cys Gln Lys Tyr Asn Ser Ala Pro Gln Thr Phe
1 5 10
<210>669
<211>11
<212>PRT
<213>人(homo sapiens)
<400>669
Cys Gln Gln Tyr Gly Ser Pro Pro Trp Thr Phe
1 5 10
<210>670
<211>11
<212>PRT
<213>人(homo sapiens)
<400>670
Cys Gln Gln Phe His Ser Thr Pro Arg Thr Phe
1 5 10
<210>671
<211>11
<212>PRT
<213>人(homo sapiens)
<400>671
Cys Gln Gln Tyr Asn Ser Phe Ser Phe Thr Phe
1 5 10
<210>672
<211>11
<212>PRT
<213>人(homo sapiens)
<400>672
Cys Gln Gln Tyr His Ser Phe Pro Tyr Thr Phe
1 5 10
<210>673
<211>11
<212>PRT
<213>人(homo sapiens)
<400>673
Cys Gln Gln Leu Asn Thr Tyr Pro Leu Thr Phe
1 5 10
<210>674
<211>11
<212>PRT
<213>人(homo sapiens)
<400>674
Cys Gln Gln Tyr Gly Ser Ser Pro Phe Thr Phe
1 5 10
<210>675
<211>11
<212>PRT
<213>人(homo sapiens)
<400>675
Cys Gln Gln Tyr Arg Ser Tyr Ser Tyr Thr Phe
1 5 10
<210>676
<211>11
<212>PRT
<213>人(homo sapiens)
<400>676
Cys Gln Gln Ser Tyr Ser Thr Pro Tyr Thr Phe
1 5 10
<210>677
<211>11
<212>PRT
<213>人(homo sapiens)
<400>677
Cys Gln Gln Tyr Asn Ile Tyr Ser Pro Thr Phe
1 5 10
<210>678
<211>11
<212>PRT
<213>人(homo sapiens)
<400>678
Cys Met Gln Ala Thr Gln Phe Pro Phe Thr Phe
1 5 10
<210>679
<211>11
<212>PRT
<213>人(homo sapiens)
<400>679
Cys Leu Gln Tyr His Tyr Leu Pro Tyr Thr Phe
1 5 10
<210>680
<211>11
<212>PRT
<213>人(homo sapiens)
<400>680
Cys Gln Gln Tyr Gly Asn Ser Pro Leu Thr Phe
1 5 10
<210>681
<211>11
<212>PRT
<213>人(homo sapiens)
<400>681
Cys Gln Gln Ala Asp Thr Phe Pro Phe Thr Phe
1 5 10
<210>682
<211>11
<212>PRT
<213>人(homo sapiens)
<400>682
Cys Met Gln Arg Ile Glu Phe Pro Tyr Thr Phe
1 5 10
<210>683
<211>11
<212>PRT
<213>人(homo sapiens)
<400>683
Cys Met Gln Thr Leu Gln Thr Pro Arg Thr Phe
1 5 10
<210>684
<211>11
<212>PRT
<213>人(homo sapiens)
<400>684
Cys Gln His Phe Ala Asn Leu Pro Tyr Thr Phe
1 5 10
<210>685
<211>11
<212>PRT
<213>人(homo sapiens)
<400>685
Cys Gln Arg Tyr Asn Ser Ala Pro Leu Thr Phe
1 5 10
<210>686
<211>12
<212>PRT
<213>人(homo sapiens)
<400>686
Cys Gln Gln Ser Tyr Ser Thr Pro Ile Phe Thr Phe
1 5 10
<210>687
<211>10
<212>PRT
<213>人(homo sapiens)
<400>687
Cys Gln Gln Arg Ser Asp Trp Leu Thr Phe
1 5 10
<210>688
<211>11
<212>PRT
<213>人(homo sapiens)
<400>688
Cys Gln Gln Leu Asn Ile Tyr Pro Leu Thr Phe
1 5 10
<210>689
<211>11
<212>PRT
<213>人(homo sapiens)
<400>689
Cys Gln His Phe Ala Asn Leu Pro Tyr Thr Phe
1 5 10
<210>690
<211>12
<212>PRT
<213>人(homo sapiens)
<400>690
Cys Gln Glu Tyr Asn Asn Trp Pro Leu Leu Thr Phe
1 5 10
<210>691
<211>11
<212>PRT
<213>人(homo sapiens)
<400>691
Cys Gln Gln Tyr Gly Thr Thr Pro Ile ThrPhe
1 5 10
<210>692
<211>12
<212>PRT
<213>人(homo sapiens)
<400>692
Cys Gln Gln Ser Tyr Ser Thr Pro Ile Tyr Thr Phe
1 5 10
<210>693
<211>11
<212>PRT
<213>人(homo sapiens)
<400>693
Cys Gln Gln Tyr Asp Asn Phe Pro Tyr Thr Phe
1 5 10
<210>694
<211>11
<212>PRT
<213>人(homo sapiens)
<400>694
Cys Gln Lys Tyr Asn Ser Ala Pro Trp Thr Phe
1 5 10
<210>695
<211>11
<212>PRT
<213>人(homo sapiens)
<400>695
Cys Gln Gln Tyr Asn Asn Trp Pro Gln Thr Phe
1 5 10
<210>696
<211>11
<212>PRT
<213>人(homo sapiens)
<400>696
Cys Gln Gln Ser Tyr Ser Phe Pro Tyr Thr Phe
1 5 10
<210>697
<211>12
<212>PRT
<213>人(homo sapiens)
<400>697
Cys Gln Gln Ser Tyr Ser Val Pro Arg Leu Thr Phe
1 5 10
<210>698
<211>10
<212>PRT
<213>人(homo sapiens)
<400>698
Cys Gln Glu Ser Phe Ser Ser Ser Thr Phe
1 5 10
<210>699
<211>10
<212>PRT
<213>人(homo sapiens)
<400>699
Cys Gln His Arg Arg Ser Trp Pro Thr Phe
1 5 10
<210>700
<211>12
<212>PRT
<213>人(homo sapiens)
<400>700
Cys Gln Gln Tyr Asn Met Trp Pro Pro Trp Thr Phe
1 5 10
<210>701
<211>11
<212>PRT
<213>人(homo sapiens)
<400>701
Cys Gln Gln Ser Tyr Ser Ile Pro Trp Thr Phe
1 5 10
<210>702
<211>11
<212>PRT
<213>人(homo sapiens)
<400>702
Cys Met Gln Ser Leu Gln Thr Ser Ile Thr Phe
1 5 10
<210>703
<211>11
<212>PRT
<213>人(homo sapiens)
<400>703
Cys Gln Gln Tyr Asn Ser Tyr Pro Tyr Thr Phe
1 5 10
<210>704
<211>11
<212>PRT
<213>人(homo sapiens)
<400>704
Cys Gln Gln Gly His Ser Thr Pro Tyr Thr Phe
1 5 10
<210>705
<211>11
<212>PRT
<213>人(homo sapiens)
<400>705
Cys Met Gln Ala Leu Gln Thr Pro Arg Thr Phe
1 5 10
<210>706
<211>11
<212>PRT
<213>人(homo sapiens)
<400>706
Cys Leu Gln His Asn Ser Tyr Pro Trp Thr Phe
1 5 10
<210>707
<211>10
<212>PRT
<213>人(homo sapiens)
<400>707
Cys Leu Gln Ala Thr Gln Phe Leu Thr Phe
1 5 10
<210>708
<211>11
<212>PRT
<213>人(homo sapiens)
<400>708
Cys Gln Gln Tyr Asp Lys Trp Pro Glu Thr Phe
1 5 10
<210>709
<211>11
<212>PRT
<213>人(homo sapiens)
<400>709
Cys Gln Gln Tyr Asp Asn Trp Leu Pro Thr Phe
1 5 10
<210>710
<211>11
<212>PRT
<213>人(homo sapiens)
<400>710
Cys Gln Gln Tyr Asn Ser Tyr Pro Leu Thr Phe
1 5 10
<210>711
<211>298
<212>PRT
<213>呼吸道合胞病毒(respiratory syncytial virus)
<400>711
Met Ser Lys Asn Lys Asp Gln Arg Thr Ala Lys Thr Leu Glu Lys Thr
1 5 10 15
Trp Asp Thr Leu Asn His Leu Leu Phe Ile Ser Ser Gly Leu Tyr Lys
20 25 30
Leu Asn Leu Lys Ser Ile Ala Gln Ile Thr Leu Ser Ile Leu Ala Met
35 40 45
Ile Ile Ser Thr Ser Leu Ile Ile Thr Ala Ile Ile Phe Ile Ala Ser
50 55 60
Ala Asn His Lys Val Thr Leu Thr Thr Ala Ile Ile Gln Asp Ala Thr
65 70 75 80
Ser Gln Ile Lys Asn Thr Thr Pro Thr Tyr Leu Thr Gln Asp Pro Gln
85 90 95
Leu Gly Ile Ser Phe Ser Asn Leu Ser Glu Ile Thr Ser Gln Thr Thr
100 105 110
Thr Ile Leu Ala Ser Thr Thr Pro Gly Val Lys Ser Asn Leu Gln Pro
115 120 125
Thr Thr Val Lys Thr Lys Asn Thr Thr Thr Thr Gln Thr Gln Pro Ser
130 135 140
Lys Pro Thr Thr Lys Gln Arg Gln Asn Lys Pro Pro Asn Lys Pro Asn
145 150 155 160
Asn Asp Phe His Phe Glu Val Phe Asn Phe Val Pro Cys Ser Ile Cys
165 170 175
Ser Asn Asn Pro Thr Cys Trp Ala Ile Cys Lys Arg Ile Pro Asn Lys
180 185 190
Lys Pro Gly Lys Lys Thr Thr Thr Lys Pro Thr Lys Lys Pro Thr Phe
195 200 205
Lys Thr Thr Lys Lys Asp His Lys Pro Gln Thr Thr Lys Pro Lys Glu
210 215 220
Val Pro Thr Thr Lys Pro Thr Glu Glu Pro Thr Ile Asn Thr Thr Lys
225 230 235 240
Thr Asn Ile Ile Thr Thr Leu Leu Thr Asn Asn Thr Thr Gly Asn Pro
245 250 255
Lys Leu Thr Ser Gln Met Glu Thr Phe His Ser Thr Ser Ser Glu Gly
260 265 270
Asn Leu Ser Pro Ser Gln Val Ser Thr Thr Ser Glu His Pro Ser Gln
275 280 285
Pro Ser Ser Pro Pro Asn Thr Thr Arg Gln
290 295
<210>712
<211>292
<212>PRT
<213>呼吸道合胞病毒(respiratory syncytial virus)
<400>712
Met Ser Lys His Lys Asn Gln Arg Thr Ala Arg Thr Leu Glu Lys Thr
1 5 10 15
Trp Asp Thr Leu Asn His Leu Ile Val Ile Ser Ser Cys Leu Tyr Arg
20 25 30
Leu Asn Leu Lys Ser Ile Ala Gln Ile Ala Leu Ser Val Leu Ala Met
35 40 45
Ile Ile Ser Thr Ser Leu Ile Ile Ala Ala Ile Ile Phe Ile Ile Ser
50 55 60
Ala Asn His Lys Val Thr Leu Thr Thr Val Thr Val Gln Thr Ile Lys
65 70 75 80
Asn His Thr Glu Lys Asn Ile Ser Thr Tyr Leu Thr Gln Val Pro Pro
85 90 95
Glu Arg Val Asn Ser Ser Lys Gln Pro Thr Thr Thr Ser Pro Ile His
100 105 110
Thr Asn Ser Ala Thr Ile Ser Pro Asn Thr Lys Ser Glu Thr His His
115 120 125
Thr Thr Ala Gln Thr Lys Gly Arg Ile Thr Thr Ser Thr Gln Thr Asn
130 135 140
Lys Pro Ser Thr Lys Ser Arg Ser Lys Asn Pro Pro Lys Lys Pro Lys
145 150 155 160
Asp Asp Tyr His Phe Glu Val Phe Asn Phe Val Pro Cys Ser Ile Cys
165 170 175
Gly Asn Asn Gln Leu Cys Lys Ser Ile Cys Lys Thr Ile Pro Ser Asn
180 185 190
Lys Pro Lys Lys Lys Pro Thr Ile Lys Pro Thr Asn Lys Pro Thr Thr
195 200 205
Lys Thr Thr Asn Lys Arg Asp Pro Lys Thr Pro Ala Lys Met Pro Lys
210 215 220
Lys Glu Ile Ile Thr Asn Pro Ala Lys Lys Pro Thr Leu Lys Thr Thr
225 230 235 240
Glu Arg Asp Thr Ser Ile Ser Gln Ser Thr Val Leu Asp Thr Ile Thr
245 250 255
Pro Lys Tyr Thr Ile Gln Gln Gln Ser Leu His Ser Thr Thr Ser Glu
260 265 270
Asn Thr Pro Ser Ser Thr Gln Ile Pro Thr Ala Ser Glu Pro Ser Thr
275 280 285
Leu Asn Pro Asn
290
<210>713
<211>77
<212>PRT
<213>呼吸道合胞病毒(respiratory syncytial virus)
<400>713
Gln Pro Thr Thr Val Lys Thr Lys Asn Thr Thr Thr Thr Gln Thr Gln
1 5 10 15
Pro Ser Lys Pro Thr Thr Lys Gln Arg Gln Asn Lys Pro Pro Asn Lys
20 25 30
Pro Asn Asn Asp Phe His Phe Glu Val Phe Asn Phe Val Pro Cys Ser
35 40 45
Ile Cys Ser Asn Asn Pro Thr Cys Trp Ala Ile Cys Lys Arg Ile Pro
50 55 60
Asn Lys Lys Pro Gly Lys Lys Thr Thr Thr Lys Pro Thr
65 70 75
<210>714
<211>77
<212>PRT
<213>呼吸道合胞病毒(respiratory syncytial virus)
<400>714
His His Thr Thr Ala Gln Thr Lys Gly Arg Ile Thr Thr Ser Thr Gln
1 5 10 15
Thr Asn Lys Pro Ser Thr Lys Ser Arg Ser Lys Asn Pro Pro Lys Lys
20 25 30
Pro Lys Asp Asp Tyr His Phe Glu Val Phe Asn Phe Val Pro Cys Ser
35 40 45
Ile Cys Gly Asn Asn Gln Leu Cys Lys Ser Ile Cys Lys Thr Ile Pro
50 55 60
Ser Asn Lys Pro Lys Lys Lys Pro Thr Ile Lys Pro Thr
65 70 75
Claims (38)
1.一种多克隆细胞系,其包括2到n个细胞亚群,每个亚群表达重组多克隆抗-RSV抗体的一个独特抗体成员,该细胞包括至少一个编码一个独特抗体成员的表达构建体,其随机且稳定地整合在基因组内,其中该重组多克隆抗-RSV抗体的独特成员选自由包括CDR1、CDR2和CDR3区的抗体分子所组成的组,其中所述区选自在本文表3中提供的VH和VL对的组。
2.权利要求1所述的多克隆细胞系,其中所述独特成员是如在本文表6中的抗体组合物1到56的任一组合。
3.权利要求2所述的多克隆细胞系,其中所述独特成员是如在本文表6中之抗体组合物2、9、13、17、18、28、33和56的任一者组合,优选抗体组合物28、33和56中任一个。
4.权利要求1或2所述的多克隆细胞系,其中所述独特成员选自由包括如本文中定义之克隆735、736、744、793、795、796、799、800、801、804、810、811、812、814、816、817、818、819、824、825、827、829、830、831、835、838、841、853、855、856、857、858、859、861、863、868、870、871、880、881、884、886、888和894之VH和VL序列的抗体所组成的组。
5.权利要求4所述的多克隆细胞系,其中所述独特成员选自由来自克隆793、800、810、816、818、819、824、825、827、831、853、855、856、858、868、880、888和894之抗体,和包括该等抗体之CDR的抗体所组成的组。
6.权利要求4所述的多克隆细胞系,其中所述独特成员选自由包括克隆810、818、819、824、825、827、858、894、793、816、853、855和856之VH和VL序列的抗体所组成的组。
7.权利要求1所述的多克隆细胞系,其中一个独特抗体成员是由克隆824编码之抗体,或具有克隆824之CDR的抗体。
8.权利要求1所述的多克隆细胞系,其中一个独特抗体成员是由克隆810编码之抗体,或具有克隆810之CDR的抗体。
9.前述权利要求中任一项所述的多克隆细胞系,其中至少一个独特抗体分子能够与F蛋白质结合,且至少一个独特抗体分子能够与G-蛋白质结合。
10.权利要求1所述的多克隆细胞系,其中n为3或更多。
11.权利要求1所述的多克隆细胞系,其中n小于30。
12.权利要求1所述的多克隆细胞系,其中表达重组多克隆蛋白质之一个独特成员的细胞源自1或多个克隆的细胞,如源自2或更多个,例如源自3或更多个,如源自4或更多个,例如源自5或更多个克隆的细胞。
13.权利要求1所述的多克隆细胞系,其中每个表达构建体均编码重链和轻链。
14.权利要求1所述的多克隆细胞系,其中分开的表达载体编码重链和轻链。
15.权利要求13和/或14所述的多克隆细胞系,其中亚基的表达在相同或同一的启动子的控制之下。
16.权利要求13所述的多克隆细胞系,其中该表达构建体编码可选择标记。
17.权利要求16所述的多克隆细胞系,其中该可选择标记是由转录物编码,其亦编码抗体或抗体亚基。
18.权利要求1所述的多克隆细胞系,其中该重组多克隆抗-RSV抗体的所有成员都属于相同的同种型。
19.权利要求1所述的多克隆细胞系,其中该宿主细胞是原核生物的。
20.权利要求1所述的多克隆细胞系,其中该宿主细胞是真核生物的。
21.一种细胞,其包括能够指导抗-RSV抗体表达的表达构建体,该抗-RSV抗体选自由至少包括在表3中列举的抗体的互补性-决定-区(CDR)的抗体所组成的组,其中该细胞包括至少一个稳定整合在基因组中之随机位置处的表达构建体。
22.权利要求21所述细胞,其中该抗-RSV抗体选自由包含来自克隆735、736、744、793、795、796、799、800、801、804、810、811、812、814、816、817、818、819、824、825、827、829、830、831、835、838、841、853、855、856、857、858、859、861、863、868、870、871、880、881、884、886、888和894之VH和VL序列对之CDR的抗体所组成的组。
23.权利要求21所述细胞,其中该细胞包括二或多个整合在基因组内不同且随机位置处的表达构建体。
24.权利要求21所述细胞,其中该抗-RSV抗体选自由来自克隆793、800、810、816、818、819、824、825、827、831、853、855、856、858、868、880、888和894的抗体,以及包含所述抗体之CDR的抗体所组成的组。
25.权利要求21所述细胞,其中该抗-RSV抗体选自由来自克隆793、800、810、818、819、824、825、827、831、853、858、888和894的抗体所组成的组。
26.权利要求21所述细胞,其中该CDR是来自克隆810。
27.权利要求21所述细胞,其中该CDR是来自克隆824。
28.权利要求21所述细胞,其中该细胞为真核生物的。
29.权利要求28所述细胞,其中该真核生物细胞选自由植物、酵母、真菌、脊椎动物或无脊椎动物所组成的组。
30.权利要求28所述细胞,其中该真核生物细胞选自由中国仓鼠卵巢(CHO)细胞、COS细胞、BHK细胞、骨髓瘤细胞(例如Sp2/0细胞、NS0、YB2/0)、NIH 3T3、成纤维细胞或永生化人类细胞,包括HeLa细胞、HEK293细胞、或PER.C6所组成的组。
31.一种用于产生能够表达抗-RSV抗体之细胞的方法,其包括在允许随机整合至该细胞之基因组内的条件下,以编码所述抗-RSV抗体的表达构建体转染细胞,并选择至少一个具有稳定整合在随机位置的表达构建体的细胞,该表达构建体编码选自由至少包括在表3中列举的抗体的互补性-决定-区(CDR)的抗体所组成的组之抗-RSV抗体。
32.权利要求31所述方法,其中该转染和/或选择是在有利于所述表达构建体扩增的条件下进行的。
33.一种制造多克隆抗-RSV抗体的方法,该方法包括:
a)提供权利要求1至20中任一所述的多克隆细胞系;
b)在允许表达该多克隆蛋白质的条件下培养所述多克隆细胞系;并
c)从培养基中回收并任选地纯化该多克隆抗-RSV抗体。
34.权利要求33所述方法,其中在容器中培养经混合的组合物,该容器选自由摇瓶、用后即丢的生物反应器、和生物反应器所组成的组。
35.权利要求34所述方法,其中在一个容器中培养表达该多克隆抗-RSV抗体之独特抗体成员的一个群体的一个多克隆细胞系,且在第二个容器中培养表达该多克隆抗-RSV抗体之独特抗体成员的第二个群体之至少第二个多克隆细胞系,且将来自每个容器的多克隆抗体在纯化之前或之后混合。
36.权利要求33所述方法,其还包括证实每个独特抗体成员存在于该经回收并任选地经纯化的多克隆抗体中的步骤。
37.一种制造抗-RSV抗体的方法,该方法包括:
a)提供源自权利要求21至29中任一项所述细胞的细胞系;
b)在允许表达该抗体之条件下培养该细胞系;并
c)从培养基中回收并任选地纯化该抗-RSV抗体。
38.权利要求37所述方法,其中该细胞系在容器中培养,该容器选自由摇瓶、用后即丢的生物反应器、和生物反应器所组成的组。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200701289 | 2007-09-07 | ||
DKPA200701289 | 2007-09-07 | ||
US97140407P | 2007-09-11 | 2007-09-11 | |
US60/971,404 | 2007-09-11 | ||
PCT/DK2008/050218 WO2009030237A2 (en) | 2007-09-07 | 2008-09-04 | Methods for recombinant manufacturing of anti-rsv antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101821289A true CN101821289A (zh) | 2010-09-01 |
Family
ID=40297785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200880106131A Pending CN101821289A (zh) | 2007-09-07 | 2008-09-04 | 重组制造抗rsv抗体的方法 |
Country Status (13)
Country | Link |
---|---|
US (2) | US20090137003A1 (zh) |
EP (1) | EP2185590A2 (zh) |
JP (1) | JP2011514139A (zh) |
KR (1) | KR20100087283A (zh) |
CN (1) | CN101821289A (zh) |
AU (1) | AU2008295248A1 (zh) |
BR (1) | BRPI0817079A2 (zh) |
CA (1) | CA2695309A1 (zh) |
MX (1) | MX2010002044A (zh) |
RU (1) | RU2010113510A (zh) |
TW (1) | TW200925279A (zh) |
WO (1) | WO2009030237A2 (zh) |
ZA (1) | ZA201000756B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111330017A (zh) * | 2012-08-23 | 2020-06-26 | 艾更斯司股份有限公司 | 结合158p1d7蛋白的抗体药物偶联物(adc) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3231442B1 (en) * | 2006-06-23 | 2019-12-25 | ADC Therapeutics SA | Polynucleotides and polypeptide sequences involved in cancer |
PT2121920E (pt) * | 2007-03-01 | 2011-10-03 | Symphogen As | Método de clonagem de anticorpos cognatos |
EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
MX2011001930A (es) * | 2008-08-29 | 2011-04-21 | Symphogen As | Metodo para clonar anticuerpos derivados de aves. |
CN102245773B (zh) | 2008-11-03 | 2014-08-27 | 阿莱斯亚生物疗法股份有限公司 | 特异性地阻滞肿瘤抗原的生物活性的抗体 |
GB0905023D0 (en) | 2009-03-24 | 2009-05-06 | Univ Erasmus Medical Ct | Binding molecules |
IN2012DN01328A (zh) * | 2009-08-13 | 2015-06-05 | Crucell Holland Bv | |
CN104628850B (zh) * | 2009-10-06 | 2020-07-28 | 医学免疫有限公司 | Rsv-特异性结合分子 |
EP2486053B1 (en) * | 2009-10-06 | 2017-01-18 | Medimmune Limited | Rsv-specific binding molecule |
US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
KR101553244B1 (ko) | 2009-12-10 | 2015-09-15 | 리제너론 파마슈티칼스 인코포레이티드 | 중쇄 항체를 만드는 마우스 |
CN103097412B (zh) | 2010-07-09 | 2016-08-10 | 克鲁塞尔荷兰公司 | 抗人呼吸道合胞病毒(rsv)抗体以及使用方法 |
BR112013025198A2 (pt) | 2011-03-31 | 2018-12-04 | Alethia Biotherapeutics Inc. | anticorpos contra antígeno 1 associado a rim e fragmentos de ligação a antígeno do mesmo |
KR102102239B1 (ko) | 2012-01-09 | 2020-04-21 | 에이디씨 테라퓨틱스 에스에이 | 유방암을 치료하기 위한 방법 |
JP5996707B2 (ja) * | 2015-04-15 | 2016-09-21 | メディミューン リミテド | Rsv特異的結合分子 |
MY189692A (en) | 2015-05-07 | 2022-02-26 | Memorial Sloan Kettering Cancer Center | Anti-ox40 antibodies and methods of use thereof |
MA43389A (fr) * | 2015-12-02 | 2021-05-12 | Agenus Inc | Anticorps anti-ox40 et leurs procédés d'utilisation |
WO2017096182A1 (en) * | 2015-12-03 | 2017-06-08 | Agenus Inc. | Anti-ox40 antibodies and methods of use thereof |
BR112019008063A2 (pt) | 2016-10-21 | 2019-07-02 | Adimab Llc | anticorpos contra o vírus sincicial anti-respiratório e métodos de sua geração e uso |
US11479600B2 (en) | 2016-10-21 | 2022-10-25 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
AU2017345786B2 (en) | 2016-10-21 | 2024-08-01 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
WO2018089628A1 (en) | 2016-11-09 | 2018-05-17 | Agenus Inc. | Anti-ox40 antibodies, anti-gitr antibodies, and methods of use thereof |
WO2018150029A1 (en) * | 2017-02-17 | 2018-08-23 | Institut Pasteur | Generation of monoclonal antibodies targeting respiratory syncytial virus (rsv) using regulatory b cells from newborns (nbregs) |
WO2021202463A1 (en) | 2020-03-30 | 2021-10-07 | Danisco Us Inc | Anti-rsv antibodies |
CA3177152A1 (en) | 2020-06-12 | 2021-12-16 | David Scott Johnson | Recombinant polyclonal proteins targeting covid-19 and methods of use thereof |
WO2022031834A1 (en) * | 2020-08-05 | 2022-02-10 | Gigagen, Inc. | Recombinant polyclonal proteins targeting zika and methods of use thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060275766A1 (en) * | 2003-01-07 | 2006-12-07 | Haurum John S | Method for manufacturing recombinant polyclonal proteins |
TWI333977B (en) * | 2003-09-18 | 2010-12-01 | Symphogen As | Method for linking sequences of interest |
RU2426795C2 (ru) * | 2004-07-20 | 2011-08-20 | Симфоген А/С | Способ структурной характеристики рекомбинантного поликлонального белка или поликлональной клеточной линии |
CA2574062A1 (en) * | 2004-07-20 | 2006-01-26 | Symphogen A/S | Anti-rhesus d recombinant polyclonal antibody and methods of manufacture |
WO2007065433A2 (en) * | 2005-12-05 | 2007-06-14 | Symphogen A/S | Anti-orthopoxvirus recombinant polyclonal antibody |
US20100040606A1 (en) * | 2006-03-06 | 2010-02-18 | Symphogen A/S | Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections |
KR20090127341A (ko) * | 2007-03-06 | 2009-12-10 | 심포젠 에이/에스 | 호흡기세포 융합 바이러스 감염 치료용 재조합 항체 |
SI2152872T1 (sl) * | 2007-05-25 | 2011-01-31 | Symphogen As | Postopek za pripravo rekombinantnega poliklonskega proteina |
-
2008
- 2008-09-04 WO PCT/DK2008/050218 patent/WO2009030237A2/en active Application Filing
- 2008-09-04 CN CN200880106131A patent/CN101821289A/zh active Pending
- 2008-09-04 KR KR1020107007563A patent/KR20100087283A/ko not_active Application Discontinuation
- 2008-09-04 MX MX2010002044A patent/MX2010002044A/es not_active Application Discontinuation
- 2008-09-04 RU RU2010113510/10A patent/RU2010113510A/ru not_active Application Discontinuation
- 2008-09-04 AU AU2008295248A patent/AU2008295248A1/en not_active Abandoned
- 2008-09-04 JP JP2010523277A patent/JP2011514139A/ja active Pending
- 2008-09-04 EP EP08784476A patent/EP2185590A2/en not_active Withdrawn
- 2008-09-04 CA CA2695309A patent/CA2695309A1/en not_active Abandoned
- 2008-09-04 BR BRPI0817079A patent/BRPI0817079A2/pt not_active IP Right Cessation
- 2008-09-05 US US12/230,885 patent/US20090137003A1/en not_active Abandoned
- 2008-09-05 TW TW097134053A patent/TW200925279A/zh unknown
-
2010
- 2010-02-01 ZA ZA2010/00756A patent/ZA201000756B/en unknown
-
2011
- 2011-09-23 US US13/243,768 patent/US20120009623A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111330017A (zh) * | 2012-08-23 | 2020-06-26 | 艾更斯司股份有限公司 | 结合158p1d7蛋白的抗体药物偶联物(adc) |
Also Published As
Publication number | Publication date |
---|---|
MX2010002044A (es) | 2010-03-18 |
TW200925279A (en) | 2009-06-16 |
EP2185590A2 (en) | 2010-05-19 |
ZA201000756B (en) | 2010-10-27 |
US20120009623A1 (en) | 2012-01-12 |
RU2010113510A (ru) | 2011-10-20 |
AU2008295248A1 (en) | 2009-03-12 |
WO2009030237A3 (en) | 2009-04-30 |
CA2695309A1 (en) | 2009-03-12 |
US20090137003A1 (en) | 2009-05-28 |
JP2011514139A (ja) | 2011-05-06 |
BRPI0817079A2 (pt) | 2016-10-11 |
KR20100087283A (ko) | 2010-08-04 |
WO2009030237A2 (en) | 2009-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101821289A (zh) | 重组制造抗rsv抗体的方法 | |
CN110914303B (zh) | 结合lag-3的抗体及其用途 | |
CN108337890B (zh) | 新型pd-1免疫调节剂 | |
KR20080113223A (ko) | 호흡기세포 융합 바이러스 감염 치료용 재조합 폴리클로날 항체 | |
KR20230002261A (ko) | 항-sars-cov-2 중화 항체 및 이의 사용 방법 | |
CN101679513A (zh) | 用于治疗呼吸道合胞病毒感染的重组抗体 | |
CN106924729B (zh) | 人巨细胞病毒中和抗体及其应用 | |
KR101418606B1 (ko) | Her-3 지향 항체 및 그 용도 | |
KR20070038556A (ko) | 항-rhesus d 재조합 폴리클로날 항체 및 이의 제조방법 | |
CN101023101A (zh) | 抗-恒河猴d重组多克隆抗体和生产方法 | |
CN112262156B (zh) | 抗her2抗体 | |
EA028433B1 (ru) | Антитело, связывающееся с вирусами гриппа b и его применение | |
KR101937733B1 (ko) | 광견병 감염의 방지 및 치료에 관한 조성물 및 방법 | |
CN108484767A (zh) | 人抗pd-1、pd-l1和pd-l2的抗体及其应用 | |
CN101282993A (zh) | 针对cd20的抗体和其用途 | |
KR101900435B1 (ko) | 인간 사이토메갈로바이러스 gB 단백질에 대한 고친화도 인간 항체 | |
CN114685652B (zh) | 针对SARS-CoV-2和SARS-CoV的全人广谱交叉中和抗体及其应用 | |
CN113402602B (zh) | 一种新型冠状病毒SARS-CoV-2中和性抗体及应用 | |
CN116249711A (zh) | SARS-CoV-2中和抗体或其片段 | |
KR102467943B1 (ko) | 항-rsv 항체 및 이를 포함하는 약학적 조성물 | |
AU2004236263A1 (en) | Compositions and methods for treatment of cryptococcosis | |
CN114685653B (zh) | 抗新冠病毒受体结合区域表位中和抗体及其应用 | |
KR101608301B1 (ko) | Her2에 특이적으로 결합하는 항체 | |
US20220089696A1 (en) | Arenavirus monoclonal antibodies and uses | |
US20240352095A1 (en) | Arenavirus monoclonal antibodies and uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20100901 |